IMPACT OF LEISHMANIA DONOVANI INFECTION ON EARLY EVENTS IN HAEMATOPOIESIS by Pinto, Ana Isabel
 
IMPACT OF LEISHMANIA DONOVANI INFECTION ON 
EARLY EVENTS IN HAEMATOPOIESIS 
 
 
Ana Isabel Pinto 
 
 
 
Doctor of Philosophy  
 
 
 
 
University of York 
 
Biology 
 
 
 
 
May 2016 
 
 2 
ABSTRACT 
Visceral leishmaniasis (VL) in humans and in animal models is associated with, among other 
factors, parasite persistence in the bone marrow (BM) and significant changes in haematological 
function. However, the mechanisms underlying haematologic dysregulation are largely unknown.  
Using a panel of stem cell markers, we characterized murine haematopoietic stem and precursor 
cells in the BM over the course of L. donovani-infection in C57BL/6 (B6) mice. In steady-state, 
the majority of LT-HSCs (Long-term haematopoietic stem cells) (LSK CD150+ CD34- CD48- 
cells) were found in a quiescent state, representing cells with the highest degree of reconstitution 
potential. In contrast, during chronic infection, most LT-HSCs were found to have progressed to 
cell-cycle and this correlated with a reduced potential to engraft into syngeneic recipients. The loss 
of quiescent LT-HSCs was associated with expansion of cells displaying a phenotype attributed to 
early, and uncommitted progenitors. However this increase in uncommitted progenitors did not 
result in an increase in effective haematopoiesis, but rather chronically infected mice displayed 
signs of anaemia and thrombocytopenia.  
The loss of quiescent HSCs and other alterations in the haematopoietic compartment were absent 
in infected RAG2 KO mice, but adoptive transfer of CD4+ T cells restored this phenotype. In 
subsequent experiments, we transferred IFNγ-deficient CD4+ T cells into RAG KO recipients and 
established that this pro-inflammatory cytokines was pivotal for the depletion of the reservoir of 
LT-HSCs in quiescence, as well as for the establishment of anaemia and thrombocytopenia. 
Subsequently, using mixed BM chimeras, we established that IFNγ signalling and TNF signalling 
pathways converge to induce an expansion of BM T cells, suggesting that both cytokines are 
required to drive the development of CD4+ T cells with the potential to cause alterations in 
haematopoiesis and haematological dysfunction in the periphery. These data suggest new avenues 
for clinical research into the pathogenesis of VL and have relevance for the development of new 
therapeutic strategies and clinical follow-up. 
 
 3 
TABLE OF CONTENTS 
ABSTRACT ...................................................................................................................................... 2	
TABLE OF CONTENTS ................................................................................................................ 3	
LIST OF FIGURES ......................................................................................................................... 6	
LIST OF TABLES ......................................................................................................................... 11	
ACKNOWLEDGEMENTS .......................................................................................................... 13	
AUTHOR’S DECLARATION ..................................................................................................... 15	
CHAPTER 1.	 GENERAL INTRODUCTION ......................................................................... 16	
1.1	 Haematopoiesis in Bone Marrow ....................................................................................... 16	
1.1.1	 Overview of Haematopoiesis in the Adult ................................................................. 16	
1.1.2	 Models for haematopoiesis in the adult ...................................................................... 17	
1.1.3	 Regulation of haematopoiesis in the adult .................................................................. 21	
1.1.3.1	 The Bone Marrow Microenvironment ................................................................ 22	
1.1.3.2	 Cytokine Receptors and Haematopoiesis ............................................................ 27	
1.1.3.3	 Transcription Factors in Lineage Commitment .................................................. 30	
1.1.4	 Haematopoietic Stem Cells in Adult Mammalians .................................................... 32	
1.1.4.1	 Haematopoietic Stem Cell, Quiescence versus Proliferation .............................. 33	
1.1.4.2	 Immunophenotypic evaluation ............................................................................ 40	
1.2	 Stress-induced Haematopoiesis ......................................................................................... 41	
1.2.1	 Overview of Stress-induced Haematopoiesis ............................................................. 41	
1.2.2	 Inflammatory Modulation of Early Events in Haematopoiesis .................................. 42	
1.2.2.1	 Regulation of stress-induced haematopoiesis by Toll-like receptor signaling .... 44	
1.2.2.2	 Regulation of Stress-induced Haematopoiesis by Cytokine Signalling .............. 45	
1.3	 Visceral Leishmaniasis ...................................................................................................... 53	
1.3.1	 Overview of Visceral Leishmaniasis .......................................................................... 53	
1.3.2	 Immunopathology in VL ............................................................................................ 54	
1.3.3	 Haematopoietic alterations during VL in experimental models of disease ................ 55	
1.3.4	 Haematopoietic alterations during VL in humans ...................................................... 58	
1.4	 Aims ................................................................................................................................... 61	
CHAPTER 2.	 MATERIALS AND METHODS ...................................................................... 62	
2.1	 Animals .............................................................................................................................. 62	
2.2	 Infections ............................................................................................................................ 62	
2.3	 Cells isolations ................................................................................................................... 63	
2.3.1	 Bone Marrow cells isolation ....................................................................................... 63	
2.3.2	 Spleen cells isolation .................................................................................................. 64	
2.4	 Flow cytomety and adoptive transfer of sorted cells ......................................................... 64	
2.4.1	 Staining for surface markers ....................................................................................... 64	
 4 
2.4.2	 Intracellular staining for cytokines ............................................................................. 65	
2.4.3	 Intracellular staining for transcription factors (GATA-3 and β-catenin) ................... 66	
2.4.4	 Intracellular staining for Annexin-V .......................................................................... 66	
2.4.5	 Intracellular staining for Wnt3a .................................................................................. 66	
2.4.6	 Cell sorting of HSCPs cells from bone marrow and adoptive transfer to lethally 
irradiated recipient mice. ......................................................................................................... 67	
2.4.7	 Establishment of BM chimeras B6.c-Myc-eGFP èWT B6.CD45.1 and intracellular 
staining for c-Myc-eGFP ........................................................................................................ 67	
2.4.8	 Cell sorting of CD4+ T cells from spleens and adoptive transfer to RAG2 KO mice. 68	
2.4.9	 Mixed BM chimeras B6.CD45.1: B6.CD45.2.Ifnγr2-/- (50:50) èB6CD45.1 mice ... 68	
2.4.10	 Mixed BM chimeras B6.CD45.1:B6.CD45.2.TNF-RdKO (50:50) è B6.CD45.1 
mice 69	
2.4.11	 Flow cytometry and sorting of CD4+ T cells from BM for RNA extraction ............ 69	
2.4.12	 Flow cytometry analysis ........................................................................................... 70	
2.5	 Blood collection and hemogram ........................................................................................ 70	
2.6	 Total RNA extractions and microarray of BM T cells ....................................................... 70	
2.6.1	 RNA extraction using the miRNeasy Micro Kit ........................................................ 71	
2.6.2	 RNA extraction using the Direct-zol™ RNA MiniPrep ............................................. 71	
2.6.3	 Microarray .................................................................................................................. 71	
2.7	 Reverse transcription reAction and Quantitative real-time polymerase chain reaction of 
total BM cells .............................................................................................................................. 72	
2.7.1	 Reverse transcription reaction (RT Reaction) ............................................................ 72	
2.7.2	 Quantitative real-time polymerase chain reaction (qRTPCR) .................................... 72	
2.8	 Staining of purified LSK cells for confocal mycroscopy analysis ..................................... 73	
2.9	 Statistical analysis .............................................................................................................. 74	
CHAPTER 3.	 ALTERATIONS IN HAEMATOPOIESIS DURING LEISHMANIA 
DONOVANI INFECTION ................................................................................................................ 77	
3.1	 Introduction ........................................................................................................................ 77	
3.2	 Results ................................................................................................................................ 80	
3.2.1	 L. donovani infection was associated with alterations in the number of HSPCs in BM 
and spleen ................................................................................................................................ 80	
3.2.2	 Experimental VL was characterized by increased numbers of primitive 
haematopoietic progenitors ..................................................................................................... 82	
3.2.3	 Experimental VL is characterized by alterations in blood homeostasis ..................... 83	
3.2.4	 L. donovani infection was not associated with increased cell death in BM ............... 84	
3.2.5	 HSPCs from infected mice showed impaired engraftment in BM and decreased 
reconstitution of the periphery ................................................................................................ 84	
 5 
3.2.6	 L. donovani infection stimulates expansion of LSK CD34- CD150+ expressing CD48
 85	
3.2.7	 L. donovani infection was associated with depletion of the reservoir of quiescent LT-
HSCs 86	
3.2.8	 LSK CD34- CD150+ CD48- cells were functionally impaired during chronic infection 
with L. donovani ..................................................................................................................... 87	
3.2.9	 Alteration in expression of transcription factors associated with cell-cycle regulation 
of HSCs during L. donovani infection .................................................................................... 89	
3.3	 Discussion .......................................................................................................................... 93	
3.4	 Figures .............................................................................................................................. 106	
CHAPTER 4.	 CELLULAR AND MOLECULAR DETERMINANTS UNDERLYING 
ALTERATIONS IN HAEMATOPOIESIS DURING INFECTON WITH L. DONOVANI .... 139	
4.1	 Introduction ...................................................................................................................... 139	
4.2	 Results .............................................................................................................................. 143	
4.2.1	 Infection with L. donovani in immunodeficient mice was not associated to the loss of 
quiescent HSCs in BM. ......................................................................................................... 143	
4.2.2	 Splenectomy did not impact in the increase of intermediary multipotent progenitors 
nor in the loss of quiescent LT-HSCs during L. donovani infection .................................... 143	
4.2.3	 L. donovani infection was characterized by increased numbers of BM T cells ....... 144	
4.2.4	 L. donovani infection results in increased numbers of “effector” T cells in BM ..... 145	
4.2.5	 The number of CD4+ T cells producing IFNγ and TNF was increased in BM 
following L. donovani infection ............................................................................................ 147	
4.2.6	 Infection-induced loss of quiescent LT-HSCs was mediated by CD4+ T cells ........ 149	
4.2.7	 Loss of LT- HSCs in quiescence was mediated by IFNγ ......................................... 151	
4.2.8	 Loss of quiescent LT-HSCs was not mediated by intrinsic IFNγ receptor signalling in 
LT-HSCs ............................................................................................................................... 152	
4.2.9	 The number of LT-HSCs and onward progenitors expressing TNF receptors was 
increased following infection with L. donovani ................................................................... 157	
4.2.10	 TNF intrinsic signalling does not regulate loss of LT-HSCs in G0 ....................... 158	
4.2.11	 Loss of TNFR signaling prevents expansion of BM CD4+ T cells with the potential 
to express IFNγ ..................................................................................................................... 162	
4.3	 Discussion ........................................................................................................................ 165	
CHAPTER 5.	 CONCLUDING DISCUSSION ...................................................................... 258	
5.1	 Figures .............................................................................................................................. 263	
ABBREVIATIONS ...................................................................................................................... 267	
REFERENCES ............................................................................................................................ 279	
 
 6 
LIST OF FIGURES 
Figure 1.1 - Models for proposed to explain the development of mature haematopoietic. ............. 19	
Figure 1.2 - Haematopoietic stem cell (HSCs) functions are supported by various BM stromal 
cells, comprising the so-called HSCs niche. . ......................................................................... 24	
Figure 1.3 - Summary of haematopoietic cytokines. ....................................................................... 28	
Figure 1.4 - Schematic overview of different HSCs cellular fate choices.. ..................................... 34	
Figure 1.5 - Overview of cell cycle. ................................................................................................ 35	
Figure 1.6- Overview of the “Push and PulL Modell” proposed to frame the alterations observed in 
haematopoiesis during infection. ............................................................................................ 43	
Figure 3.1 - L. donovani parasites in BM. BM smear from B6 mouse infected for 28 days. ........ 106	
Figure 3.2- Diagram of stepwise differentiation of haematopoietic precursors and panel of 
associated surface molecular markers commonly used to characterize the different 
haematopoietic stem and progenitor cells (HSPCs). ............................................................. 107	
Figure 3.3 - Gating strategy for characterizing multipotent progenitors using flow cytometry 
analysis. ................................................................................................................................. 108	
Figure 3.4 - Gating strategy for characterizing BM populations enriched for lineage-committed 
haematopoietic progenitors using flow cytometry. ............................................................... 109	
Figure 3.5 - Sca1 was expressed in the vast majority of HSPCs in the BM of L. donovani infected 
mice. ...................................................................................................................................... 110	
Figure 3.6 - The kinetics of parasite burden in the BM and the spleen of L. donovani infected mice.  
L. donovani infected B6 mice were examined for parasite burden at times indicated. ........ 111	
Figure 3.7 - L. donovani infection affects the BM and the spleen cellularity. .............................. 112	
Figure 3.8 - L. donovani infection results in changes to the number of HSPCs in BM. ............... 113	
Figure 3.9 - L. donovani infection results in changes to the number of HSPCs in the spleen. (a) 
Relative frequency of Lineage- cKit+ cells (enriched for HSPCs). ....................................... 115	
Figure 3.10 - L. donovani infection results in increased numbers of multipotent haematopoietic 
progenitors without a reciprocal increase in lineage-committed progenitors.. ..................... 117	
Figure 3.11 - L. donovani infection was associated to decreases in mature blood cells in 
circulation.. ........................................................................................................................... 118	
Figure 3.12 - L. donovani infection was not associated with increased cell death in the bone 
marrow.. ................................................................................................................................ 119	
Figure 3.13 - HSPCs from infected mice showed impaired engraftment in BM and decreased 
reconstitution of the periphery. ............................................................................................. 120	
Figure 3.14 - Increased expression of CD48 on LSK CD150+ CD34- cells (enriched for phenotypic 
LT-HSCs) following L. donovani infection. ......................................................................... 122	
Figure 3.15 - Loss of quiescent LSK CD34- CD150+ CD48- cells (enriched for LT-HSCs) 
following L. donovani infection. ........................................................................................... 123	
 7 
Figure 3.16 - LSK CD150+ CD34- CD48- cells (enriched for HSCs) from infected mice were 
impaired in their efficiency to engraft and poorly reconstituted the periphery. (a ............... 124	
Figure 3.17 - LSK CD150+ CD34- CD48- cells (enriched for HSCs) from infected mice were 
impaired in engraftment efficiency in secondary adoptive transfer. ..................................... 126	
Figure 3.18 - LSK CD34- CD150+ CD48- cells (enriched for LT-HSCs) accumulate higher levels 
of β-Catenin.  ........................................................................................................................ 128	
Figure 3.19 - Mature haematopoietic cells in bone marrow of L. donovani infected mice express 
increased levels of Wnt3a protein. ........................................................................................ 129	
Figure 3.20 - Accumulation of Wnt3a mRNA is reduced in total BM cells from L. donovani 
infected mice.. ....................................................................................................................... 130	
Figure 3.21 - HSCs in BM expressed increased levels of c-Myc during infection with L. donovani..
 ............................................................................................................................................... 131	
Figure 3.22 - The expression of CD29 levels in LT-HSCs was unaltered during infection with L. 
donovani. ............................................................................................................................... 132	
Figure 3.23 - The frequency of LSK CD150+ CD48- cells (enriched for LT-HSCs) expressing 
GATA-3 was increased following L. donovani infection. .................................................... 133	
Figure 3.24 - The distribution of LSK CD150+ CD48- cells (enriched for LT-HSCs) segregated 
according with the expression of GATA-3 and Ki67 is altered following L. donovani 
infection. ............................................................................................................................... 134	
Figure 3.25 - Cycling LSK CD150+ CD48- cells (enriched for LT-HSCs) upregulated GATA-3 
expression following L. donovani infection. ......................................................................... 135	
Figure 3.26 - Detection of the subcellular localization of GATA-3 protein by immunofluorescence 
microscopy analyses in total thymocytes. ............................................................................. 136	
Figure 3.27 - GATA-3 protein subcellular localization by immunofluorescence microscopy 
analyses in LSK cells from BM. ........................................................................................... 137	
Figure 3.28 - Leishmania donovani infection resulted in the depletion of the reservoir of quiescent 
LT-HSCs in BM. ................................................................................................................... 138	
Figure 4.1 - RAG2 KO mice do not lose quiescent HSCs following infection with L. donovani. 187	
Figure 4.2 - The number of HSPCs was increased in the spleen following infection with L. 
donovani. ............................................................................................................................... 188	
Figure 4.3 - The number of HSPCs was increased in spleen following infection with L. donovani.
 ............................................................................................................................................... 189	
Figure 4.4 - Alterations in BM cellularity occurred independently from the processes taking place 
in the spleen. ......................................................................................................................... 190	
Figure 4.5 - L. donovani infection lead to the expansion of T cell compartment in BM. ............. 192	
Figure 4.6 - L. donovani infection was associated with the contraction of the B cell compartment in 
BM, during chronic phase of infection. ................................................................................ 193	
 8 
Figure 4.7 - L. donovani infection was not associated with alterations in the number of total 
CD11b+ cells in BM. ............................................................................................................. 194	
Figure 4.8 - L. donovani infection was associated with alterations in the number of MSCs in BM.
 ............................................................................................................................................... 195	
Figure 4.9 - L. donovani infection was not associated with alterations in the number of regulatory 
T cells in BM. ....................................................................................................................... 196	
Figure 4.10 - The number of T cells CD62L-/low CD44high increased in the BM following L. 
donovani infection. ............................................................................................................... 198	
Figure 4.11 - Following infection with L. donovani the number of CD4+ T cells CD62L-/lo CD44hi 
increased in the spleen. ......................................................................................................... 200	
Figure 4.12 - The number “Effector” CD4+ and CD8+ T cells increase in BM following L. 
donovani infection. ............................................................................................................... 201	
Figure 4.13 - L. donovani infection was associated with an increase in the number of BM CD4+ T 
cells with potential for IFNγ expression. .............................................................................. 203	
Figure 4.14 - L. donovani infection was associated with increased number of BM CD4+ T cells 
with potential for TNF expression. ....................................................................................... 205	
Figure 4.15 - The number of BM CD4+ T cells with potential for IL-10 expression increased 
following L. donovani infection. ........................................................................................... 207	
Figure 4.16 - In BM the distribution of cells expressing TNF and/or IL-10 within CD4+ T cells 
IFNγ+ was unchanged following L. donovani infection. ...................................................... 209	
Figure 4.17 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during the chronic infection with L. donovani (1). ..................................... 210	
Figure 4.18 - CD4+ T cells mediated expansion of intermediary non-committed progenitors 
onward LT-HSCs in BM following L. donovani infection.. ................................................. 211	
Figure 4.19 - CD4+ T cells mediated the loss of HSCs in G0 in BM, following infection with L. 
donovani. ............................................................................................................................... 213	
Figure 4.20 - CD4+ T cells did mediate alteration in the number of myeloid-committed 
progenitors, following infection with L. donovani. .............................................................. 216	
Figure 4.21 - The transfer of CD4+ T cells to naive RAG2 KO mice was not associated to 
alteration in the number of HSPCs in BM. ........................................................................... 217	
Figure 4.22 - CD4+ T cells mediate the establishment of mild anaemia and thrombocytopenia 
following infection with L. donovani. ................................................................................... 218	
Figure 4.23 - CD4+ T cells do not induce anaemia and thrombocytopenia in naive RAG2 KO mice.
 ............................................................................................................................................... 219	
Figure 4.24 - CD4+ T cells mediated control of parasite burden during chronic infection with L. 
donovani in immunodeficient mice. ..................................................................................... 220	
Figure 4.25 - Adoptively transferred CD4+ T cells expand in infected RAG2 recipients and 
displayed a phenotype similar to BM CD4+ T cells of infected WT mice. .......................... 221	
 9 
Figure 4.26 - CD4+ T cells through an IFNγ-dependent mechanism mediated the expansion of 
intermediary multipotent progenitors following infection with L. donovani. ...................... 223	
Figure 4.27 - CD4+ T cells through an IFNγ-dependent mechanism mediated the loss of HSCs in 
G0 following infection with L. donovani. ............................................................................. 224	
Figure 4.28 - CD4+ T cells through an IFNγ-dependent mechanism mediated the establishment of 
anaemia and thrombocytopenia following infection with L. donovani. ............................... 226	
Figure 4.29 - CD4+ T cells through an IFNγ-dependent mechanism mediated decrease in 
parasites/1000 nuclei in the spleen following infection with L. donovani. .......................... 227	
Figure 4.30 - Following transfer of CD4+ T cells to RAG2KO mice infected with L. donovani for 
28 days, WT CD4+ T cells and IFNγ KO CD4+ T cells expanded at similar extent and 
displayed an “activated” phenotype. ..................................................................................... 228	
Figure 4.31 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during chronic infection with L. donovani (2). ........................................... 230	
Figure 4.32 - Experimental design for competitive mixed bone marrow chimeras using wild-type 
(WT) and IFNγR2 knockout (IFNγR2 KO). ......................................................................... 231	
Figure 4.33 - The reconstitution potential of WT HSCs and IFNγR2−/− HSCs was similar in 
infected mixed BM chimeras. ............................................................................................... 232	
Figure 4.34 - The frequency of Lin- cKit+ Sca1- cells was decreased in the WT but not IFNγR2−/− 
donor cells, following infection with L. donovani. ............................................................... 233	
Figure 4.35 - L. donovani infection was associated with an increase in intermediary non-
committed progenitors within WT and IFNγR2−/− donor cells. ............................................ 235	
Figure 4.36 –The number of myeloid progenitors in BM was unchanged within WT and IFNγR2−/− 
donor cells, following L. donovani infection. ....................................................................... 236	
Figure 4.37 - The absence of direct IFNγ signaling in LT-HSCs did not prevent the depletion of 
the reservoir of quiescent HSCs, following L. donovani infection. ...................................... 237	
Figure 4.38 - In the absence of intrinsic IFNγ signaling the expansion of T cells was limited in BM 
of mice infected with L. donovani.. ...................................................................................... 239	
Figure 4.39 - The absence of direct IFNγ signaling limited the expansion of macrophages in BM 
and spleen in mice infected with L. donovani. ...................................................................... 241 
Figure 4.41 - The number of LT-HSCs and onward multipotent progenitors expressing TNF-R1a 
increased following L. donovani infection. ........................................................................... 242	
Figure 4.42 - The number of HSPCs (enriched in Lineage- cKit+ cells) expressing TNF-R1b 
increased following L. donovani infection. ........................................................................... 243	
Figure 4.43 - The number of LT-HSCs and onward multipotent progenitors expressing TNF-R1b 
increased following L. donovani infection. ........................................................................... 244	
Figure 4.44 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during the chronic infection with L. donovani (3).  .................................... 245	
 10 
Figure 4.45 - Experimental design for competitive mixed BM chimeras using wild-type (WT) and 
TNF-R double knockout (TNF-RdKO HSCs) BM cells. ...................................................... 246	
Figure 4.46 - The reconstitution potential of WT HSCs and TNF-RdKO donor cells changed 
following infection with L. donovani. ................................................................................... 247	
Figure 4.47 - Following infection with L. donovani the frequency of Lin- cKit+ Sca1- cells within 
WT and TNF-RdKO donor cells decreased in BM. .............................................................. 248	
Figure 4.48 - L. donovani infection was associated with an increase in intermediary non-
committed progenitors within WT and TNF-RdKO donor cells in BM. .............................. 249	
Figure 4.49 - The absence of intrinsic TNF-RdKO signaling did not prevent the depletion of the 
reservoir of quiescent HSCs, following L. donovani infection. ............................................ 250	
Figure 4.50 - Following infection with L. donovani, alterations in the frequency of myeloid 
progenitors were similar within WT and TNF-dKO donor cells. ......................................... 252	
Figure 4.51 - The absence of intrinsic TNF receptor signaling prevented the expansion of T cells in 
the BM of mice infected with L. donovani.. ......................................................................... 253	
Figure 4.52 - The absence of intrinsic TNF receptor signaling prevented the expansion of T cells in 
the spleen, following infection with L. donovani. ................................................................ 254	
Figure 4.53 - The absence of TNF receptor signaling did not prevent the expansion of the myeloid 
cells in the spleen, following infection with L. donovani. .................................................... 255	
Figure 4.54 - Intrinsic TNF receptor signaling mediated expansion of CD4+ T cells expressing 
IFNγ in the BM following infection with L. donovani. ........................................................ 256	
Figure 4.55 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during the chronic infection with L. donovani (4). ..................................... 257	
Figure 5.1 - Changes in blood parameters after 5-FU treatment.. ................................................. 263	
Figure 5.2 - DE genes in BM CD4+ T cells of naïve vs. L. donovani infection mapped to IPA 
canonical pathway of Th cell differentiation. . ..................................................................... 266	
 11 
LIST OF TABLES 
Table 1.1 - Soluble factors produced by BM cellular niches that participate in the regulation of 
haematopoiesis ........................................................................................................................ 25	
Table 1.2 - Summary of relevant genetic mouse models that contributed to the identification of 
molecular modulators of HSCs cell-cycle .............................................................................. 39	
Table 1.3 - Summary of most commonly used combinations of cell surface marker used to 
segregate HSPCs ..................................................................................................................... 40	
Table 2.1 - Surface markers used to characterize HSPCs by flow cytometry analysis ................... 65	
Table 2.2 - Monoclonal antibodies used to evaluate expression of surface cell markers, cytokines 
and transcription factor by flow cytometry analysis ............................................................... 75	
Table 5.1 - Top ten significantly up-/down-regulated genes in BM CD4+ T cells from mice 
infected with L. donovani for 28 days (compared to uninfected controls) ........................... 264	
 
 
 
 
 
 
 
 
 
 
 
 
 
 12 
 
 
 
 
 
 
 
 
 
 
“Afinal, a melhor maneira de viajar é sentir.  
Sentir tudo de todas as maneiras.  
Sentir tudo excessivamente,  
Porque todas as coisas são, em verdade, excessivas  
E toda a realidade é um excesso, uma violência,  
Uma alucinação extraordinariamente nítida  
Que vivemos todos em comum com a fúria das almas,  
O centro para onde tendem as estranhas forças centrífugas  
Que são as psiques humanas no seu acordo de sentidos. (…)”   
 
Álvaro de Campos  
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CHAPTER 1. GENERAL INTRODUCTION 
1.1 HAEMATOPOIESIS IN BONE MARROW 
1.1.1 Overview of Haematopoiesis in the Adult  
The haematopoietic system, comprises blood leucocytes, erythrocytes, platelets and their 
precursors, therefore this system plays a vital role in immune surveillance, dissemination of 
essential nutrients, tissue repair and enabling clotting. Almost all organs are circunscribed by 
anatomical barriers and perform interconnected functions, while the haematopoietic system is 
poorly delimited and covers a variety of non-related functions (W. C. Aird, 2003). 
The haematopoietic system is complex and dynamic. The majority of blood cells are short-lived 
and it has been estimated that the turnover of cells of the haematopoietic system is 1 trillion cells 
per day in steady-state, including 400 billion platelets, 200 billion erythrocytes and 70 billion 
neutrophils (K. S. Fernandez and P. A. de Alarcon, 2013). 
The maintenance of the number cellular components of blood in steady-state (steady-state 
haematopoiesis), as well as in stress situations, such as an infection (demand-adapted 
haematopoiesis) relies on the continuous and dynamic replacement of haematopoietic cells in a 
process called haematopoiesis. Haematopoiesis is a strictly regulated process that depends on a 
very small pool of somatic stem cells, which have self-renewal capacity and potential to originate 
all mature cells during the lifespan of an individual, the so-called HSCs (M. Kondo et al., 2003a).  
As such, the homeostasis of the haematopoietic system depends on the capacity of HSCs to 
maintain a tight balance between differentiation and self-renewal. The majority of haematopoietic 
stem cells and progenitors cells reside in the bone marrow, where regulation of their self-renewal 
and differentiation relies on the intrinsic activation of transcription factors (TFs), in association 
with extrinsic cytokine signaling that depends not only on signals from their microenvironment 
(the “niche”), but also on remote signals from the periphery (H. Takizawa et al., 2012). 
All the terminally differentiated cells originate from HSCs that differentiate into immature 
progenitors that are related during development, which we will discuss in further detail later in this 
chapter. As such, classically based on functional and developmental differences, B cells, T cells 
and NK cells are referred to as lymphoid cells while, erythrocytes, thrombocytes, granulocytes and 
macrophages are classified as the myeloid or myeloerythroid cells  ((S. Doulatov et al., 2012). 
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1.1.2 Models for haematopoiesis in the adult 
The identification of intermediary haematopoietic progenitor cells is the result of a 
characterization based on cell surface markers and functional evaluation that has been ongoing for 
many decades. The process of development from pluripotent progenitors to lineage-committed 
progenitors and finally to terminally differentiated mature cells has been proposed as a stepwise 
linear model. Accordingly, in each step of development the progenitor cell becomes more 
committed and progressively looses the potential to become other cell type. However, some 
studies suggested that a certain degree of lineage plasticity might be present in late stages of 
haematopoietic development (M. Kondo et al., 2003b). 
According to the classical view of haematopoietic development in mice, the production of all 
mature haematopoietic cells starts with the long-term haematopoietic stem cells (LT-HSCs) that 
differentiate into the so-called short-term haematopoietic stem cells (ST-HSCs) still multipotent, 
but with limited self-renewal capacity. The ST-HSCs proceed to form the heterogeneous group of 
cells called multipotent progenitors (MPPs) that have lost self-renewal capacity, but conserve a 
range of multipotency. The MPPs will give rise to a succession of intermediary progenitors that 
become the common lymphoid progenitors (CLPs) that develop into lymphoid progeny and the 
common myeloid progenitors (CMPs) with erythromyeloid potential. Further on, CMPs may give 
rise to both granulocyte/macrophage progenitors (GMPs), which differentiate into the 
myelomonocytic lineage, and the megakaryocytic/erythrocyte progenitors (MEPs), the precursors 
of red blood cells and platelets (L. D. Wang and A. J. Wagers, 2011). The combination of 
haematopoietic stem cells and haematopoietic progenitors cells are commonly designated as 
HSPCs (haematopoietic stem and progenitor cells) (M. J. Pittet et al., 2014). 
The classic model for haematopoiesis was based on in vitro assays and on the study of the 
functions of different HSPCs upon transplantation into irradiated recipients to determine lineage 
potential and self-renewal properties, but both ex vivo culture systems and myeloablative 
conditions may not be ideal to fully understand HSCP function during homeostatic haematopoiesis 
(R. A. Nimmo et al., 2015). 
According to this model, lineage commitment would take place downstream of HSCs and 
culminate with the branching into lymphoid and myeloerythroid lineage commitment. 
Nonetheless, initial gene profiling of highly purified HSCs and ST-HSCs/MPPs demonstrated the 
promiscuous expression (albeit at low level) of non-haematopoietic, as well as multiple lineage-
restricted genes.  In contrast, CMPs and CLPs express more lineage-restricted genes. These studies 
suggested that HSCs maintain a permissive chromatin arrangement allowing a “primed-state” that 
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works as the foundation for later commitment/differentiation; a phenomenon referred to as 
multilineage priming (K. Akashi et al., 2003, R. A. Nimmo et al., 2015). 
The nature of cell fate decisions in HSPCs is still largely unknown, since studies into cell 
populations do not distinguish between a phenotypically homogeneous group of cells and a 
heterogeneous set of cells with a diverse degree of lineage bias and self-renewal potentials. 
Therefore, to elucidate the molecular basis of cell fate decisions techniques to assess gene 
expression in individual HSPCs are required (R. A. Nimmo et al., 2015). 
Studies coupling clonal functional assays and singe cell gene expression analysis have shown that 
within phenotypically defined HSCs and MPPs, there is a wide range of heterogeneity and confirm 
simultaneous lineage priming at the individual cell level. The differential potential of HSPCs 
cannot be fully predicted with currently known markers, albeit inheritable lineage predisposition is 
found within the so-far defined progenitor cell populations (R. A. Nimmo et al., 2015). 
In the light of more recent studies, the classical model of haematopoiesis has been questioned and 
the assumption that lineage restriction takes place downstream of HSCs in a linear progression 
coupled to increasing loss of self-renewal potential has been challenged. Two other models of 
haematopoietic development have been proposed: the “Revised Model” and the “Myeloid Bypass 
Model” (Figure 1.1) (R. A. Nimmo et al., 2015).  
The “Revised Model” for haematopoietic development suggests a very early bifurcation in 
ontogeny between Megakaryocytes/Erythrocytes (MegE) and lymphomyeloid differentiation 
capacity. This model was proposed following the description of lymphomyeloid-restricted 
progenitors in Flt3+ (FMS-like tyrosine kinase 3) MPPs, named lymphoid primed multipotent 
progenitors (LMPPs). LMPPs were found to be the first cells in ontogeny expressing common 
lymphoid genes, together with myeloid-associated genes, but no longer expressing MegE-
associated genes. In contrast, both are expressed at low level in HSCs. More, functional 
characterization of Flt3+ LMPPs showed no potential for producing MegE progeny (R. A. Nimmo 
et al., 2015).  
In support of the “Revised Model”, it was suggested that MegE progenitors separate first and the 
megakaryocyte lineage begins within the most primitive cells. Using a GFP reporter knocked into 
the von Willebrand factor (vWF) gene, it was found that vWF+ HSCs exhibited clear 
Megakaryocyte-bias and give rise to myeloid progeny, whereas vWF- HSCs were lymphoid-
biased. Both were capable of long-term reconstitution, but only vWF+ HSCs could originate vWF- 
HSCs (R. A. Nimmo et al., 2015). 
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It is becoming accepted that haematopoietic cell development relies on two distinct steps; (1) first, 
lineage priming takes place most likely in pluripotent progenitors that become competent to cell 
specification; (2) lineage priming is then followed by commitment that constrains the primed 
progenitor to a specific cell type (R. A. Nimmo et al., 2015). 
These processes are well represented in B cell differentiation, where it was determined that 
priming occurs in LMPPs, while commitment takes place in a subpopulation of CLPs. It was 
shown that Ebf1 (Early B cell factor 1) initiates B cells specification in lymphoid-primed cells, but 
the accomplishment of mature B cell differentiation requires the co-expression of the deterministic 
factor for commitment, PAX5 (M. Kondo et al., 2003a). 
 
Figure 1.1 - Models for proposed to explain the development of mature haematopoietic. 
(A) The classical model purposed that HSCs and non-committed multipotent progenitors 
differentiate in a stepwise process in lineage restricted myeloid or lymphoid progenitors that no 
longer display self-renewal capacity. In this model common myeloid progenitors (CMP) and 
common lymphoid progenitors (CLP) represent the initial step in the lineage commitment. (B) The 
revised model emerged following the observation that MPPs contain lymphomyeloid-restricted 
progenitors (LMPPs) that have no longer MegE potential. Additionaly, HSCs display MegE 
potential of differentiation and but no longer lymphoid potential, suggesting that MegE 
commitment nay take place in HSCs, representing a first lineage restriction point. According with 
the classical model and the revised model, self-renewal capacity and multipotentiality are 
attributes of HSCs. (C) The myeloid bypass model was proposed as a result of studies performing 
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multilineage clonal tracking of single HSCs. This model proposed that megakaryocyte- and 
myeloid-restricted progenitors are already generated in the HSCs compartment, and are capable of 
long-term self-renewal and reconstitution of restricted myeloid lineages. In contrast to previous 
models (A, B) this model purposes that self-renewal and multipotentiality can be uncoupled. 
Abbreviations: c-Kit, c-Kit proto-oncogene; Ery, erythroid;; G/M, granulocyte/monocyte; GMP, 
granulocyte/monocyte progenitor; HSC, haematopoietic stem cell;; Meg, megakaryocyte; MegE, 
megakaryocyte/erythroid; MEP, megakaryocyte/erythroid progenitor; MPP, multipotent 
progenitor; MyRP, myeloid-restricted progenitor; (Adapted from (R. A. Nimmo et al., 2015)). 
 
The alternate “Myeloid Bypass Model” emerged from studies based on single cell transplantation 
of LT-HSCs, defined as cKit+ Sca1+ Lineage- (LSK) CD150+ CD41- CD34- cells. In recipient 
mice, it was found that some phenotypic HSCs could be committed to the myeloid lineage, but not 
give rise to LMPPs, and these were termed myeloid-restricted progenitors (MyRPs). Among these 
MyRPs, there were progenitor cells with a spectrum of differentiation potential: either restricted to 
myeloid, megakaryocyte and erythroid lineages (common myeloid repopulating progenitors or 
megakaryocyte), or restricted to megakaryocytes and erythroid lineages (megakaryocyte-erythroid 
repopulating progenitors), or restricted to megakaryocyte lineages only (megakaryocyte 
repopulating progenitors). All these progenitors, although lineage restricted, displayed self-
renewal and long-term reconstitution potential (hallmarks of HSCs) in primary and secondary 
recipient mice (R. Yamamoto et al., 2013). 
Further, in studies where paired daughter cell assays were coupled to single cell adoptive transfers, 
it was shown that MyRP arose directly from HSCs and not from CMPs (R. Yamamoto et al., 
2013). In clear opposition to both the classical and the revised models, the myeloid bypass model 
therefore proposes that the loss of multipotency is not coupled to the loss of self-renewal potential 
(R. A. Nimmo et al., 2015). 
In the light of these findings, the contribution of the different non-restricted and lineage-biased 
progenitors (long-lived and classically defined) to homeostatic haematopoiesis is not clear. 
Moreover, when so much is yet to be defined regarding the mechanisms regulating 
haematopoiesis, the emergent demand to revise the models of blood development point to a far 
more complex regulation of haematopoiesis than could have been predicted (R. A. Nimmo et al., 
2015). 
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1.1.3 Regulation of haematopoiesis in the adult 
Haematopoiesis ensures the production of the required number of each mature cell type in a 
strictly regulated process that, most likely, results from the cumulative contributions of extrinsic 
signals and intrinsic/internal processes working in a concerted mode to instruct for lineage choice 
of HSPCs and subsequent stability of cell identity (M. Endele et al., 2014). 
The extrinsic factors comprise local signals provided by the BM niche and systemically produced 
cytokines. The intrinsic regulation includes different internal processes such as activation of 
transcription factors, epigenetic and post-translational regulation (M. Endele et al., 2014). 
The extent of the contribution of different factors for lineage commitment is technically difficult to 
demonstrate and therefore still elusive. From longstanding studies to assess the role of cytokines 
and internal processes in haematopoiesis two general models were proposed: the “Instructive 
Model” and the “Permissive/stochastic Model” (L. Robb, 2007). 
According to the “Instructive Model”, cytokines as well as other molecular signaling mediators 
can directly instruct lineage decisions in non-committed multipotent progenitors and are 
fundamental to cell type specification, whilst still recognizing the importance of transcription 
factors in haematopoiesis (M. Endele et al., 2014). 
Initial in vitro studies using culture systems showed that some cytokines could specifically favor 
the development of specific lineages, while others cytokines had a pleiotropic effect in 
haematopoietic development. Early data supporting the instructive model came from the 
demonstration that Granulocyte-Macrophage colony forming cells (GM-CFCs) in the presence of 
Macrophage colony stimulating factor (M-CSF) would differentiate in macrophages, but if the 
GM-CFCs were cultured in the presence of granulocyte colony stimulating factor (G-CSF), they 
would instead give rise to granulocytes (L. Robb, 2007). 
In support of the “Instructive Model”, a more recent study showed that in vitro M-CSF stimulation 
upregulated PU.1 transcription factor expression (master regulator for myelo-monocytic 
differentiation) in highly purified HSCs (N. Mossadegh-Keller et al., 2013). In this study from 
Mossadegh-Keller et al., in adoptive transfer experiments HSCs derived from mice treated with 
exogenous M-CSF  display to an increased myeloid to lymphoid cell ratio in peripheral blood after 
4 weeks when transferred to irradiated recipient mice, compared to HSCs derived from untreated 
controls (N. Mossadegh-Keller et al., 2013). This upregulation of PU.1 by M-CSF on HSCs was 
critically dependent on the expression of M-CSF receptor (N. Mossadegh-Keller et al., 2013), 
which is nonetheless most likely regulated by intrinsic processes. 
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The “Permissive/stochastic Model” suggests that the “decision-making” of a progenitor cell to 
generate a specific cell type arises from stochastic internal processes promoting the upregulation 
of cytokine receptors in progenitor cells, which in turn become responsive to cytokine signals (M. 
Endele et al., 2014). This model is supported by studies showing that among phenotypically 
defined non-committed progenitor cells, individual cells show a high degree of variability in the 
promiscuous expression of lineage-specific genes (R. A. Nimmo et al., 2015). 
So far gene-targeting studies in vivo showed that mice lacking a single cytokine or its receptors are 
not completely defective in any mature cells, albeit reductions in lineage-specific cells have been 
observed. Overall these reports suggested that cytokines impact on lineage-primed HSPCs 
expansion, survival and maturation but are not required for lineage commitment (L. Robb, 2007). 
It also has to be taken in consideration that compensatory mechanisms can take place in vivo, 
suggesting caution in the interpretation of such loss of function studies (M. Endele et al., 2014). 
Most likely lineage priming in HSPCs will allow different receptors to be expressed among 
phenotypically defined population of progenitors with a variable range of responsiveness to the 
milieu of signals, preventing exhaustion and simultaneously assuring a degree of lineage plasticity 
(L. Robb, 2007, R. A. Nimmo et al., 2015). 
In the next sections, the internal and external regulatory processes involved in the differentiation 
of HSCs and lineage commitment of multipotent progenitors will be discussed. The regulation of 
HSCs quiescence and self-renewal will be discussed in more detail in Section 1.1.4.1. 
1.1.3.1 The Bone Marrow Microenvironment 
Haematopoiesis takes place in different anatomic sites during mammalian development, first in 
extra-embryonic tissues and then progressively in the aorta–gonad–mesonephros area, then in the 
fetal liver and spleen, and postnatally in BM, where most of homeostatic blood cell formation 
takes place throughout adult life (S. H. Orkin and L. I. Zon, 2008, F. E. Mercier et al., 2012).  
The BM is the major haematopoietic organ in adults, but haematopoiesis can also occur in 
extramedullary sites, such as the spleen and the liver. For example, in mice the spleen is a site of 
effective haematopoiesis, while in humans it is less defined although stress-induced 
extramedullary haematopoiesis has been reported (F. E. Mercier et al., 2012). 
The initiation and maintenance of haematopoiesis is a complex process that depends on the 
participation of support cells, which generate the microenvironmental conditions that maintain the 
size of the stem cell pool and regulate the differentiation of HSCs into the appropriate number of 
mature blood cells, both under steady-state and during homeostatic imbalance. Therefore, control 
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of the differentiation of HSPCs is a dynamic process depending on specific direct cell interactions, 
growth factors, cytokines and components of the extracellular matrix (F. E. Mercier et al., 2012). 
This supporting microenvironment is composed of mesenchymal stem and progenitor cells 
(MSPCs; also called skeletal stem cells), osteoprogenitors, osteoblasts, osteocytes, osteoclasts, 
fibroblasts and chondrocytes, together forming the so-called BM stroma (P. S. Frenette et al., 
2013, B. A. Anthony and D. C. Link, 2014). Other cell populations that reside in BM that may also 
participate in the regulation of haematopoiesis include neuronal cells, glial cells, leukocytes, 
macrophages and adipocytes (Figure 1.2) (K. Tokoyoda et al., 2009b, B. A. Anthony and D. C. 
Link, 2014). 
The BM stroma is organized into functional domains, forming specialized niches that regulate the 
development of HSCs and lineage restricted haematopoietic progenitor cells (F. E. Mercier et al., 
2012, B. A. Anthony and D. C. Link, 2014). At different stages of development HSPCs will 
require different cellular/molecular interactions, some of which were summarize in supplementary 
Table 1.1 (adapted from (F. E. Mercier et al., 2012)) and reviewed in excellent reviews (F. E. 
Mercier et al., 2012, L. D. Wang and A. J. Wagers, 2012, B. A. Anthony and D. C. Link, 2014). In 
this introduction, the focus is on examples of BM components that impact in early events in 
haematopoiesis. 
Within the BM stroma, HSCs localize in haematopoietic stem cells niches, which provide a 
specialized microenvironment that tightly regulates the balance between self-renewal and 
differentiation. The identification of cell markers expressed in HSCs allowed the examination of 
their localization in BM, that were predominantly localized in contact with sinusoidal endothelium 
and associated with endosteum (M. J. Kiel et al., 2005). These findings were followed by studies 
showing that most HSCs are found in close association with perivascular C-X-C motif chemokine 
12 (CXCL12)-abundant reticular (CAR) cells and nestin-GFP+ stromal cells (B. A. Anthony and 
D. C. Link, 2014).  
In the BM, the perivascular spaces are filled with MSPCs in close proximity to HSPCs. MSCPs 
are a heterogeneous population able to differentiate into osteoblasts, chondrocytes, adipocytes and 
fibroblasts and participate in BM stroma regeneration (F. E. Mercier et al., 2012, P. S. Frenette et 
al., 2013).  
So far, it is not possible to phenotypically select for single mesenchymal stem cells (MSCs), but 
by methods to isolate MSCs-enriched cell populations it has been established in mice that ~4% of 
CD45– lineage– PDGFRa+ Sca+ cells have CFU (colony forming units)-F (fibroblast) activity and 
~1% of nestin-GFP+ stromal cells have CFU-F activity, while in humans CD146-expressing 
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stromal cells characterize a BM cell population enriched for MSCs. Other studies reported that 
platelet-derived growth factor receptor (PDGFR) and CD51 expression may also select for a cell 
population that is highly enriched for MSCs and can support HSPCs expansion in vitro, both in 
mice and in humans (B. A. Anthony and D. C. Link, 2014).  
 
 
Figure 1.2 - Haematopoietic stem cell (HSCs) functions are supported by various BM 
stromal cells, comprising the so-called HSCs niche. In BM HSCs are found in close proximity 
with BM stromal cells: endothelial cells, mesenchymal stem cells (MSCs), which are included in 
the chemokine CXC ligand (CXCL)12-expressing mesenchymal cells (CEMCs). CEMCs are 
perivascular stromal cells and express various factors that support HSCs, such as CXCL12, 
angiopoietin, and stem cell factor (SCF). CEMCs are composed by various cell-types including, 
CXCL12-abundant reticular (CAR) cells, leptin receptor+ stromal (Lepr+) cells, and Nestin-
GFP+ cells. Osteoblasts and spindle-shaped N-cadherin+ osteoblast (SNO cells) support HSCs 
throught the expression of thrombopoietin (TPO) and CXCL12. Sympathetic neurons modulate 
HSCs functions by the induction of CXCL12 expression by other stromal cells. Glial cells, 
produce transforming growth factor (TGF)-β, and it has been also suggested that might regulate 
HSCs functions (Adapted from (B. A. Anthony and D. C. Link, 2014)). 
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Table 1.1 - Soluble factors produced by BM cellular niches that participate in the regulation 
of haematopoiesis 
 
CXCL12-CXCR4 signaling is essential to the maintenance of the HSCs pool. In mice, the 
administration of CXCR4 antagonist induces increased frequency of HSPCs in circulation and the 
conditional deletion of CXCR4 was associated with vulnerability to myelosuppressive stress, 
related to a dramatic decrease in the HSCs pool. Within the BM, CXCL12 is expressed in 
osteoblasts lining the bone surface and in endothelial cells, but the cells that express the highest 
levels of this cytokine are chemokine CXC ligand (CXCL)12-expressing mesenchymal cells 
(CEMCs) present in the perivascular region. CEMCs, include CXCL12-abundant reticular (CAR) 
cells, leptin receptor+ stromal (Lepr+) cells, and Nestin-GFP+ cells (P. S. Frenette et al., 2013). The 
CAR cells are also a major source of stem cell factor (SCF) and their localization in close 
association with HSPCs suggested that CAR cells might be a key component of HSC niches (F. E. 
Soluble factor  Bone marrow source  Effects on HSCs or immune cells
Angiopoietin 1 
Osteoblastic cells, nestin-expressing 
MSCs Maintenance of long-term repopulating activity and quiescence
CXCL12
CAR cells, nestin-expressing MSCs, 
endothelial cells, osteoblastic cells, Homing and retention; maintenance of the HSC pool size
SCF 
Endothelial cells, osteoblastic cells, nestin-
expressing MSCs Maintenance of long-term repopulating activity
Notch ligands  Endothelial cells, osteoblastic cells
Increased expression on osteoblastic cells after parathyroid hormone stimulation 
is associated with increased HSC numbers in the bone marrow; however, loss of 
this signalling pathway does not impair HSC function in the steady state
Thrombopoietin  Osteoblastic cells Maintenance of long-term repopulating activity and quiescence
WNT ligands  Osteoblastic cells
Conflicting findings: enhanced self-renewal when used pharmacologically; 
however,loss of this signalling pathway does not impair HSC function in the 
steady state; inhibition by osteoblastic cell-specific expression of DKK1 
increased HSC cycling andreduced HSC serial transplant capability
APRIL 
Granylocytes, lymphocytes, dendritic 
cells, megakaryocytes Survival of plasma cell precursors
BAFF Granulocytes, lymphocytes, dendritic cells Survival of plasma cell precursors
CXCL12 
CAR cells, nestin-expressing MSCs, 
endothelial cells, osteoblastic cells
Retention of B lymphoid progenitors in the bone marrow; homing and retention 
of plasma cell precursors; homing and retention of HSCs
IL-6 
Endothelial cells, osteoblastic cells, 
megakaryocytes Survival of plasma cells; pleiotropic effects on HSCs and myeloid progenitors
IL-7  IL-7-secreting stromal cells Support of early B cell lymphopoiesis; survival of memory T cells
MIF Dendritic cells Survival of plasma cell precursors
APRIL, a proliferation-inducing ligand; BAFF, B cell activating factor; CAR, CXCL12-abundant reticular; CXCL12, CXC-chemokine ligand 
12; DKK1, dickkopf-related protein 1; HSC, haematopoietic stem cell; IL, interleukin; MIF, macrophage inhibitory factor; MSC, mesenchymal 
stromal cell; SCF, stem cell factor
Factors that affect HSCs
Factors that affect immune cells
Table 1.1: Soluble factors produced by bone marrow cellular niches that participate in the regulation of HSCs and other immune cells 
functions
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Mercier et al., 2012, P. S. Frenette et al., 2013). Furthermore, short-term ablation of CEMCs cells 
using a CXCL12-DTR-GFP mice showed a significant decrease in HSCs in the BM (T. Sugiyama 
et al., 2006).  
Endothelial cells were also shown to support the proliferation of HSPCs in vitro. For example, 
deletion of the endothelial specific adhesion molecule, E-selectin, resulted in increased HSCs 
quiescence, and the deletion of Kit ligand (SCF) from endothelial cells resulted in the loss of 
HSCs. Collectively, these findings suggested that endothelial cells are required for HSCs 
proliferation regulation and maintenance (B. A. Anthony and D. C. Link, 2014).  
Several studies have pointed out an inhibitory role for adipocytes in haematopoiesis. HSCs were 
decreased in BM areas rich in adipocytes and in mice pharmacological inhibition of adipogenesis 
was associated with an improved haematopoietic recovery following stem cell transplantation in 
myeloablated mice (B. A. Anthony and D. C. Link, 2014). 
In BM, autonomic nerves have been shown to be in close proximity to HSCs and, recently, several 
studies have been shown that neurological components may also regulate haematopoiesis. For 
example, it was reported that pharmacological ablation of adrenergic signaling inhibits G-CSF-
induced HSPCs mobilization. G-CSF has been long used in the clinic to mobilizes HSPCs from 
BM to the periphery through mechanisms that include the induction of proteolytic activity that 
cleaves CXCL12 (S. Mendez-Ferrer et al., 2008). 
In the endosteal niche, osteoblasts interact with HSCs at the interface between the bone and the 
marrow space. The genetic ablation of osteolineage cells was associated with a dramatic increase 
in extramedullary haematopoiesis (D. Visnjic et al., 2004) and in a study, where osteoblasts were 
expanded by enforced expression of parathyroid hormone receptor 1, HSCs were shown to 
increase in number (B. A. Anthony and D. C. Link, 2014). The BM osteolineage cells secrete 
cytokines such as M-CSF, GM-CSF, IL (Interleukin)-1, IL-6, IL-7, Thrombopoietin (TPO) and 
CXCL12, all soluble haematopoietic factors. Moreover, osteoblasts express adhesion molecules 
such as VCAM1, ICAM1, annexin II, N-cadherin, CD44 and CD164, that may be implicated in 
cell-cell interactions within the niche (F. E. Mercier et al., 2012).  
BM stromal macrophages (distinguished by CD169 expression) are also associated with the 
endosteal and the vascular niches and may also have a role in the regulation of haematopoietic 
stem cells niches, through the regulation of the expression of CXCL12 by BM stromal cells (F. E. 
Mercier et al., 2012, M. Casanova-Acebes et al., 2013). For example, the depletion of CD169+ BM 
macrophages in vivo resulted in a higher frequency of LSK cells in circulation. This increased 
mobilization was associated with a decrease in the levels of CXCL12 expression by Nestin+ 
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MSCs, following depletion of BM macrophages in vivo. These findings suggested that BM 
macrophages contributed to the retention of HSCs in the BM by acting on Nestin+ MSCs (A. 
Chow et al., 2011). 
T cells are not regarded as “BM stromal cells”, but are present in the BM and they are well known 
sources of haematopoietic growth factors, such as IL-3 and GM-CSF. Their role in homeostatic 
haematopoiesis, however, remains unclear (J. P. Monteiro and A. Bonomo, 2005). In athymic 
BALB/c nu/nu mice (which lack T cells), it was reported that the accumulation of immature myeloid 
cells and reduced numbers of granulocytes in peripheral blood could be rescued by the 
reconstitution with purified CD4+ T cells, but not purified CD8+ T cells (J. P. Monteiro et al., 
2005). T cells are sources of the pro-inflammatory cytokines IFNγ (Interferon-gamma) and TNFs 
and several reports suggested that both cytokines might impact on the modulation of 
haematopoiesis in BM (C. Selleri et al., 1995, M. T. Baldridge et al., 2010, C. J. H. Pronk et al., 
2011, F.-c. Lin et al., 2014). Collectively, these studies point to a regulatory role for T cells in both 
homeostatic and stress-induced haematopoiesis.  
1.1.3.2 Cytokine Receptors and Haematopoiesis 
Haematopoiesis relies on strictly regulated pathways that assure the continuous production of 
mature cells from HSCs (M. Kondo et al., 2003a). Theses processes are crucial to survival since 
the majority of mature haematopoietic cells are short lived and cytokines have been shown to be 
required to modulate not only steady-state haematopoiesis, but also events that require stress-
induced haematopoiesis, such as bleeding and infection (M. Kondo et al., 2003a, J. L. Zhao and D. 
Baltimore, 2015). 
The roles of various cytokines in haematopoiesis are still elusive, therefore in this section we 
aimed to give some examples of cytokines which role have been well established in lineage 
commitment, which alongside other relevant cytokines were summarize in Figure 1.3. 
c-Kit receptor tyrosine kinase for the stem cell factor (SCF) is expressed in HSCs, MPPs and in 
early lineage-committed progenitors. SCF seems to act at various levels of ontogeny cooperating 
with other growth factors in lymphopoiesis, erythropoiesis and megakaryopoiesis (S. D. Lyman 
and S. E. W. Jacobsen, 1998). For example, the null alleles for c-Kit cause embryonic lethality 
associated with severe anemia, but viable alleles with impaired c-Kit tyrosine kinase activity have 
allowed the study of SCF signaling in haematopoiesis. The defective SCF signaling in HSCs was 
associated to decreased number of HSCs in BM of adult mice and impaired long-term 
reconstitution potential that could not be rescued by the overexpression of the anti-apoptotic factor 
BCL2, suggesting that cKit signaling is required to preserve extensive self-renewing divisions and 
therefore crucial to HSCs function (L. A. Thoren et al., 2008). 
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Figure 1.3 - Summary of haematopoietic cytokines. Several cytokines modulate the 
differentiation of multipotential progenitors and their lineage-committed providing survival, 
proliferation or instructive signals. BCP, B-cell progenitor; CLP, common lymphoid progenitor; 
CMP, common myeloid progenitor; EP, erythroid progenitor; HSC, haematopoietic stem cell; 
GMP, granulocyte–macrophage progenitor; MEP, megakaryocyte erythroid progenitor; MkP, 
megakaryocyte progenitor; TNK, T-cell natural killer cell progenitor (Adpated from (L. Robb, 
2007)). 
 
The first haematopoietic growth factor identified was later called erythropoietin. The kidney 
produces the vast majority of erythropoietin, where juxta-tubular interstitial cells are capable of 
sensing the levels of tissue oxygenation. Erythropoietin blood levels are tuned by the level of 
oxygenation and according to homeostatic requirements modulate the expansion of erythroid 
progenitor cells, promoting progression in cell cycle and increased expression of the anti-apoptotic 
protein BCLXL (K. Kaushansky, 2006). 
The growth factors more commonly associated with myeloid lineage cells development were 
initially identified by their potential to support different myeloid cell colonies when added to 
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cultures of BM cells in a semisolid medium. These myeloid associated growth factors include the 
macrophage colony-stimulating factor (M-CSF), granulocyte/macrophage colony-stimulating 
factor (GM-CSF), the granulocyte colony-stimulating factor (G-CSF) and the multi colony-
stimulating factor known as interleukin-3 (multi-CSF or IL-3), and are produced in various organs 
by several cell types including endothelial cells, fibroblasts, and macrophages (D. R. Barreda et 
al., 2004).  
M-CSF promotes monocyte/macrophage development, while G-CSF has been more associated to 
granulocyte development and in vivo studies using knockout mice identified G-CSF as an essential 
growth factor for terminal normal maturation of neutrophil progenitors. IL-3 and GM-CSF 
promote the granulocytic, macrophage and granulocyte-macrophage colony formation and its 
believed that these growth factors exert their function in more immature myeloid progenitors. 
These factors show some level of functional redundancy since in vivo defect in one of these 
growth factors does not lead to a serious impact on homeostasis (D. R. Barreda et al., 2004). 
Thrombopoietin (TPO) was identified as the primary regulator of platelet production, supporting 
the proliferation and survival of megakaryocyte progenitors through the upregulation of the cell-
cycle regulator cyclin D and anti-apoptotic molecule BCLXL. In mice deficient for TPO or its 
receptor the production of megakaryocytes was reduced and platelets production severely 
impaired. TPO is mostly produced in the liver but kidney and skeletal muscles also produce TPO 
and the number of platelets in circulation and megakaryocytes in BM regulates its blood levels (K. 
Kaushansky, 2006).  TPO was also shown to be very important for the survival and expansion of 
HSCs. Donor HSCs from mice deficient for TPO or its receptor (c-mpl) showed impaired capacity 
to reconstitute recipient mice. Additionally, patient with c-mpl defects present thrombocytopenia 
and severe anemia due to BM exhaustion (K. Kaushansky, 2006). 
Flt3 (fms-like tyrosine kinase 3) receptor tyrosine kinase is expressed in MPPs and early myeloid 
and lymphoid lineage-committed progenitor cells and binds to FLt3 ligand (FL), which is 
expressed in various tissues (S. D. Lyman and S. E. W. Jacobsen, 1998). This tyrosine kinase 
seems to be important in the generation of CLPs since mice deficient in expression of FL showed 
primarily impairment of lymphopoiesis, although NK and dendritic cells were also reduced (E. 
Sitnicka et al., 2002). 
IL-7 production has been detected in several non-lymphoid cells in lymphoid organs, such as 
thymus, BM, spleen and kidney. Its importance became evident after the observation that mice 
deficient for IL-7 were highly lymphopenic. Today is well established that IL-7 is essential to 
lymphopoiesis both in early and later stages of lymphoid lineage specification, it plays both 
instructive and permissive functions in lymphoid development such as promotion of survival 
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signals (e.g. BCL2 expression) and upregulation of lineage transcription factors (e.g. Ebf-1) (U. 
Vonfreedenjeffry et al., 1995, Q. Jiang et al., 2005, P. Tsapogas et al., 2011). 
1.1.3.3 Transcription Factors in Lineage Commitment 
The process of differentiation of multipotent cells towards different blood cell lineages depends on 
the initiation and the sustainment of lineage specific genetic programs. It has been shown that 
multiple different lineage-restricted genes are expressed in multipotent progenitors and it has been 
suggested that the processes of lineage commitment require not only the induction/reinforcement 
of lineage-specific genes but also the repression of genes associated with other lineages (M. A. 
Rieger and T. Schroeder, 2012). The establishment of stable gene programs depends on 
transcription networks sustained by transcription factors in association with cofactors, chromatin 
modifiers, and regulatory RNAs (M. A. Rieger and T. Schroeder, 2012). 
The intrinsic molecular networks for lineage differentiation are discussed in excellent reviews (S. 
I. Kim and E. H. Bresnick, 2007, S. H. Orkin and L. I. Zon, 2008, E. M. Mercer et al., 2011, G. 
Sashida and A. Iwama, 2012, R. A. Nimmo et al., 2015). In this section, we aimed to at some 
extent give examples that emphasize the role of transcriptions networks in haematopoiesis.  
The requirements for TFs have been temporally defined and vary in different stages of 
development (S. H. Orkin and L. I. Zon, 2008). For example SCL/tal1 is essential for the 
formation of haematopoietic system during embryogenesis. Nonetheless the study of this TF in 
adult mice using conditional mutants and competitive BM chimeras showed that SCL/tal1 is not 
required for HSCs survival and functions (self-renewal and multilineage repopulation of the 
haematopoietic system) but essential for the terminal differentiation of erythroid and 
megakaryocytic precursors (H. K. A. Mikkola et al., 2003). 
TFs determine lineage specification and commitment, in a context-depend process, (H. Iwasaki et 
al., 2006, S. H. Orkin and L. I. Zon, 2008) with PU.1 and GATA-1 serving as prototypical 
examples in haematopoiesis. The co-upregulation of PU.1 and GATA-1 may be one of the earliest 
steps in lineage commitment of HSCs to CMPs but later in development their expression is 
segregated. The predominance of GATA1 has been associated to myeloerythroid bias and the 
predominance of PU.1 to myelolymphoid lineage bias in HSCs (J. Zhu and S. G. Emerson, 2002). 
GATA-1 is essential for terminal differentiation of erythroid precursors since it promotes the 
expression of several erythroid genes. GATA-1 is not appreciably expressed in myeloid cells and 
induced expression of GATA-1 in the myeloid progenitor line 416B blocked myeloid 
differentiation and induced erythroid, megakaryocytic, and eosinophilic characteristics in cultured 
cells (S. H. Orkin, 2000). On the other hand, PU.1 is expressed in myeloid and lymphoid 
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progenitor cells and in mice deficient for PU.1 gene the development of both lineages was 
impaired. It was found that this TF is necessary for the transcription regulation of other factors 
required for lymphoid and myeloid lineage differentiation, such as IL-7 receptor and M-CSF 
receptor, respectively. It was showed that PU.1 induced expression alone could commit 
multipotent haematopoietic progenitors to monocytic/granulocytic lineages direction (J. Zhu and 
S. G. Emerson, 2002).  
The potential for inhibitory interactions between transcription factors was implied by the 
observations that overexpression of GATA-1 or PU.1 blocks myeloid or erythroid differentiation, 
respectively. It has been proposed that these factors physically interact and antagonize each other’s 
actions, and an extended body of literature supports the proposition that GATA-1 and PU.1 are 
expressed at low level in undifferentiated stable progenitor that differentiates into to one of the 
main lineage branches when one of the proteins is expressed at higher levels (S. H. Orkin and L. I. 
Zon, 2008). 
Despite these roles in early commitment of myeloerythroid/myelolymphoid lineages both GATA-1 
and PU.1 interact (synergistic or antagonizing interactions) with other TFs across haematopoietic 
development, emphasizing how fine tuned and complex is the genetic regulation from HSCs to 
mature blood cells. For examples: GATA-1 and Friend of GATA-1 (FOG-1) are required for in 
erythroid differentiation; PU.1 and Gfi1 in monocytes and neuthrophil cells development, 
respectively; and in T cell development repression of PU.1 by notch signaling (S. H. Orkin and L. 
I. Zon, 2008). 
One example of the relevance of the order of TFs expression came from Iwasaki H. studies in vitro 
showing that eosinophils and basophils development from purified GMPs requires the both the 
expression of GATA-2 and CCAAT enhancer-binding protein α (C/EBPα). Importantly it was 
showed that the differentiation of these two mature cell types critically depended on the order of 
expression of these two TFs to specifically promote the genetic program for each of these lineages 
(H. Iwasaki et al., 2006). 
The classic representation of haematopoiesis in hierarchic diagrams offer an over simplistic view 
that although useful does not include the more updated view of the processes of ontogeny. In the 
light of new findings, haematopoietic populations are best understood as group of cells with 
different developmental potentials with outcomes that depend on the dynamic crosstalk between 
intrinsic factors (such as TFs and epigenetic regulation) and signals from their niches. The 
“lineage priming” phenomenon equipped the HSPCs with flexibility to face the need of blood cells 
replenishment in homeostasis and injury, but in order to preserve integrity of haematopoietic 
system the regulation as to be very tight. In this context the further study of TFs is extremely 
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relevant to determine a clearer picture of haematopoiesis, in the development of cellular therapies 
and in the study of haematopoietic malignancies where many genes for TFs have been found 
mutated or translocated (S. H. Orkin and L. I. Zon, 2008, R. A. Nimmo et al., 2015). 
1.1.4 Haematopoietic Stem Cells in Adult Mammalians 
The exposure to radiation during the World War II showed for the first time how ionizing radiation 
damaged the haematopoietic system (J. Domen et al., 2006). These effects were replicated in mice 
and it was found that a lethal outcome could be prevented if a bone or the spleen were protected 
from irradiation, as well as by transplantation of BM cell suspensions (J. Domen et al., 2006). 
Seminal experiments from Till and McCulloch found that in mice subjected to heavy doses of 
radiation, if limiting BM cell suspensions (sub-radioprotective) were transferred between day 
seven and ten, macroscopic clusters of haematopoietic cells would appear in the spleen. These 
clusters were composed of dividing haematopoietic cells that could differentiate in erythroid, 
myeloid and megakaryoid lineages. Furthermore, when a very low number of BM cells displaying 
an abnormal karyotype (due to exposure to ionizing radiation) were transferred to lethally 
irradiated mice, it was observed that each cluster in the spleen arose from a single clone; since the 
daughter cells in each colony presented the same unique alterations in their chromossomes. As 
such, it was demonstrated that in the BM, cells with the unique ability to perform multilineage 
haematopoietic reconstitution are present, the so called HSCs (A. J. Becker et al., 1963). 
In subsequent experiments it was observed that some of these spleen colonies were constituted by 
identical daughter cells and could form multilineage colonies in the spleens of secondary irradiated 
recipients. More, each clonogenic colony contained a variable number of cells and a variable 
composition of mature and progenitor cells. Collectively these findings suggested that the 
haematopoietic system would arise from a rare group of BM cells that were characterized by 
“stemness “, self-renewal capacity, capacity to originate multi haematopoietic lineages and high 
proliferative potential, the nowadays well established HSCs (A. J. Becker et al., 2014). Further 
developments in this field came from studies in vitro and in vivo, all pointed to a hierarchic 
haematopoietic development from a multipotential progenitor to lineage restricted progenitors (C. 
J. Eaves, 2015).  
Nonetheless, only in 1996 was the proof of principle for an HSC established by Osawa, when the 
injection of a single lineage negative (negative for a pool of canonical markers for mature 
haematopoietic cells) CD341o/- c-Kit+ Sca-1 (Stem cell antigen)+ cell reconstituted the lympho-
haematopoietic system of a recipient mouse for more than four months (M. Osawa et al., 1996, C. 
J. Eaves, 2015). 
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HSCs have been extensively studied over the past decades because they provide a source of 
potential stem cell based therapeutic tools in the approach of a wide range of haematopoietic, 
genetic and immune disorders. HSCs transplantation (enriched from BM cells, mobilized 
peripheral blood stem cells or umbilical cord blood) is nowadays a well-established procedure that 
saves thousand of lives every year, but it still relies on the availability of donors with matching 
human leukocyte antigens (HLA) (M. A. Walasek et al., 2012). 
In humans, patient survival upon the HSCs transplantation has been directly associated to the 
initial amount of stem cells (CD34+ cells in humans). To face the scarcity of HSCs obtained by 
conventional sources, many attempts have been made to establish protocols to expand HSCs ex 
vivo but it was soon found that in vitro HSCs readily differentiate and loose self-renewal attributes, 
becoming therefore inadequate to reconstitute the haematopoietic system when transplanted (M. 
A. Walasek et al., 2012). 
The culture conditions that allow HSCs to undergo ex vivo symmetrical self-renewal over 
unlimited differentiation divisions have not yet be defined. However the intense research over the 
past decades on the mechanisms regulating of expansion and maintenance of self-renewal of HSCs 
has disclosed some molecular mechanisms and regulatory networks that modulate HSCs fate (M. 
A. Walasek et al., 2012, S. Lin et al., 2015). 
The lack of a protocol suitable to expand HSCs for clinical purposes, despite its importance in a 
wide range of disease scenarios, illustrates two important features regarding the study of HSCs in 
adult mammalians: 1) the regulation of HSCs seems to be extremely complex and depend on 
intricate dynamics between intrinsic and extrinsic factors; 2) the study of HSCs is technically 
challenging due to their scarcity in the adult and rapid differentiation in ex vivo settings.  
In the next sections, we will discuss some molecular mechanisms relevant to the regulation of 
HSCs function.  
1.1.4.1 Haematopoietic Stem Cell, Quiescence versus Proliferation  
The hallmarks of stem cells are their dual capacity to produce more identical stem cells (self-
renewal) and to produce cells that ultimately will give rise to mature cells (multipotential of 
differentiation). One strategy by which HSCs can accomplish these two tasks is either by 
asymmetric cell division, in which the stem cell divides to generate one daughter with a stem-cell 
fate (self-renewal) and one daughter that initiate differentiation. Or alternatively, symmetrical 
divisions may give rise to two identical stem cells (self-renewal) or two lineage-committed 
daughter cells (differentiation) (Figure 1.4) (A. D. Ho and W. Wagner, 2007). 
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Figure 1.4 - Schematic overview of different HSCs cellular fate choices. Quiescent HSCs (G0) 
can be activated to enter the cell-cycle (G1/S/G2/M phases) to self-renew and/or differentiate by 
cell-intrinsic or cell-extrinsic factors, leading to symmetric or asymmetric cell divisions. HPC 
(heamatopoietic peogenitor cell) (Adapted from (A. Nakamura-Ishizu et al., 2014)).  
 
In this section, we provide some examples of in vivo studies that lead to the characterization of 
molecular factors relevant in the regulation of HSCs fate. These examples, and others not 
discussed here, are summarized in Table 1.2 (Adapted from (K. W. Orford and D. T. Scadden, 
2008, M. R. Warr et al., 2011, A. Nakamura-Ishizu et al., 2014)). 
The quiescent HSCs reside at the top of the haematopoietic hierarchy and fine tuned regulation of 
their cell cycle, decision to self-renew and/or differentiate is therefore required to maintain the 
adequate production of blood cells at the expense of minimum stem cell exhaustion. It is accepted 
that the decision to exit quiescence depends both on cell-intrinsic and -extrinsic factors that induce 
quiescent HSCs to proliferate and differentiate (A. Nakamura-Ishizu et al., 2014). 
Murine embryonic stem cells (mES) can be expanded in vitro without compromising their self-
renewal potential and this ability has been attributed to their shorter cell cycle. mES have reduced 
G1 phase because they have constitutive cyclin E-cdk2 activity and express very low levels of the 
D-type cyclins. In contrast, in adult cells cyclin E-cdk2 activity is transient peaking at the G1 to S 
transition. Likewise, mES do not display early G1 phase or restriction point of cell cycle (Figure 
1.5). In contrast, most somatic cells to progress through the early G1 phase of the cell cycle require 
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mitogen activated protein kinase (MAPK) signaling, which was shown (particularly prolonged 
MAPK signaling) to be an inducer of differentiation. Therefore it was suggested that the absence 
of early G1 in mES cells might allow them to escape the differentiation-inducing effects of certain 
mitogenic signaling pathways, otherwise active during early G1 in somatic cells. Therefore, it is 
not surprising that many factors associated with the regulation of HSCs quiescent/self-renewal 
potential are molecular factors that regulate the cell cycle (K. W. Orford and D. T. Scadden, 2008). 
 
Figure 1.5 - Overview of cell cycle. Cell proliferation occurs through a series of stages that are 
collectively termed the cell-cycle. Classically, the cell-cycle has been divided into four phases that 
are organized around the synthesis (S) phase and mitotic segregation (M) phase of the genome 
with two intervening gap phases (G1 and G2) preceding S and M phases, respectively. Progression 
through the cell cycle is highly regulated, particularly at the transitions from G1 phase to S phase 
and from G2 phase to M phase. In addition to other cell-intrinsic checkpoints (for example, the 
evaluation of the integrity of the genome), combinations of intrinsic and extrinsic signals regulate 
the passage from early to late G1 phase in somatic cell. This transition is called the restriction (R) 
point, and divides the G1 phase of the cell cycle into the mitogen-dependent early G1 phase and 
the mitogen-independent late G1 phase. In general, cells nave to be stimulated by mitogenic 
signals (for example, soluble growth factors) to “cut through” the G1 phase and enter into the cell-
cycle. The R point represents the ‘point of no return’ for the cell, after which the cell has 
committed to enter the cell-cycle and mitogenic stimuli are no longer required. In the absence of 
mitogenic stimulation, cells can exit from the cell cycle during early G1 phase and enter a 
dormant, or quiescent, state called the G0 phase that is characterized by small cellular size and low 
metabolic activity (Adapted from (K. W. Orford and D. T. Scadden, 2008)). 
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The cyclin-dependent kinase (CDK)-inhibitor p21 seems to be important in DNA damage 
responses but its role in the steady-state is less clear. Initial studies showed p21−/− lineage negative 
cells (enriched for HSPCs) were more proliferative and displayed self-renewal defects, 
characterized by early exhaustion following serial BM transfer and repeated 5- Fluorouracil (FU) 
treatments (M. R. Warr et al., 2011). Then, an other study using a more purified population 
enriched for LT-HSCs (LSK CD150+ CD48-) showed conflicting results. The number of quiescent 
HSCs was maintained in mice deficient for p21. However, in the absence of this factor, the 
function of HCSs was impaired compared to wild type (WT) HSCs in BM transplant (BMT) 
assays, but only if the transplanted BM cells were first treated with 2Gy irradiation. This suggested 
that p21 was important for DNA repair but not crucial in HSCs function (R. Van Os et al., 2007) 
The transcription factor c-Myc has been implicated in the regulation of cell proliferation, 
differentiation, and apoptosis. c-Myc heterodimerizes with its partner Max induce the expression 
of genes that promote cell-cycle G1 /S transition (including cyclin D1, cyclin D2, cyclin E and cyclin 
A) and represses the expression of cell cycle inhibitors p27 and p21, favoring cell-cycle 
progression (M. J. Murphy et al., 2005). Conditional deletion of Myc in BM was associated to 
severe anemia and leucopenia and increased number of HSCs (defined as LSK Flt3-). Myc-
deficient HSCs failed to engraft in recipient, suggesting that Myc-deficient HSCs were 
functionally defective, and that in the basis of this impaired haematopoiesis was an intrinsic defect 
in HSCs function (A. Wilson et al., 2004). Interestingly p21 a c-Myc target with disputed roles in 
cell-cycle regulation and in HSCs self-renewal, was found upregulated in HSCs following 
conditional deletion of c-Myc in vivo, and it was proposed that c-Myc may modulate HSCs 
functions through p21 repression (E. Baena et al., 2007). 
An example of the role of extrinsic factors in regulating HSCs function comes from the canonical 
Wnt signalling cascade, which has been implicated not only in the regulation of HSCs function but 
also in the development of other haematopoietic progenitors. The specific impact of canonical Wnt 
signalling in haematopoiesis is still disputed, due to opposing outcomes resulting from various 
inducible Wnt-signaling loss-of-function and gain-of-function models (T. C. Luis et al., 2010a). 
Wnts are secreted glycoproteins that bind to membrane-associated receptors, the Frizzled (FZD) 
proteins, a family of seven-pass transmembrane receptors. So far, nineteen different Wnt ligands 
and ten FZD receptors have been identified in humans and mice, and the complexity is further 
increased because Wnts can use distinct co-receptor proteins that initiate canonical and non-
canonical signaling pathways. The activation of canonical Wnt signaling pathway is defined by the 
translocation of the transcriptional co-activator β-catenin to the nucleus, where together with T-
cell factor (TCF) and lymphoid enhancer binding factor (LEF) initiates the transcription of target 
genes. When Wnt signaling is not activated, β-catenin is associated in the cytoplasm to a protein 
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complex responsible for the phosphorylation and degradation of β-catenin, preventing it 
accumulation in the cytoplasm and nuclear translocation. This destruction complex is composed 
by axis inhibition protein 1 (AXIN1), adenomatous polyposis coli complex (APC), and the 
serine/threonine glycogen synthase kinase 3 beta (GSK3β) (C. J. Cain and J. O. Manilay, 2013). 
The role of canonical Wnt signaling became evident when it was shown that Wnt3a-deficient mice 
die around embryonic day (E) 12.5.  HSCs from fetal liver (FL) showed cell intrinsic defects, such 
as severely reduced reconstitution capacity as measured in transplantation assays into Wnt3a 
competent mice (T. C. Luis et al., 2009). 
Nonetheless in adult Mx-Cre-mediated β-catenin deficiency, under control of the type I interferon-
inducible Mx promoter, did not impact in haematopoiesis, although this might be explained by 
incomplete deletion of Wnt signaling. In contrast, when Wnt signalling was inhibited by 
ectopically expressing Axin in HSCs, these showed a dramatic impairment in the reconstitution of 
lethally irradiated mice when compared to control transduced HSCs (T. Reya et al., 2003). To add 
more confusion, other gain of function assays to determine role of Wnt canonical signaling 
resulted in conflicting outcomes (T. C. Luis et al., 2010a). 
A more recent work, suggested that Wnt signaling during haematopoiesis has to be tightly 
regulated. This study was performed using mouse models carrying specific hypomorphic 
mutations at the Apc gene resulting in specific Wnt signaling dosage. Mildly increased activation 
(two fold) of the Wnt signaling pathway in HSCs resulted in increased frequency of repopulating 
cells compared to control donor HSCs, 12 weeks after transplantation, both in primary and 
secondary transplantation assays. On the other hand, donor HSCs expressing higher levels of 
canonical Wnt activation had decreased reconstitution potential in lethally irradiated recipients 
compared to control donor cells. This suggested that only mildly increased levels of activation 
enhance long-term repopulation capacity (T. C. Luis et al., 2011). 
Another example how the same TFs may play different roles in different stages of haematopoietic 
development is the role of GATA-3, for long known to be crucial in the development of T cells at 
multiple stages in the thymus and for Th2 differentiation in the peripheral organs. The TF GATA-
3 was found also expressed in various haematopoietic progenitor populations in BM, with HSCs 
expressing the highest levels of GATA-3 (C.-J. Ku et al., 2012). Recent studies have suggested 
that GATA-3 is important the maintenance of a normal number of HSCs and to be required for 
their entry into the cell cycle, however it was also implicated in loss of self-renewal potential 
during stress-induced haematopoiesis (C.-J. Ku et al., 2012, C. Frelin et al., 2013) . 
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For example, it was shown that upon poly I:C treatment, proliferating HSCs showed nuclear (i.e. 
active) GATA-3 and were only capable of short-term multilineage reconstitution. After the 
proliferative stimulus was removed, GATA-3 re-localized to the cytoplasm and long-term lineage 
reconstitution was restored. Further, in competitive transplant assays of BM cells from poly I:C 
treated GATA-3 cKO and WT mice, GATA-3 deficient donor cells were more efficient in 
performing haematopoietic reconstitution, upon 32 weeks. These data suggested that GATA-3 
might limit long-term self-renewal during proliferation of HSCs. The localization of GATA-3 in 
the nucleus depended directly on p38α activation in culture, as shown by in vitro pharmacological 
inhibition (C. Frelin et al., 2013). Additionally, the activation of the p38 MAPK pathway in 
response to reactive oxygen species has been reported to cause HSC exhaustion, pharmacological 
inhibition of p38 MAPK maintained stemness of cultured mouse and human HSCs, and in vitro 
studies showed that p38 MAPK modulates the activity of the critical regulator of HSC quiescence 
p57 (Cdkn1c) (C. Frelin et al., 2013, M. Tesio et al., 2015). 
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Table 1.2 - Summary of relevant genetic mouse models that contributed to the identification 
of molecular modulators of HSCs cell-cycle  
 
Cyclin A Conditional KO Increased Decreased
Rb family (Rb1, 
Rbl1, Rbl2)
Triple KO
(Mx-1-Cre) Increased Decreased
Cdkn2a (p16) KO (aged mice) Increased Increased
Cdkn1a (p21) KO
 Decreased or Unchanged
Decreased
Cdkn1c (p57)
 Conditional KO
(Mx1-Cre)  Decreased Decreased
p53 (Trp53) KO Increased Increased
Myc/Mycn
Conditional KO 
(Mx-1-Cre) Decreased differentiation Decreased
Fbxw7
Conditional KO
(Mx-1-Cre) Increased Decreased
Runx1
Conditional KO 
(Mx-1-Cre) Increased Decreased
Gfi1 KO Increased
Unable to engraft in 
CRA
Mef (Elf4) KO Increased Increased
Foxo1/3/4 KO Increased Decreased
Bmi1 KO Increased Decreased
Foxo1/3/4 KO Increased Decreased
Pten
Conditional KO 
(Mx-1-Cre) Increased Decreased
Mysm1 KO Increased Decreased
Dnmt3a Conditional KO Decreased Decreased
Tpo KO Increased Decreased
Ang-1
Retroviral 
expression Increased Decreased
Kit
Hypomorphic 
allele Increased Decreased
Cxcr4 Conditional KO Increased Decreased
Epigenic Regulators
Table  1.2: Table summarizing relevant genetic mouse models that have contributed to the understanding of 
HSCs cell cycle regulation
CRA, competitive repopulation assay; HSC, haematopoeitic stem cell; KO, knockout, Ang, Angiopoietin; Tpo, 
Trombopoietin. 
Cell cycle regulators
Nuclear regulators
Cell intrinsic 
regulators
Gene Mouse model HSCs cell cycle activity Effect on repopulation 
potential
Environmental factors
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1.1.4.2 Immunophenotypic evaluation 
The assessment of HSCs function (‘stemness’) in vivo has been possible due to constant technical 
improvements: in ex vivo culture systems, in cell purification strategies throught a set of cell-
surface markers, in cell-cycle status evaluation and in vivo long-term reconstitution assays upon 
transplantation to conditioned recipients. In spite of decades of research on HSCs, the 
characterization of markers for isolation is still in flux, with the frequent description of new 
markers for HSCs purification (Table 1.3). This requires retrospective studies to be evaluated with 
caution. Another constraint in the study of HSCs function comes from their relative scarcity, 
which restricts the study of HSCs function to approaches that do not require large amounts of 
starting material or throught inference. More recently, advances in in vivo imaging and 
transcriptomic analysis at the single cell level have started to provide important insights on HSC 
biology (G. A. Challen et al., 2009, A. Nakamura-Ishizu et al., 2014). 
 
Table 1.3 - Summary of most commonly used combinations of cell surface marker used to 
segregate HSPCs 
 
The phenotypic identification of haematopoietic progenitor cells relies on the expression (or lack 
of expression) of a combination of cell surface expressed proteins (markers) on individual cells, 
since a unique surface-cell marker has yet to be defined to segregate HSCs from onward 
progenitors. Using flow cytometry became possible to determine which fluorochrome conjugated 
!
Cell type Phenotype Ref. 
Long-term hematopoietic stem cells (LT-
HSCs) Lineage
-/low Sca1+ cKithi FLt3- CD34- 
(Kondo et al., 
2003) 
 
Short-term hematopoietic stem cell (ST-HSC) Lineage-/low Sca1+ cKithi FLt3- CD34- 
Multipotent progenitors (MPP) Lineage-/low Sca1+ cKithi FLt3+ CD34- 
   
Hematopoietic stem cells (HSCs) Lineage-/low Sca1+ cKithi CD150+ CD48- 
(Oguro et al., 
2013) Hematopoietic progenitor cells 1 (HPC-1) Lineage
-/low Sca1+ cKithi CD150- CD48+ 
Hematopoietic progenitor cells 2 (HPC-2) Lineage-/low Sca1+ cKithi CD150+ CD48+ 
   
Common lymphoid progenitors (CLP) Lineage-/low cKithi IL-7Rα+ CD34-/low 
(Kondo et al., 
2003) 
(Belyaev et al., 
2010) 
Common myeloid progenitor (CMP) Lineage-/low cKithi CD16/32-/low IL-7Rα- CD34+ 
Granulocyte-macrophage progenitor (GMP) Lineage-/low cKithi CD16/32+ IL-7Rα- CD34+ 
Megakaryocyte-erythrocyte progenitor (MEP) Lineage-/low cKithi CD16/32- IL-7Rα- CD34- 
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monoclonal antibodies binds to each cell, allowing not only the identification of different cell 
populations but also the isolation of live cells (cell-sort) to use in further functional assays, using 
the so-called fluorescence activated cell sorting (FACS) technology (G. A. Challen et al., 2009). 
The vast majority of HSCs isolation approaches include the selection of cells expressing c-Kit 
(stem cell growth factor receptor/CD117) and Sca-1 and negative selection for markers of mature 
haematopoietic cell lineages (typically B220, CD4, CD8, Gr-1, Mac-1 and Ter-119), the so-called 
LSK which are enriched in cells with haematopoietic reconstituting activity, about 10% of LSK 
cells are bona fide long-term HSCs (G. A. Challen et al., 2009). For the further enrichment in 
murine HSCs and onward progenitors a variety of combinations of cell-surface marker have been 
proposed, the most commonly used were resumed in Table 1.3.  
1.2 STRESS-INDUCED HAEMATOPOIESIS 
1.2.1 Overview of Stress-induced Haematopoiesis 
In spite of decades of investigation, much is yet to learn about the regulation of haematopoiesis, 
and this lack of knowledge becomes further evident regarding the cell fate of HSPCs in non 
steady-state conditions, such as infection, inflammation or anaemia (J. L. Zhao and D. Baltimore, 
2015). 
A classic example of stress-induced haematopoiesis is the rapid increased production of myeloid 
cells in response to acute systemic bacterial infection, often referred to as emergency 
myelopoiesis. The emergency myelopoiesis is characterized by, leukocytosis, neutrophilia, 
emergence of immature neutrophils in peripheral blood (PB) and increased production of 
myelomonocytic cells in BM. The aforementioned phenomenon in an illustrative example of how 
the haematopoietic system evolved to respond fast and efficiently to the higher demand of innate 
immune cells to fight an acute infection (H. Takizawa et al., 2012).   
Most haematopoietic cells are post mitotic requiring the de novo production from BM HSPCs, 
when they are consumed in response to injury, during an immune response or due to blood loss. 
Therefore, chronic uncontrolled stimulation may be detrimental to the long-term function of HSCs, 
on the top of blood cell production. It has been reported that highly proliferative cells (for 
example, during experimental serial transplantation) showed intrinsic reduced self-renewal 
activity, suggesting that sustained stress-induced haematopoiesis may result in exhaustion of 
functional HSCs and increased probability of occurring cumulative genetic alterations (K. Y. King 
and M. A. Goodell, 2011, H. Takizawa et al., 2012).  
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In humans it was not yet established if dysregulation of stress-induced haematopoiesis contributes 
to haematological disorders, such as BM failure or neoplasias, nonetheless epidemiological studies 
have shown an association between chronic immune stimulation (infections and autoimmune 
diseases) and increased risk of posterior development of myeloproliferative neoplasms, BM 
fibrosis and myelodysplastic syndromes (J. L. Zhao and D. Baltimore, 2015). 
The adaptation of haematopoiesis to dynamic homeostatic requirements is possible due to the 
expression of different receptors at each developmental step, which integrate the information 
provided by different stress mediators.  
Haematopoietic progenitors have different mechanism to sense injury that may collaborate to 
respond to the specific haematopoietic demands: (1) respond to anemia, for example producing 
more erythrocytes upon sensing increased levels of erythropoietin; (2) respond to inflammatory 
mediators produced during an immune response to an infection, for example in a mouse model of 
malaria, IFNγ signaling induce the emergency of an IL-7R+ cKithi myelolymphoid progenitor 
population that contribute for the increased production myeloid cells beneficial for infection 
resolution; (3) respond to pathogen-associated molecular patterns (PAMPs) and danger-associated 
molecular patterns (DAMPs) directly through toll like receptors (TLRs), for example, in mice 
infected with Pseudomonas aeruginosa the expansion of LSK depended on the expression of 
TLR4, the main receptor for lipopolysaccharide (LPS); (5) respond to signals from the BM 
mesenchymal stem cell niche, for example mice with infected with Listeria monocytogenes have 
increased serum levels of G-CSF, which was shown to repress the expression of CXCL12 by 
osteoblasts promoting increased mobilization of HSPCs; (6) so far there are no evidence that 
HSPCs themselves could be infected by pathogens, nonetheless in theory this may be a further 
mechanism of haematopoietic regulation (C. Cheers et al., 1988, N. N. Belyaev et al., 2010, K. Y. 
King and M. A. Goodell, 2011, H. Takizawa et al., 2012, J. L. Zhao and D. Baltimore, 2015).  
1.2.2 Inflammatory Modulation of Early Events in Haematopoiesis 
The impact of infection on haematopoiesis has been reported in many models, regulated by both, 
systemic demand for immune cells, and direct sensing of “infection” by haematopoietic 
precursors, the so-called “Push and Pull Model” (Figure 1.6) (K. Y. King and M. A. Goodell, 
2011).  
Another common feature associated to haematopoietic alterations during chronic infections is the 
establishment of extramedullary haematopoiesis that may occurs due to an increased egress of 
immature haematopoietic cells from the BM to the periphery or in sito expansion of circulating 
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HSPCs (V. M. Peterson et al., 1994, Y. F. Zhan et al., 1998) (A. M. Mirkovich et al., 1986, S. E. 
J. Cotterell et al., 2000a, T. Junt et al., 2007, S. Massberg et al., 2007). 
In steady state, HSCs are mostly found in quiescence and it was formerly believed that HSCs were 
protected in their niches from infectious challenge. Nowadays, is well established that HSCs play a 
central role in the responses to infection (H. Takizawa et al., 2012). 
In the following section we will discuss the effects of inflammation on the modulation of 
haematopoiesis in different models of infection and its functional consequences, focusing in HSCs 
and immediate early progenitors. 
 
Figure 1.6- Overview of the “Push and PulL Modell” proposed to frame the alterations 
observed in haematopoiesis during infection. All haematopoietic cells originate from a small 
population of haematopoietic stem cells (HSC), which is separable into at least two subsets: long-
term reconstituting HSC (LT-HSC) and short-term reconstituting HSCs (ST-HSC). Differentiation 
of ST-HSCs generates multipotent progenitors (MPP) and then lineage-committed oligopotent 
progenitors derived from MPP. These include the common lymphoid progenitor (CLP), common 
myeloid progenitor (CMP), megakaryocyte-erythrocyte progenitor (MEP) and granulocyte-
monocyte progenitor (GMP) populations. To explain demanded- haematopoiesis during infection a 
model defined as “The push and pull on HSCs” has been proposed; the “push” being associated 
with the direct response of HSC to stimuli associated with infections (including pathogen-
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associated molecular patterns (PAMPs) or in response to pro-inflammatory cytokines; and the 
“pull” associated with the HSCs proliferation due to the depletion of committed progenitor 
populations from the bone marrow.  CCL2, CC-chemokine ligand 2; CLP,; IFN, interferon; IL-6, 
interleukin-6; LPS, lipopolysaccharide; MEP, megakaryocyte and erythrocyte progenitor; MPP, 
multipotent progenitor; NK, natural killer; TNF, tumor necrosis factor (Adapted from (K. Y. King 
and M. A. Goodell, 2011, L. D. Wang and A. J. Wagers, 2011)). 
 
1.2.2.1 Regulation of stress-induced haematopoiesis by Toll-like receptor signaling 
Pathogen-associated molecular patterns (PAMPs), including lipids, lipoproteins, proteins and 
nucleic acids, can be recognized by germline-encoded pattern-recognition receptors (PRRs), 
including Toll-like receptors (TLRs), C-type lectin receptors and NOD-like receptors, amongst 
others expressed in immune cells. For example, TLRs recognized PAMPs derived from various 
pathogens and initiate MyD88-dependent or TIR-domain-containing adapter-inducing interferon 
beta (TRIF)-dependent signaling pathways, leading to the activation of IRF3 and/or late-phase 
nuclear factor kappa light chain enhancer of activated B cells (NF-κB) TF (T. Kawai and S. Akira, 
2010). 
HSPCs have high expression and respond to engagement of TLR2 and TLR4 with entry into cell 
cycle and selective myeloid lineage differentiation in vitro (Y. Nagai et al., 2006a) and in vivo (J. 
Megias et al., 2012) . 
For example, during sepsis using an established murine model by inoculation of the virulent strain 
of P. aeruginosa UCBPP-PA14 or P. aeruginosa LPS it was observed a significant increase in 
LSK cells, but BM cellularity was reduced, as well as BM Gr1+Mac1+ population, which includes 
maturing myeloid cells, monocytes, and neutrophils, suggesting a block in myeloid differentiation. 
In competitive BMT assays, BM donor cells pre-challenged with P. aeruginosa LPS showed low 
engraftment potential, both in the long and short term periods, and defective ability to generate 
myeloid progenitors, in comparison to control BM donor cells. TLR4 expression was upregulated 
in LSK by LPS, and in mutant mice deficient for TLR4 the phenotype upon LPS challenge 
observed in WT mice was at great extent prevented, LSK cells were not significantly increased, 
and the number of myeloid cells preserved, suggesting that TLR4 signaling could modulate HSCs 
functions (long-term self-renewal and multilieage differentiation) (S. Rodriguez et al., 2009). 
Staphylococcus aureus infection was also associated to an expansion of HSCs and multipotent 
progenitors. However, in mice MyD88-/- TRIF-/- (dKO) mice, which lack all TLR signaling the 
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expansion of HSPCs was comparable to infected WT mice, suggesting that TLR signaling is not 
required for HSPCs activation during S. aureus infection (P. O. Scumpia et al., 2010).  
It was also proposed that the modulation of HSPCs function may also be mediated by TLR 
signaling in non-haematopoietic cells that compose their microenvironment.  In this study using 
BM mixed chimeric challenged with Escherlichia coli, it was established that endothelial cells 
produce increased level of G-CSF production in a MyD88-dependent mechanism, which results in 
emergency myelopoiesis and reduced BM cellularity in this model of infection (S. Boettcher et al., 
2014). 
Stress-induced haematopoiesis complex and dynamic processes integrate signals from the 
pathogen, HSPCs, BM stromal cells, and non-haematopoietic tissues. The aforementioned studies 
discussed in this section suggested that the TLR signaling impact in stress-induced haematopoiesis 
is pathogen-specific, can be deleterious or advantages and most likely characterized by 
redundancy with other mechanisms coping in each infectious context (J. L. Zhao and D. 
Baltimore, 2015). 
1.2.2.2 Regulation of Stress-induced Haematopoiesis by Cytokine Signalling 
In response to an infection a wide range of soluble factors are released locally, and as soon as its 
levels increase in serum they become available to impact in the BM niches for haematopoiesis. 
The soluble factors, as referred above, include PAMPs but also cytokines (colony-stimulating 
factors, interleukins and interferons) and chemokines, for which HSPCs express cognate receptors 
(H. Takizawa et al., 2012). 
Initial studies on the impact of infection in haematopoietic development focused in immune 
effector cells and committed progenitors, and the alterations were described as an homeostatic 
reaction to the increased demand of immune effector cells described as “emergency 
myelopoiesis/granulopoiesis” and “emergency lymphopiesis”. In order to maintain a reservoir of 
HSCs for the lifetime of an organism, these rare cells are in either a dormant or homeostatic 
proliferative state, but in the light of recent findings HSCs have assumed a preeminent role in the 
response to infection, because alterations in its function have been described in a wide range of 
acute and chronic infection models (M. T. Baldridge et al., 2011, K. Y. King and M. A. Goodell, 
2011). 
Many growth factors required for steady-state haematopoiesis may be present the serum in 
increased levels in inflammatory contexts such as, G-CSF, M-CSF, GM-CSF, IL-3, IL-6, and Flt3 
ligand, with the potential to modulate cell fate “decisions” both in non-committed and lineage-
committed precursors (H. Takizawa et al., 2012). Beside the release of haematopoietic growth 
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factors, during infection may occur the release of pro-inflammatory cytokines such as interferon 
(IFN)α/β, IFNγ and tumor necrosis factor (TNF), which have been implicated in the direct 
modulation of HSCs function in various pathogen-specific contexts (M. T. Baldridge et al., 2011). 
M-CSF, traditionally viewed as a lineage-specific cytokine, provides an example for the potential 
impact of a growth factor in increased availability in the HSCs cell-fate decisions, promoting 
higher availability of innate immune cells in response to an infection. M-CSF is strongly induced 
during infection and it was shown that high systemic levels of M-CSF could act on M-CSF 
receptor expressed on HSCs and induce the expression of the transcription factor PU.1, a key 
regulator of haematopoietic differentiation. In vivo experiments showed the induction of PU.1 
expression in HSCs after transfer to LPS-challenged hosts or after injection of recombinant M-
CSF. The adoptive transfer of in vivo M-CSF primed HSCs to non-stimulated recipients showed 
an increase in the GMPs:MEPs progenitors ratio in the spleen and an increased myeloid to 
lymphoid cell ratio in circulation, the ratios returned to baseline upon six weeks and long-term 
multi-lineage contribution of M-CSF-primed HSCs was not compromised (N. Mossadegh-Keller 
et al., 2013). 
Another example illustrating that alterations in haematopoiesis due to infection can impact 
positively in the immune response came from experimental model for malaria. In this model IFNγ 
signalling led to the emergence of a Lin- IL-7R+cKithi progenitor with myelolymphoid potential of 
differentiation that in vivo generated mainly myeloid cells. This alteration in haematopoiesis 
seemed to be advantageous in response to infection since when infection-induced atypical 
progenitors from infected mice were transplanted into non-irradiated mice infected prior to P. 
chabaudi infection, the recipient mice showed significantly lower parasitemia compared to 
untransplanted infected controls (N. N. Belyaev et al., 2010).  
The rapid activation of HSCs to proliferate and differentiate, often along the myeloid lineage, 
during infection in response to pro-inflammatory cytokines may be required, because enhanced 
haematopoiesis dependent solely on onwards progenitors could not be equipped to sustain the 
demand of effector cells required to resolve infection, and prevents the accumulation 
differentiation-ready progenitor cells in steady-state. If in acute conditions HSCs activation may 
assist in host defense, the continuous activation of HSCs during chronic inflammation or infection 
may be detrimental for HSCs function, impairing their ability to cope with future demands 
(proliferation-associated functional exhaustion) or increasing the rate of genetic mutation 
accumulation (neoplastic syndromes) (K. W. Orford and D. T. Scadden, 2008, C. Mirantes et al., 
2014). In humans several haematological disorders have been associated to the overproduction of 
proinflammatory cytokines and therefore increasing efforts have been made to clarify the impact 
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of these immunomodulators on HSCs function, with the aim to improve treatment of chronic 
inflammation and blood disorders (C. Mirantes et al., 2014, J. L. Zhao and D. Baltimore, 2015).  
Several studies have suggested that chronic IFN stimulation might lead HSCs to functional 
exhaustion that in long run might result in anergy or increased death susceptibility (M. T. 
Baldridge et al., 2011, C. Mirantes et al., 2014). 
Interferons are produced by immune cells in response to intracellular pathogens, such as viruses 
and bacteria, but also tumor cells. In steady-state IFNs are constitutively produced, albeit at very 
low levels. The Type I IFNs contain multiple IFNα species and a single IFNβ, which are expressed 
by many cell types. The type II IFNs are comprised solely by IFNγ, mainly produced by NK 
(Natural Killer) and T cells. The IFNs are important in the limitation of replication of virus 
through innate mechanisms (induction of anti-proliferative state and pro-apoptotic “antiviral 
state”), and in the generation of adaptive immune responses, in collaboration with other immune 
cells, to resolve infections and produce immunological memory to prevent reinfection (A. M. 
Prendergast and M. A. G. Essers, 2014). 
The Type I IFNs, IFNα and IFNβ/α signal through the IFNα/β receptor (IFNAR), and their potent 
expression can be induced by the viral RNA, which can be mimicked by the double-stranded RNA 
mimetic polyinosinic-polycytidylic acid (poly(I:C)). The type I IFN-inducible Mx1–Cre allele has 
been commonly used in mouse lines to eliminate genes flanked by loxP sites (floxed) in HSCs and 
other haematopoietic cells. In these mutant mice the expression of the Cre recombinase is 
controlled by the Mx1 promoter, since the expression of MX1 gene in heamatopoietic cells is 
induced by interferon α or β and by pI-pC (an interferon inducer), this system allows gene 
targeting in hematopoietic cells (R. Kuhn et al., 1995). It was first observed that poly(I:C) 
treatment induced the proliferation of HSCs both in mice containing or lacking the Mx1-Cre or 
floxed genes. Then, in WT mice poly(I:C)-mediated proliferation of homeostatic HSCs and also 
dormant HSCs (BrdU long-retainer cells), but this effect was prevented in in mice deficient for 
IFNAR. These findings suggested that IFNα signalling induced HSCs proliferation in vivo, which 
was quite a surprise at the data since it had been extensively showed in vitro that IFNα act as an 
inhibitor of cellular proliferation for multiple other cells types, including haematopoietic 
progenitors. These findings also should be considered in the interpretation of other studies using 
this conditional loss-of-function approach to study the biology of HSCs (M. A. G. Essers et al., 
2009). 
The functional relevance of chronic IFNAR signaling was demonstrated in vivo BM transplant 
(BMT) competitive assays. In mixed BM chimeric mice 50:50% wild type:Ifnar-/- upon eight 
challenges with poly(I:C) (every second day) and eight day of recovery, HSCs from WT donors 
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could not be detected and all the HSCs in BM, as well as the vast majority of mature cells derived 
from Ifnar-/-donor. These findings strongly suggested that chronic activation of IFN-α signaling 
significantly impairs HSCs function (M. A. G. Essers et al., 2009). 
A mechanism to explain the impact of type I interferon was proposed in a study by Pitetras et al. 
In this work, it was showed that IFN-α induced HSC proliferation by 12 h, with BrdU 
incorporation peaking after 1–3 days of poly I:C treatment, while upon 5-30 days of continuous 
administration of poly I:C the incorporation of BrdU in HSCs was at basal levels, suggesting that 
IFN-α challenge induces a rapid and transitory proliferation in HSCs, which rapidly return to a 
quiescent state during chronic exposure (E. M. Pietras et al., 2014). 
In subsequent experiments it was showed that HSCs chronically exposed IFN-α were functionally 
impaired compared to “intact” HSCs, in despite of returning to quiescence. IFN-Is have been 
shown to be pro-apoptotic in multiple cell types, therefore in subsequent experiments the 
expression of pro-apoptotic and pro-survival was assessed in HSCs challenged in vivo with poly 
I:C for either three (cycling) or seven (quiescent) days directly ex vivo and upon forced to 
proliferation in in vitro culture, transplantation, or 5-FU-mediated myeloablation. These 
esperiments lead to the proposal of the following model: in steady-state HSCs are largely found in 
quiescence and protected from pro-apoptotic signals, upon IFN-α exposition HSCs enter in cell-
cycle due to transitory down regulation of quiescence-enforcing mechanisms and are therefore 
vulnerable to pro-apoptotic signals, if IFNα levels remain elevated the HSCs return to quiescence 
to prevent IFN-α induced apoptosis, nonetheless if due to other stimuli they are forced to enter in 
cell-cycle p53-dependent proapoptotic gene program may be activated rendering HSCs highly 
susceptible to cell-death (E. M. Pietras et al., 2014). 
In humans there are studies establishing an association between inflammatory contexts and 
alterations in BM functions, therefore indicating that inflammatory stimuli have the potential to 
modulate humans HSCs functions. Across the few studies performed in human the pro-
inflammatory cytokines that are more prevalent were IFNγ and TNF, which expression was 
increased in BM of patients with myelodisplasic syndrome (MDS), idiopathic aplastic anemia and 
Fanconi Anemia (FA) (M. Kitagawa et al., 1997, L. G. Schuettpelz and D. C. Link, 2013). 
Additionally, alterations in haematopoiesis have been often reported among patient in anti-TNF-α 
agents and interferon therapeutic regimes (L. G. Schuettpelz and D. C. Link, 2013). For example, 
in BM samples from MDS patient it was found the expression of TNF and IFNγ mRNA, otherwise 
not detected in control samples and these results were then confirmed by immunohistochemical 
staining in BM sections (M. Kitagawa et al., 1997). 
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Aplastic anaemia (AA) is a clinical syndrome characterized by hypocellular BM and 
pancytopenia, which in the most severe presentations results in BM failure (BMF). There are 
inherited and acquired forms of AA: inherited forms have been associated to genetic defects, 
including DNA repair defects (Fanconi anemia, FA), abnormal telomere physiology (dyskeratosis 
congenita,) or abnormalities of ribosomal biogenesis (Shwachman-Diamond syndrome); it as been 
suggested that acquired forms of AA, are in most of the cases idiopathic and may result from the 
autoimmune response of cytotoxic T cells targeting HSPCs inducing apoptosis and BMF (A. E. 
DeZern and E. C. Guinan, 2014). 
In patients with idiopathic AA it was initially found that IFNγ concentration was increased in the 
supernatants of PB mononuclear cells (PBMNCs), as well as in the supernatant of stimulated BM 
T-lymphocytes, compared to healthy controls. Following theses experiments, IFNγ and TNF 
mRNA expression was detected in the BM of newly diagnosed patients, but not in the BM of 
healthy controls or AA patients treated with immunossupressive drugs. Furthermore, it was found 
that AA patient bear in their BM more CD4+ and CD8+ T cells compared to healthy controls, and 
these lymphocytes have an increased potential to produce IFNγ and TNF upon stimulation. 
Interestingly, it was found that in PB the fraction of T cells producing IFNγ and TNF was 
comparable among AA patients and controls, suggesting that “reactive” T cells may localize 
preferentially in BM were they exert their deleterious effects upon HSPCs (C. Dufour et al., 2001). 
More recently it was determined that an individual homozygous for a single mutation (in intron 1 
at position -874, T→A) that results in increased levels of IFNγ expression was associated to a 
higher predisposition to AA (B. Serio et al., 2011). 
According with the aforementioned findings it was proposed a model to explain the pathogenesis 
of AA: lymphocytes T are activated by an unknown antigen become autorreactive and sustain the 
anomalous secretion of pro-inflammatory mediators such as IFNγ and TNF, which by not yet 
completely defined mechanisms may impair effective haematopoiesis (C. Dufour et al., 2001). 
This proposed immunopathogenic model have been supported by several studies performed in 
experimental models of disease (F.-c. Lin et al., 2014, C. Arieta Kuksin et al., 2015).  
More recently it have been shown that CD4+ T cells play an important role in alterations observed 
at the haematopoietic progenitors during infection, using experimental models of disease for AA 
and human monocytic ehrlichiosis (HME) (Y. Zhang et al., 2013, F.-c. Lin et al., 2014, C. Arieta 
Kuksin et al., 2015) . 
For example, it was shown using mutant mice (IFNγ ARE-del mice), in which IFNγ is constantly 
expressed in T cells and NK cells that this is sufficient to promote AA phenotype (BM 
hypocellularity and pancytopenia). In the BM of IFNγ ARE-del mice it was determined that HSCs 
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(LSK CD34– Flt3– CD150+ cells) numbers were increase, MPPs were maintained and all the 
lineage-committed progenitors decreased. The functions of CMPs, GMPs, and MEPs were 
analyzed in vitro using colony-forming assay, in IFNγ ARE-del mice their ability to form colonies 
was significantly decreased, suggesting quantitative and qualitatively impairment. The functional 
impairment in differentiation was further evidenced by the accumulation in immature erythrocytes 
and a two-fold decrease in the mature erythrocytes, disruption in early B-cell differentiation and 
decreased potential of proliferation among lineage-committed progenitors. Using BM chimeras it 
was shown that it was a cell intrinsic defect, ARE-del èWT chimeras showed clinical signs of 
AA while WTèARE-del chimeras presented haematological parameters within the normal range. 
As such, this study suggested that abnormal expression of IFNγ have the potential to establish AA 
in mice, as shown by the capacity of its chronic expression to suppress efficient haematopoiesis in 
a cell-intrinsic manner (F.-c. Lin et al., 2014).  
In steady-state mature CD4+ T cells and CD8+ T cells reside in BM in low numbers, where 
priming of antigen-specific T cells can take place, and BM was found to be a privileged site for 
homing of memory T cells (F. Di Rosa and R. Pabst, 2005).  
During homeostatic traffic T cells migrate to the BM in response to chemokines, such as stromal-
cell derived factor-1a (SDF-1a or CXCL12), the ligand for the chemokine receptor CXCR4 
expressed in CD4+ T cells. Recently, it was shown that CXCR4 mediates migration of pathogenic 
T cells to the BM in an experimental model for lethal AA, characterized by pancytopenia, 
increased levels of IFNγ and TNF, all features found in patients with AA. In this study, it was 
reported that expression of CXCR4 was increased in T cells isolated the BM of AA mice and 
when the SDF-1a–CXCR4 interactions were pharmacologically prevented there was a significant 
reduction in BM T cells infiltration in AA mice compared to controls. Because it was showed in 
breast cancer models that NF-kB signaling modulates CXCR4 expression, the authors 
pharmacologically inhibited NF-kB signaling in AA mice. Blocking NF-kB signaling in AA mice 
prevented BM hypocellularity, BM T cell infiltration, pancytopenia and increased concentration of 
TNF and IFNγ in PB. Overall this study suggested that anomalous expression of CXCR4 
dependent on NF-kB-signaling may be one of the mechanisms underlying AA progression (C. 
Arieta Kuksin et al., 2015). 
The regulation of stress-induced haematopoiesis by infection is poorly understood, however 
studies using a wide range of infection models have been showing that activated immune cells act 
upon haematopoietic BM compartment. Also in the models of infections where alterations were 
reported, those were commonly associated to the increased expression of TNF and IFNγ (S. E. J. 
Cotterell et al., 2000a, L. G. Schuettpelz and D. C. Link, 2013, A. M. de Bruin et al., 2014), and 
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IFNγ has been appointed as a major regulator of functional activation of HSCs during infection 
(M. T. Baldridge et al., 2010, Y. Zhang et al., 2013).  
Initial studies performed in vitro showed that IFNγ decreased CFU activity of BM cells, as well as 
their long-term repopulating activity upon in vivo transfer. On the other hand, in vivo studies 
showed that upon immune challenge, IFNγ induced expansion of LSKs and impaired HSCs long-
term functions (M. T. Baldridge et al., 2010, A. M. de Bruin et al., 2014). 
The mouse model of M. avium infection allowed the study of the impact of infection on HSCs 
function in a chronic non-cytopenic systemic infection. In BM it was reported an increase in the 
proportion of cycling of LT-HSCs (LSK CD34- Flt3- or LSK CD150+, or LSK Side Population) 
and an increase in the absolute number of ST-HSCs (LSK CD34+ Flt3-) and MPPs (LSK CD34+ 
Flt3-), while the number of myeloid lineage committed precursors was decreased. The increased 
proliferation of HSCs accounted for functional impairment, in BMT assays LT-HSCs recovered 
from M. avium-infected mice showed impaired engraftment in comparison to LT-HSCs derived 
from not infected mice. In vitro, HSCs proliferated when challenged with purified mouse 
recombinant IFNγ (rIFNγ), and no increase in apoptosis was reported. In addition, in vivo 
challenge with rIFNγ induced a significant increase in the fraction of HSCs in cell division. The 
alterations in haematopoietic progenitors during M.avium infection were abrogated in mice lacking 
IFNγ receptor 1 (Ifngr1) or the Stat1, encoding the downstream signal transducer for IFNγ 
receptor subunit 1. This set of experiments suggested that the increase in proliferating HSCs and 
subsequent functional impairment during M. avium infection could be mediate solely by IFNγ (K. 
Y. King et al., 2010). 
Other example, come from mouse model for HME which is an infectious disease caused by the 
obligate intracellular pathogen Ehrlichia chaffeensis, characterized by anemia and 
thrombocytopenia. In mice, Ehrlichia muris infection was used as experimental model of HME 
and it was found that the infection was associated to the expansion of LSK cells in BM dependent 
of IFNγR signalling. In WT mice at day 8 post-infection (p.i.) were reported alterations in PB, 
decrease in hemoglobin, platelets, lymphocytes and increase in monocytes concentrations, and all 
these manifestation of disease were much less expressive in IFNγR deficient mice (K. C. 
MacNamara et al., 2011b). In following studies using this same experimental model it was 
determined that in BM of infected mice CD4+ T cells mice play a non-redundant role in LSK 
expansion being the main source of IFNγ (Y. Zhang et al., 2013). 
Fanconi anemia (FA) is a rare genetic disease characterized by BMF and susceptibility to cancer, 
most often acute myelogenous leukemia. Most genetic alteration described so for were in genes 
implicated in DNA repair. In a clinical study, it was showed that the frequency of BM cells from 
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FA patients expressing TNF and IFNγ was very increased compared to BM cells from controls. 
Interestingly, using colony-forming assays it was reported that in FA patients the number of CFU-
E was lower compared to the controls, but upon addition of anti-TNF fusion protein the number of 
CFU-E resulting from BM cells derived from FA patients increased significantly, while in control 
BM cells the addition of anti-TNF had no impact. These finding suggested that TNF may 
participate in the development of erythropoietic failure in FA patients, and its reasoned to 
speculate that this might also true regarding other haematopoietic lineages not assessed in this 
clinical study (C. Dufour et al., 2003). The increased production of TNF in FA was confirmed by 
other studies in humans and in experimental models of the disease (W. Du et al., 2014). 
TNF anomalous expression is commonly associated to a wide range of haematopoietic alterations, 
nonetheless the mechanisms by which this pro-inflammatory regulates stress-induced 
haematopoiesis renain unresolved. Different in vitro studies suggested adverse and beneficial 
impact of TNF in HSPCs growth and development (T. Tian et al., 2014). More recently, a study in 
vivo reported that BM cells from TNF receptor deficient mice showed competitive advantage over 
WT BM cells in their ability to long-term reconstitute myeloid and lymphoid cell lineages in 
myeloablated recipients. In addition, administration of TNF results in reduced BM cellularity, that 
is further evident in mice treated with 5-FU, suggesting that in vivo TNF signaling may be 
detrimental for HSCs functions (C. J. H. Pronk et al., 2011). 
The sum of the studies reported in this section pointed out for a beneficial role of stress-induced 
haematopoiesis in acute infection, favoring the formation of immune cells in enough number to 
mount an effective response against an pathogen in detriment of erythropoiesis, which transient 
suppression might be tolerated and leaves more growth factors and space available in the BM to 
assist emergency myelopoiesis. Nonetheless if the pro-inflammatory stimuli are chronically 
sustained it might lead in first instance to anemia and thrombocytopenia, since erythrocyres and 
platelets are required in very higher number and have a small life span, and in more severe cases it 
may underlie the establishment of pancytopenia due to exhaustion of HSCs function rendering the 
individual more vulnerable to subsequent infections or BMF.  
The impact of cytokines in the regulation of HSCs function is far from fully clarified, therefore 
more studies are required to understand the modulation of HSCs responses to infection and injury, 
to improve diagnostic, prophylactic and therapeutic approaches to the immense range of 
debilitating haematological alterations that afflict patients suffering from autoimmune disorders 
and chronic infections. 
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1.3 VISCERAL LEISHMANIASIS 
1.3.1 Overview of Visceral Leishmaniasis 
Visceral leishmaniasis (VL) is an intracellular infection caused by the protozoan Leishmania 
donovani and L. infantum in vertebrate hosts, including humans. The main targets of parasitation 
in mammalian host are the liver, the spleen and the BM, where the parasites may establish a 
chronic infection (P. Kaye and P. Scott, 2011). 
Leishmaniasis is a vector-borne parasitic disease caused by protozoan of the genus Leishmania, 
consisting of trypanosomatid protozoans belonging to the order Kinetoplastida. There are 
approximately twenty species identified and different species types have been characterized 
among different endemic areas. Leishmania is found in the Old World (Europe, Asia and Africa) 
and in the New World (Central and South America), where female sandflies, belonging to the 
genera Phlebotomus in the Old World and Lutzomyia in the New World, are the vectors for 
Leishmaniasis transmission (D. Pace, 2014). 
The propagation of leishmaniasis relies on the accomplished transmission between the sandfly 
vector and a mammalian reservoir. Leishmania parasites have a complex life-cycle: 1) in the 
sandfly parasites reside in the gut where they multiply as free flagellated promastigotes, 2) then the 
parasites differentiate into non-dividing ‘metacyclic’ promastigotes transmitted in the course of a 
sandfly blood meal, 3) finally within the mammal host through additional morphological changes, 
parasites differentiate into non-flagellated amastigotes that multiply as obligatory intracellular 
parasites mostly in mononuclear phagocytes, eventually parasites are released to infect other cells 
when an infected host cell bursts, 4) if an infected individual is again bitten the cycle of 
transmission resumes (P. Kaye and P. Scott, 2011). 
VL is still a neglected tropical infection and responsible for significant morbidity and mortality in 
the developing world, particularly in India, Sudan, Nepal, Bangladesh, and Brazil. The 
epidemiological impact of this disease can only be estimated, due to insufficient epidemiological 
supervision and lack of appropriate diagnostic “tools” in endemic areas. The most recent estimates 
indicated that the number of new VL cases ranges between 0.2 to 0.4 million and 20,000 to 40,000 
leishmaniasis deaths per year (D. Pace, 2014).  
The main groups of individuals infected with VL vary on endemic geographic areas, for example 
in Europe, North Africa and West and Central Asia, children between one and four years old are 
the most affected group, while in East Africa VL occurs more frequently in adults. Upon infection 
the emergence of clinical symptomology can take ten days to over one year, and the main 
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manifestations include fever, anorexia, weight loss, abdominal distension due to splenomegaly and 
hepatomegaly, hyperglobulonemia and disturbances in the haematopoietic homeostasis, including 
anemia, leucopenia and thrombocytopenia (D. Pace, 2014).  
Post-kala-azar dermal leishmaniasis (PKDL) may occur as a complication of VL, months to years 
after treatment of VL. It takes place mainly in India, Kenya, and Sudan in 20-50% of treated 
patient. In PKDL patients present with macules, papules, or nodules in the skin as a result of 
dermal parasitic persistence, which constitutes an important reservoir for transmission (A. Ismail 
et al., 2006). 
VL is fatal if left untreated and due to lack of investment an effective vaccine is not yet available 
(A. Maroof et al., 2012). The most commonly drugs used to treat infected people are pentavalent 
antimony and amphotericin B (and its liposomal derivatives), which have been associated with 
parasite resistance and increased drug toxicity, caused by the need for long periods of treatment. 
The pharmacological treatment is highly effective however the frequency of relapses within six to 
twelve months is significant, and even with treatment patients may succumb to VL-associated 
pathology or increased vulnerability to opportunistic infections. In the absence of treatment, VL 
patients may develop anaemia, haemorrhagic bleeding secondary to low platelets, secondary 
infections and death within two to three years (D. Pace, 2014). 
1.3.2 Immunopathology in VL 
In order to develop new effective prophylactic or therapeutic approaches intrusive techniques 
would be required to analyze responses in VL patients, therefore our current understanding of the 
host immune response during VL largely derives from studies performed in mice (P. M. Kaye et 
al., 2004). 
In mice, it was found that parasites establish chronic infection in the spleen and BM (S. E. J. 
Cotterell et al., 2000b), whilst the infection in the liver was self-resolving within 6–8 weeks and 
relies on the development of a Th1-dominated granulomatous response. In the liver parasites are 
mostly found in Kupffer cells (KCs) the most prevalent population of hepatic resident 
macrophages, that upon infection release chemokines including CCL3 (MIP-1a), CCL2 (MCP-1) 
and CXCL10 (gIP-10), which results in the rapid increase of monocytes, neutrophils and T cells. 
Activated T cells are responsible for the secretion of Th1 cytokines such as IL-12, IFNγ, TNF, 
lymphotoxin-α (LT), GM-CSF and IL-2. These cytokines are required for the activation of KCs 
and other macrophage to produce leishmanicidal molecules such as reactive oxygen intermediates 
(ROI) and reactive nitrogen intermediates (RNI) and the establishment of granulomas (A. C. 
Stanley and C. R. Engwerda, 2007). 
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In the spleen, IFNγ-producing Th1 responses are not able to control parasite replication, although 
why this happens is unclear, various mechanisms have been proposed. The presence of high levels 
of TNF, which is a key cytokine for parasite clearance in the liver, promotes the disruption of the 
splenic marginal zone micro-architecture, impeding the migration of DCs and naive T cells to the 
T-cell area. Furthermore, the presence of suppressive CD4+ T cells secreting IL-10 and IFNγ was 
reported, and these cells have also been observed in VL patients (S. Staeger et al., 2010). More 
recently, it was shown that at 28 days p.i. with L. donovani there was an increase in the frequency 
of DCs CD11clo CD45RB+ in the spleen and in vitro cells with this same phenotype after 
lipopolysaccharide (LPS) stimulation produced large amounts immunorregulatory cytokine IL-10 
(A. Wakkach et al., 2003). 
BM has long been recognized as a site of infection in mice (V. Leclercq et al., 1996) but much less 
is known about the relationship between parasite dynamics in this organ, changes in cytokine and 
chemokine expression, and local haematopoietic activity. Nevertheless, a striking correlation 
between increased haematopoietic activity and parasite growth in both the spleen and BM has been 
noted previously (S. E. J. Cotterell et al., 2000a).  
1.3.3 Haematopoietic alterations during VL in experimental models of disease 
Inbred mice have been widely used to study the VL immunology due to the genetic homogeneity 
among strains and the great availability of “tools” for immunological assessment. Nonetheless the 
course of infection varies considerably between mice and human, for instance in mice VL is not 
fatal, the infections becomes chronic in the spleen but it is self-resolving in the liver with the Th1-
dependent formation of granulomas (P. M. Kaye et al., 2004).  
Another experimental model widely used to study VL is the Syrian golden hamster (Mesocricetus 
auratus), despite of limited availability of immunological reagents and more genetic variability. 
Syrian golden hamsters are very susceptible to L. donovani infection requiring a much smaller 
inoculum of parasites and the progression of disease during the course of infection is much closer 
to humans; persistence of parasites in the BM, spleen, and liver, hepatosplenomegaly, anaemia, 
leucopenia and death by 9–10 weeks after infection (J. M. Requena et al., 2000). In hamsters it 
was shown that regardless of the infection-driven high expression of Th1 cytokines in the liver, 
spleen, and BM, macrophages were enable to induce Nitric oxide synthase 2 (NOS2) activity, 
which is an essential antileishmanial effector mechanism in mice. The expression of IL-10 and 
TGF-β was significantly increased in infected hamsters, and both cytokines are known inhibit 
macrophage activation and NOS2 expression (P. C. Melby et al., 2001). 
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The establishment of anemia in the Syrian golden hamster during the course of infection is well-
characterized, initial studies reported drop a in haemoglobin levels followed by a significant 
increase in the reticulocyte in circulation and suggested that osmotic fragility was on the basis of 
anaemia (T. Biswas et al., 1992). 
More recently an extensive study focusing on the impact of L.donovani infection on erythropoiesis 
in the spleen and BM of infected Syrian hamsters was performed. In this study it was described 
that in infected hamster the number of erythrocytes and leukocytes were decreased. Using colony-
forming assays, it was determined that the frequency of erythroid progenitors was increased both 
in BM and spleen, indicating that disruption of erythropoiesis might occur in later stages of 
differentiation and not due to lack of progenitors. Subsequent experiments showed that the 
expression of erythroid differentiation genes (alpha-globin, beta-globin, and ALAS2) was 
decreased in BM while increased in the spleen of infected hamster compared to the controls. The 
expression of mRNA for IL-10, TGF-β, and IFNγ mRNA was highly increased in BM and the 
spleen of infected mice and all these cytokines have been showed to be able to inhibit 
erythropoiesis. Furthermore, the fraction of apoptotic erythroblasts was higher in infected hamsters 
than control hamsters. According to these findings it was suggested that the occurrence of anemia 
could be due to an impairment of terminal differentiation of erythrocytes and/or increased 
apoptosis of erythroblasts that resulted in the establishment of emergency extramedullary 
erythropoiesis in the spleen (W. P. Lafuse et al., 2013). 
In mice experimental model of VL, chronic infection has been associated with alteration in the 
haematopoietic progenitors and in the stroma of haematopoietic sites. During the course of L. 
donovani infection, it was observed that the increase in parasite burden in the BM and spleen was 
associated with a gain in HSPCs numbers at both haematopoietic sites. Using colony-forming 
precursors assays it was found that in the BM there was an increase in colony forming unit-
granulocyte, erythrocyte, monocyte, megakaryocyte (GEMM-CFU), CFU-granulocyte, monocyte 
(GM-CFU) and burst forming unit–erythrocyte (BFU-E), while in the spleen there was a specific 
increase in GM-CFU. These findings suggested that the infection could induce an increase in the 
egress of haematopoietic precursors and/or in the rates of haematopoiesis in extramedullary sites 
(S. E. J. Cotterell et al., 2000a). 
In the same study, it was shown that the frequency of cycling progenitors in the spleen of scid 
mice was not increased following infection, while in the BM the frequency of cells in proliferation 
increased about 1.5 fold in both the infected scid mice (lacking functional T and B lymphocytes) 
and infected BALB/C mice. In addition, it was determined that there were higher levels of mRNA 
for the growth factors G-CSF, M-CSF and GM-CSF in the BM and spleen from infected scid mice 
and infected BALB/C, during chronic phase of infection. This upregulation of the colony 
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stimulating factors was observed in the BM of infected BALB/C and scid mice but not in the 
spleen of the latter. Taken together the findings suggested the modulation of haematopoiesis might 
rely that different cellular and molecular signaling pathways at these two distinct sites during 
chronic infection with L. donovani (S. E. J. Cotterell et al., 2000a). 
Studies have shown that BM macrophages could become infected with L. donovani both in vivo 
and in vitro, but there were no indication that a significant number of progenitors harbored 
parasites. Infected BM derived macrophages showed an increased efficiency to support the 
formation of GM-CFU in vitro. When BM or spleen cells were plated in methylcellulose in the 
absence of exogenous growth factors, the addition of 14M1.4 (BM derived macrophage-like cells 
line) promoted formation of CFU-GM, BFU-E, and additionally in BM, CFU-GEMM. 
Furthermore, the addition of L. donovani-infected 14M1.4 cells instead to these assays was 
associated to a specific increase in CFU-GM formation. The infected macrophages express more 
GM-CSF and TNF, and the addition of neutralizing antibodies to the cultures caused a reduction in 
the formation of GM-CSF. These in vitro experiments suggested that L donovani infection has the 
potential to selectively enhance myelopoiesis, acting upon the stromal macrophages (S. C. Smelt et 
al., 2000).  
In vitro splenic stromal cells from mice infected with L. donovani had an enhanced capacity to 
direct haematopoietic progenitors (BM Lineage- cells) toward a regulatory dendritic cells (rDCs) 
phenotype in vitro, CD11clow CD45RB+, while DCs derived from co-cultures of BM Lineage- cells 
with naive stroma cells or GM-CSF protocol were CD11chi. These in vitro generated rDCs 
expressed higher levels of IL-10 compared to the controls (GM-CSF derived DCs) and using co-
cultures with primed rDCs and it was showed that these could induce CD4+ T cells to produce 
immunossupressor IL-10, while primed GM-CSF derived DCs induced CD4+ T cells to secrete 
pro-inflammatory IFN-γ, under the same experimental conditions (M. Svensson et al., 2004).  
Following in vitro studies, using transwell co-cultures suggested that the infection of the MBA-1 
cell line (BM derived stromal cell line) with L. donovani could promote the differentiation of 
haematopoietic precursors (BM Lin- cKit+) towards immunossupressor DCs in vitro. When CD4+ 
T cells were stimulated either with GM-CSF-LPS-stimulated DCs alone, or in the presence of 
CD11c+ DCs differentiated in co-culture with control MBA-1 cells, or CD11c+ cells differentiated 
in co-culture with infected MBA-1 cells, it was observed that DCs generated in the presence of 
MBA-1 infected cells could prevent T cells proliferation, suggesting that they were functionally 
immunossupressor. It was determined that in the spleen of infected mice the mRNA expression of 
CCL8 and CXCL12 was increased. Taking advantage of the transwel co-culture system and using 
neutralizing Abs for CXCL12 and CCL8 it was determined that these two chemokines collaborate 
in the recruitment of HSPCs induced by MBA-1 cell line in vitro. All these finding suggested that 
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infected splenic stromal cells could induce the increase seeding of HSPCs and modulate their 
differentiation favoring the generation of rDC, during L. donovani infection (A. T. Nguyen Hoang 
et al., 2010).  
Taken together the aforementioned studies suggest that the L. donovani infection might regulate 
haematopoiesis by modulating the function of cells that compose the haematopoietic supporting 
stroma.  
Recently our laboratory reported that alterations in peripheral blood (PB) also take place in mice 
chronically infected with L. donovani (28 days post-infection), such as a significant decrease in the 
number of erythrocytes (normocytic anemia), leukocytes (leucopenia) and platelets 
(thrombocytopenia) which dropped 36.7%, 43% and 88%, respectively in infected mice compared 
to controls. Within the leukocytes compartment, it was also noticed that there is an inversion in the 
T cell:B cell relation, in healthy animals there are more B cells than T cells but upon infection the 
number of T cells in circulation was almost twice that of the B cells (F. A. d. Pinho, 2015). 
The histopathologic evaluation of the BM from mice chronically infected with L. donovani 
revealed significant alterations in the myeloid/erythroid ratio, with infected mice bearing more 
myeloid lineage cells and less mature erythrocytes. Other morphological alterations were also 
reported, such as asynchronous nuclear-cytoplasmic maturation (reflecting delayed or incomplete 
nuclear maturation relative to cytoplasmic development), presence of megalocytes and binucleated 
erythroid cells, among other atypical cells. Additionally, profound alterations were described in 
BM architecture, in infected mice there was significant increase in cells expressing the 
macrophage specific marker F4/80, and in further characterization a significant alteration in the 
distribution of different mature myeloid cell populations within the BM of infected mice was 
noticed (F. A. d. Pinho, 2015). These findings suggested that haematopoietic alterations in BM 
during VL are clinically relevant being expressed in significant decrease of haematopoietic 
components of PB, and indicate that impaired haematopoiesis could be one of the mechanisms 
underlying cytopenias in chronic VL. Nonetheless the mechanisms underlying the impact of 
infection on haematopoiesis and its consequences to the immune responses to VL are yet to be 
determined.  
1.3.4 Haematopoietic alterations during VL in humans 
In humans, a wide range of alteration to the haematopoietic system following L. donovani 
infection have been described, which are reflected in the haematopoietic composition of PB and 
BM cellularity. The alterations in PB are very common but the degree of alteration varies 
considerably in terms of severity (N. Varma and S. Naseem, 2010). 
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Normochromic normocytic anemia was described as a common finding among VL patients in 
several clinical reports, both in adults and children. The presentation of anaemia is quite variable 
amongst patients, accounting for mild to severe anaemia with haemoglobin values ranging from 
2.4 to 8.3 g/dl, compared to 11.5 to 18g/dl normal reference values (G. E. Cartwright et al., 1948, 
N. Marwaha et al., 1991, N. A. M. Aljurayyan et al., 1995). Various mechanisms have been 
proposed to explain the onset of anemia in VL patients: haemolysis in spleen and liver, 
haemodilution due to expansion of the plasma volume, inhibition of erythrocyte enzymes, and 
immune mechanisms of haemolysis such as increased vulnerability to complement and presence of 
anti-erythrocyte antibodies (N. Varma and S. Naseem, 2010). 
According with several clinical reports, leucopenia was reported in over 60% of VL patients and it 
was characterized by low number of neutrophils and eosinophils in circulation and mild 
lymphocytosis (G. E. Cartwright et al., 1948, N. Marwaha et al., 1991, N. Varma and S. Naseem, 
2010, Y. Agrawal et al., 2013). 
Thrombocytopenia has been reported as a later occurrence in the course of infection. The values 
for platelets number varied considerably among patients ranging from 4-633 x 109/l, and over 
50%-85% of patients were thrombocytopenic according to different clinical reports, both in adults 
and children. Antibodies against platelets have not yet been reported in VL patients and the most 
consensual explanation for thrombocytopenia have been the splenic sequestration and progressive 
loss of hepatic function, the main responsible for thrombopoietin production in adult (G. E. 
Cartwright et al., 1948, N. Marwaha et al., 1991, N. A. M. Aljurayyan et al., 1995, G. A. Hamid 
and G. A. Gobah, 2009).  
Splenic sequestration has been appointed as the main cause behind peripheral cytopenias in VL 
patients but cannot account for the emergence of BM alterations. The alterations most commonly 
described in BM aspirates included erythroid hyperplasia, increased frequency of plasma cells, 
increased frequency of granulocytic and megakaryocyte immature forms, dyserythropoeisis, bi and 
multinuclearity in the erythroid series and histiocytic hyperplasia, suggesting that alterations in 
haematopoiesis could contribute to pancytopenia (K. K. Dhingra et al., 2010, N. Varma and S. 
Naseem, 2010). However the degree of BM alterations was not correlated to the level of BM 
parasitemia (N. Varma and S. Naseem, 2010). Furthermore, several clinical reports described 
pancytopenia in VL patients followed by BM multilineage myelodisplasia reminiscent of true 
myelodysplastic syndrome (MDS), which could not be explained by the presence of 
hypersplenism, suggesting the presence of ineffective haematopoiesis (N. Yarali et al., 2002, P. 
Kopterides et al., 2003, G. M. de Vasconcelos et al., 2014). 
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The onset of pancytopenia extensively contributes to the morbidity and mortality following L. 
donovani infection; therefore more efforts should be made to elucidate the impact of infection in 
haematopoiesis. Understand the mechanism underlying the establishment of haematopoietic 
dysfunction in VL patients would contribute to the development of better clinical approaches and 
prevent fatal outcomes due to massive bleeding or increased vulnerability to secondary infections.  
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1.4 AIMS 
It is well established that haematopoietic dysfunction (notably various forms of cytopenias) is 
associated with human VL, and may contribute to the disease outcome. However the mechanisms 
underlying the impairment of haematopoietic function are poorly defined (G. E. Cartwright et al., 
1948, N. Varma and S. Naseem, 2010). The aim of this thesis was to characterize the alterations in 
BM haematopoiesis during experimental infection with L. donovani and establish whether there is 
a correlation with the establishment haematopoietic dysfunction in the periphery.  The specific 
aims were as follows: 
Chapter 3 
• To characterized alterations in BM haematopoiesis;  
• To examine phenotypic alterations of LT-HSCs;  
• To examine functional alterations of LT-HSCs;  
• To relate the alteration in the proliferative status of LT-HSCs with changes in the 
expression of selected transcription factors. 
Chapter 4 
• To examine alterations in cellular components of the BM microenvironment; 
• To establish whether there was a correlation between changes in cellular components of 
BM and alterations in haematopoiesis;  
• To characterize phenotypic and functional changes in BM T cells and assess the role of 
CD4+ T cells in regulating changes in haematopoiesis;  
• To examine the specific contributions of IFNγ and TNF signalling in haematopoietic 
dysfunction. 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 ANIMALS 
Mouse lines C57/BL6 (Black 6 (B6)), (B6).CD45.1, B6.CD45.2, B6.CD45.1xCD45.2 and 
B6.Rag2KO.CD45.1Cg (Z. Y. Hao and K. Rajewsky, 2001) used in this study, were bred and 
maintained under SPF conditions at the Biological Services Facility (BSF) within the University 
of York.  
B6.Myc-eGFP were originally developed by Dr. Ching-Yu Huang (Department of Pathology and 
Immunology, Washington University School of Medicine, St. Louis, USA) (C.-Y. Huang et al., 
2008). Both B6.Myc-EGFP mice and derived BM cells were kindly provided by Dr. Dinis Pedro 
Calado (Cancer Research UK, The Francis Crick Institute London, United Kingdom). BM cells 
from mice lacking the ifngr2 gene (IFNγ-R2 KO) on B6 background were generously provided by 
Dr. John Grainger (Faculty of Life Sciences, University of Manchester, United Kingdom)(B. F. 
Lu et al., 1998). Tnfrsf1-dKO B6.129S mice (TNF receptor double KO) were originally obtained 
from the Jackson Laboratory (stock no. 003243) followed by subsequent backcrossing for at least 
ten generations to C57BL/6 mice at the Lund University animal facility. Tnfrsf1-dKO mice were 
originally generated through the interbreeding of mice deficient for Tnfrsf1a (or Tnfr-p55, 
generated on a C57BL/6 background) with mice deficient for Tnfrsf1b (or Tnfr-p75, generated on 
a 129 background) (J. J. Peschon et al., 1998). Dr. Bengt Johansson Lindbom (Division of 
Immunology, Faculty of Medicine Lund University, Sweden) generously provided BM cells from 
TNF receptor double KO mice. IFNγ-KO (B6.129S7-Ifngtm1Ts/J, stock no. 002287) mice, in B6 
background, were obtained from the Jackson Laboratory (D. K. Dalton et al., 1993). 
All mice were females between 5-8 weeks of age at the start of experimental work, except for the 
experiment with B6.Rag2KO.CD45.1Cg that included in the naive controls male mice. All 
experiments in this thesis were carried out with the approval of the UK home office (United 
Kingdom Home Office Project License PPL 60/4377) and under ARRIVE guidelines. 
2.2 INFECTIONS 
Mice were infected via the lateral tail vein with 3x107 amastigotes of the Ethiopian strain of 
Leishmania donovani (LV9), maintained by passage in B6.Rag2KO.CD45.1Cg and B6. EYFPKI. 
Rag1KO immunodeficient mice. Amastigotes were isolated from infected spleens. The infected 
spleens were removed following CO2 euthanisation and dislocation of the neck. The spleen was 
homogenized in RPMI 1640 medium (Gibco, Paisley, UK) in a glass homogenizer (Fisher 
Scientific, UK), the resulting suspension was transferred to 50 milliliters (ml) Falcon tube 
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(Sarstedt AG & Co, Germany) and centrifuged at 137 G for 5 minutes at room temperature (RT) 
in a Heareus Multifuge 3S-R (DJB labcare, UK). The supernatant was retained and transferred to 
a 50ml Falcon tube coated with 25mg saponin (BDH, Leicestershire, UK) per 20ml supernatant, 
for 5 minutes at RT to lyse erythrocytes. The suspension was washed with in RPMI 1640 medium 
at 2063 G at 37oC for 10 minutes three times. Finally, the pellet was suspended in RPMI 1640 
medium and passed through a 26-guage needle (BD Biosciences, USA) 2-3 times to break up 
clumps of parasites using a 10 ml syringe (BD Biosciences, USA). Parasites were counted using a 
Thomas bacteriological counting chamber (Weber Scientific International, Middlesex, UK).  
Spleen parasite burden was determined from impression smears following methanol fixation and 
Giemsa staining. Parasite burden was expressed as Leishmania-Donovani units (LDU), where 
LDU was equal to the number of parasites per 1,000 host nuclei times the organ weight in 
milligrams or, alternatively, it was expressed as number of parasites per 1,000 host nuclei. BM 
aspirates from the iliac crest were removed with the aid of a 23G needle and a 5ml syringe, placed 
onto a slide (Thermo Scientific) and squashed between two slides (“squash” technique). Dr. 
Flaviane Pinho performed this procedure. Smears were then fixed with methanol and stained with 
Hemacolor Rapid staining of blood smears (Merck, Germany). The parasite burden was 
determined microscopically as the number of parasites per 1,000 host nuclei. 
2.3 CELL ISOLATIONS 
2.3.1 Bone Marrow cells isolation 
Mice were sacrificed by CO2 euthanisia and followed by dislocation of the neck. The tibias and 
fibias were removed and placed into a petri dish containing Dulbecco's Modified Eagle Medium 
(DMEM) (Gibco, Paisley, UK). All the fat and muscles were removed from the bones using a 
scalpel (Swann-Morton, Sheffield, UK) and the very edges of the bones were cut. Each bone was 
flushed with 10 ml of phosphate buffered saline (PBS) 1x with 2% HyClone foetal calf serum 
(FCS) (purchased from Thermo Fisher Scientific (Loughborough, UK) and heat inactivated by 
incubating in a 56°C water bath for 30 minutes) and forced through a 70µm strainer (Scientific 
Laboratory Supplies (SLS), East Riding of Yorkshire, UK) into a 50 ml Falcon tube. The cell 
suspensions were centrifuge for 7 minutes at 309 G at 4oC, and the resulting pellets were 
suspended in 1ml of ACK Lysing Buffer (Gibco, Paisley, UK) for 2 minutes at RT to lyse the 
erythrocytes. After adding 18 ml of 1x PBS with 2% FCS, the cell suspensions were centrifuged 
at 309 G for 10 minutes at 4oC and the resulting pellets suspended in 10 ml of complete DMEM 
(DMEM containing 10% of FCS, 100 U/ml penicillin (Sigma-Aldrich, Dorset, UK) and 100 µg 
(milligrams)/ml streptomycin (Sigma-Aldrich, Dorset, UK). The cell viability and concentrations 
were assessed manually by dye exclusion with Trypan Blue (Sigma-Aldrich, Dorset, UK) and 
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counted on an Improved Neubauer haemocytometer (Weber Scientific International, Middlesex, 
UK) or using the Vi-CELL Cell Viability Analyzer (Beckman Coulter, HighWycombe, UK) 
(adapted from (S. E. J. Cotterell et al., 2000a)). 
2.3.2 Spleen cells isolation 
Spleens were removed from sacrificed animals and placed in a petri dish containing RPMI-1640, 
and all the fat and muscle were removed using a scalpel. The tissue was forced through a 70 µm 
(micrometers) strainer using the back of a 10 ml syringe into a 50ml Falcon. Cell suspensions 
were centrifuged at 309 G for 7 minutes at 4oC, the resulting pellets were suspended in ACK 
lysing Buffer for 5 minutes to lyse erythrocytes. After adding 18 ml of 1x PBS with 2% FCS, the 
cell suspensions were centrifuged at 309 G for 10 minutes at 4oC and the resulting pellets were 
resuspended in 10 ml complete DMEM. The cell viability and concentration were assessed 
manually by dye exclusion with Trypan Blue and counted on an Improved Neubauer 
haemocytometer or using the Vi-CELL Cell Viability Analyser (adapted from (S. E. J. Cotterell et 
al., 2000a)). 
2.4 FLOW CYTOMETY AND BM TRANSFER ASSAYS 
2.4.1 Staining for surface markers 
HSPCs were assessed according with the phenotype for expression of surface markers displayed 
in supplementary Table 2.1. Cell suspensions were diluted to a concentration of 20-30 x 106 
cells/ml, and then 200 ul (microliters) were transferred to individual wells on a 96 round bottom 
well plate (Sarstedt AG & Co, Germany). The cell suspensions were incubated for 20 min at 4°C 
with 0.125µg/100 µl fragment crystallizable region receptor (FcR block) (CD16 (Fc gamma III 
Receptor) and CD32 (Fc gamma II Receptor); eBioscience) and then centrifuged for 7 min at 309 
G at 4°C. The supernatants were discarded and the pellet was suspended in optimized 
concentration of surface antibodies (Table 2.2) and fixable live-dead dye (Invitrogen, Paisley, 
UK) diluted in 1x PBS 1% FCS and left at 4°C for 30 minutes in the dark. Plates were centrifuged 
for 7 min at 309 G at 4°C, supernatants were discarded and the cells were washed twice in 1x PBS 
1 % FCS by centrifugation at 309 G for 7 min at 4°C. When only surface staining was performed, 
cells were fixed post-washing in 200 µl 2% formaldehyde (PFA) (Sigma-Aldrich) for 20 min at 
4°C in the dark, followed by two washes with 1x PBS 1% FCS by centrifuging at 309 G for 7 min 
at 4°C. Finally, cells were suspended in 400 µl of 1x PBS 1% FCS and stored protected from light 
at 4°C until acquisition on either the BD LSR Fortessa X-20 (BD Biosciences, Oxford, UK) or the 
CyAn ADP analyzer (Beckman Coulter, High Wycombe, UK). 
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Table 2.1 - Surface markers used to characterize HSPCs by flow cytometry analysis 
 
2.4.2 Intracellular staining for cytokines  
Cell suspensions were diluted to 3x107 cells/ml in complete DMEM and 200 µl were transferred 
to individual wells on round bottom 96 well plates. Unstimulated cells were used as controls. For 
stimulation, required volumes of Phorbol-12-myristate-13-acetate (PMA) (Sigma-Aldrich) and 
ionomycin (Sigma-Aldrich) were added to final concentrations of 10 ng/ml of PMA and 1 µg/ml 
of ionomycin to the cells. Cells were then incubated at 37°C in 5% CO2 for 2 hours. Brefeldin A 
(Sigma-Aldrich) was then added to each well at a final concentration of 10 µg/ml and the cells 
incubated for a further 3 hours at 37 °C in 5% CO2. The plates were centrifuged at 309 G for 7 
minutes at 4°C, the resulting pellets suspended in complete DMEM and then stained as described 
in section 2.4.1. Following surface staining the cells were fixed in 2% PFA and washed twice 
with 1x PBS 1% FCS by centrifuging at 309 G for 7 minutes at 4°C, and suspended in 200 µl of 
permeabilisation buffer (1x PBS, 1% FCS, 0.2% saponin and 0.5 % bovin serum albumin (BSA) 
(Sigma-Aldrich, Dorset, UK)). The cells were centrifuged at 309 G for 7 minutes at 4°C and the 
pellets suspended in optimized concentrations of intracellular antibodies diluted in 
permeabilization buffer (Table 2.2) and left at 4°C for 30 minutes in the dark. Then, the cell 
suspensions were washed twice by centrifugation at 309 G for 7 minutes at 4°C in 
permeabilization buffer, and washed further twice in 1x PBS 1% FCS by centrifugation at 309 G 
for 7 minutes at 4°C. Finally, the pellets were suspended in 400 µl of 1x PBS 1% FCS and stored 
protected from light at 4°C until acquisition on either the BD LSR Fortessa X-20 (BD 
Biosciences, Oxford, UK) or the CyAn ADP analyzer (Beckman Coulter, High Wycombe, UK). 
(Adapted from (T. Jung et al., 1993)) .  
!
Table 1.3: Summary of most commonly used combination of cell markers used to segregate murine HSPCs 
Cell type Phenotype Ref. 
Long-term hematopoietic stem cells (LT-
HSCs) Lineage
-/low Sca1+ cKithi FLt3- CD34- 
(Kondo et al., 
2003) 
 
Short-term hematopoietic stem cell (ST-HSC) Lineage-/low Sca1+ cKithi FLt3- CD34- 
Multipotent progenitors (MPP) Lineage-/low Sca1+ cKithi FLt3+ CD34- 
   
Hematopoietic stem cells (HSCs) Lineage-/low Sca1+ cKithi CD150+ CD48- 
(Oguro et al., 
2013) Hematopoietic progenitor cells 1 (HPC-1) Lineage
-/low Sca1+ cKithi CD150- CD48+ 
Hematopoietic progenitor cells 2 (HPC-2) Lineage-/low Sca1+ cKithi CD150+ CD48+ 
   
Common lymphoid progenitors (CLP) Lineage-/low cKithi IL-7Rα+ CD34-/low 
(Kondo et al., 
2003) 
(Belyaev et al., 
2010) 
Common myeloid progenitor (CMP) Lineage-/low cKithi CD16/32-/low IL-7Rα- CD34+ 
Granulocyte-macrophage progenitor (GMP) Lineage-/low cKithi CD16/32+ IL-7Rα- CD34+ 
Megakaryocyte-erythrocyte progenitor (MEP) Lineage-/low cKithi CD16/32- IL-7Rα- CD34- 
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2.4.3 Intracellular staining for transcription factors (GATA-3 and β-catenin) 
Following surface staining the cells were centrifuged at 309 G for 7 min at 4oC and suspended in 
ice-cold fixation-permeabilisation buffer (eBioscience, Hatfield, UK) for 2-16 hours at 4oC in the 
dark. Cells were washed by centrifugation at 309 G for 7 min once in permeabilization buffer 
(eBioscience, Hatfield, UK), suspended in optimized concentrations of intracellular antibodies 
diluted in permeabilization buffer (Table 2), and left at 4°C for 60 min in the dark. Cells were 
washed twice by centrifugation at 309 G for 7 minutes in permeabilization buffer and then 
washed further twice by centrifugation at 309 G for 7 min in PBS1x 1% FCS. Finally, the pellets 
were suspended in 400 µl of 1x PBS 1% FCS and stored protected from light at 4°C until 
acquisition on either the BD LSR Fortessa X-20 (BD Biosciences, Oxford, UK) or the CyAn ADP 
analyzer (Beckman Coulter, High Wycombe, UK). 
2.4.4 Intracellular staining for Annexin-V  
BM cells were isolated as described in section 2.3.1. Cell suspensions were diluted to a 
concentration of 20-30 x 106 cells/ml and 200ul of cell suspensions were transferred to individual 
wells on a 96 round bottom well plate. The cells suspensions were incubated for 20 minutes at 
4°C with 0.125µg/100 µl FcR block and then centrifuged for 7 minutes at 309 G at 4°C. 
Supernatants were discarded and the pellets were suspended in optimized concentration of surface 
antibodies CD45, Lineage cocktail, Sca1, cKit, CD150, CD48, CD34 and (Table 2.2) and fixable 
live-dead dye (Invitrogen, Paisley, UK) diluted in 1x PBS 1% FCS and left at 4°C for 30 min in 
the dark. The plate was centrifuged for 7 minutes at 309 G at 4°C, the supernatant was discarded 
and the cells were washed in 1x PBS 1 % FCS by centrifugation at 309 G for 7 minutes twice. 
Following the second wash, cell pellets were suspended in 250 µl of 1x Binding Buffer (Annexin-
V: PE apoptosis detection kit, BD Biosciences, Oxford, UK) and 12.5 µl of Anexin V-PE was 
added. The cells were gently vortexed and incubated for 15 minutes at RT in the dark. Then cells 
were washed in Binding Buffer by centrifugation at 309 G for 7 minutes twice, and fixed in 2 % 
PFA diluted in Binding Buffer for 20 min at o4C. Finally, the cells were washed in Binding Buffer 
by centrifugation at 309 G for 7 minutes twice and suspended in 400 µl of Binding Buffer and 
stored protected from light at 4°C until acquisition on either the BD LSR Fortessa X-20 (BD 
Biosciences, Oxford, UK) or the CyAn ADP analyzer (Beckman Coulter, High Wycombe, UK). 
2.4.5 Intracellular staining for Wnt3a 
BM cells were isolated as described in section 2.3.1 and suspended in complete DMEM. 
Brefeldin A was then added to each well at a final concentration of 10 µg/ml and the cells were 
incubated for 2 hours at 37°C in 5% CO2 incubator. The cells were stained for Sca1, cKit, CD150, 
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CD48, CD34 and Live-dead staining as described in section 2.4.1. Following surface staining 
cells were stained for Wnt3a in the presence of Rat serum (1:500) as described in section 2.4.2. 
All buffers were kept ice-cold. 
2.4.6 Cell sorting of HSCPs cells from bone marrow and adoptive transfer to lethally 
irradiated recipient mice. 
BM cells were isolated from naive and 28 days infected mice as described in section 2.3.1. Cell 
suspensions were diluted to a final concentration of 30 x 106 cells/ml and transferred to a sterile 5 
ml BD Falcon Round Bottom Polystyrene capped tube. The cells were labeled with in optimized 
concentration of CD45.2, Lineage cocktail, Sca1, cKit, CD150, CD48 and CD34 (Table 2.2) 
diluted in 1x PBS 1% FCS and left at 4°C for 30 minutes in the dark. Then 2 ml 1x PBS 1% FCS 
were added and the cells were centrifuged for 10 minutes at 309 G. The resulting pellets were 
washed with a further 4 ml of PBS. The samples were then suspended in 1x PBS 5% FCS and 
filtered through a 70 µm and a 40 µm strainers. Cells were sort purified according with the 
following phenotype: CD45+ Lin- Sca1+ cKit+ CD150+ CD48- CD34- cells (HSCs); CD45+ Lin- 
cells (enriched for HSCPs), CD45+ Lin- Sca1-cKit- cells (LSKneg) and CD45+ Lin- Sca1+ cKit+ cells 
(LSK). Cells were sorted into pre-coated 50 ml Falcon tubes containing complete DMEM. 
Following the cell-sort in the MoFlo Astrios (Beckman Coulter, High Wycombe, UK), the 
purities of the various selected cell populations were assessed to attest that purity of sorted cells 
were > 95%. Sorted cells were centrifuged at 4°C for 15 minutes at 309 G, suspended in RPMI-
1640 and then 200 µl were transplanted into recipient mice via the lateral tail vein post-irradiation 
treatment. Recipient mice were placed with water acidified with hydrochloric acid (pH 2.5) for 
five days, then irradiated with 550 rad / 5 minutes on two consecutive days and they were kept in 
Baytril (Bayer) for seven day upon first irradiation treatment. In competitive adoptive transfer 
experiments infected and naive donor cells were mixed at 50:50 ratio, in non-competitive 
adoptive transfer experiments a minimum of 3.5 x 105 radio protective total bone marrow cells 
were transferred together with the sorted donor cells. 
2.4.7 Establishment of BM chimeras B6.c-Myc-eGFP èWT B6.CD45.1 and intracellular 
staining for c-Myc-eGFP 
BM cells from B6.CD45.1 donor mice were isolated as described in section 2.3.1. Vials 
containing frozen BM cells from B6.Myc-EGFP (CD45.2) were placed in on water bath pre-
heated to 370C for 1-2 minutes to thaw (defrost). Cell suspensions were transferred to a 50 ml 
Falcon tubes and topped up with warmed complete DMEM, centrifuged at 309 G for 5 minutes, 
the resulting pellets were suspended and the cells counted. Each recipient B6.CD45.1 received a 
2x106 BM cells from B6.Myc-EGFP cell (CD45.2) donors post-irradiation treatment. Recipient 
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mice were placed with water acidified with hydrochloric acid (pH 2.5) for three days, then 
irradiated with 550 rad/5 minutes on two consecutive days and then they were kept in Baytril 
(Bayer) for seven day upon first irradiation treatment. Following a period of 10 weeks, recipient 
mice were infected with LV9 for 28 days. 
Mice were sacrificed by CO2 euthanization and followed by dislocation of the neck. BM cells 
from recipient mice were isolated as described in section 2.3.1. Cells were labeled for CD45.2, 
Lineage cocktail, Sca1, cKit, CD150, CD48, CD34 and Live-dead staining, as described in 
section 2.4.1. Following surface staining the cells were centrifuged at 309 G for 7 minutes at 4oC 
and suspended in cold 2% PFA for 60 minutes on ice protected from light. Cells were washed by 
centrifugation at 309 G for 7 minutes once in permeabilization buffer (eBioscience, Hatfield, 
UK), suspended in permeabilization buffer and left at 4°C for 60 min in the dark. The cells were 
washed twice by centrifugation at 309 G for 7 minutes in permeabilization buffer and then 
washed further twice by centrifugation at 309 G for 7 minutes in 1x PBS 1% FCS. Finally, the 
pellets were suspended in 400 µl of 1x PBS 1% FCS and stored protected from light at 4°C until 
acquisition on BD LSR Fortessa X-20 (BD Biosciences, Oxford, UK). 
2.4.8 Cell sorting of CD4+ T cells from spleens and adoptive transfer to RAG2 KO mice. 
Splenocytes were isolated from naive and infected mice as described in section 2.3.2. Cell 
suspensions were diluted to a concentration of 30 x 106 cells/ml and transferred to a sterile 5 ml 
BD Falcon Round Bottom Polystyrene capped tube. The cells were labeled with in optimized 
concentration of CD45, CD4, CD8, B220, TCRγδ, CD49b and CD3 antibodies (Table 2.2) diluted 
in 1x PBS 1% FCS and left at 4°C for 30 minutes in the dark. Then 2 ml 1x PBS 1% FCS were 
added and the cells were centrifuged for 10 minutes at 309 G. The resulting pellets were washed 
with a further 4 ml of 1x PBS 1% FCS. The samples were then suspended in 1x PBS 5% FCS and 
filtered through 70 µm and 40 µm strainers. CD45+ CD4+ CD3+ CD8- B220- TCRγδ- CD49b- cells 
were sort-purified using the MoFlo Astrios (Beckman Coulter, High Wycombe, UK). Cells were 
sorted into pre-coated 50 ml Falcon tubes containing complete DMEM. Following the cell-sort, 
the purities of the cell populations were assessed to attest that purity of sorted cells were > 95%. 
Sorted cells were centrifuged at 4°C for 15 minutes at 309 G, resuspended in RPMI-1640 at 3x106 
cells/ml, then 200µl were transplanted into B6.Rag2KO.CD45.1Cg recipient mice via the lateral 
tail vein. In the following day recipient mice and controls were infected with LV9 as described in 
section 2.2. 
2.4.9 Mixed BM chimeras B6.CD45.1: B6.CD45.2.Ifnγr2-/- (50:50) èB6CD45.1 mice 
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BM cells from WT B6.CD45.1 and B6.IFNγ-R2KO donor mice were isolated as described in 
section 2.3.1. Each recipient B6.CD45.1 received 1x106 BM cells from WT B6.CD45.1 donor 
mice and 1x106 BM cells from B6.IFNγ-R2KO donor mice post-irradiation treatment. Recipient 
mice were previously placed with water acidified with hydrochloric acid (pH 2.5) for three days, 
then irradiated with 550rad /5 minutes on two consecutive days and then they were kept in Baytril 
(Bayer) for seven day upon first irradiation treatment. Recipient mice were infected with LV9 for 
28 days, following nine weeks from the adoptive transfer. 
2.4.10 Mixed BM chimeras B6.CD45.1:B6.CD45.2.TNF-RdKO (50:50) è  B6.CD45.1 mice 
BM cells from WT B6.CD45.1 donor mice were isolated as described in section 2.3.1. Vials 
containing frozen BM cells from mice deficient for both Tnfrsf1a (TNF-R1a, p55) and Tnfrsf1b 
(TNF-R1b, p75) receptors, hereafter called TNF-RdKO (CD45.2), were placed in on water bath 
pre-heated to 370C for 1-2 minutes to thaw (defrost). Cell suspensions were transferred to a 50 ml 
Falcon tube, topped up with pre-warmed complete DMEM and centrifuged at 309 G for 5 
minutes. The resulting pellets were suspended and the cells counted. Each recipient B6.CD45.1 
received a 2x106 BM cells from each donor post-irradiation treatment. Recipient mice were 
previously placed with water acidified with hydrochloric acid (pH 2.5) for three days, then 
irradiated with 550rad /5 minutes on two consecutive days and then they were kept in Baytril 
(Bayer) for seven day upon first irradiation treatment. Recipient mice were infected with LV9 for 
28 days, following nine weeks from the adoptive transfer. 
2.4.11 Flow cytometry and sorting of CD4+ T cells from BM for RNA extraction 
BM cells were isolated from naive and infected mice as described in section 2.3.1. Cell 
suspensions were diluted to a concentration of 30 x 106 cells/ml and transferred to a sterile 5 ml 
BD Falcon Round Bottom Polystyrene capped tube. The cells were labeled with in optimized 
concentration of CD45, CD4, CD8, TCRγδ, B220 (CD45R), DX5 (CD49d) and CD3 antibodies 
(Table 2.2) diluted in 1x PBS 1% FCS and left at 4°C for 30 min in the dark. Then 2 ml 1x PBS 
1% FCS were added and the cells were centrifuged for 10 minutes at 309 G, the resulting pellets 
were washed with a further 4 ml of PBS. The samples were then suspended in 1x PBS 5% FCS 
and filtered through 70 µm and 40 µm strainers. CD45+ CD4+ CD3+ CD8- B220- DX5- cells (CD4+ 
T cells) and CD45+ CD4- CD3+ CD8+ B220- DX5- cells were sort-purified using the MoFlo 
Astrios cell sorter (Beckman Coulter, High Wycombe, UK). Cells were sorted into pre-coated 50 
ml Falcon tubes (Sigma-Aldrich, Dorset, UK) containing complete DMEM. Following the sort, 
cell purities were assessed to ascertain > 95% purity. Sorted cells were centrifuged at 4°C for 15 
minutes at 309 G, the supernatant was discarded, the pellets were suspended in DMEM and 
transferred to an RNAse free 1.5 ml Eppendorf, cells were centrifuged at 4°C for 10 minutes at 
 70 
425 G in a Accuspin Micro centrifuge (Fisher Scientific, Pittsburg, USA). The supernatant was 
carefully removed and cell pellet suspended in 700 µl of Qiazol (Qiagen, UK), vortexed for 1 
minute and then placed on dry ice before storing the samples at -80°C. 
2.4.12 Flow cytometry analysis 
For phenotypic analysis and cell sorting, cell suspensions were stained with monoclonal 
antibodies as described in Supplementary Table 2.2. Negative controls were stained with 
matched-isotype controls. Dead cells were excluded by Fixable Viability Dye eFluor780 
(eBioscience) or LIVE/DEAD Fixable Aqua Cell Stain (ThermoFisher) and cellular aggregates 
were electronically excluded in all experiments. A Fortessa II (Becton Dickinson) or CyAn 
(Dako-Beckman) were used for analytical flow cytometry, and data were analyzed with FlowJo 
software (TreeStar).  
The measurements derived from flow cytometric analysis were presented in relative and absolute 
quantifications. The frequencies of various cell populations although important to determined the 
relative proportion of each cell type within the tissue may be vary due to egress or ingress of cells, 
and therefore not reflect a true alteration in the number of cells in the organ.  
2.5 BLOOD COLLECTION AND HEMOGRAM 
Mice were anesthetized by inhalation (dispensed by Apollo TEC3 Isoflurane Vaporise, Sound 
Veterinary Equiment) of Isoflurane (Baxter)(2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane) 
and blood was then collected through heart puncture into 1.5 ml Eppendorfs coated with heparine 
(Sigma-Aldrich) or Microtainer Blood Collection Tubes with K2EDTA (Becton, Dickinson and 
Company). Hemavet (Drew Scientific) and Vet abc Plus+ (Horiba Medical) were used to 
determine blood parameters.  
2.6 TOTAL RNA EXTRACTIONS AND MICROARRAY OF 
BM T CELLS 
Sorted BM CD8+ T cells (section 2.4.11) were stored at -80°C in 700 µl of Qiazol (Qiagen, 
Manchester, UK) and used to test the miRNeasy Micro Kit (Qiagen, Manchester, UK) and the 
Directzol kit (Zymo Research Corporation, Irvine, USA). Extracted RNA was kindly assessed by 
Dr. Sally James (Genomics, Technology facility, York, UK) for yield and quantity, using the 
Agilent RNA 6000 Pico Kit (Agilent Technologies, USA), according to the manufacturer’s 
instructions. The Directzol kit showed best results with limiting number of sorted cells and, 
therefore, was selected to perform the RNA extraction on our samples (BM CD4+ T cells). 
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2.6.1 RNA extraction using the miRNeasy Micro Kit 
Sorted T cells were stored at -80°C in 700 µl of Qiazol. Samples were allowed to thaw and RNA 
extracted by carrying out a Qiazol/chloroform phase extraction. Once the samples had thawed, 
200 µl of chloroform were added and the tubes shaken vigorously by hand for 2 minutes. The 
samples were allowed to stand at room temperature for 5 minutes and then spun down at 13,000 x 
g for 15 minutes in a microcentrifuge (Microcentrifuge 5424R, Eppendorf) at 4°C. The aqueous 
phase was carefully pipetted out and transferred to a fresh Eppendorf tube. 1.5 volumes of 100% 
ethanol were added, the samples thoroughly mixed and subsequently the extractions were carried 
out using the miRNeasy micro kits (Qiagen, Manchester, UK), according to the manufacturer’s 
instructions. On-column DNase digestion was carried out to remove any contaminating genomic 
DNA using the RNAse-free DNase set (Qiagen, Manchester, UK) according to the manufacturer’s 
instructions. RNA quality and quantity was assessed by measuring the absorbance at 230, 260 and 
280 nm with a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Loughborough, 
UK) and by Sally James using the Agilent RNA 6000 Pico Kit according to the manufacturer’s 
instructions (Genomics, Technology facility, York, UK). All samples were then stored at -80 °C. 
2.6.2 RNA extraction using the Direct-zol™ RNA MiniPrep 
One volume ethanol (100%) was added directly to one volume sample homogenate (1:1) in 
Qiazol and mixed well by vortexing. The mixture was loaded into a Zymo-Spin™ IIC Column in 
a Collection Tube and centrifuge for 30 seconds. The column was transferred into a new 
collection tube. At this point, on-column DNase digestion was carried out to remove any 
contaminating genomic according to the manufacturer’s instructions (Direct-zol™ RNA 
MiniPrep). 400 µl Direct-zol™ RNA PreWash was added to the column and centrifuge for 30 
seconds and the flow-through discarded, this step was then repeated. 700 µl RNA Wash Buffer 
was added to the column and centrifuged for 2 minutes to ensure complete removal of the wash 
buffer. The column was transferred carefully into an RNAse free Eppendorf tube. 25 µl of 
DNase/RNase-Free Water were pipetted directly onto the column matrix and centrifuge for 30 
seconds. RNA quality and quantity was assessed by measuring the absorbance at 230, 260 and 
280 nm in a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Loughborough, UK) 
and by Sally James using the Agilent RNA 6000 Pico Kit according to the manufacturer’s 
instructions (Genomics, Technology facility, York, UK). All samples were then stored at -80 °C. 
2.6.3 Microarray 
The microarray was performed using the microarray slide SurePrint G3 Mouse Gene Expression 8 
x 60K Microarray (Agilent Technologies, Stockport, UK), composed by eight arrays and 
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representing a complete coverage of known coding transcripts (59308 transcripts). Dr. Sally 
James conducted the microarray according to the manufacturer’s instructions (Genomics, 
Technology facility, York, UK). The resulting data was analyzed by Dr. Sandy McDonald 
(Genomics, Technology facility, York, UK) using GeneSpring GX Software (Agilent 
Technologies, Stockport, UK).  
2.7 REVERSE TRANSCRIPTION REACTION AND 
QUANTITATIVE REAL-TIME POLYMERASE CHAIN 
REACTION OF TOTAL BM CELLS 
BM cell suspensions were obtained as described in section 2.3.1, and then centrifuged at 4 °C for 
15 minutes at 309 G. The supernatants were discarded; the pellets suspended in DMEM and 
transferred to RNAse free 1.5 ml Eppendorf tubes. Cells were centrifuged at for 10 minutes at 425 
G in Accuspin Micro centrifuge (Fisher Scientific, Pittsburg, USA). The supernatants were 
carefully removed, cell pellets suspended in 700 µl of Qiazol (Qiagen, UK), vortexed for 1 
minutes and then placed on dry ice before storing the samples at -80°C. Total RNA was extracted 
as previously described in section 2.6.2. 
2.7.1 Reverse transcription reaction (RT Reaction) 
The cDNA syntheses were performed with the Superscript II reverse transcriptase system 
(Invitrogen), according to manufacture’s instructions. Previously, RNA purity was assessed in the 
device a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Loughborough, UK). 
About 1 µl Oligo (dT)12-18 (0,5µg/µl), 1µl dNTPs [10mM] and appropriate volume of nuclease free 
water (Qiagen, UK)  to complete a final volume of 13 µl were added to 500 ng of total RNA. This 
mixture was heated for 5 minutes at 65oC and then placed immediately in ice. Then the cDNA 
synthesis master mix (4 µl of 5x Reverse Transcription Buffer, 1 µl DTT (0.1 M; 
dithiothreitol), 1 µl RNase Out (40U/µl) and 1 µl Superscript Reverse Transcriptase II (200 
U/ul)) was prepared, mixed thouroughly and spun down at 10000 G for 5 seconds. 8 µl of master 
mix were added to 12 µl of RNA/ Oligo (dT)12-18 to complete a final volume of 20 µl per reaction. 
cDNA synthesis reaction mixtures were incubated for 60 minutes at 50oC, and then for 5 minutes 
at 70oC and finally placed on ice. The newly generated cDNA was stored at -20 oC. 
2.7.2 Quantitative real-time polymerase chain reaction (qRTPCR) 
The qRT-PCR of Wnt3a mRNA expression in total BM was performed with the SYBR-green 
qPCR Kit (Applied Biosystems, Warrington, UK) in StepOnePlus Real Time PCR detection 
system (Applied Biosystems), accordingly to manufacturers’ instructions. The reactions were 
 73 
performed in MicroAmp Optical 96-well reaction plates (Applied Biosystems) in ice-cold 
conditions. Reactions contained 10 µl Fast SYBR Green Mix (2x), 0.8 µl of cDNA, 8.2 µl of 
nuclease free water (Qiagen, UK) and 0.5 µl of mix of primers pair (10 µM of each primer) 
(FORWARD: tactacgaggcctcacccaa; REVERSE: acccatctatgccatgcgag). The plates were sealed 
and centrifuged to assure all liquid was at the bottom of the well. Then qRT-PCRs were 
performed under the following cycling conditions: 95°C for 20 seconds followed by 40 cycles of 
95°C for 1 second and 60°C for 20 seconds. Data were analysed using the StepOne Software 
version 2.2.2 (Applied Biosystems, Warrington, UK). mRNA expression levels were normalized 
to HPRT1 housekeeping gene using ΔΔCt calculations. Mean relative microRNA expression 
levels between control and experimental groups were calculated using the 2-ΔΔCt calculations. 
2.8 STAINING OF PURIFIED LSK CELLS FOR CONFOCAL 
MICROSCOPY ANALYSIS 
BM cell suspensions were obtained as described in section 2.3.1, and following cell-surface 
staining (described in section 2.4.1), were sort-purified in the MoFlo Astrios (Beckman Coulter). 
Sort-purified LSK cells were centrifuged for 7 minutes at 309 G at 4°C, the supernatant was 
discarded and the cells were fixed of 2% PFA (Sigma-Aldrich) for 20 minutes at 4°C in the dark. 
Cells were washed twice with 1x PBS 1% FCS by centrifugation at 309 G for 7 minutes and 
suspended in 1x PBS 1% FCS. Following the slides preparation, chamber and blotter were placed 
carefully in the Cytospin™ 4 Cytocentrifuge (Thermo Scientific). Then, 100 µl of cell 
suspensions were placed into the slide chamber and spun down at 137 G for 5 minutes. Slides 
were carefully removed from the cytospin-centrifuge and left to dry, prior to staining. The areas 
containing the samples on the slides were delimited with an ImmEdge pen (Vector Laboratories, 
USA). The slides were washed in PBS 0.05% Bovine Serum Albumin (BSA) (Sigma-Aldrich), 
hereafter called wash buffer, then blocked by the addition of 10% Goat serum (Sigma-Aldrich) 
and 0.001mg of Fc block diluted in wash buffer for 20 minutes at RT. Excess wash buffer was 
removed and the cells were permeabilized by addition of PBS + 0.2% Triton X-100 (Sigma-
Aldrich) for 5-10 minutes at RT. The slides were washed by incubation with wash buffer for 5 
minutes, then anti-GATA-3 (HG3-31, Santa Cruz Inc.) (1:500) or Isotype control (anti-IgG1 
mouse, eBioscience) were added diluted in PBS containing 10% Goat serum and 0.001 mg of Fc 
block. Slides were incubated overnight at 4oC. The slides were washed three times in wash buffer 
the following day. Then secondary antibody IgG goat anti-mouse Alexa 594 (Invitrogen) (1:400) 
was added diluted in PBS containing 10% Goat serum and 0.001 mg of Fc block and the slides 
were incubated for 30 minutes at RT. The slides were wash three times in wash buffer and then 
once in PBS. 1µg/ml DAPI (4',6-diamidino-2-phenylindole) (Sigma-Aldrich) diluted in PBS was 
added to the slides, incubated for 5 minutes and then washed twice in PBS. Excess PBS was 
removed and a small amount of ProlongGold (Invitrogen) was applied in each sample to mount 
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by the placement coverslips over the samples. Slides were kept protected from light overnight at 
4oC, and were then sealed with nail varnish. Slides were stored protected from light at 4oC until 
analysis in confocal microscope (Zeiss LSM 710, Zeiss). 
2.9 STATISTICAL ANALYSIS 
In most experiments the statistical analyses were performed by parametric or non-parametric 
tests, selected according to the distribution of the raw data. The comparisons between 
experimental groups were performed using student Unpaired t test, Mann-Whitney and one-way 
ANNOVA. The analysis of population distribution was performed using Chi-square test. The 
statistical analyses fold changes were performed using Wilcoxon signed-rank test. All analyses 
were conducted using GraphPad InStat (versions 5 and 6) software (GraphPad software, San 
Diego, California, US). 
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Table 2.2 - Monoclonal antibodies used to evaluate expression of surface cell markers, 
cytokines and transcription factor by flow cytometry analysis  
 
 
 
 
Antigen   Clone Fluorochrome Supplier 
β-Catenin 15B8 PE eBioscience
Wnt3a 217804 APC R&D Systems
TNF MP6-XT22 PE eBioscience
Ter-119 TER-119 PE-Cy7 eBioscience
TCRγδ eBioGL3 (GL-3, GL3) PE eBioscience
Mouse Lineage Antibody Cocktail (CD3e, Ly-
6G and Ly-6C, TER-119, CD45R, CD11b)
145-2C11, RB6-8C5, TER-
119, RA3-6B2, M1/70 PerCPCy5.5 Becton Dickinson (BD) Bioscience
MHC II M5/114.15.2 APC eBioscience
MHC II M5/114.15.2 PerCP-Cy5.5 Biolegend
MHC II M5/114.15.2 eF450 eBioscience
Ly6C AL-21 FITC Becton Dickinson (BD) Bioscience
Ly6A/E (Sca1)  D7 BV510 Becton Dickinson (BD) Bioscience
Ly6A/E (Sca1)  D7 APC eBioscience
Ly6A/E (Sca1)  D7 V500 Becton Dickinson (BD) Bioscience
Ki67 MOPC-21 PE Becton Dickinson (BD) Bioscience
IL-10 JES5-16E3 APC eBioscience
IFNγ XMG1.2 APC eBioscience
IFNγ XMG1.2 eF450 eBioscience
GR1 RB6-8C5 PE-Cy7 eBioscience
GATA3 16E10A23 BV421 Biolegend
FOXP3 FJK-165 APC eBioscience
F4/80 BM8 FITC eBioscience
F4/80 BM8 BV421 Biolegend
CD8α 53-6.7 APC Becton Dickinson (BD) Bioscience
CD8α 53-6.7 PE eBioscience
CD8 H35-17.2 PerCP-eF710 eBioscience
CD62L MEL-14 PE eBioscience
CD51 RMV-7 PE eBioscience
CD49b DX5 PE eBioscience
CD48 HM48-1  Pe-Cy7 eBioscience
CD45R (B220) RA3-6B2 Alexa 647 eBioscience
CD45R (B220) RA3-6B2 PE eBioscience
CD45R (B220)  RB6-8C5 PE Biolegend
CD45.2 104 APC-eFluor 780 eBioscience
CD45.2 104 FITC eBioscience
CD45.2 104 Alexa 700 eBioscience
Table 2.1 - Monoclonal antibodies used for detection of surface markers, cytokines and transcription factors by flow cytometry
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Table 2.2 (cont.) - Monoclonal antibodies used to evaluate expression of surface cell 
markers, cytokines and transcription factor by flow cytometry analysis 
 
 
 
 
Antigen   Clone Fluorochrome Supplier 
CD45.1 A20 FITC Becton Dickinson (BD) Bioscience
CD45.1 A20 BV650 Biolegend
CD45.1 A20 PE Becton Dickinson (BD) Bioscience
CD45 30-F11 Alexa 700 eBioscience
CD45 30-F11 APC eBioscience
CD44 IM7  Alexa647 Biolegend
CD4 4SM95 ef660 eBioscience
CD4 GK1.5 APC eBioscience
CD4 RM4-5 Briliant Violet 650 Biolegend
CD4 RM4-5 FITC Biolegend
CD34 RAM34 FITC Becton Dickinson (BD) Bioscience
CD31 390 FITC eBioscience
CD3 145-2C11 FITC eBioscience
CD3 145-2C11  Pe-Cy7 Biolegend
CD3 MEC14.7 BV421 Biolegend
CD29 (Integrin beta 1) eBioHMb1-1 (HMb1-1) PE eBioscience
CD25 PC61 Pe-Cy7 Biolegend
CD16/32 93 PE-Cy7 eBioscience
CD150 TC15-12F12.2 Briliant Violet 421 Biolegend
CD150 TC15-12F12.3 Briliant Violet 650 Biolegend
CD135 (Flt3)  A2F10 Biotin eBioscience
CD127 A7R34 Briliant Violet 421 Biolegend
CD127 A7R34 eF450 eBioscience
CD127 A7R34 PE-Cy5 eBioscience
CD120b (TNF R Type II/p75) 55R-286 PE Biolegend
CD120a (TNF R Type I/p55) TR75-89 PE Biolegend
CD11c N418 PE Biolegend
CD11b M1/70 Alexa 488 eBioscience
CD11b M1/70 BV510 Biolegend
CD11b M1/70 APC eBioscience
CD117 (cKit) 2B8 PE Becton Dickinson (BD) Bioscience
CD117 (cKit) 2B8 Briliant Violet 421 Biolegend
CD117 (cKit) 2B8 FITC Biolegend
B220 (CD45R) RA3-6B2 Alexa 647 Biolegend
B220 (CD45R) RA3-6B2 PE eBioscience
 Strepdavidin PE-Cy7 Becton Dickinson (BD) Bioscience
Table 2.2 - Monoclonal antibodies used for detection of surface markers, cytokines and transcription factors by flow cytometry
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CHAPTER 3.  ALTERATIONS IN HAEMATOPOIESIS 
DURING LEISHMANIA DONOVANI INFECTION 
3.1 INTRODUCTION 
VL is a vector-borne disease caused by the intracellular protozoa Leishmania donovani and L. 
infantum. In vertebrate hosts, including humans, parasites reside mainly in mononuclear 
phagocytes where they multiply as obligatory intracellular amastigotes. L. donovani amastigotes 
are detected primarily in the spleen, lymph nodes, BM and liver, and their persistence contributes 
to chronic infection (E. Handman, 2000).  
In humans, VL is characterized by hypergammaglobulinaemia, hepato-splenomegaly and 
disturbances in blood homeostasis, including anemia, thrombocytopenia, leucopenia and 
neutropenia. Unfortunately, an effective vaccine has not yet been produced and the therapeutic 
drugs available have been associated with increased parasite resistance and toxicity (C. R. Davies 
et al., 2003, C. R. Engwerda et al., 2004a). It has been estimated that 500,000 new cases of VL 
occur annually. The infection is fatal without drug treatment and even treated patients may die 
from the pathology, bleeding or opportunistic bacterial infections (M. A. Santos et al., 2002, V. E. 
Miranda de Araujo et al., 2012). 
In humans, splenic sequestration and ineffective haematopoiesis have been suggested as possible 
causes to explain peripheral cytopenia. In addition to alterations in the blood, VL has been 
associated with the alterations in the BM, including erythroid hyperplasia, increased plasma cells, 
increased frequency of granulocytic and megakaryocyte immature forms, and histiocytic 
hyperplasia (N. Varma and S. Naseem, 2010). Furthermore, several clinical reports described 
pancytopenia in VL patients followed by BM multilineage myelodisplasia reminiscent of true 
myelodysplastic syndrome (MDS), suggesting the presence of ineffective haematopoiesis (N. 
Yarali et al., 2002, P. Kopterides et al., 2003, G. M. de Vasconcelos et al., 2014). 
Experimental mouse models have been extensively used to study the immunopathology of VL, 
and these have reported alterations in haematopoietic function. For example, in the spleen, a 
secondary site of haematopoiesis in adult mice, higher frequencies of macrophages and dendritic 
cells (DCs) were described in chronic infection (J. E. Dalton et al., 2010). DCs that produce low 
levels of the proinflammatory cytokine IL-12 and high levels of the immunorregulatory cytokine 
IL-10 were found in the spleen of infected mice, and it was shown that these impact negatively on 
parasite clearance (B. M. J. Owens and P. M. Kaye, 2012). Splenic stromal cells isolated from L. 
donovani infected mice showed an enhanced capacity in vitro to direct haematopoietic progenitors 
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toward a regulatory dendritic cell (rDC) phenotype (M. Svensson et al., 2004), suggesting that L. 
donovani infection is able to modulate haematopoiesis and alters the function of immune effector 
cells towards immunosuppression in the spleen. Alterations in spleen function in experimental VL 
are further described in Chapter 4.  
In experimental VL, amastigotes also persist during chronic infection in the BM (S. E. J. Cotterell 
et al., 2000a, S. E. J. Cotterell et al., 2000b) (Figure 3.1), though the impact of infection at this 
site is less well studied. During the course of L. donovani infection in BALB/c mice, increased 
BM parasite burden was associated with increased numbers of all haematopoietic precursor cells, 
as assessed by the number of colony-forming units in culture (S. E. J. Cotterell et al., 2000a). 
These studies showed that BM macrophages (including stromal macrophages defined by CD169 
expression) could become infected with L. donovani both in vivo and in vitro, but there were no 
indications that a significant number of haematopoietic progenitor cells harbored parasites (S. E. 
J. Cotterell et al., 2000b). Infected BM-derived macrophages showed an increased efficiency to 
support the formation of GM-CFU in vitro, and this effect was partially mediated by higher 
expression of GM-CSF and TNF by infected macrophages (S. C. Smelt et al., 2000). Furthermore, 
infection of a fibroblast-like BM stromal cell line (MBA-1) with L. donovani directed 
differentiation of haematopoietic precursors into “regulatory DCs”, and this is thought to be due 
to an infection-dependent increase in the levels of CCL8 expression (A. T. N. Hoang et al., 2010). 
Taken together these findings indicated that VL has the potential to alter haematopoiesis. This 
could be due to the modulation of haematopoiesis-supporting stromal cells, or through the 
systemic action of cytokines or other mediators. Hence, the mechanisms underlying the impact of 
infection on haematopoiesis and its consequences on immune responses during VL remain 
unclear.  
During infection, the systemic release of pro-inflammatory mediators induces changes in BM 
populations, either directly or through alteration in their microenvironment, which may impact on 
their rates of proliferation, lineage fates or mobilization (K. Y. King and M. A. Goodell, 2011). 
Therefore, an impact of infection on haematopoiesis has been reported in association with many 
infections, although with variable pathogen-specific outcomes. An increase in haematopoietic 
stem and progenitor cells (HSPCs) has been reported to occur in response to the increased 
demand for immune cells and/or in direct response to pathogen associated molecular patterns 
(PAMPs) and pro-inflammatory cytokines, recognized respectively by the pattern recognition 
receptors and cytokines receptors expressed by HSPCs (K. Y. King and M. A. Goodell, 2011). 
Within several infectious contexts, HSCs have in recent years emerged as central players in the 
development of immune responses, nonetheless in some models, infection-induced 
haematopoiesis was reported to negatively impact on HSCs function (M. T. Baldridge et al., 
2011). 
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Haematopoiesis is a strictly regulated process that depends on a very small pool of long-term 
haematopoietic stem cells (LT-HSCs), which have self-renewal capacity and the potential to give 
rise to all mature blood cells during the lifespan of an individual. According to the classical 
pathway of haematopoiesis, LT-HSCs differentiate into short-term haematopoietic stem cells (ST-
HSCs) that then give rise to a heterogeneous group of multipotent progenitors (MPPs). LT-HSCs, 
ST-HSCs and MPPs are contained within the LSK population, so called for their lack of 
expression of mature blood cell-associated markers (Lineage negative) and their expression of 
Sca1 (Stem cells antigen 1) and cKit (Stem cell factor receptor). MPPs give rise to a succession of 
intermediary progenitors, the common lymphoid progenitors (CLPs) and the common myeloid 
progenitors (CMPs). CMPs may then give rise to both granulocyte/macrophage progenitors 
(GMPs), and the megakaryocytic/erythrocyte progenitors (MEPs). The lineage-committed 
precursors, CMPs, CLPs, GMPs and MEPs are all contained in the Lineage negative, Sca1 
negative and cKit positive cell population (cKithi) [24]. Herein, we use the term HSPCs to 
collectively include all Lineage negative cKit+ cells (multipotent progenitors and lineage-
committed progenitors), each defined by their pattern of surface molecular markers, as 
highlighted in Figure 3.2 (M. Kondo et al., 2003a). 
In this chapter, we aimed to characterize HSPCs during experimental L. donovani infection in 
order to establish whether infection affects their function and / or survival. This is the first study 
evaluating HSPCs in the BM directly ex vivo in experimental VL. Using a panel of stem cell 
markers, we characterized HSPCs over the course of L. donovani-infection in C57BL/6 (B6) 
mice. Chronically infected mice showed a significant increase in intermediary non-committed 
multipotent haematopoietic precursors (Lineage- Sca1+ cKit+ (LSK), CD150+ CD48+ cells) 
without reciprocal increases in either lineage-committed precursors or mature cells in circulation. 
In steady state, the majority of LT-HSCs (LSK CD150+ CD48- CD34- cells) were found in a 
quiescent state, representing cells with the highest degree of reconstitution potential. In contrast, 
during chronic infection most were found to have progressed to cell-cycle and this correlated with 
a reduced potential to engraft into syngeneic recipients. These finding suggested that L. donovani 
infection have the potential to impair haematopoietic development through the “functional 
exhaustion” of HSCs. 
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3.2 RESULTS 
3.2.1 L. donovani infection was associated with alterations in the number of HSPCs in BM 
and spleen 
Alterations in the number of haematopoietic progenitors, both in BM and spleen during L. 
donovani infection have been previously described during the course of infection in BALB/c mice 
using colony-forming assays (S. E. J. Cotterell et al., 2000a). To confirm the previously reported 
increase in haematopoietic progenitors during the course of infection, we quantified HSPCs 
(including LT-HSCs, ST-HSCs, MPPs, CMPs, GMPs, MEPs and GMPs) in the BM and in the 
spleen of B6 mice infected with L. donovani over a period 64 days, using a flow cytometric rather 
than functional approaches.  
Haematopoietic progenitors were defined using a panel of cellular markers as previously 
described (M. Kondo et al., 2003a) (Figure 3.3;Figure 3.4). In several models of infection, it has 
been reported that Sca1 expression was upregulated in all progenitors upon infection (N. N. 
Belyaev et al., 2010, K. Y. King and M. A. Goodell, 2011, K. C. MacNamara et al., 2011b, J. L. 
Granick et al., 2012). We observed the same phenomenon in mice chronically infected with L. 
donovani (Figure 3.5). Therefore, we included all Lineage- cKit+ cells even those expressing Sca1 
to quantify lineage-committed precursors in all the experiments where a group of infected mice 
was included.  
During the course of L. donovani infection, the parasite burden in the spleen increased from day 3 
to day 28, with a degree of resolution by d64 p.i. (Figure 3.6a). Nevertheless, splenomegaly and 
increased number of splenocytes were maintained in infected mice at day 64 (Figure 3.6c; Figure 
3.7b), which suggested that in spite of the decline in parasite burden the inflammation persisted. 
Parasite burden in BM followed a similar trend (Figure 3.6b). In contrast, the number of cells in 
BM was decreased at later time points (Figure 3.7a). 
The relative frequency of HSPCs in BM within Lineage- cKit+ cells was increased on day 7 (1.434 
± 0.064, x̄ ± SEM). On days 16 and 28 p.i. with L. donovani, the frequencies of HSPCs were 
comparable to naive mice. However by day 64 p.i., their frequency was increased 2.039 ± 0.232 
fold compared to naive controls (Figure 3.8a). A similar biphasic response was observed when 
evaluating the absolute number of HSPCs (Figure 3.8b). In the spleen, the relative frequencies of 
HSPCs in BM were increased compared to control uninfected mice from day 16, peaked at day 28 
and declined at day 64 p.i.  (Figure 3.9a), again with a similar trend observed in terms of absolute 
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numbers (reflecting fourteen times more HSPCs in the spleen of infected mice compared to the 
controls at later time points; Figure 3.9b).  
The increase in the frequency of multipotent progenitors was an early event following infection in 
BM, with the maximum fold increase taking place at day 28 p.i..  The frequency of CD150+ Flt3- 
CD34- (LT-HSCs) cells was increased 117.750 ± 32.684 fold and the frequency of CD150+ Flt3- 
CD34+ cells (ST-HSCs) was increased 22.175 ± 6.974 fold at 28 days p.i.. At later time points, the 
frequencies of LSK CD150+ Flt3- CD34- cells and LSK CD150+ Flt3- CD34+ cells remained high 
in infected mice compared to control mice (Figure 3.8c). Changes in LSK CD150- Flt3+ CD34+ 
cell (MPPs) frequencies during the course of infection were relatively mild compared to earlier 
progenitors (of LSK CD150+ Flt3- CD34- cells and LSK CD150+ Flt3- CD34+ cells). On day 28 
p.i., there was a 18.750 ± 7.091 fold increase in MPPs frequency in infected mice, but this 
normalized by day 64 p.i. (Figure 3.8c). Changes in the absolute number of LSK CD150+ Flt3- 
CD34- cells, LSK CD150+ Flt3- CD34+ cells and LSK CD150- Flt3+ CD34+ cells followed the 
same trend (Figure 3.8d).  
The frequency of lineage-committed precursors during the course of infection was also assessed 
in BM. By day 7 p.i., the frequency of GMPs increased 1.584 ± 0.245 fold,  but was comparable 
to naive at other time points. The frequency of CMPs increased 2.079 ± 0.333 fold at day 28 p.i., 
returning to normal by d64 p.i.. MEPs frequency remained relatively unchanged during the course 
of infection, with only a 2.814 ± 1.747 fold increase at d64 p.i. (Figure 3.8e). In term of absolute 
numbers, CLPs were significantly increased only at day 7 p.i. (1.88 ± 0.29 fold). At latest time 
point, MEPs were found 2.386 ± 0.829 fold increased at day 64 p.i.. The absolute number of 
CMPs and GMPs did not alter as a result of infection (Figure 3.8f). 
In the infected spleen, there was an increase in multipotent progenitors, with the peak fold 
increase at day 28 p.i., following the same pattern observed in BM (Figure 3.9c; Figure 3.9d). At 
day 28 p.i., the frequency of LSK CD150+ Flt3- CD34- cells was 1051.128 ± 228.787 fold and 
LSK CD150+ Flt3- CD34+ cells was 46.470 ± 8.165 fold increased in infected mice, their 
frequencies remained high at the latest time point (Figure 3.9c). In early time points, we could not 
detect LSK CD150- Flt3+ CD34+ cells in the spleen of infected or naive mice, but at day 28 p.i. the 
frequency of LSK CD150- Flt3+ CD34+ cells was increased 11.777 ± 3.863 fold, while at day 64 
p.i. it was comparable to naive controls (Figure 3.9c). This pattern was repeated in terms of 
absolute numbers for multipotent progenitors in the spleen (Figure 3.9d). For lineage-committed 
precursors in the spleen, MEPs increased 16.353 ± 4.63 fold at day 28 p.i., remaining high at day 
64 p.i.. The frequency of CMPs in infected mice was not significantly different at any evaluated 
time point. The frequency of GMPs increased 3.451 ± 0.188 fold on day 64 p.i., while CLPs were 
reduced (0.455 ± 0.080 fold) at this time point (Figure 3.9e). Absolute cell numbers showed a 
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similar trend for GMPs and MEPs. However, the number of CMPs was 5.105 ± 1.814 and 7.216 ± 
1.533 fold increased in infected, at days 28 and 64, respectively. The number of CLPs was not 
significantly changed in the spleen of infected mice at all time points (Figure 3.9f). 
In spite of the significant changes in the number of multipotent progenitors, the overall number of 
total cells in BM remained relatively unchanged in mice infected with L. donovani over a period 
64 days (Figure 3.7a). In contrast, the increased number of HSPCs in the spleen coincided with 
increased cellularity over time (Figure 3.7b). 
Overall, these data showed a significant increase in the number of multipotent precursors both in 
BM and spleen, during the course of infection that was most evident at day 28, overlapping with 
the peak of parasite burden both in the spleen and in the BM. At day 28, the extent of increase in 
non-committed progenitors was not reproduced in the degree of alterations in the lineage-
committed progenitors both in BM and in the spleen. This suggested the possibility of inhibition 
in HSPCs differentiation and that the expansion/accumulation of multipotent progenitors might 
not be underlying an increase in effective haematopoiesis, during the chronic phase of infection, 
previously defined as the stage of infection when pathological remodeling of lymphoid tissue 
becomes prominent i.e. post d21(C. R. Engwerda et al., 2004a) (28 and 64 days p.i.). 
In further analysis, we focused on day 28 p.i., where both the parasite burden and altered 
cellularity were most striking.  
3.2.2 Experimental VL was characterized by increased numbers of primitive 
haematopoietic progenitors 
To confirm changes in BM HSPCs at day 28 p.i., further independent experiments were 
conducted.  In the BM of the infected mice the frequency of LSK cells increased approx. 10-fold 
and the absolute number increased approx. 8 fold compared to naive mice (Figure 3.10a). 
Next we focused in the most immature haematopoietic progenitors, which are contained within 
the LSK population. The frequency and number of LSK Flt3- CD150+ CD34- cells was 
significantly increased in the mice infected with L. donovani (Figure 3.10a; Figure 3.10b). 
LSK Flt3- CD150+ CD34+ cells and LSK Flt3+ CD150- CD34+ cells were also increased in both 
frequency and number in infected mice (Figure 3.10a; Figure 3.10b). These results also indicate 
that among early progenitors considered in these analyses, LSK Flt3- CD150+ CD34- cells were 
the largest contributor to the observed increase in total LSK cells. 
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For Lineage- cKit+ cells, which are enriched for all HSPCs, there was a significant though modest 
increase in frequency (3.35% ± 0.52 vs. 2.30% ± 0.53 in day 28 infected and control mice 
respectively) (Figure 3.10c) although absolute number was unchanged (Figure 3.10d). The 
frequency and absolute number of CMPs, GMPs and MEPs in the BM of infected mice were not 
significantly different from naive controls. CLPs frequency was found slightly increased in 
infected mice, but the absolute cell number was not significantly change upon infection (Figure 
3.10c; Figure 3.10d). 
In summary, these independent experiments confirmed our initial observations (Figure 3.8) 
pointing to significant differences in BM cellularity at 28 day of L. donovani infection. These 
alterations were characterized by a large increase in the number of early multipotent progenitors, 
suggesting that haematopoiesis was significantly modulated at the peak of L. donovani infection.  
3.2.3 Experimental VL is characterized by alterations in blood homeostasis 
In order to determine if the aforementioned alterations in the BM (section 3.2.2) were 
accompanied by alterations in the blood, we performed a completed blood count, hemogram, as a 
broad screening test to assess for haematological disorders at day 28 p.i.  
In infected mice we found that the number of erythrocytes (red blood cells) were significantly 
decreased, 5.84 x106 (M)/µl ± 0.61 (x̄ ± SD), compared to the basal values obtained in naive 
controls, 7.69 K/µl ± 0.85 (Figure 3.11a). Haematocrit, which indicates the percentage of volume 
occupied by red blood cells in a given volume of whole blood, was also significantly lower in 
infected mice (31.46% ± 3.11) in comparison to naive controls (40.20% ± 4.86)  (Figure 3.11b). 
The other parameter assessed was the concentration of hemoglobin in PB, which in line with the 
others parameters was also found decreased in infected mice (6.93 g/dl ± 0.77) compared to the 
values determined for controls (8.50 g/dl ± 1.31) (Figure 3.11c). 
The number of platelets in circulation in infected mice was also significantly lower in infected 
mice (246.1K/µl ± 61.87) when compared to the number of platelets found in healthy controls 
(435.6 K/µl ± 187.7) (Figure 3.11d).  The number of total leukocytes (or white blood cells) in PB 
in infected mice and controls was comparable. However, when we analyzed the number of 
leukocytes segregated into different cell types we found significant differences between infected 
and non-infected mice. In infected mice the number of neutrophils was increased, while the 
number of basophils and eosinophils contracted (Figure 3.11e). 
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In summary, these analyses indicate that anaemia, thrombocytopenia, coupled with mild 
neutrophilia and basopenia / eosinopenia, emerge in B6 mice as a consequence of L. donovani 
infection.  
3.2.4 L. donovani infection was not associated with increased cell death in BM 
Pro-inflammatory cytokines commonly released in response to infection have the potential to 
induce increased cell-death in BM (C. Selleri et al., 1995, K. Y. King and M. A. Goodell, 2011). 
We observed that during the peak of infection with L. donovani there was a specific increase in 
early non-committed progenitors, however infected mice displayed anaemia and 
thrombocytopenia. It was conceivable that an increase susceptibility to cell death of 
haematopoietic progenitors was on the basis these alterations; as such, the proportion of 
live/viable cells, excluding both dead and apoptotic cells was assessed, in BM cells from mice 
infected with L. donovani for 28 days (Figure 3.12a). 
The analysis performed in BM to determine the proportion of live cells among stromal cells 
(CD45- Lineage- cells) and mature haematopoietic cells (CD45+ Lineage+ cells) revealed that there 
were no differences between infected and healthy controls (Figure 3.12b). Surprisingly across all 
the populations of HSPCs assessed, we found that infected mice showed a significant increase in 
the fraction of live cells (i.e. neither dead nor apoptotic) (Figure 3.12b). 
Hence, increased cell death and apoptosis in BM could be excluded as a mechanism underlying 
the establishment of impaired haematopoietic function in PB. Collectively, these findings raised 
the possibility that infection could induce changes in haematopoietic differentiation prior to 
lineage commitment. Therefore, we decided to study in further detail the phenotypic and 
functional alterations in early haematopoietic progenitors. 
3.2.5 HSPCs from infected mice showed impaired engraftment in BM and decreased 
reconstitution of the periphery 
To evaluate whether L. donovani infection affected the function of HSPCs, we used a competitive 
adoptive transfer model. BM lineage negative cells (enriched for HSPCs) from day 28 infected 
B6.CD45.2 mice and from uninfected B6.CD45.1 mice were mixed 50:50 and transferred into 
non-infected x-irradiated (B6.CD45.1 x B6.CD45.2)F1 recipients. By using donor cells expressing 
distinct CD45 isoforms, we could follow the fate of the transferred cells in recipient mice and 
separate these from any cells not eliminated by irradiation (which co-express CD45.1 and 
CD45.2). Analyses were performed seven weeks after adoptive transfer (Figure 3.13a).  
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The contribution to haematopoiesis was significantly different between the donor populations, 
with infected donor-derived cells accounting for 21.81% ± 11.27 in comparison to 78.19% ± 
11.27 of naive donor-derived cells amongst total donor cells in the BM of recipient mice (Figure 
3.13b). In the spleen, the results followed the same trend, with infected donor cells contributing 
for 24.76 % ± 2.43 of total splenocytes while naive donor cells comprised 75.24% ± 2.43 of total 
donor-derived splenocytes (Figure 3.13b).  
To assess whether L. donovani infection could impact on the differentiation potential of HSPCs, 
the frequencies of terminally differentiated blood cells were determined in the spleen (here 
representing the periphery). There were no significant differences found in the frequencies of B 
cells, T cells and CD11b+ cells (Myeloid cells) arising from infected and naive donor cells (Figure 
3.13c). In the BM of recipient mice, we assessed the frequency of the multipotent progenitors, 
LSK CD150+ Flt3- CD34- cells, LSK CD150+ Flt3- CD34+ cells and LSK CD150- Flt3+ CD34+ 
cells (Figure 3.13d) and the lineage committed precursors, CMPs, GMPs, MEPs and CLPs 
(Figure 3.13e), within the two groups of donor cells. No significant differences were determined 
in their frequencies between infected and naive derived donor cells.  
Collectively, these data suggested that infection is impacting negatively on the reconstitution 
potential of HSPCs, both in BM and spleen, where the frequency of infected donor cells, in both 
sites, was significantly lower compare to naive donor cells.  Despite the overall lower frequency 
of infected donor cells, the infection did not promote alterations in cell fate, since no changes 
were detected in the relative proportion of different progeny when transferred to a healthy 
recipient.  Hence, infection may result in cell intrinsic functional impairment of HSCs prior to 
lineage commitment.  
3.2.6 L. donovani infection stimulates expansion of LSK CD150+ CD34- expressing CD48  
CD48 is a GPI-linked member of the signaling lymphocyte activation molecule (SLAM) family 
broadly expressed on haematopoietic cells except for LT-HSCs (M. J. Kiel et al., 2005).  It acts as 
ligand for 2B4 receptor expressed in T and NK cells and has been implicated in cell activation, 
proliferation and differentiation (M. Elishmereni and F. Levi-Schaffer, 2011).  
The frequency and the number LSK CD150+ CD34- cells (enriched for LT-HSCs) not expressing 
CD48 were unchanged upon infection with L. donovani (Figure 3.14a; Figure 3.14b). In contrast, 
the frequency and absolute number of LSK CD150+ CD34- CD48+ cells were significantly 
increased in the BM of infected mice compared to the controls (Figure 3.14a; Figure 3.14b).  
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Whereas at steady-state the vast majority of LT-HSCs, as defined so far (LSK CD150+ CD34- 
cells) lacked CD48, upon infection less than 5% of phenotypic LT-HSCs were CD48 negative 
(Figure 3.14c; Figure 3.14d). Hence, these data suggested that during infection phenotypic LT-
HSCs population have progressed further in their differentiation, since CD48 expression is 
associated to a loss of stemness (M. J. Kiel et al., 2005, M. J. Nemeth and D. M. Bodine, 2007). 
3.2.7 L. donovani infection was associated with depletion of the reservoir of quiescent LT-
HSCs  
LT-HSCs are largely in G0 or G1 and it has been shown that the quiescent state is functionally 
important. Studies in experimental models characterized by increased proliferation of multipotent 
progenitors reported loss of LT-HSCs and increased susceptibility to stress-induced 
haematopoietic exhaustion (K. W. Orford and D. T. Scadden, 2008). In order to shed some light 
into the mechanisms responsible for the increase in the most immature haematopoietic precursors 
and loss of reconstitution potential, we determined the frequency and number of HSCs in G0, by 
staining for Ki67, an antigen expressed in all phases of the cell-cycle, but absent in quiescent or 
resting cells (J. Gerdes et al., 1984). 
Within the population of LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs) approximately 
half were quiescent (43.05 ± 0.017 expressing Ki67) in steady-state. At day 28 p.i., the frequency 
of cells that progressed into cell-cycle was significantly increased (96.52% ± 3.19 of total LSK 
CD150+ CD34- CD48- cells). On the other hand, onward populations of multipotent progenitors, 
namely LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells were highly proliferative 
both in steady-state and upon infection, with more than 90% expressing Ki67 (Figure 3.15a). 
The absolute number of cells in proliferation showed that the overall increase of multipotent 
progenitors was due to the increase in the number of LSK CD150+ CD34- CD48+ Ki67+ cells and 
LSK CD150+ CD34+ Ki67+ cells in infected mice (90 fold and 4.8 fold, respectively, increased 
compared to naive mice) (Figure 3.15b). The number of LSK CD150+ CD34- CD48- Ki67+ cells 
(enriched for LT-HSCs) although significantly altered in infected compared to naive mice, was 
increased to a lesser extent in comparison with the other populations assessed (1.5 fold increased 
in infected mice; Figure 3.15b). 
These results showed that the upregulation of CD48 in HSCs (see section 3.2.6, above) was 
associated with the progression into active cell-cycle, with almost all the CD48 positive cells also 
expressing Ki67, both in non-infected and infected mice. Furthermore, the loss of LSK CD150+ 
CD34- CD48- Ki67- cells (enriched for quiescent LT-HSCs) during infection represents a 24 fold 
decrease in the number (from 831 ± 0.017 to only 34.62 ± 31.93 cells in total BM) of this already 
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very rare cell population (Figure 3.15c; Figure 3.15d). This alteration may account for the loss of 
reconstitution efficiency of HSPCs in adoptive transfer, suggesting that proliferation may be 
depleting the reservoir of HSCs with long-term reconstitute potential.  
3.2.8 LSK CD34- CD150+ CD48- cells were functionally impaired during chronic infection 
with L. donovani 
Mice chronically infected with L. donovani showed alterations in HSCs proliferative status that 
may reflect impairment in the mechanisms regulating proliferation. It has been shown that 
quiescence is inherently related to the ability of HSCs to achieve long-term reconstitution of the 
haematopoietic system in lethally irradiated recipient mice (A. Nakamura-Ishizu et al., 2014). 
Therefore loss of quiescence during L. donovani infection may account for loss of HSCs function 
(i.e. long-term multilineage reconstitution and self-renewal).  
To test this hypothesis, we performed long-term non-competitive adoptive transfer of LSK 
CD150+ CD34- CD48- cells (enriched for LT-HSCs) from CD45.2 naive or infected mice into 
naive CD45.1 recipients (Figure 3.16a). Donor mice belonged to a congenic mouse strain 
expressing the same allelic variant of CD45 (CD45.2), excluding the impact of subtle functional 
differences of CD45.1 and CD45.2 in their efficiency to reconstitute the haematopoietic system 
following transplant into lethally irradiated recipients (S. Basu et al., 2013). 
LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs) from infected mice in comparison to 
naive donor cells were less efficient in their ability to reconstitute the haematopoietic system of 
lethally irradiated recipient mice. The contribution of donor HSCs from infected mice showed a 
trend towards being lower both in BM (51.60% ± 22.95 vs. 21.17% ± 27.68, for naive and 
infected mice, respectively) and in the spleen (32.30% ± 16.76 vs. 10.81% ± 18.75, for naive and 
infected mice, respectively). However, the large variation within groups prevented this being 
significantly different (Figure 3.16b). 
The number of BM cells derived from naive mice (2.72 x 107 ± 1.41 x 107) was significantly 
greater than those derived from infected donor cells (6.95 x 106 ± 7.89 x 106).  In the spleen, one 
sample could not be used to perform absolute quantification due to technical problems. In the 
spleen the number of cells derived from infected donor was on average 3.4 fold decreased 
compared to the number of cells recovered from naive donor in the recipient mice (Figure 
13.16c). 
In infected mice, the frequencies of HSPCs derived from naive and infected mice donor cells were 
comparable in the BM of recipient mice, except for LSK CD150+ FLT3- CD34- cells (enriched for 
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LT-HSCs). The frequency of these most immature progenitors was significantly higher within 
naive donor cells suggesting that HSCs from infected mice were less efficient in their ability to 
reconstitute the rare pool of HSCs (i.e. loss of self-renewal potential; Figure 3.16d). 
In spleen, here representing the periphery, we could not detect any alteration in the distribution 
mature cells derived from infected compared to naive donor cells; we detected an overall decrease 
in all populations in mice receiving HSCs from infected mice, but not a lineage bias toward any 
cell population (Figure 3.16e). 
To further investigate the long-term reconstituting potential and to more accurately evaluate the 
reduction in functional capacity of HSCs from infected mice, we transferred a reduced number of 
LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs) that were isolated from the primary 
adoptive transfer recipients into secondary recipients. Once again, we used different CD45 
isoforms expressed in donor and recipient cells to track the progeny of transferred cells (Figure 
3.17a). 
Unfortunately one of the mixed BM chimeric died leaving us with small number of samples in the 
group receiving cells primarily derived from infected donors, further the variation within groups 
was very high. Nevertheless the results were suggestive of further functional impairment in HSCs 
primarily derived from infected donors, in the secondary adoptive transfers. Regarding cells 
derived from infected mice, we could detect infected donor cells in the BM of two out of three 
recipients, and in the spleen of one out of three recipients, whereas donor cells derived from HSCs 
isolated from naive mice were detected in the BM and spleen of 4/4 recipients of HSCs from 
naive mice (Figure 3.17b). 
Furthermore, in one of the recipient mice receiving HSCs isolated from infected donor we were 
unable to detect any LSK cells, and in the remaining two recipients the numbers of total 
progenitors was on average less than 30 cells (Figure 3.17c). Furthermore, in only one recipient 
receiving cells derived from infected donors, were Lin- cKithi cells (enriched for lineage-
committed progenitors) detected in BM (Figure 3.17d). However, in all secondary recipient mice 
transplanted with HSCs isolated from non-infected mice we could detect donor HSPCs for the 
three lineages in BM of recipient mice (Figure 3.17c; Figure 3.17d).  
In summary, these data show that following an overall period of 40 weeks of transfer into healthy 
recipients, LSK CD150+ CD34- CD48- cells derived from naive donors were capable of self-
renewal and of giving rise to all lineages (hallmarks of stemness). In secondary recipient mice, 
2316 ± 3472 LSK CD150+ CD34- CD48- cells derived from the original naive donor were present 
in total BM. In contrast, in the only secondary recipient where LSK CD150+ CD34- CD48- cells 
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could be found that originated from HSCs derived from infected mice, only 16 LSK CD150+ 
CD34- CD48- cells were present (Figure 3.17c). Similarly, in all recipient mice transplanted with 
HSCs originating from non-infected mice we could consistently detect mature progeny in both the 
lymphoid and myeloid lineages, whereas among recipient receiving HSCs originating from 
infected mice we could only detect very low numbers of mature cells in the spleen of one out of 
three recipient mice (Figure 3.17e). Collectively, these data suggested that HSCs from infected 
mice show intrinsic long-term functional impairment, linked to alterations in cell-cycle regulation. 
3.2.9 Alteration in expression of transcription factors associated with cell-cycle regulation 
of HSCs during L. donovani infection 
3.2.9.1 LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs) in infected mice expressed of 
β-catenin at increased levels 
It has been showed that wingless and int (Wnt) signaling is required for the adequate function of 
HSCs using several gain and loss-of-functions approaches. However the results from different 
studies aimed at clarifying its role in HSCs self-renewal were conflicting (P. Kirstetter et al., 
2006, T. C. Luis et al., 2010a, C. J. Cain and J. O. Manilay, 2013). More recently experiments 
using different combinations of APC (Adenomatous polyposis coli gene) mutants have shown that 
mild increases (about 2 fold) in Wnt signaling enhanced HSC function, while impaired HSC 
repopulation capacity was associated with intermediate and higher levels of activation of the Wnt 
signaling pathway (T. C. Luis et al., 2011). 
In order to assess if a higher degree of activation of Wnt canonical signal was associated with the 
alterations observed in HSCs during infection with L. donovani, we used intracellular flow 
cytometry to assess the relative accumulation of β-catenin in multipotent progenitors in naive and 
day 28 infected mice. The relative amount of β-catenin protein in multipotent progenitors was 
determined by the fold change in Mean Intensity Fluorescence (MFI), since we found β-catenin to 
be expressed in all multipotent progenitors (Figure 3.18a). We observed a significant increase in 
β-catenin protein detected in LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs), LSK 
CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells in the BM of infected mice (1.41 ± 
0.39 fold, 1.49 fold ± 0.45 and 1.33 ± 0.24 fold, respectively in infected compared to naive mice; 
Figure 3.18b). 
Wnt3a, the prototypical Wnt ligand for the canonical pathway, has been suggested to play an 
important role in activation of HSCs that express its cognate receptors (R. Sugimura et al., 2012). 
Therefore, we next assessed expression of Wnt3a, using flow cytometry to detect intracellular 
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expression in cells treated with brefeldin A prior to staining, to promote Wnt3a intracellular 
accumulation.   
Across all the populations assessed in BM, we could not detect a significant increase in the 
frequency of cells expressing Wnt3a during infection (Figure 3.19a; Figure 3.19d). However, 
when we evaluated the amount of Wnt3a expressed in each cell population significant alterations 
were detected. In infected mice, mature haematopoietic cells (CD45+ Lin+ cells) expressed higher 
levels of Wnt3a as assessed by the MFI, than naive mice (Figure 3.19b; Figure 3.19c). A 
significant increase in Wnt3a expression, following L. donovani infection, was also determined in 
LSK CD150+ CD48- cells (enriched for LT-HSCs) displaying a 1.5 fold increase in Wnt3a 
expression (Figure 3.19b; Figure 3.19c).  
Thus, we assessed if Wnt3a mRNA accumulation was altered in total BM in infected mice 
compared to naive mice. Contrary to protein expression, the Wnt3a mRNA accumulation was 
decreased in total BM cells from infected mice (Figure 3.20), suggesting that level of Wnt3a 
could be controlled by post-transcriptional mechanisms. 
Overall these findings suggested that alterations in BM during infection with L. donovani were 
associated with enhanced activation of Wnt canonical pathway in haematopoietic progenitors that 
may be supported by an increase availability of Wnt3a in BM stem cells niche, as well as by 
increased autocrine Wnt3a signaling in LT-HSCs. 
3.2.9.2  LSK CD150+ CD34- CD48- cells (LT-HSCs) in infected mice have increased 
expression of the transcription factor c-Myc  
The Myc proto-oncogene has been described as a central transcription factor in haematopoiesis, 
and is expressed in all haematopoietic progenitors. Mice deficient for Myc dye before birth and its 
believed that defects in the haematopoietic system development are the basis of embryonic 
lethality (M. D. Delgado and J. Leon, 2010).  This hypothesis was confirmed by observing the 
marked haematological changes associated with conditional Myc deletion, in MxCre;c-mycflox/flox 
mice (A. Wilson et al., 2004). These studies also suggested that Myc participates in the regulation 
of HSCs self-renewal and differentiation through the regulation of adhesion molecules expression, 
notably CD29 (A. Wilson et al., 2004).  
The HSCs phenotype we observed during L. donovani infection shared many features that have 
been reported in mice following conditional ablation of Myc (A. Wilson et al., 2004). Therefore, 
we next assessed the expression of c-Myc in HSCs. c-Myc protein is difficult to detect by direct 
antibody staining. Therefore we transferred total BM cells from c-Myc-Egfp mice, expressing 
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EGFP under the control of the c-Myc endogenous promoter, into lethally irradiated recipients. 
After a period of ten weeks, these mice were infected with L. donovani and HSPCs phenotype 
examined at day 28 p.i., using intracellular flow cytometry to detect the EGFP tag. In infected 
mice, LSK CD150+ CD48- cells (enriched for LT-HSCs) expressed more c-Myc compared to 
naive mice, and the same trend was observed in LSK CD150+ CD48+ cell (Figure 3.21). We also 
assessed the level of CD29 protein expression in haematopoietic multipotent progenitors 
including HSCs, but we could not determine any significant differences between naive controls 
and mice infected mice (Figure 3.22). In summary, although we identified an increase in the 
expression c-Myc in LT-HSCs isolated from L. donovani infected mice, this was not coupled to a 
detectable change in expression of the adhesion molecule CD29. 
3.2.9.3 LSK CD150+ CD48- cells (enriched for LT-HSCs) in infected mice have increased 
expression of the transcription factor GATA-3 
The transcription factor GATA-3 is expressed in various haematopoietic progenitor populations in 
BM, with HSCs expressing the highest levels of GATA-3 (C.-J. Ku et al., 2012). Recent studies 
have suggested that GATA-3 is important in the regulation of HSCs proliferative status and self-
renewal potential during stress-induced haematopoiesis (C.-J. Ku et al., 2012, C. Frelin et al., 
2013). For example, in GATA-3 KO mice the deleterious impact of Poly:IC challenge on HSCs 
function could be prevented (C.-J. Ku et al., 2012, C. Frelin et al., 2013). We observed that during 
L. donovani infection the number of HSCs in active cell-cycle increased with concomitant loss of 
quiescent cells, suggesting an alteration in the regulation of cell-cycle, which prompted us to 
investigate intracellular expression of GATA-3 in HSPCs.  
We first observed that neither the frequency of mature haematopoietic cells nor the frequency of 
total HSPCs (enriched in Lin- cKit+ cells) expressing GATA-3 was altered by the infection 
(Figure 3.23a). Upregulation of GATA-3 expression in BM was restricted to the most immature 
cells contained in the LSK CD150+ cells compartment (Figure 3.23a; Figure 3.23c). The 
frequency LSK CD150+ CD48- cells (enriched for LT-HSCs) expressing GATA-3 was 48.93% ± 
21.11 in infected mice compared to 21.31% ± 13.61 in naive controls (Figure 3.23a). Within LSK 
CD150+ CD48+ cells (other multipotent progenitors) the increase in cells expressing this 
transcription factor was also significant in BM of infected mice compared to naive mice (54.82% 
± 27.80 vs. 79.15% ± 9.47) (Figure 3.23a; Figure 3.23c). This increase in very immature cells 
expressing GATA-3 was concomitant with a 1.22 ± 0.19 fold increase in the amount of GATA-3 
expressed in LSK CD150+ CD48- GATA-3+ cells, and a 1.29 ± 0.16 increase in LSK CD150+ 
CD48+ GATA-3+ cells in infected compared to naive controls, as assessed by the fold change in 
MFI (Figure 3.23b).  
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We next sought to determine whether the expression of GATA-3 could be related to the 
proliferative state of LSK CD150+ CD48- cells (enriched LT-HSCs). In infected mice, a 
significant alteration in the distribution of LSK CD150+ CD48- cells segregated according with 
the expression of GATA-3 and Ki67 was observed (Figure 3.24).  
In fact, we observed that the expression of this transcriptional factor was almost absent in cells in 
G0 (Ki67- cells). In naive mice, 43.24% ± 5.69 of LSK CD150+ CD48- cells were Ki67- GATA-3-, 
but following infection there was a significant decrease in cells falling in this group (5.20% ± 
5.31). Also, concomitant with chronic infection, we observed a significant increase in LSK 
CD150+ CD48- cells expressing Ki67 and GATA-3 (17.64 ± 11.23 vs. 46.68 ± 21.66, in naive and 
infected, respectively), while in steady-state the majority of LSK CD150+ CD48- cells in cycle 
were GATA-3 negative (Figure 3.25).  
These data demonstrate that GATA-3 expression was up-regulated in LSK CD150+ CD48- cells 
(enriched LT-HSCs) during induced haematopoiesis following L. donovani infection. As such, 
GATA-3 over expression due to inflammation may represent a mechanism for impaired 
maintenance of homeostatic numbers of LT-HSCs in quiescence, during L. donovani chronic 
infection. 
It is known that upon poly I:C treatment, GATA-3 re-locates to the nucleus in proliferating HSCs 
and restricts these cells to short-term multilineage reconstitution, however after the removal of 
proliferative stimulus, GATA-3 returns to the cytoplasm and long-term lineage reconstitution is 
restored (C. Frelin et al., 2013). We therefore attempted to determine the subcellular localization 
of GATA-3 in HSCs in infected vs. naive mice. We optimized protocols for sort purification of 
HSCs and for imaging GATA-3 expression by confocal microscopy, using thymocytes in 
suspension as a positive control (Figure 3.26). Despite our efforts in sorted LSK we were unable 
to obtain a reliable staining (Figure 3.27). 
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3.3 DISCUSSION 
VL in humans and animal models is associated with significant changes in haematological 
function, and parasite persistence in BM is well characterized (G. E. Cartwright et al., 1948, S. E. 
J. Cotterell et al., 2000a, N. Varma and S. Naseem, 2010, W. P. Lafuse et al., 2013, F. A. d. 
Pinho, 2015). However, very little is known about the impact of L. donovani infection on 
upstream processes underlying haematopoiesis. 
In this chapter, we showed that L. donovani infection impacts on BM haematopoiesis. Using a 
panel of stem cell markers, we characterized murine HSPCs in the BM over the course of L. 
donovani-infection in B6 mice. At the peak of infection, mice showed a significant increase in 
intermediary non-committed multipotent haematopoietic precursors (LSK CD150+ CD34- CD48+ 
cells and LSK CD150+ CD34+ cells) without reciprocal increases in either lineage-committed 
precursors or mature cells in circulation. In the steady-state, the majority of LT-HSCs (LSK 
CD150+ CD34- CD48- cells) were quiescent, representing cells with the highest degree of 
reconstitution potential. In contrast, during infection most were found to have progressed to cell-
cycle and this correlated with a reduced potential to engraft into syngeneic recipients. The 
functional alterations in proliferative LT-HSCs were associated with the upregulation of the co-
activator surface molecule CD48 and the transcriptions factors GATA-3 and β-catenin.  
In the only work that previously characterized the alteration in haematopoiesis in experimental 
VL, it was shown that following infection with L. donovani myelopoiesis was increased, both in 
BM and in the spleen. This study by Cotterell and colleagues used an assay of colony-forming 
precursors and progenitors to determine the association between L. donovani parasite burdens and 
changes in haematopoietic activity. They showed that the frequency of all progenitor cells from 
the BM increased during the course of L. donovani infection; while in the spleen there was a 
specific increase in GM-CFU. These correlate with the increase in parasite burden both in the BM 
and the spleen. Furthermore, the proportion of progenitors in S phase in both the spleen and BM 
increased, indicating a higher level of proliferation, during chronic infection. Additionally, it was 
found that there is greater accumulation of mRNA for the growth factors G-CSF, M-CSF, and 
GM-CSF in the BM during chronic phase of infection (S. E. J. Cotterell et al., 2000a).  
This study was performed in BALB/c while our model of experimental VL was established in B6 
mice. The outcome of L. donovani infection varies considerably among mouse strains, for 
example BALB/c genetic background was associated to an impaired clearance of parasites from 
the liver compared to B6 mice (M. Lipoldova and P. Demant, 2006). Therefore, we decided to 
characterize the kinetics of alterations in HSPCs and parasite burden during the course of 
infection in B6 mice. 
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Instead of CFU assays, we chose to characterize HSPCs (LT-HSCs, ST-HSCs, MPPs, CMPs, 
GMPs, MEPs and CLPs), as defined previously (M. Kondo et al., 2003a, J. L. Granick et al., 
2012) according with their pattern of surface markers expression using flow cytometry, directly ex 
vivo. More, although short-term cultures are very useful to study lineage-committed progenitor 
cells that differentiate in less than 3 weeks, they are unable to quantify more primitive progenitors 
that require longer culture periods to produce mature cells (L. Coulombel, 2004). On the other 
hand, the usage of long-term cultures could overcome this limitation, but the growth factors 
required for HSCs and immediate progeny culture are not well established and may, therefore, 
impact in the differentiation process (L. Coulombel, 2004). 
In steady-state, the LSK cell population contains the most immature non-committed progenitors, 
conventionally called haematopoietic progenitor cells (HPCs) (K. Y. King and M. A. Goodell, 
2011), whereas lineage-committed progenitors are contained in the Lineage- Sca1- cKit+ cells 
(cKithi cells; Figure 3.2) (M. Kondo et al., 2003a). In adults, Sca1 expression is mainly restricted 
to non-committed progenitors but its expression may be induced in other cells by Interferon Type 
I and II, TNF and IL-1, commonly found present at increased levels at sites of infections (A. 
Sinclair et al., 1996, S. Maltby et al., 2014).  It has also been shown in a wide range of infection 
models that Sca1 expression is upregulated in all HSPCs. Likewise upon an infection; the 
immune-phenotypically defined LSK fraction may contain functional lineage-committed 
progenitors (N. N. Belyaev et al., 2010, M. B. Buechler et al., 2013, E. M. Pietras et al., 2014). 
During the course of infection we observed the expansion of the LSK compartment concomitant 
with the contraction in Lineage- Sca1- cKit+ cell number. Taking in account the above findings, we 
included Lineage- cKit+ Sca1+/- cells in the process of selecting for lineage-committed progenitors 
in addition to the other defined cell surface markers. 
In B6 mice, contrary to BALB/c mice, the peak parasite burden was reached at day 28 p.i. and by 
day 64 the number of parasites in the BM and spleen were very low, although the splenomegaly 
was maintained indicating that inflammation persisted. Another difference related to the number 
of myeloid progenitors in BM that, except for MEPs, were not significantly increased (S. E. J. 
Cotterell et al., 2000a). Over 64 days following infection the number multipotent progenitors, 
namely LSK CD150+ Flt3- CD34- cells and LSK CD150+ Flt3- CD34+ cells increased steadily, and 
their number remained high even at the latest time point, when the parasite burden was minimal in 
BM and in the spleen. The number of multipotent progenitors was increased in the spleen at later 
time points, as well as, CMPs and MEPs.  
The detection of HSPCs in increased number in the spleen has been described in other models of 
infection (K. C. MacNamara et al., 2009, M. T. Baldridge et al., 2010). HSCs survey the 
periphery and have the potential to seed and originate myeloid immune cells in extramedullary 
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tissues. It was suggested that during infection migratory HSCs may function as a prompt provider 
of progenitors that expand in situ and give rise to myeloid effector cells (S. Massberg et al., 
2007). In the spleen of mice infected with L. donovani the frequencies of macrophages and 
dendritic cells (DCs) are found increased (J. E. Dalton et al., 2010). Most likely, the increase in 
HSPCs that occurs during infection may result from non-exclusive phenomena such as alteration 
in the egress of HSCs from BM, splenic sequestration and subsequent expansion and 
differentiation in loco. 
Dramatic increases in LSK CD150+ Flt3- CD34- cells and LSK CD150+ Flt3- CD34+ cells in BM 
were observed at day 28 p.i. that was highly consistent across multiple experiments. Yet the 
number of lineage-committed progenitors remained at basal values, providing the first evidence 
for a block in HSPCs progression.   
The expansion of HSCs and/or onward multipotent progenitors has been described in a wide 
range of experimental models of infections (S. Rodriguez et al., 2009, M. T. Baldridge et al., 
2010, K. C. MacNamara et al., 2011a, S. Maltby et al., 2014). The acute model of respiratory 
infection (pneumonia virus of mice) provides an example of the impact of a localized infection on 
alterations in haematopoiesis. In mice infected with pneumonia virus of mice (PMV), the fraction 
of LSK cells and LT-HSCs (LSK CD150+ CD48- cells) expanded in BM, while the number of 
granulocytes was found greatly increased in peripheral blood (S. Maltby et al., 2014). In the 
present study, we observed expansion of LT-HSCs (LSK CD150+ Flt3- CD34- cells) in BM of L. 
donovani infected mice, but only a modest neutophilia was observed. 
In a model of sepsis, an increase in the number of LSK cells, as well as LT-HSCs (LSK Flt3- 
CD34- cells) and MPPs (LSK Flt3+CD34+ cells) was observed following inoculation with a 
virulent Pseudomonas aeroginosa strain. These mice displayed severe neutropenia that was 
partially explained by a block in differentiation of MPPs to myeloid lineage-committed 
progenitors. CMPs and GMPs were found at very decreased number in BM and expressed less 
lysozyme compared to controls, an indication of delayed maturation (S. Rodriguez et al., 2009).  
The accumulation of immunophenotypic LT-HSCs (characterized as LSK CD150+ Flt3- cells) was 
reported in the BM in other models of acute infection (P. O. Scumpia et al., 2010, K. C. 
MacNamara et al., 2011a). In mice inoculated with Ehrlichia muris, it was reported that an 
accumulation of LT-HSCs and loss of functional myeloid committed progenitors occurred in BM 
(K. C. MacNamara et al., 2011a). Furthermore, similarly to our model, mice infected with E. 
muris displayed splenomegaly, thrombocytopenia and anaemia, features common to human 
monocytic ehrlichiosis (K. C. MacNamara et al., 2009). Interestingly, in mice infected with 
Ehrlichia muris erythroid progenitors also expand in great number (defined by the expression of 
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CD71 and Ter119) (K. C. MacNamara et al., 2009). Data from our laboratory showed that in 
spleens of mice infected with L. donovani, the number of erythroid progenitors is also greatly 
increased (O. Preham unpublished data). The data provided here on the number of MEPs in the 
spleen support the proposition that during infection the spleen becomes a site of extramedullary 
erythropoiesis.  
Activation of multipotent progenitors toward expansion is not restricted to models of acute 
infection, for instance in mice, chronic systemic infection with Mycobacterium avium resulted in 
enlarged spleens, thrombocytopenia, the accumulation of immunophenotypic ST-HSC (defined as 
LSK Flt3- CD34+ cells) and marginal increase in the number of LT-HSC (defined as LSK Flt3- 
CD34- cells and MPPs (defined as LSK Flt3+ CD34+ cells) in the BM. In the spleen, the number 
of LT-HSCs (defined as LSK CD150+ cells) was also very increased in mice chronically infected, 
suggesting that the infection may result in the mobilization of progenitors to the periphery (M. T. 
Baldridge et al., 2010). These findings resemble the phenotype we described in mice infected 
with L. donovani for 28 days.   
The clinical symptoms vary considerably among VL patients, ranging from asymptomatic to very 
severe clinical symptoms, including fever, splenomegaly and hepatomegaly, cachexia, 
pancytopenia and hypergammaglobinemia. Anaemia is often described in association with L. 
donovani chronic infection, but there are many reports showing that other haematological 
alterations may emerge such as, leucopenia, thrombocytopenia, pancytopenia, haemophagocytosis 
and coagulation abnormalities (G. E. Cartwright et al., 1948, N. Varma and S. Naseem, 2010). In 
addition to alterations in peripheral blood, several clinical reports describe alteration in BM 
cellularity; these alterations include histiocytic hyperplasia, erythroid hyperplasia, increase in the 
number immature forms of granulocyte and megakaryocyte (N. Yarali et al., 2002, N. Varma and 
S. Naseem, 2010). These haematological alterations have been mainly attributed to spleen 
sequestration of circulating cells and ineffective haematopoiesis (G. E. Cartwright et al., 1948, N. 
Yarali et al., 2002, N. Varma and S. Naseem, 2010). 
In the present study, we found that mice infected with L. donovani show signs of impairment of 
haematopoietic function, such as anaemia and thrombocytopenia. 
In the experimental model of VL using Syrian golden hamsters infected with L. donovani, an 
experimental model that more resembles end stage human VL, it has been shown that chronic 
infection is associated with anaemia and leucopenia and increased number of erythroid 
progenitors both in BM and in the spleen. In hamsters, the increase in erythroid progenitors and 
the emergence of stress-induced erythropoiesis in the spleen was associated to the elevation in the 
concentration of erythropoietin in circulation, as a response to the increase cells death of BM 
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erythroblasts (W. P. Lafuse et al., 2013). Dogs bearing natural L. donovani infection have also 
been described to have significant haematological alterations, including anaemia, 
thrombocytopenia and leucopenia, alongside with alteration in BM cellularity (F. A. d. Pinho, 
2015). 
In contrast to human disease, and that in hamsters and dogs, experimental VL in mice is not fatal 
and although parasites number increase in spleen and liver following infection, in the latter the 
infection is self-resolving with the formation of granulomas (P. M. Kaye et al., 2004). 
Nevertheless, more recently it was reported that B6 mice chronically infected with L. donovani 
display mild pancytopenia (anemia, leucopenia and thrombocytopenia) (F. A. d. Pinho, 2015). 
These findings were obtained through the analysis of PB using flow cytometric approaches, and 
agree with results we obtained using automated method to perform PB hemogram at same time 
point of infection. Furthermore, in B6 mice were also described morphological alterations in BM, 
such as asynchronous nuclear-cytoplasmic maturation, presence of megalocytes and binucleated 
erythroid cells (F. A. d. Pinho, 2015). Overall these findings suggested that stress induce 
haematopoiesis during chronic infection with L. donovani may induce ineffective haematopoiesis 
and contribute to the (most likely multifactorial) establishment of cytopenias, in spite of the 
increased haematopoietic activity in BM.  
In malaria infection, anaemia is a common finding and contributes very significantly to the 
morbidity and mortality of this parasitic infection. Its thought that on the basis of anaemia is the 
destruction of infected erythrocytes and changes in erythropoiesis (J. Pablo Quintero et al., 2011). 
Alteration in haematopoietic function were also described in experimental models of disease, in 
which besides the establishment of anaemia were described alterations of haematopoiesis such as 
decreased clonogenic activity of BM cells in colony-forming assays and decreased number of 
phenotypic myeloid-committed progenitors in BM (N. N. Belyaev et al., 2010, N. N. Belyaev et 
al., 2013).   
Expansion of the LSK compartment in the BM may be required to respond to the increase demand 
of immune cells during the response to an acute infection. For example, the infection with 
Plasmodium chabaudi results in the IFNγ-dependent emergence of a LSK IL7-Rα+ progenitor cell 
otherwise absent in steady-state, with the potential to produce myeloid cells that contributed to the 
parasite clearance (N. N. Belyaev et al., 2010). In response to acute pneumovirus infection the 
expansion of LSK in BM is concomitant with the increase of functional myeloid progenitors, as 
determined by CFU in BM cells. In this model of infection the increase in myeloid-committed 
progenitors is TNF- and IFNγ-dependent, since administration of anti-TNF or anti-IFNγ 
prevented the increase in myeloid progenitors and lead to an increased the virus load in the lung 
in comparison to the controls (S. Maltby et al., 2014).  
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However in several models of disease it was showed that the sustainment of the stress-induced 
haematopoiesis such as during a chronic infection might result in the functional exhaustion of 
HSCs (K. Y. King and M. A. Goodell, 2011, C. Mirantes et al., 2014). For instance in humans, 
anaemia, leucopenia, or pancytopenia have been commonly described in association with chronic 
infectious diseases, such as HIV, atypical mycobacterial infection and viral hepatitis (A. Jain and 
M. Naniwadekar, 2013).  
In fact, it was shown in various models of infection or following poly:IC stimulation (inducer of 
Interferons Type I release) that HSCs perform poorly reconstitution of the haematopoietic system 
when transplanted to lethally irradiated syngeneic mice (S. Rodriguez et al., 2009, K. C. 
MacNamara et al., 2011a, A. M. de Bruin et al., 2013, C. Frelin et al., 2013, K. A. Matatall et al., 
2014).  As so, we hypothesized that infection with L. donovani resulted in the activation of HSCs 
followed by their functional compromise.  
To evaluate if the expansion of LSK compartment accounted for functional alterations early in 
haematopoiesis or down the line in lineage-committed progenitors we established competitive 
radiation BM chimeras with equal numbers of BM Lineage- cells (enriched for all HSPCs) sort-
purified from naive and infected mice. In recipient mice, donor cells derived from infected mice 
were much less efficient in their ability to engraft in BM and reconstitute the periphery. However, 
in spite of the overall lower number of infected donor mice we failed to determined any lineage 
bias. These findings suggested that L. donovani infection was impacting early in haematopoiesis 
prior to lineage-commitment, and the increase in HSCs cell number was not associated with an 
increase in stem cell activity, but resulting from cell-intrinsic functional impairment of 
multipotent progenitors, as observed previously in several models of infection (S. Rodriguez et 
al., 2009, K. C. MacNamara et al., 2011a, A. M. de Bruin et al., 2013, C. Frelin et al., 2013, K. A. 
Matatall et al., 2014).  
HSCs are far from being fully characterized. The most common markers to select HSCs are LSK 
cells, CD34 negative/low and Flt3 negative and more recently LSK CD150 positive and CD48 
negative, and it was shown that the self-renewal and reconstituting potentials of HSCs decrease as 
CD150 expression levels decline (G. A. Challen et al., 2009). Nevertheless, the alterations in the 
phenotype of HSCs and MPPs in proinflammatory conditions are yet to be fully resolved (J. L. 
Granick et al., 2012).  
In the present study, the magnitude of the increase in the number of phenotypic LT-HSCs induced 
following L. donovani infection was such that it raised the possibility that LSK CD150+ FLt3- 
CD34- cells could no longer be true LT-HSCs. As such, we have included CD48 as an extra 
surface marker to select for true LT-HSCs. 
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CD48 expression was shown to be transiently upregulated when HSCs were stimulated to cycle 
by systemic administration of 5-flurouracil (5-FU) (which promotes cell death in dividing cells), 
and using BMT assays it was found that the majority of HSCs with long-term potential of 
reconstitution were contained in the CD48 negative compartment. Furthermore, in CD48-deficient 
mice it was described that HSCs are more quiescent both in steady-state and upon 5-FU 
administration, suggesting that the repression of CD48 expression may be required to preserve the 
pool of LT-HSCs in G0 (M. J. Kiel et al., 2005, N. C. Boles et al., 2011).   
In steady-state, we found that CD48 was not expressed in the vast majority of LSK CD150+ FLt3- 
CD34- cells but was up-regulated upon infection with L. donovani in the majority of phenotypic 
LT-HSCs. Therefore, in subsequent experiments LT-HSCs were defined as LSK CD150+ CD48- 
CD34- cells. In fact, when CD48 was used as an additional maker of haematopoietic 
differentiation, we found that the number of LT-HSCs (LSK CD150+ CD48- CD34- cells) was 
conserved in the BM, but this was followed by a significant increase in intermediary non-
committed precursors. Similarly, in mice infected with E. muris, it was reported that while in 
steady-state the LSK CD150+ Flt3- cells express low levels of CD48, upon infection it is almost 
evenly expressed at high levels in LSK CD150+ Flt3- cells (K. C. MacNamara et al., 2011a). 
In the adult, LT-HSCs are mainly found in a quiescent state and the regulation of HSC 
quiescence/proliferation relies on cell-intrinsic and -extrinsic factors, which availability may vary 
considerably between homeostatic haematopoiesis and infection-induced haematopoiesis (K. Y. 
King and M. A. Goodell, 2011, C. Mirantes et al., 2014, A. Nakamura-Ishizu et al., 2014).  The 
proliferative status of HSCs has been assessed in various models of infection. For instance, in 
mice infected with Ehrlichia muris, the number of dividing phenotypic HSCs increase almost two 
fold following infection (K. C. MacNamara et al., 2011a). Identical alterations in HSCs cell-cycle 
activation were made in mice challenged with Poly:IC (C. Frelin et al., 2013, D. Walter et al., 
2015), mice infected with Mycobacterium avium (M. T. Baldridge et al., 2010) and mice infected 
with LCMV (K. A. Matatall et al., 2014). In all these studies the increase in proliferative activity 
in HSCs correlated with loss of long-term reconstitution potential upon transplant into lethally 
irradiated recipients, suggesting that proliferation of HSCs under infection–induced conditions 
may result in cell-intrinsic functional impairment.  
In line with the above studies, we also found that in steady state the majority of LSK CD150+ 
CD34- CD48- cells (LT- HSCs) were quiescent. However, during L. donovani infection the vast 
majority progressed into active cell-cycle, resulting in a dramatic depletion in the reservoir of 
quiescent LT-HSCs. On the contrary, the other populations of multipotent progenitors 
characterized, namely LSK CD150+ CD34+ CD48+ cells and LSK CD150+ CD34+, were highly 
proliferative both in steady-state and upon infection.  
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Decision making for HSC progression to active cell-cycle and subsequent decision to self-renew 
and/or differentiate (symmetric versus asymmetric division) is far from fully understood. 
However in the past decade many progresses were made to address these questions (K. W. Orford 
and D. T. Scadden, 2008). It is known that signaling by morphogens, such as Wnt, Notch and 
Hedgehog pathways have the potential to regulate entry to the G1 phase of the cell-cycle, and the 
presence of these morphogens was reported in stem cell niches raising the possibility that 
morphogen signaling prevents HSCs differentiation. In very simple lines, it was proposed that the 
decision towards self-renewal and/or differentiation depends on the different balances established 
by the availability of mitogens inducing differentiation (such as cytokines and growth factor 
inducing MAPK signaling) and the availability of morphogens promoting self-renewal (K. W. 
Orford and D. T. Scadden, 2008). Hence, it would be possible that during infection the relative 
abundance of pro-inflammatory mediators and growth factors could promote an “excess” of stem 
cell commitment that was not compensated by the mechanisms regulating quiescence and self-
renewal, increasing the chances of HSCs functional exhaustion in the long-term. 
It has long been postulated that the maintenance of adults stem cell quiescence is an evolutionary 
advantage, protecting them from genomic instability and therefore, preventing accumulation of 
mutations that could be perpetuated in their progeny (A. Trumpp et al., 2010). Nevertheless, only 
recently a direct correlation was established between stress-induced haematopoiesis and the 
deterioration of HSCs function. In mice stimulated with Poly:IC, there is an immediate activation 
of LT-HSCs (LSK CD150+ CD34- CD48- cells) into active cell-cycle, and this is concomitant 
with the accumulation DNA double-strand breaks and single-strand breaks. Moreover, these same 
effects were replicated in mice stimulated with IFN-α, G-CSF, TPO or by serial bleeding, 
suggesting that the emergence of damages in DNA is a common result of stress-induced HSCs 
proliferation and may therefore, be present during infection-induced haematopoiesis (D. Walter et 
al., 2015). The functional consequences of the accumulation of DNA damage in LT-HSCs 
became evident throught the observation that in competitive BM transfer donor cells derived from 
mice subjected to extended poly:IC treatment had a two fold decrease in their repopulating 
activity compared to controls, 24 weeks upon transplant (D. Walter et al., 2015). This work, for 
the first time established a direct evidence that increased proliferation of HSCs may account for 
accumulation of defects, that if sustained beyond the limit of repair may result in BM failure, but 
also provides a plausible explanation to the increased frequency of haematopoietic dysplastic cells 
observed in chronic VL (N. Yarali et al., 2002, N. Varma and S. Naseem, 2010, G. M. de 
Vasconcelos et al., 2014, F. A. d. Pinho, 2015). 
Nowadays, it is indisputable that infection has the potential to drive proliferation with outcomes 
that vary considerably from pathogen to pathogen (K. Y. King and M. A. Goodell, 2011, C. 
Mirantes et al., 2014, A. M. Prendergast and M. A. G. Essers, 2014). In our model of 
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experimental VL, we determined that the fraction of proliferative LT-HSCs was increased and 
this related to loss of potential to perform long-term haematopoietic reconstitution in healthy 
recipients, indicating that L. donovani infection led to cell-intrinsic functional impairment. 
Aiming to determine potential molecular targets underlying these alteration, we then evaluated the 
expression of several transcription factors previously determined to play important roles 
regulating of LT-HSCs proliferation including, β-catenin (T. C. Luis et al., 2011), GATA-3 (C.-J. 
Ku et al., 2012, C. Frelin et al., 2013), and c-Myc (A. Wilson et al., 2004).  
Canonical Wnt signaling pathway is very important mediator of HSCs functions (T. C. Luis et al., 
2011, W. Lento et al., 2013). For example, it was shown that Wnt3a deficient mice die around 
embryonic day (E) 12.5, and HSCs from fetal livers showed cell intrinsic defects, such as severely 
reduced reconstitutive activity (T. C. Luis et al., 2009). Furthermore, in adult mice its activity 
seems to be very fine-tuned. Using mutant displaying Wnt signaling pathway at different levels of 
activation, it was shown that mild increase in Wnt signaling activation enhances HSCs function, 
nevertheless higher levels of activation of the Wnt signaling pathway impair HSCs repopulation 
capacity (T. C. Luis et al., 2011). 
Wnt canonical signaling is initiated when Wnt ligands engage their cognate receptor complex in 
the membrane of the target cell, which ultimately results in the translocation of β-catenin, a 
transcriptional coactivator, to the nucleus, where it binds to the classical canonical Wnt 
transcription factors, T-cell factor (TCF) and lymphoid enhancer binding factor (LEF) to initiate 
transcription of target genes. When Wnt receptors are not engaged, β-catenin is localized to the 
cytoplasm, and in association a destruction complex, which target β-catenin for proteasomal 
degradation (T. Reya and H. Clevers, 2005, C. J. Cain and J. O. Manilay, 2013).  In mice 
expressing a stable form of β-catenin under the control of Mx-cre, resulting in higher expression 
of Wnt target genes in BM cells, signs of pancytopenia and an accumulation of granulocytic cells 
and immature erythroid cells in the BM were reported. Underlying these alterations was the 
establishment of a block in differentiation of all three lineages, expansion of LSK cells, 
accumulation of multipotent progenitors (LSK Flt-3– CD34+ cells), decreased number of lineage-
committed progenitors, and finally functional decline of LT-HSCs (LSK Flt-3– CD34– cells) 
which were unable to perform reconstitution in competitive adoptive transplant assays (P. 
Kirstetter et al., 2006). Mice expressing a stable form of β-catenin display a severe form of the 
haematopoietic alterations, resembling the phenotype we observed in mice infected with L. 
donovani, including pancytopenia, accumulation of intermediary multipotent progenitors and 
impairment of LT-HSCs function. Therefore, we evaluated the relative accumulation β-catenin in 
LT-HSCs, and found this to be increased following infection, suggestive of increased activation 
of Wnt signaling pathway in LT-HSCs. Future experiments should seek to evaluate β-catenin 
subcellular localization.  
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Wnt–β-catenin signaling canonical pathway is activated following binding of Wnt1, Wnt3a, or 
Wnt8 to its receptor the seven-transmembrane domain receptor Frizzled (Fzd) and co-receptor, 
the single-membrane-spanning low-density receptor-related protein 5/6 (LRP5/6), expressed in 
target cell (L. Grumolato et al., 2010). Wnt3a was the first Wnt protein purified and it has been 
described as the prototypical Wnt ligand for the canonical pathway. Wnt3a homozygous mutants 
die early during embryonic development, and it was showed using a Wnt reporter that Wnt3a is 
unique in its ability to activate canonical Wnt signaling in the HSCs in fetal livers (T. C. Luis et 
al., 2009, T. C. Luis et al., 2010b). Studies in vitro showed that adult HSCs stimulated with 
purified Wnt3a had an improved capacity to reconstitute the haematopoietic system of 
conditioned mice in vivo (T. Reya and H. Clevers, 2005). These studies suggested that Wnt3a 
may play an important role in activation of HSCs that express its cognate receptors (R. Sugimura 
et al., 2012). Therefore, we assessed expression of Wnt3a on BM cells in mice infected with L. 
donovani. 
In the BM of infected mice we found that of Wnt3a was expressed at increased levels by mature 
haematopoietic cells (CD45+ Lineage+ cells), suggesting increased availability of Wnt3a in the 
BM microenvironment during infection might drive an enhanced activation of Wnt canonical 
pathway within LT-HSCs. LT-HSCs did also expressed increased levels of Wnt3a following 
infection with L. donovani. Interestingly, it was previously described that HSCs display an 
increased potential to produce Wnt3a, and therefore mediate autocrine induction of canonical Wnt 
signaling, as a compensatory mechanism in the absence of Wnt expression by osteoblasts (C. 
Schaniel et al., 2011).     
We failed to determine an increase in the Wnt3a mRNA expression in total BM cells from 
infected, suggesting that protein levels may depend of post-transcriptional regulation. 
c-Myc was identified as a Wnt/β-catenin target gene in colorectal cancer cell lines characterized 
by the accumulation of β-catenin and the activation of Wnt target genes including c-Myc (M. D. 
Delgado and J. Leon, 2010). This transcription factor is implicated in the regulation of a wide 
range of gene groups including, apoptosis, cell-cycle regulation and metabolism. However, c-Myc 
may play as a transcriptional repressor of genes regulating cell adhesion and quiescence, for 
example the cyclin-dependent kinase inhibitors p21CIP1 and p15INK4B (J. A. Wilkins and O. J. 
Sansom, 2008).  
Alterations in c-Myc expression have been also reported in various haematological malignancies, 
and c-Myc seems to act as an important regulator of haematopoiesis, for instance mice deficient 
for c-Myc die before birth, mostly due to defective haematopoiesis (M. D. Delgado and J. Leon, 
2010). 
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In the adult, the function of c-Myc in haematopoiesis was evaluated using c-Myc conditional KO 
mice under the control of MX-cre transgene (MxCre;c-mycflox/flox mice). In these mice observed 
the following was observed: an accumulation of non-committed multipotent progenitors (LSK 
Flt3- cells) in BM, severe pancytopenia, and HSPCs were very impaired in their ability to 
reconstitute conditioned recipient mice, which was associated to the inability of HSCs to 
proliferate (A. Wilson et al., 2004). One the other hand, over expression of c-Myc lead to loss of 
HSCs, and in mixed BM chimeric mice donor cells overexpressing c-Myc although capable of 
homing in BM and perform multilineage reconstitution in the short-term, in the long-term they 
nearly disappear, and it was proposed that enforced expression of c-Myc may result in HSCs 
premature functional exhaustion due to premature differentiation (A. Wilson et al., 2004, M. J. 
Murphy et al., 2005). These studies revealed that the fine-tuning of c-Myc expression in HSCs 
might be very important in the modulation of cell self-renewal and differentiation (A. Wilson et 
al., 2004). In the present study, we found the expression of c-Myc increased in LT-HSC following 
infection, suggesting that c-Myc upregulation may contribute to the impairment of HSCs function 
under pro-inflammatory conditions established by L. donovani infection.   
c-Myc deficiency in HSCs is not associated with significant alterations in differentiation in vitro, 
therefore is thought that the alterations observed in vivo may be partially explained by changes 
HSCs-BM stroma signals crosstalk (M. J. Murphy et al., 2005). In MxCre;c-mycflox/flox mice there 
were alterations in the expression of several adhesion molecules in LSK cells, including the 
increased expression of CD29 (β1-integrin), and it was suggested that c-Myc conditional deletion 
resulted in accumulation of HSCs and impaired differentiation due to withholding of HSCs in the 
BM niche (A. Wilson et al., 2004). In mice chronically infected with L. donovani we failed to 
determine any alteration in the expression of CD29. Overall, these finding suggested that L. 
donovani infection prompted the up-regulation of c-Myc in HSCs, but there was no indication that 
this was associated with impaired HSC-niche adhesion, at least mediated by CD29.  
The transcription factor GATA-3 is expressed in various HSPCs in BM, with LT-HSCs 
expressing the highest levels of GATA-3. In competitive transfer assays, GATA-3-null 
haematopoietic donor cells are less efficient to engraft, even though the fraction HSCs in 
quiescence is higher compared to WT mice. Furthermore, upon myelossuppression LT-HSCs 
from GATA-3 deficient mutants fail to enter into active cell-cycle, suggesting that GATA-3 is 
required for HSCs proliferation under conditions of stress-induce haematopoiesis (C.-J. Ku et al., 
2012).  More recently it was shown that upon poly I:C treatment proliferating HSCs display 
nuclear GATA-3 (active form), and although capable of performing short-term multilineage 
reconstitution are no longer efficient in long-term multilineage reconstitution of lethally irradiated 
recipients. However, if the proliferative stimulus is removed, GATA-3 re-localizes to the 
cytoplasm and the long-term lineage reconstitution is restored. Additionally, in competitive 
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transplant assays of BM cell from poly I:C treated GATA-3-deficient and WT mice, GATA-3 
deficient cells are much more efficient performing haematopoietic reconstitution. These data 
suggested that GATA-3 might limit self-renewal during proliferation of HSCs (C. Frelin et al., 
2013). 
Despite the conflicting data from the above cited studies, both pointed out that GATA-3 has a role 
in cell-cycle entry regulation in LT-HSCs during stress induced haematopoiesis (T. Yoshida and 
K. Georgopoulos, 2013). In mice infected with L. donovani, we determined that GATA-3 
expression was up-regulated in LT-HSCs. However, its expression was mainly restricted to LT-
HSCs in active cell-cycle. In fact, LT-HSCs in active cell-cycle expressing GATA-3 were the 
population that mostly contributed to the overall increase of LT-HSCs in proliferation, since the 
fraction of proliferating LT-HSCs not expressing GATA-3 remain unchanged following infection. 
The specific increase of GATA-3 in proliferative HSCs but not HSCs in G0 following L. 
donovani, and its limited contribution to the fraction of HSCs in homeostatic proliferation, 
suggested GATA-3 over expression due to inflammation was associated with an impaired 
maintenance of homeostatic numbers of LT-HSCs in quiescence, during L. donovani chronic 
infection. Therefore, GATA-3 and upstream regulators should be considered as potential targets 
for therapeutic intervention in the prevention of HSCs impairment during stress-induced 
haematopoiesis. 
In vitro studies suggested that nuclear localization of GATA-3 depends directly on p38 MAPK 
activation, as shown by pharmacological inhibition (C. Frelin et al., 2013). More recently, it was 
shown that the (deubiquitinase cylindromatosis) CYLD - (tumor necrosis factor–associated factor 
2) TRAF2 pathway is very important for the regulation of LT-HSCs quiescence through the 
repression of p38MAPK activity (M. Tesio et al., 2015). In Mx1-Cre conditional KO for 
functional CYLD (CYLDΔ932Mx) mice, the majority of LT-HSCs are found in active proliferation 
and in BMT assays BM cells from CYLDΔ932Mx mice perform very poor reconstitution of all 
lineages in blood and HSCs in BM. TRAF2 is a CYLD substrate and using mutant mice 
displaying hyper-ubiquitinated TRAF2, it was observed loss of quiescent LT-HSCs was similar to 
that seen in CYLDΔ932Mx mice. TRAF2 controls the activation of p38 MAPK, and it was shown 
that therapeutic inhibition (using two different specific inhibitors) in vivo of p38 activation could 
restore the frequency of quiescent LT-HSCs to baseline levels both, in mutant mice displaying 
hyperubiquitinated TRAF2 and in CYLDΔ932Mx mice, suggesting that CYLD–TRAF2 pathway 
regulates HSCs passage to active cell-cycle preventing p38MAPK activity (M. Tesio et al., 2015). 
However, in these experiments p38 activity was inhibited in all cells, as such to isolate the impact 
of p38 in HSCs, those cells from mice treated with the pharmacological inhibitors should have 
been transfer to conditioned recipients. These studies emphasize the pertinence of the further 
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investigation focusing in the role of p38MAPK and GATA-3 in loss of HSCs function in the 
context of chronic infection.    
Alterations in haematopoietic function have been commonly found in patents suffering from 
chronic infections. VL is a pernicious chronic infection that has been associated with the 
establishment of haematopoietic alterations and increased vulnerability to secondary infections or 
bleeding (P. M. Kaye et al., 2004). Nevertheless, very few systematic reports have addressed the 
underlying mechanisms responsible for these haematological alterations or their association with 
the stage of disease, geographic area, response to treatment and relapse, among others (G. E. 
Cartwright et al., 1948, N. Varma and S. Naseem, 2010).  The research discussed in this Chapter 
provides a first step in readdressing this deficiency in knowledge on the impact of L. donovani in 
the haematopoietic function. We have shown that following L. donovani infection in mice, 
expansion of multipotent progenitors occurs at the expense of quiescent LT-HSCs, which resulted 
in intrinsic impairment of HSCs function (Figure 3.28). We were able to relate the alteration in 
the proliferative status of LT-HSCs and consequent functional decline with the upregulation of 
the co-activator CD48, and transcription factors β-catenin, c-Myc and GATA-3. These findings 
support the hypothesis that during L. donovani chronic infection, sustained infection-induced 
immune responses compromise HSCs function and in the long-term the sustainability of the 
haematopoietic compartment. Furthermore, we identified potential molecular targets that, 
although requiring further investigation, could be in the basis of novel therapeutic approaches to 
address haematological impairment in VL patients, and other chronic inflammatory conditions. 
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3.4 FIGURES 
 
 
Figure 3.1 - L. donovani parasites in BM. BM smear from B6 mouse infected for 28 days. 
Parasite indicated by arrow. Giemsa staining 63x. Source: Pinho F. and Pinto A.I. (Unpublished). 
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Figure 3.2- Diagram of stepwise differentiation of haematopoietic precursors and panel of 
associated surface molecular markers commonly used to characterize the different 
haematopoietic stem and progenitor cells (HSPCs). According with the “Classical Model” of 
haematopoiesis, all haematopoietic cells originate from a small population of haematopoietic stem 
cells (HSCs), which can be subdivided into at least two subsets based on the period of 
maintenance of self-renewal potential following transfer to lethally irradiated recipient mice: 
long-term reconstituting HSC (LT-HSCs) and short-term reconstituting HSCs (ST-HSCs). 
Differentiation of ST-HSCs generates multipotent progenitors (MPPs) and then lineage-
committed oligopotent progenitors derived from MPPs. These include the common lymphoid 
progenitor (CLPs), common myeloid progenitor (CMPs), megakaryocyte-erythrocyte progenitor 
(MEP) and granulocyte-monocyte progenitor (GMP) populations (Adapted from (M. J. Nemeth 
and D. M. Bodine, 2007)). 
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Figure 3.3 - Gating strategy for characterizing multipotent progenitors using flow cytometry 
analysis. Representative dot plots from BM cells from a naive B6 mouse. LSK CD150+ Flt3- 
CD34- cells (enriched for phenotypic LT-HSCs), LSK CD150+ Flt3- CD34+ cells (enriched for 
phenotypic ST-HSCs) and LSK CD150- Flt3+ CD34+ cells (enriched for phenotypic MPPs). LSK 
stands for Lineage neg (CD3e- CD45R/B220- TER-119- Ly-6G- Ly-6C- cells) Sca1hi cKithi cells. 
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Figure 3.4 - Gating strategy for characterizing BM populations enriched for lineage-
committed haematopoietic progenitors using flow cytometry. Representative dot plots of 
characterization of lineage-committed progenitor cells in the BM of a naive B6 mouse. CMPs 
(common myeloid progenitor cells), GMPs (granulocyte-monocyte progenitor cells), MEPs 
(megakaryocyte-erythrocyte progenitor cells) and CLPs (common lymphocyte progenitor cells). 
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Figure 3.5 - Sca1 was expressed in the vast majority of HSPCs in the BM of L. donovani 
infected mice. Representative dot plots of expression of Sca1 within lineage negative cells in the 
BM of a naive (left) and day 28 - infected mice  (right). b) Representative dot plots from BM cells 
from a B6 mouse infected for 28 days with L. donovani. LSK CD150+ Flt3- CD34- cells (enriched 
for phenotypic LT-HSCs), LSK CD150+ Flt3- CD34+ cells (enriched for phenotypic ST-HSCs) 
and LSK CD150- Flt3+ CD34+ cells (enriched for phenotypic MPPs). LSK stands for Lineage neg 
(CD3e- CD45R/B220- TER-119- Ly-6G- Ly-6C- cells) Sca1hi cKithi cells.c) Representative dot 
plots of characterization of lineage-committed progenitor cells in the BM of B6 mouse infected 
for 28 days with L. donovani. CMPs (common myeloid progenitor cells), GMPs (granulocyte-
monocyte progenitor cells), MEPs (megakaryocyte-erythrocyte progenitor cells) and CLPs 
(common lymphocyte progenitor cells). 
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Figure 3.6 - The kinetics of parasite burden in the BM and the spleen of L. donovani infected 
mice.  L. donovani infected B6 mice were examined for parasite burden at times indicated. (a) 
Spleen parasite burden determined from Giemsa stained impression smears and expressed as 
Leishman Donovan Units (LDU). (b) BM parasite burden determined from BM aspirates smears 
stained with eosin and azur staining and expressed as number of amastigotes per 1,000 host cells. 
(c) Degree of splenomegaly, expressed as spleen / body weight ratio. Data from one experiment 
represented as Mean ± SD (n=3-4 mice per time point). 
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Figure 3.7 - L. donovani infection affects the BM and the spleen cellularity.  (a) Absolute cells 
number of BM cells per two legs for each sample at indicated times post infection with L. 
donovani. (b) Absolute cells number of splenocytes. Data presented as Mean ± SD for (n=4 mice 
per group per time point). Data from one experiment was presented as Mean ± SD, p values were 
determined using unpaired t test: *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001. 
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Figure 3.8 - L. donovani infection results in changes to the number of HSPCs in BM. (a) 
Relative frequency of Lineage- cKit+ cells (enriched for HSPCs). (b) Relative number of Lineage- 
cKit+ cells (enriched for HSPCs). (c) Relative frequency of LSK CD150+ Flt3- CD34- cells 
(enriched for phenotypic LT-HSCs), LSK CD150+ Flt3- CD34+ cells (enriched for phenotypic ST-
HSCs), and LSK CD150- Flt3+ CD34+ cells (enriched for phenotypic MPPs). (d) Relative number 
of LSK CD150+ Flt3- CD34- cells, LSK CD150+ Flt3- CD34+ cells and LSK CD150- Flt3+ CD34+ 
cells. (f) Relative frequency of CMPs, GMPs, MEPs and CLPs. (f) Relative number of CMPs, 
GMPs, MEPs and CLPs. Data from one experiment was presented as Mean ± SD of normalized 
values for each infected mice (n=4) with the mean of values determined in naive mice (n=4), for 
each time point. Measurements were performed at 3 (n=4), 16 (n=4), 28 (n=4) and 64 (n=3) days 
post-infection with L. donovani in the BM (two femurs and two tibias per mice). Significant 
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differences with control (* p < 0.05) were determined by one-way ANOVA followed by post-hoc 
analysis using Dunnett's Multiple Comparison Test. 
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Figure 3.9 - L. donovani infection results in changes to the number of HSPCs in the spleen. 
(a) Relative frequency of Lineage- cKit+ cells (enriched for HSPCs). (b) Relative number of 
Lineage- cKit+ cells (enriched for HSPCs). (c) Relative frequency of LSK CD150+ Flt3- CD34- 
cells (enriched for phenotypic LT-HSCs), LSK CD150+ Flt3- CD34+ cells (enriched for 
phenotypic ST-HSCs), and LSK CD150- Flt3+ CD34+ cells (enriched for phenotypic MPPs). (d) 
Relative number of LSK CD150+ Flt3- CD34- cells, LSK CD150+ Flt3- CD34+ cells and LSK 
CD150- Flt3+ CD34+ cells. (f) Relative frequency of CMPs, GMPs, MEPs and CLPs. (f) Relative 
number of CMPs, GMPs, MEPs and CLPs. Data from one experiment was presented as Mean ± 
Standard Error Mean (SD) of normalized values for each infected mice (n=4) against the mean of 
values determined in naive mice (n=4), for each time point. Measurements were performed at 3 
(n=4), 16 (n=4), 28 (n=4) and 64 (n=3) days post-infection with L. donovani in the spleen. 
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Significant differences with control (* p < 0.05) were determined by one-way ANOVA followed 
by post-hoc analysis using Dunnett's Multiple Comparison Test. 
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Figure 3.10 - L. donovani infection results in increased numbers of multipotent 
haematopoietic progenitors without a reciprocal increase in lineage-committed progenitors. 
(a) Frequency of Lineage- Sca1+ cKit+ cells (LSK), enriched for multipotent progenitors, LSK 
CD150+ Flt3- CD34- cells (enriched for phenotypic LT-HSCs), LSK CD150+ Flt3- CD34+ cells 
(enriched for phenotypic ST-HSCs) and LSK CD150- Flt3+ CD34+ cells (enriched for phenotypic 
MPPs). (b) Number of LSKs, LSK CD150+ Flt3- CD34- cells, LSK CD150+ Flt3- CD34+ cells and 
LSK CD150- Flt3+ CD34+ cell. (c) Frequency of CMPs, GMPs, MEPs and CLPs. (d) Number of 
CMPs, GMPs, MEPs and CLPs. Measurements were performed at 28 post-infection with L. 
donovani (Ld28) in BM. Absolute number calculated from two femurs and two tibias for each 
mouse. Comparisons were made between naive (n=12) and infected mice (n=8) in three 
independent experiments. Data presented as Mean ± SD, p values were determined using unpaired 
t test: *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001.  
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Figure 3.11 - L. donovani infection was associated to decreases in mature blood cells in 
circulation. (a) Concentration of red blood cells (RBC) in peripheral blood (PB). (b) PB 
hematocrit (HCT). (c) Concentration of hemoglobin (Hb) in PB. (d) Concentration of platelets 
(PLT) in PB. (e) Concentrations of total white blood cells (WBC), lymphocytes (LY), neutrophil 
(NE), monocytes (MO), basophils (BA) and eosinophils (EO) in PB. Values were determined in 
whole blood collected in heparin using an automated system for blood cell counting (Hemavet). 
Comparisons were made between mice at day 28 p.i. (Ld28) (n=9) and naive mice (n=9). Data 
from two independent experiments is presented as Mean ± SD, p values were determined using 
unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001. 
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Figure 3.12 - L. donovani infection was not associated with increased cell death in the bone 
marrow. The frequency of live/viable cells was determined within mature cells and HSPCs in 
bone marrow through the exclusion of cells permeable to the live dead dye (dead) and/or positive 
to annexin-v (apoptotic). (a) Representative dot plots of gating applied to select live/dead cells. 
(b) Frequency of live/viable cells within CD45- Lin- cells (stromal cells), CD45+ Lin+ cells 
(mature haematopoietic cells), CD45+ Lin- (enriched for haematopoietic progenitor cells), CD45+ 
LSK CD150+ CD34- cells (enriched for LT-HSCs) and CD45+ LSK CD150+ CD34- (enriched for 
ST-HSCs). Comparisons were made between mice infected with L. donovani for 28 days (Ld28) 
(n=4) and naive mice (n=4). Data from one experiments is presented as Mean ±	SD, p values 
were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, 
****p ≤0.0001. 
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Figure 3.13 - HSPCs from infected mice showed impaired engraftment in BM and decreased 
reconstitution of the periphery. (a) Diagram of experimental design: non-infected B6.CD45.1 x 
CD45.2 (n=4) lethally irradiated recipient mice received BM Lineage negative cells from 
B6.CD45.2 mice infected for 28 days with L. donovani and B6.CD45.1 naive mice (50:50 mixed 
BM chimera). After seven weeks, the contribution of each group of donor cells to the 
reconstitution of the haematopoietic system was assessed in the BM and spleen of recipient mice, 
by gating on single CD45.1 or CD45.2 cells. (b) Frequency of donor haematopoietic cells in BM 
and spleen of recipient mice. (c) Frequencies of T cells, B cells and myeloid cells (CD11b+) 
within donor compartment in the spleen of non-infected recipient mice. (d) Frequencies LSKs, 
LSK CD150+ Flt3- CD34- cells, LSK CD150+ Flt3- CD34+ cells and LSK CD150- Flt3+ CD34+ cell 
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within each donor compartment in the BM of non-infected recipient mice. (e) Frequency of 
CMPs, GMPs, MEPs and CLPs within each donor compartment in the BM of non-infected 
recipient mice. Data presented as Mean and Scatter plot. Comparisons made between infected 
donor cells and naive donor cells. p value were determined using Mann Whitney test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ****p ≤0.001. 
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Figure 3.14 - Increased expression of CD48 on LSK CD150+ CD34- cells (enriched for 
phenotypic LT-HSCs) following L. donovani infection. (a) Frequency of LSK CD150+ CD34- 
CD48- cells, LSK CD150+ CD34+ CD48+ cells and LSK CD150+ CD34+ cells in BM of B6 mice 
non-infected and infected mice. (b) Number of LSK CD150+ CD34- CD48- cells, LSK CD150+ 
CD34+ CD48+ cells and LSK CD150+ CD34+ cells in BM of B6 mice non-infected and infected 
mice. (c) Frequency of cells not expressing CD48 within LSK CD150+ CD34- cell in BM of B6 
mice non-infected and infected mice. (d) Representative dot plots of gating strategy applied to 
define CD48 positive expression according with the isotype control background (top left), dot 
plots displaying frequency of CD48+ and CD48- cells within LSK CD150+ CD34- population in a 
naive (bottom left) and in a infected mouse (bottom right). Comparisons were always made with 
BM cells recovered from non-infected mice and mice infected with L. donovani for 28 days 
(Ld28). Absolute numbers were calculated from two femurs and two tibias for each mouse. 
Comparisons were made between naive (n=12) and infected mice (n=12), from three independent 
experiments. Data was presented as Mean ± SD, p values were determined using unpaired t test: 
not significant, *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001.  
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Figure 3.15 - Loss of quiescent LSK CD34- CD150+ CD48- cells (enriched for LT-HSCs) 
following L. donovani infection. (a) Frequency of Ki67+ within LSK CD150+ CD34- CD48- cells, 
LSK CD150+ CD34+ CD48+ cells and LSK CD150+ CD34+ cells in BM of B6 mice non-infected 
and infected mice. (b) Number of LSK CD150+ CD34- CD48- cells, LSK CD150+ CD34+ CD48+ 
cells and LSK CD150+ CD34+ in active cell-cycle (expressing Ki67) in BM of B6 mice non-
infected and infected mice. (c) Number of LSK CD150+ CD34- CD48- cells in G0 (not expressing 
Ki67) in BM of B6 mice non-infected and infected with LV9 for 28 days. (d) Representative dot 
plots of gating strategy applied to define Ki67 expression according with the isotype control 
background (top left), dot plots displaying frequency of Ki67+ and Ki67- cells within LSK 
CD150+ CD34- CD48- population in a naive (bottom left) and in a infected mouse (bttom right). 
Comparisons were always made with cells recovered from the BM of non-infected mice (n=10) 
and mice infected with L. donovani for 28 days (Ld28), (n=11). Absolute numbers were 
calculated from two femurs and two tibias for each mouse. Data presented from three independent 
experiments was presented as Mean ± SD, p values were determined using unpaired t test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001. 
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Figure 3.16 - LSK CD150+ CD34- CD48- cells (enriched for HSCs) from infected mice were 
impaired in their efficiency to engraft and poorly reconstituted the periphery. (a) 
Representative dot plots of gating strategy used to segregate between recipient (CD45.1) and 
donor cells (CD45.2) within live cells, displaying frequency for each population in BM: naive B6 
CD45.1 control (left), recipient transplanted HSCs derived from naive donor (center) and 
recipient transplanted with HSCs derived from infected donor (right). (b) Frequency of donor 
haematopoietic cells in the BM and in the spleen of recipient mice. (c) Number of donor 
haematopoietic cells in the BM and in the spleen of recipient mice. (d) Frequency of donor 
haematopoietic progenitors cells: Lin- Sca1- cKit+ cells (enriched for lineage-committed 
progenitors), LSK cells (enriched for non-committed progenitors), LSK CD150+ FLT3- CD34- 
cells, LSK CD150+ FLT3- CD34+ cells, LSK CD150+ FLT3+ CD34+ cells within donor cells in 
BM of recipient mice. (e) Frequency of mature haematopoietic cells: B cells, T cells and CD11b+ 
cells (myeloid cells) within donor cells in the spleen of recipient mice. Analysis were performed 
16 weeks after transplant of CD45.2 HSCs (160 cells) sort purified from mice naive or day 28 
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infected mice along with a radiation protective dose of 3.5 x 105 CD45.1 total BM cells to lethally 
irradiated CD45.1 recipients. Absolute numbers were calculated from two femurs and two tibias 
for each mouse. Data shown as scatter plot and mean bar. Comparisons were made between naive 
donor cells (n=4) and infected donor cells (n=4 or n=3). p values were determined using unpaired 
t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ****p ≤0.001. 
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Figure 3.17 - LSK CD150+ CD34- CD48- cells (enriched for HSCs) from infected mice were 
impaired in engraftment efficiency in secondary adoptive transfer. (a) Representative dot 
plots of gating strategy used to segregate between recipient (CD45.1) and donor cells (CD45.2) 
within live cells, displaying frequency for each population in BM: naive B6 CD45.1 control (left), 
recipient transplanted HSCs derived from naive donor (center) and recipient transplanted with 
HSCs derived from infected donor (right). (b) Number of donor haematopoietic cells in the BM 
and in the spleen. (c) Number of LSK cells (enriched for non-committed progenitors), LSK 
CD150+ CD48- cells and LSK CD150+ CD48+ cells derived from donor cells, in BM. (d) Number 
of lineage-committed progenitors (enriched among Lin- Sca1- cKithi cells), CMPs, GMPs, MEPs 
and CLPs derived from donor cells in the BM. (e) Number of mature haematopoietic cells derived 
from donor cells in the spleen of recipient mice: B cells, T cells and CD11b+ cells, CD11b- F4/80+ 
cells, CD11c+ MHC II+ cells. Analysis performed 24 weeks after transplant into B6 CD45.1 
lethally irradiated mice of radiation protective total BM cells (3.5x105) and 50 CD45.2 HSCs 
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(LSK CD150+ CD34- CD48- cells) sort purified from CD45.1 recipient mice previously that were 
previously adoptively transferred with CD45.2 HSCs from mice naive or day 28 infected mice, 
alongside a radiation protective dose of total BM cells, to lethally irradiated CD45.1 recipient 
mice for 16 weeks. Absolute numbers were calculated from two femurs and two tibias for each 
mouse. Data was presented as scatter plot and mean bar. 
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Figure 3.18 - LSK CD34- CD150+ CD48- cells (enriched for LT-HSCs) accumulate higher 
levels of β-Catenin. (a) Representative histogram overlay of β-catenin expression in LSK CD34- 
CD150+ CD48- cells (enriched for LT-HSCs): isotype control (grey), naive mouse (green) and 
infected mouse (orange). (b) Fold change in mean intensity fluorescence (MFI) of β-catenin in 
LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs), LSK CD150+ CD34- CD48+ cells and 
LSK CD150+ CD34+ cells infected mice, in each experiment the MFI calculated for infected mice 
was divided by the average MFI calculated for naive controls in each experiment. Comparisons 
were always made with cells recovered from the BM of non-infected mice (n=13) and mice 
infected with L. donovani for 28 days (Ld28), (n=13). Data presented from three independent 
experiments was presented as Mean ± SD, p values were determine using Wilcoxon signed-rank 
test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001. 
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Figure 3.19 - Mature haematopoietic cells in bone marrow of L. donovani infected mice 
express increased levels of Wnt3a protein. (a) The frequency of cells Wnt3a+ was determined 
within CD45- Lin- cells (stromal cells), CD45+ Lin+ cells (mature haematopoietic cells), CD45+ 
Lin- cells (enriched for haematopoietic progenitor cells), CD45+ LSK CD150+ CD48+ cells and 
CD45+ LSK CD150+ CD48- cells. (b) Mean intensity fluorescence (MFI) of Wnt3a in LSK 
CD150+ CD48- cells (enriched for LT-HSCs) and LSK CD150+ CD48+ cells expressing Wnt3a in 
BM of naive and infected mice. (c) Representative histogram overlay of Wnt3a expression in 
LSK CD150+ CD48- cells (enriched for LT-HSCs): naive isotype control (dark grey), infected 
isotype control (light grey), naive mouse (green) and infected mouse (orange). (d) Representative 
dot plots of gating applied to select Wnt3a positive cells in CD45+ Lin+ cells. Comparisons were 
always made with cells recovered from the BM of non-infected mice (n=4) and mice infected 
with L. donovani for 28 days (Ld28), (n=4). Data from one experiment was presented as Mean ± 
SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, 
***p ≤0.001, ****p ≤0.0001. 
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Figure 3.20 - Accumulation of Wnt3a mRNA is reduced in total BM cells from L. donovani 
infected mice. Quantitative PCR (qPCR) analysis of Wnt3a mRNA accumulation in total bone 
marrow cells cells. Results are presented in-terms of a fold change after normalizing with HPRT1 
mRNA. Comparisons were made with cells recovered from the BM of non-infected mice (n=3) 
and mice infected with L. donovani for 28 days (Ld28), (n=3). Data from one experiment was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001, ***p ≤0.0001.  
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Figure 3.21 - HSCs in BM expressed increased levels of c-Myc during infection with L. 
donovani. (a) Mean intensity fluorescence (MFI) of cMyc-EGFP in LSK CD150+ CD48- cells 
(enriched for LT-HSCs) and LSK CD150+ CD48+ cells in BM of naive and infected mice. (b) 
Representative histogram overlay of c-Myc-EGFP expression in LSK CD150+ CD48- cells 
(enriched for LT-HSCs): WT control (grey), naive mouse (green) and infected mouse (orange). 
Comparisons were always made with cells recovered from the BM of non-infected mice (n=3) 
and mice infected with L. donovani for 28 days (Ld28), (n=3). Data from one experiment was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001, ***p ≤0.0001. 
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Figure 3.22 - The expression of CD29 levels in LT-HSCs was unaltered during infection with 
L. donovani. (a) Mean intensity fluorescence (MFI) of CD29 in LSK CD150+ CD34- CD48- cells 
(enriched for LT-HSCs) LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells in BM 
of naive and infected mice. (b) Representative histogram overlay of CD29 expression in LSK 
CD150+ CD34- CD48- cells (enriched for LT-HSCs): WT control (grey), naive mouse (green) and 
infected mouse (orange). Comparisons were always made with cells recovered from the BM of 
non-infected mice (n=3) and mice infected with L. donovani for 28 days (Ld28), (n=3). Data from 
one experiment was presented as Mean ± SD, p values were determined using unpaired t test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ***p ≤0.0001. 
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Figure 3.23 - The frequency of LSK CD150+ CD48- cells (enriched for LT-HSCs) expressing 
GATA-3 was increased following L. donovani infection. (a) The frequency of GATA-3+ cells 
was determined within CD45+ Lin+ cells (mature haematopoietic cells), CD45+ Lin- cKit+ cells 
(enriched for haematopoietic progenitor cells), CD45+ LSK CD150+ CD48+ (other multipotent 
progenitors) cells and CD45+ LSK CD150+ CD48- cells (enriched for LT-HSCs). Data from two 
independent experiment was presented as Mean ± SD, p values were determined using unpaired t 
test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ***p ≤0.0001. (b) Fold change in 
mean intensity fluorescence (MFI) of GATA-3 in LSK CD150+ CD48- cells and LSK CD150+ 
CD48+ cells expressing GATA-3 in BM of infected mice calculated using the average MFI 
determined in naive mice for each experiment. Data from two independent experiment was 
presented as Mean ± SD, p values were determined using Wilcoxon signed-rank test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ****p ≤0.0001. Comparisons were always 
made with cells recovered from the BM of non-infected mice (n=8) and mice infected with L. 
donovani for 28 days (Ld28), (n=8). (c) Representative dot plots of gating applied to select 
GATA-3 positive cells in LSK CD150+ cells. 
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Figure 3.24 - The distribution of LSK CD150+ CD48- cells (enriched for LT-HSCs) 
segregated according with the expression of GATA-3 and Ki67 is altered following L. 
donovani infection. (a) Distribution of cells according with Ki67 and GATA-3 expression within 
LSK CD150+ CD48- cells. Comparisons were always made with cells recovered from the BM of 
non-infected mice (n=8) and mice infected with L. donovani for 28 days (Ld28), (n=8). Data 
presented from two independent experiment is presented as Mean, p value was determined using 
Chi-square test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001, ***p ≤0.0001. (b) 
Representative dot plots of Ki67 and GATA-3 expression within LSK CD150+ CD48- cells. 
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Figure 3.25 - Cycling LSK CD150+ CD48- cells (enriched for LT-HSCs) upregulated GATA-
3 expression following L. donovani infection. Frequency of cells expressing Ki67 and GATA-3 
within LSK CD150+ CD48- cells, in BM of naive and infected mice. Comparisons were always 
made with cells recovered from the BM of naive mice (n=8) and mice infected with L. donovani 
for 28 days (Ld28), (n=8). Data from two independent experiment was presented as Mean ± SD, p 
values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p 
≤0.001, ****p ≤0.0001. 
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Figure 3.26 - Detection of the subcellular localization of GATA-3 protein by 
immunofluorescence microscopy analyses in total thymocytes. Representative confocal 
immunofluorescence microscopy images of thymocytes of mice infected with L. donovani for 28 
days were fixed, permeabilized, and examined for GATA-3 (red) and the DNA-intercalating dye 
DAPI (blue) expression. Confocal fluorescent images were obtained with a objective Plan-
Apochromat 63x. Bar, 5 µm 
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Figure 3.27 - GATA-3 protein subcellular localization by immunofluorescence microscopy 
analyses in LSK cells from BM. Representative confocal immunofluorescence microscopy 
images of sorted LSK cells from the BM of mice infected with L. donovani for 28 days, which 
were fixed, permeabilized, and examined for GATA-3 (red) and the DNA-intercalating dye DAPI 
(blue) expression. Confocal fluorescent images were obtained with objective Plan-
Apochromat 63x. Bar, 5 µm. 
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Figure 3.28 - Leishmania donovani infection resulted in the depletion of the reservoir of 
quiescent LT-HSCs in BM. Following L. donovani infection LT-HSCs and onward multipotent 
progenitors expand greatly at the expense of LT-HSCs in G0. The accumulation of intermediary 
multipotent progenitors is not associated to an increase in effective haematopoietic activity since 
the numbers of effector haematopoietic cells are unchanged or even reduced in circulation. 
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CHAPTER 4. CELLULAR AND MOLECULAR 
DETERMINANTS UNDERLYING ALTERATIONS 
IN HAEMATOPOIESIS DURING INFECTON 
WITH L. DONOVANI 
4.1 INTRODUCTION 
VL is still one of the most neglected tropical diseases despite its dramatic impact in morbidity and 
mortality in endemic areas. This infection is fatal if left untreated and a prophylactic vaccine is 
not yet available. In very severe cases, patients may die due to increased vulnerability to 
secondary infection or due to coagulopathies (M. A. Santos et al., 2002, V. E. Miranda de Araujo 
et al., 2012). In humans, the clinical manifestations of disease vary considerably from sub-clinical 
to severe and include, hepatosplenomegaly, fever, weight loss and pancytopenia (P. M. Kaye et 
al., 2004).  
Alterations in the haematological system are common in chronic VL, not only in humans and 
dogs, natural reservoirs for L. donovani (N. Varma and S. Naseem, 2010, F. A. d. Pinho, 2015), 
but also in experimental models of disease such as mice and hamsters (W. P. Lafuse et al., 2013, 
F. A. d. Pinho, 2015). The impairment of the haematological system includes changes not only in 
peripheral blood, such as anaemia, thrombocytopenia and leucopenia, but also alterations in BM 
such as erythroid hypoplasia, dysplasia of myeloid cells, accumulation of blasts and histiocytic 
hyperplasia (N. Varma and S. Naseem, 2010, F. A. d. Pinho, 2015). Nevertheless, the mechanisms 
by which VL modulates alterations in the haematological system remain elusive. 
The induction of stress-induce haematopoiesis during infection have been long described as 
means to replace the large numbers of immune effector cells consumed fighting invading 
pathogens, for example emergency myelopoiesis in septicemia. In recent years, it has been shown 
that HSPCs, besides responding to the increased demand for immune cells, can be directly 
activated by pathogen-associated patterns and pro-inflammatory cytokines, recognized 
respectively by pattern recognition receptors and cytokines receptors, expressed on their surface. 
Furthermore, the impact of infection is not restricted to lineage-committed progenitors, but 
includes more immature cells such as LT-HSCs (K. Y. King and M. A. Goodell, 2011). 
The regulation of LT-HSCs numbers is a strictly regulated process aiming to maintain the 
homeostatic levels of blood cells and simultaneously prevent LT-HSCs exhaustion (C. Mirantes et 
al., 2014). Under homeostatic condition most LT-HSCs are in quiescence, which have been 
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correlated to the maintenance of long-term self-renewal potential and multipotency, and protects 
these cells from cytotoxicity and mutagenesis (M. R. Warr et al., 2011). Nevertheless, LT-HSCs 
can be very quickly pushed into active cell-cycle by a multiplicity of stimuli, including TLR-
signalling, pro-inflammatory cytokines and growth factors (K. Y. King and M. A. Goodell, 2011). 
Haematopoietic progenitors possess the machinery to directly sense infectious particles, such as 
TLRs, and high expression of TLR2, TLR4, and MD-2 mRNA was observed in HSCs (Y. Nagai 
et al., 2006b). In vitro cultures of purified LSK cells (a population highly enriched in HSCs) 
showed that these primitive cells respond to LPS, a TLR4 ligand, or Pam3CSK4, a ligand for 
TLR2, increasing the expression of markers associated with myeloid lineage commitment. The 
stimulation of TLR2 and TLR4 was also associated with increased proportions of cells in cell-
cycle within HSCs (LSK Flt3- cells), as assessed by BrdU labelling experiments (Y. Nagai et al., 
2006a). In mice infected with Pseudomonas aeroginosa, a model for severe sepsis, intact TLR4 
signalling was required to activate LSK cells into proliferation in response to the infection (S. 
Rodriguez et al., 2009). 
It was proposed that during infection, high systemic levels of M-CSF may act on M-CSF receptor 
expressed on LT-HSCs and induce the expression of the transcription factor PU.1, driving HSCs 
differentiation toward the myelomonocytic lineage (N. Mossadegh-Keller et al., 2013). In vivo 
experiments showed the induction of PU.1 expression in LT-HSCs in LPS-challenged hosts or 
after injection of recombinant M-CSF, and this was correlated to an increase in myeloid 
progenitors in BM and myeloid effector cells in the spleen (N. Mossadegh-Keller et al., 2013).  
The mouse model of M. avium infection allowed the study of HSC in a chronic non-cytopenic 
systemic infection, characterized by the maintenance of the absolute number of mature cells in 
circulation. During infection an increase in the proliferation and mobilization of LT-HSCs was 
observed, and these displayed decreased repopulation capacity in secondary recipients. These 
features were abrogated in mice lacking IFNγ receptor 1 (Ifngr1) or Stat1, encoding the 
downstream signal transducer for IFNγ receptor subunit 1 (M. T. Baldridge et al., 2010). 
In addition to systemic factors, signals provided by the BM microenvironment including 
osteoblasts, osteoclasts, endothelial cells, adipocytes and mesenchymal stem and progenitor cells, 
the so-called BM stroma (F. E. Mercier et al., 2012), regulate the functions of HSCs and other 
haematopoietic progenitors. Several studies have suggested that the BM stroma can respond to 
infection through the expression and secretion of immunomodulatory molecules, which can then 
modulate the haematopoiesis (F. E. Mercier et al., 2012). For example, it has been showed that 
following LPS administration, MSCs express CCL2, and this was also reported in mice infected 
with Listeria monocytogenes. The deletion of CCL2 in MSCs (Nestin+ cells) was associated with 
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impaired monocyte emigration from the BM resulting in increased susceptibility to L. 
monocytogenes infection (C. Shi et al., 2011). Furthermore, exogenous administration of G-CSF, 
which is released during inflammation, was associated with a decrease in CXCL12 production by 
osteoblasts that resulted in increased mobilization of HSCs (M. J. Christopher et al., 2009).  
More recently, it was shown that in mice infected with LCMV, a model of acute viral infection, 
CD8+ T cells expressing IFNγ favor myelopoiesis indirectly through the induction of IL-6 
secretion by BM stromal cells (C. M. Schuerch et al., 2014), suggesting that BM T cells may have 
an important role in mediating changes in haematopoiesis during infection. 
T cells reside in BM, composing 4-8% of total BM cells. The function of the T cell compartment 
in BM has, however, seldom been investigated. Recent studies positioned BM as a preferential 
site for homing and persistence of memory T cells with high proliferative potential to a second 
encounter with a cognate antigen (F. Di Rosa and R. Pabst, 2005, K. Tokoyoda et al., 2009b, K. 
Tokoyoda et al., 2010). Furthermore, alterations in BM T cells have been reported in patients 
suffering from BMF syndromes (C. Dufour et al., 2003) and in experimental models for aplastic 
anaemia (AA) (F.-c. Lin et al., 2014, C. Arieta Kuksin et al., 2015).  
The association between alterations in haematopoietic function and changes in BM T cells were 
also described in mice infected with Ehrlichia muris, displaying severe haematopoietic 
impairment (K. C. MacNamara et al., 2011b, Y. Zhang et al., 2013). In infected mice, LSK cells 
were found to be proliferating, which was mediated by IFNγ acting directly on LT-HSCs, with 
BM CD4+ T cells defined as the main source of IFNγ (Y. Zhang et al., 2013). 
The integration of systemic and local signals by HSCs and other haematopoietic progenitors may 
be a mechanism to allow these cells to respond the presence of invading pathogens, and guide 
progenitors to supply the haematopoietic systems with adequate cell types and amounts of 
effector cells required to mount an efficient immune response (C. Mirantes et al., 2014). On the 
other hand, prolonged activation of HSCs into active proliferation has been associated with 
functional exhaustion in several infection models (S. Rodriguez et al., 2009, M. T. Baldridge et 
al., 2010, Y. Zhang et al., 2013, K. A. Matatall et al., 2014), and may underlie the association 
between chronic infection and hematological dysfunction, commonly described in humans (A. 
Jain and M. Naniwadekar, 2013).  
Very recently it was showed that in mice challenged with Poly (I:C) (TLR3 ligand), which 
mimics the conditions for infection-induced haematopoiesis, HSCs are “pushed” to active cell-
cycle and this was associated with the acquisition of DNA-damage and severe functional 
impairment in long-term BMT assays (D. Walter et al., 2015). As such, study of the mechanisms 
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underlying haematological dysfunctions, frequently emerging as a consequence of an infection, 
are fundamental in the process of developing improved therapeutic approaches for the prevention 
of BMF syndromes.  
In Chapter 3, we established that L. donovani chronic infection induced the activation of LT-
HSCs into active proliferation at the expense of cells in quiescence, and this was related to the 
functional impairment of LT-HSCs following transfer to lethally irradiated mice. Both in humans 
and in experimental models of disease, the basis for the establishment of haematological 
alterations during chronic infection with L. donovani remain elusive. As such, in this chapter we 
aimed to study the molecular and cellular determinants underlying the impairment haematological 
function during experimental chronic VL.  
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4.2 RESULTS 
4.2.1 Infection with L. donovani in immunodeficient mice was not associated to the loss of 
quiescent HSCs in BM. 
Our initial characterization of L. donovani infection kinetics showed an overlap between the 
major alterations in the number of HSPCs and the peak of infection at 28 days p.i., both in BM 
and the spleen. In BM, there was a significant expansion of non-committed progenitors at the 
expense of LT-HSCs in G0 (Chapter 3). To determine whether these alterations were a function of 
parasite load per se, we infected immunodeficient Recombination activating gene 2 knockout 
(RAG2 KO) mice, establishing the conditions for a super-infection. We could not detect any 
differences in the number of multipotent haematopoietic progenitors onward from LT-HSCs in 
day 28 infected mice vs. non-infected mice (Figure 4.1a). Furthermore RAG2 KO mice were not 
depleted in the reservoir of quiescent HSCs upon infection (Figure 4.1b). As expected, extensive 
differences in parasite burden were found between RAG2 KO and wild-type (WT) mice (Figure 
4.1c) and splenomegaly was absent (Figure 4.1d). These data indicated that the alterations in LT-
HSCs and onward progenitors were not directly induced by parasite-derived molecules or through 
stimulus of innate immune response, but rather suggested a central role for the adaptive immune 
system as a driver of the haematopoietic alterations observed in WT mice.  
4.2.2 Splenectomy did not impact in the increase of intermediary multipotent progenitors 
nor in the loss of quiescent LT-HSCs during L. donovani infection  
In experimental VL, previous work using BALB/c mice suggested that the number of myeloid 
progenitors was increased in the spleen of infected mice based on the observation that the 
development of GM-CFU derived from infected mice splenocytes was enhanced in vitro assays 
(S. E. J. Cotterell et al., 2000a). To confirm these findings in B6 mice we evaluated the number of 
haematopoietic progenitors in the spleen of mice chronically infected with L. donovani directly ex 
vivo using flow cytometry. In the spleens of B6 we found significant increases in the frequency 
and number of HSPCs during chronic phase of infection (Figure 4.2a; Figure 4.2b). There were 
also significant alterations in lineage-committed cell compartment both in relative and absolute 
numbers. (Figure 4.3a; Figure 4.3b). These findings confirmed that experimental chronic VL is 
characterized by a noticeable increase in haematopoietic progenitors in the spleen, and therefore 
the establishment of extramedullary haematopoiesis. 
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To determine the impact of the spleen in the alterations seen in the BM, we assessed the effect of 
splenectomy on BM cellularity in mice infected for 28 days with L. donovani.  Our data showed 
that splenectomy did not impact on changes in BM cellularity during chronic phase of L. 
donovani infection. Splenectomized mice and “sham” infected mice showed the same degree of 
losses in the reservoir of quiescent HSCs (Figure 4.4a; Figure 4.4b), as well as, similar increases 
in multipotent precursors (Figure 4.4c; Figure 4.4d). We also could not determine any differences 
between splenectomized and “sham” infected mice regarding alteration neither in the frequency of 
lineage-committed progenitors (Figure 4.4e; Figure 4.4f), nor in the frequency of mature 
haematopoietic cells in BM (Figure 4.4g; Figure 4.4h). 
Hence, we could conclude that the alterations in the spleen and BM haematopoietic compartment 
during chronic infection with L. donovani were independent processes, and that the presence of 
splenomegaly was not impacting directly in the haematopoiesis in BM during chronic infection.  
If extramedullary haematopoiesis is taking place in the spleen its efficiency should be very limited 
since its abolishment did not account for further impairment in the haematopoietic system, such as 
further loss of HSCs in G0 or further alterations in lineage-committed progenitors and mature 
cells. Furthermore, recent findings from our laboratory determined that in B6 mice chronically 
infected with L. donovani splenectomy prior to the establishment of infection could not prevent 
the onset of anaemia, but limited thrombocytopenia (Preham O., unpublished data). Nevertheless, 
it is conceivable that compensatory mechanisms of extramedullary haematopoiesis take place in 
other organs following infection. 
4.2.3 L. donovani infection was characterized by increased numbers of BM T cells  
In the steady state CD4+ T cells represented 0.64 % ± 0.19 of total BM cells, or 2.26 x105 ± 7.49 x 
104 cells / femur-tibia pair. CD4+ T cells increased 24-fold (4.42 x 106 ± 2.92 x 106) during L. 
donovani infection, composing now 8.71% ± 2.83 of total BM cells (Figure 4.5a; Figure 4.5b). 
The frequency of CD8+ T cells in BM was also increased in infected compared to naive mice 
(2.74 % ± 0.98 vs 1.43 % ± 0.45, respectively), mirrored by an ~2-fold increase in the CD8+ T 
cell number (1.10 x 106 ± 7.99 x 105 vs. 5.07 x 105 ± 1.17 x 105) (Figure 4.5a; Figure 4.5b). CD3+ 
CD4- CD8- (double negative (DN)) T cells comprised 0.94 % ± 0.41 of BM cells in healthy 
controls, but their frequency dropped to 0.56 % ± 0.43 in the BM of chronically infected mice, 
however in absolute number no changes were observed following L. donovani infection (Figure 
4.5a; Figure 4.5b). The extent of the CD4+ T cell increase in BM was much more evident 
compared to the other lymphocytes evaluated, and accounted for an inversion in the proportion of 
CD4+ / CD8+ T cells in BM of mice chronically infected with L. donovani (Figure 4.5c). 
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The B cell compartment also presented significant changes during infection. The frequency of B 
cells was 3 fold decreased in the BM of infected mice (Figure 4.6a), consistent with a reduction in 
absolute number from 4.72 x 106 ± 2.32 x 106 in naive to 1.24 x 106 ± 3.50 x 106 cells in infected 
mice (Figure 4.6b).  We also assessed the frequency and number of overall myeloid cells (CD11b+ 
cells) in non-infected and infected mice. Despite the modest increase in the frequency of CD11b+ 
we did not find any significant alterations in cell number after 28 days of L. donovani infection 
(Figure 4.7a; Figure 4.7b). 
We then assessed if the stromal compartment presented alterations during infection. As there are 
not yet definitive cell markers to select for stromal cells in BM, we selected for cell populations 
enriched for MSCs (CD45- Ter119- CD31- Sca1+ CD51+ cells), osteoblastic lineage cells (CD45- 
Ter119- CD31- Sca1- CD51+ cells), and endothelial cells (CD45- Ter119- CD31+ cells), using 
parameters defined by others previously (I. G. Winkler et al., 2010, D. Fonseca-Pereira et al., 
2014) (Figure 4.8a). The overall stromal compartment (CD45- Ter119- cells) did not show 
significant differences during infection, either in frequency and absolute cell number (Figure 4.8b; 
Figure 4.8c). However a small but significant increase in MSCs was observed in infected mice 
(Figure 4.8d; Figure 4.8e). 
The analysis of cell distribution and counts revealed that the infection was modulating BM 
cellularity during chronic infection with L. donovani, of which amplification of the BM T cell 
pool was the most substantive.  
4.2.4 L. donovani infection results in increased numbers of “effector” T cells in BM 
Given the increase in number and frequency of BM CD4+ T cells during infection, these were 
further characterized for phenotype and function. CD4+ T regulatory cells (Tregs), defined as 
CD45+ CD3+ B220- CD4+ CD25hi FOXP3+ cells, were not contributing to the increase in total 
CD4+ T cell number (Figure 4.9a; Figure 4.9b). In contrast, Treg numbers did increase in the 
spleen (Figure 4.9c; Figure 4.9d). 
Next, we used CD62L (L-selectin) and CD44 to discriminate naive (CD62Lhigh CD44-/low), 
effector memory (CD62L-/low CD44high) and central memory (CD62Lhigh CD44high) CD4+ T cells 
(J. Hu and A. August, 2008, T. Lucas et al., 2010). In the BM of mice infected mice, CD62L-/low 
CD44high effector T cells appeared to contribute most to the changes in overall CD4+ T cell 
frequency and number in BM (Figure 4.10a; Figure 4.10b). 
Within the CD8+ T cell compartment, “central memory” and “effector memory” CD8+ T cells also 
increased in frequency and number  (Figure 4.10c; Figure 4.10d).  
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When we analyzed the distribution of each subset within the total CD4+ T cell compartment, it 
was clear that the majority of CD4+ T cells were CD62L-/low CD44high in the BM of infected mice 
(91.66 % ± 2.17 vs. 58.09% ± 8.36 in infected vs. naive respectively) (Figure 4.10e; Figure 
4.10g).  The proportion of CD62L-/low CD44high CD8+ T cells within the CD8+ T cell compartment 
also increased significantly at the expense of CD62Lhigh CD44-/low cells  (Figure 4.10f).  
It was reported by others that the distribution of T cells populations differs considerably between 
the BM and the spleen (P. W. Price and J. Cerny, 1999). Therefore these analyses were also 
performed on splenic T cells (Figure 4.11). The increase of CD4+ T cells in the spleen of infected 
mice appeared mainly due to CD62L-/low CD44high CD4+ T cells (Figure 4.11a; Figure 4.11b). 
Similarly, analysis of the frequencies of CD62L-/low CD44-/low and CD62Lhigh CD44high CD8+ T 
cells in total splenocytes showed no differences in infected mice compared to healthy controls 
(Figure 4.11c), although both populations increased in absolute cell number in infected mice 
(Figure 4.11d). 
In comparison to BM, CD4+ and CD8+ T cell subsets were more heterogeneous in spleen. Over 
half of CD4+ T cells were CD62L-/low CD44high in the BM of infected mice (26.93 % ± 3.58 vs 
60.28 % ± 7.27, naive vs infected), while CD62Lhi CD44low the most representative population in 
naive mice was decreased in chronically infected mice (47.21 % ± 7.85 vs. 23.76 % ± 8.71, naive 
vs. infected) (Figure 4.11e; Figure 4.11g). The proportion of CD62L-/low CD44high CD8+ T cells 
also increased significantly at the expense of CD62Lhigh CD44-/low cells (Figure 4.11f).  
To determine if BM T cells were phenotypically similar to the recently described BM resident 
effector cells, we examined the expression of CD127 and Ly6C (F. Di Rosa and R. Pabst, 2005, 
K. Tokoyoda et al., 2010). In the BM of infected mice the total number of “activated cells” 
(defined by the high expression of CD44) was 12 fold increased compared to that in naive mice 
(Figure 4.13a). The CD4+ T cells CD44high Ly6C-/low CD127-/low (“effector T cells”) was the 
population with the maximum increase in absolute cell number (4.47 x 104 ± 3.46 x 104 vs. 1.26 x 
106  ± 3.21 x 105, naive vs infected). The number of CD4+ T cells CD44high Ly6Chigh CD127high 
(“memory T cells”) was also increased in the BM of infected mice (6.15 x 103 ± 5.04 x 103 vs. 
2.42 x 104 ± 9.56 x 103, naive vs. infected), but their contribution to the overall increase in CD4+ 
T cell CD44high was limited compared to those from CD4+ T cells CD44high Ly6C-/low CD127-/low. 
Additionally, the number of CD4+ T cells CD44high Ly6C-/low CD127high and CD4+ T cells CD44high 
Ly6Chigh CD127-/low were also increased in the BM of infected mice compared to healthy controls 
(Figure 4.12a). 
We also analysed of the frequencies of CD44high CD4+ T cells segregated according to the 
expression of Ly6C and CD127 within total CD4+ T cells. In the BM we found that the majority 
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of CD4+ T cells were CD44high cells, increasing from 72.22 % ± 8.67 of total CD4+ T cells in 
naive mice to 93.56 % ± 1.39 in infected mice, and the most abundant population of CD4+ T cells 
was CD44high Ly6C-/low CD127-/low (“effector T cells”) (Figure 4.12b; Figure 4.12e).  
The number of CD44high CD8+ T cells was 5 fold increased in the BM of infected mice compared 
to naive mice (Fig. 4.13c), due largely to increases in the CD44high Ly6C-/low CD127-/low CD8+ T 
cells and CD44high Ly6Chigh CD127-/low populations (Figure 4.12d; Figure 4.12e).  
Together, these data shows that the increase in T cells in the BM of infected mice was due to 
expansion and/or accumulation of activated CD4+ T cells, the majority of which were 
phenotypically characterized as CD44high Ly6C-/low CD127-/low “effector” T cells, consistent with 
the accumulation of BM resident effector CD4+ T cell during chronic infection with L. donovani. 
4.2.5 The number of CD4+ T cells producing IFNγ and TNF was increased in BM 
following L. donovani infection 
Pro-inflammatory cytokines including IFNγ and TNF are important in the immunopathology of L. 
donovani infection. In mice, hepatic infection is self-resolving through the Th1-dominated 
formation of granulomas. On the other hand, in the spleen where parasites remain persistent, TNF 
is responsible for the disruption of the microarchitecture that is associated with impaired 
immunity (S. Staeger et al., 2010). Several reports suggested that both cytokines might impact 
negatively on the modulation of haematopoiesis in the BM (M. T. Baldridge et al., 2010, C. J. H. 
Pronk et al., 2011, C. Mirantes et al., 2014). 
To characterize the potential for cytokine production by BM T cells, we used ex vivo stimulation 
of cells with Phorbol Myristate Acetate (PMA) and ionomycin stimulation followed by flow 
cytometry. The frequency of CD4+ T cells capable of producing IFNγ within the total BM was 
very low (0.10% ± 0.05) in naive mice, but increased substantially following infection (7.64% ± 
3.57 of total BM cells). The percentage of CD8+ T cells with the potential to produce IFNγ also 
increased in the BM of infected mice (0.24% ± 0.14 vs 1.16% ± 1.03, naive vs. infected) (Figure 
4.13a). 
The absolute number of CD4+ T cells capable of producing IFNγ+ in naive mice increased >40 
fold in infected compared to naive mice. In contrast, we did not detect a significant change in the 
absolute numbers of CD8+ T cell able to produce IFNγ (Figure 4.13b).  Within the CD4+ T cell 
population, 82.06% ± 14.23 had the potential to produce IFNγ in infected BM, compared to 
17.33% ± 8.95 in naive controls (Figure 4.13c; Figure 4.13f). Similarly, the percentage of IFNγ+ 
CD8+ T cells within total BM CD8+ T cells also significantly increased in infected mice (Figure 
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4.13c). Analysis of the MFI for IFNγ+ within CD4+ T cells also demonstrated an increase in 
cytokine production on a per cell basis, compared to CD4+ T cells from naive mice, and this was 
also observed with CD8+ T cells (Figure 4.13d). 
Next, we assessed cytokine production by cells from naive and infected mice directly ex vivo as a 
better measure of ongoing function. Less than 1% of steady-state CD4+ T cells expressed IFNγ 
(0.33% ± 0.39), while in infected mice 9.29% ± 3.22 were IFNγ positive (Figure 4.13e; Figure 
4.13f). Surprisingly the fraction of CD8+ T cells producing IFNγ recovered from the BM of 
infected mice was very low (< 1%) and was comparable to naive controls (Figure 4.13e).  
We then examined BM T cells for TNF production. After PMA and ionomycin stimulation the 
frequency of CD4+ T cells but not CD8+ T cells in total BM producing TNF was increased (Figure 
4.14a). The number of CD4+ T cells with the potential to produce TNF was increased almost 17 
fold in infected compared to naive mice (Figure 4.14b). Within total BM CD4+ T cells and CD8+ 
T cells, the fraction of cells producing TNF was unchanged following infection, suggesting that 
the increase in TNF+ CD4+ T cells resulted from the overall expansion of CD4+ T cell 
compartment in the BM of infected mice (Figure 4.14c; Figure 4.14f). However, it was also found 
that the amount of TNF expressed by stimulated CD4+ T cells (as judge by MFI) was enhanced in 
infected mice compared to naive controls (Figure 4.14d). Increased levels of TNF expression 
were also seen in TNF+ CD8+ T cells (Figure 4.14d). Direct ex vivo analysis showed that in steady 
state less than 0.42% ± 0.35 of CD4+ T cells expressed TNF, while in infected mice 1.54% ± 0.91 
were TNF+ (Figure 4.14e; Figure 4.14f). Similarly, the fraction of BM CD8+ T cells spontaneously 
producing TNF increased following infection, to a lesser extent than observed in BM CD4+ T 
cells (Figure 4.14e). 
IL-10 is generally considered an immunossupressive cytokine, since in vitro studies showed that 
IL-10 limits the production of pro-inflammatory cytokines such as TNF, IL-1a, IL-1b and IL-6 by 
activated immune cells (W. Ouyang et al., 2011). IL-10 is known to play a central role in the 
immune response to L. donovani infection, as blockade of IL-10 signalling blockade caused rapid 
clearance of the parasite, whilst mice over expressing IL-10 were unable to control the parasite 
burden (H. W. Murray et al., 2002). In the spleen of chronically infected mice, CD4+ T cells co-
expressing IL-10 and IFNγ have been described (S. Stager et al., 2006). However, no published 
study has determined whether BM T cells produce IL-10 following L. donovani infection. 
Following stimulation with PMA/Ionomycin, the frequency of BM CD4+ T cells from infected 
mice that were IL-10+ was increased compared to naive controls, but nevertheless comprised a 
small fraction of total BM. The frequency of BM CD8+ T cells with the potential to produce IL-10 
was unchanged (Figure 4.15a). Similar trends were determined for the absolute numbers of BM T 
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cells expressing IL-10 (Figure 4.15b). The fraction of CD4+ T cells expressing IL-10 cells was 
unchanged in infected mice compared to naive, whilst the fraction of CD8+ T cells IL-10+ in total 
BM CD8+ T was only slightly increased (Figure 4.15c; Figure 4.15f). Additionally, the analysis of 
the IL-10 MFI within CD4+ T cells IL-10+ and CD8+ T cells IL-10+ showed no significant 
alteration upon infection (Figure 4.15d). 
Directly ex vivo, the fraction of IL-10+ cells within CD4+ T cells was comparable between naive 
and infected mice, whereas, the fraction of CD8+ T cells producing IL-10 increased from 0.30% ± 
0.32 in naive mice to 0.75% ± 0.35 in infected mice (Figure 4.15e). Within the BM CD4+ T cells 
IFNγ+ population the proportion of cells that expressed either or both TNF and IL-10 was 
unchanged following infection (Figure 4.16a; Figure 4.16c), and the same was observed for CD8+ 
T IFNγ+ cells (Figure 4.16b). As such, the increase of total CD4+ T cells observed in BM of 
chronically infected mice was mainly due to the accumulation of IFNγ+ or IFNγ+ TNF+ CD4+ T 
cells (Figure 4.16a; Figure 4.16c). 
Overall these data show that L. donovani promoted alterations in the cytokine milieu in BM. This 
was mainly due to the increased production of cytokines by CD4+ T cells with the potential to 
promote inflammation in the BM through the expression of Th1 cytokines.  
4.2.6 Infection-induced loss of quiescent LT-HSCs was mediated by CD4+ T cells  
Based on the data presented above, we hypothesized that CD4+ T cells might act as drivers of the 
alterations observed in the haematopoietic compartment during chronic infection (Figure 4.17). 
To assess whether this was the case, RAG2 KO mice were adoptively transferred with sorted 
CD4+ T cells from naive mice, and then infected in the following day with L. donovani. At day 28 
p.i., we analysed the distribution of haematopoietic progenitors in the BM, compared to WT 
infected mice and infected RAG2 KO mice that did not receive adoptively transferred CD4+ T 
cells. Analyses of cell frequencies were performed gating on Lineage negative cells, to avoid 
biases due to the lack of lymphocytes in RAG2 KO mice. The transfer of CD4+ T cells to infected 
RAG2 KO mice was associated with a recovery of the phenotype observed in WT infected mice 
(Figure 4.18; Figure 4.19; Figure 4.20; Figure 4.21). Adoptive transfer of CD4+ T cells prior to 
infection significantly increased the frequency and the number of LSK cells and intermediary 
non-committed progenitors (LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells) to a 
similar extent as observed in infected WT mice (Figure 4.18a-h). More importantly, infected 
RAG2 KO mice preserved their reservoir of quiescent HSCs, whereas these were significantly 
depleted in RAG2 KO mice given CD4+ T cells, (Figure 4.19a; Figure 4.19b). In RAG2 KO 
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infected mice, 42.85% ± 21.69 of LT-HSC were in G0, but this was reduced to 8.82% ± 3.27 in 
mice that received CD4+ T cells prior to the infection (Figure 4.19c; Figure 4.19d).    
CD4+ T cell transfer was not associated with alteration in the frequencies of CMPs or GMPs, and 
only minor changes in absolute number of CMPs were observed, among lineage-commited 
progenitors (Figure 4.20). CLPs were decreased irrespective of the presence of CD4+ T cells, 
which may be due to their inherent inability to produce de novo T and B cells (Figure 4.20f; 
Figure 4.20j). The frequency of MEPs was increased in BM of infected RAG2 KO mice 
adoptively transferred with CD4+ T cells in comparison to naive RAG2 KO mice, a trend 
observed in infected WT mice compared to naive WT. However, in absolute number, there were 
no differences amongst all the experimental groups (Figure 4.20e; Figure 4.20i). 
To exclude that these alterations were the result of homeostatic proliferation of T cells in the RAG 
host, HSPC populations and the proliferative status of LT-HSCs were assessed in adoptively 
transferred RAG2 mice that were not subsequently infected (Figure 4.21). These control mice 
were unaltered compared to naive RAG2 KO mice with regards the number of the HSPCs (Figure 
4.21a; Figure 4.21c) and the frequency of LT-HSCs in G0 (Figure 4.21b). As such, the expansion 
of multipotent progenitors and subsequent loss of LT-HSCs in G0 following T cell transfer 
requires T cell activation as a consequence of infection. 
In infected WT mice, we observed signs of mild anaemia and thrombocytopenia, features absent 
in infected RAG2 KO mice. On the other hand, infected RAG2 KO mice adoptively transferred 
with CD4+ T cells showed a significant loss of RBCs (Figure 4.22a), lower concentration of 
haemoglobin (Figure 4.22c) and reduced platelet counts (Figure 4.22b). These haematological 
alterations were absent in RAG2 KO mice adoptively transferred with CD4+ T cells but not 
infected (Figure 4.23a-d). These findings suggested that alterations in CD4+ T cell compartment 
were sufficient to mediate the onset of anaemia and thrombocytopenia in experimental VL. 
CD4+ T cells are crucial for the control of parasite burden. In WT mice the number of parasites 
per 1000 nuclei in the spleen was on average 31.25 ± 28.49. This value increase to 1469 ± 1334 
parasites/1000 nuclei in infected RAG2 KO. However in RAG2 KO mice given CD4+ T cells 
prior to infection the parasite counts dropped to 64.89 ± 68.92 parasites/1000 nuclei (Figure 
4.24a). Moreover, in RAG2 KO mice given CD4+ T cells following infection developed 
splenomegaly, as observed in WT mice (Figure 4.24b), suggesting that CD4+ T cells were 
required to drive inflammation in the spleen. 
CD4+ T cells expanded greatly in the BM of RAG2 KO mice following infection, with associated 
signs of activation (Figure 4.25a). In WT infected mice, the number of CD44high Ly6C-/low CD127-
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/low CD4+ T cells was on average 13 fold increased compare to naive mice, and the number CD4+ 
T cells CD44high Ly6Chigh CD127-/low about 19 fold (Figure 4.25b). In adoptively transferred RAG2 
KO mice, the number of CD44high Ly6C-/low CD127-/low CD4+ T cells was on average 72 fold, and 
the number CD44high Ly6Chigh CD127-/low CD4+ T cells about 174 fold, greater in infected mice 
compared to naive mice where only homeostatic proliferation of T cells occurred (Figure 4.25b). 
The analysis of the distribution of cells within CD4+ T cells showed that in uninfected RAG2 KO 
mice most cells displayed an phenotype CD44high Ly6Chigh CD127high attributed to “memory T 
cells”, while in RAG2 KO infected mice CD4+ T cells were mainly CD44high Ly6Chigh CD127-/low 
or CD44high Ly6C-/low CD127-/low (phenotype attributed to “BM effector T cells”), as observed in 
WT infected mice (Figure 4.25c). 
In summary, CD4+ T cells transferred to RAGKO mice and examined 28 days after L. donovani 
infection displayed immunophenotype alterations that resemble those found in similarly infected 
WT mice. 
4.2.7 Loss of LT- HSCs in quiescence was mediated by IFNγ 
About 90% of total BM CD4+ T cells were primed to produce IFNγ, and even in the absence of in 
vitro stimulation a significant fraction was found actively producing this pro-inflammatory 
cytokine following infection (section 4.2.6). We also showed that CD4+ T cells, which were found 
in expanded numbers and were the major producer of IFNγ in BM following L. donovani 
infection, could mediate the loss of HSCs in G0 (section 4.2.8). As such, we assessed whether 
IFNγ KO CD4+ T cells were also able to affect BM function. 
As previously shown in Figure 4.21, the transfer of WT CD4+ T cells to RAG2 KO mice prior to 
infection with L. donovani resulted in the increased frequency of LSK cells, LSK CD150+ CD34- 
CD48+ cells and LSK CD150+ CD34+ cells, within Lineage negative population. However, CD4+ 
T cells derived from IFNγ KO mice were unable to mediate these effects (Figure 4.26a). Instead, 
in RAG2 KO mice that received IFNγ KO CD4+ T cells, there was a significant increase in the 
frequency of CMPs and GMPs in comparison to infected RAG2 KO and RAG2 KO transplanted 
with WT CD4+ T cells, and we did not observed significant differences in MEPs and CLPs in 
comparison with infected RAG2 KO (Figure 4.26b). 
Likewise, whereas transfer of WT CD4+ T cells to RAG2 KO mice resulted in a significant 
decrease in the frequency and number of LT-HSCs in G0, this did not occur following transfer of 
IFNγ KO CD4+ T cells (Figure 4.27a; Figure 4.27b). As with infected RAG2 KO mice, infected 
mice given IFNγ KO CD4+ T cells had approximately half their LT-HSC population in 
quiescence (48.40% ± 11.30), whereas this was significantly reduced in infected RAG2 KO given 
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WT CD4+ T cells mice (8.82% ± 3.27) (Figure 4.27c Figure 4.27d). These findings suggested that 
IFNγ production by CD4+ T cells underlies the depletion in the reservoir of quiescent LT-HSCs, 
as well as, the expansion of intermediate multipotent progenitors in BM during infection with L. 
donovani.  
Infected RAG2 KO mice given WT CD4+ T cells developed anaemia and thrombocytopenia, but 
this did not occur in RAG2 KO mice given IFNγ KO CD4+ T cells prior to infection (Figure 
4.28a-d). As such, IFNγ production by CD4+ T cells also underlies impaired haematological 
function. 
Not surprisingly, IFNγ produced by CD4+ T cells was important to limit the number of 
parasites/1000 nuclei in the spleen, as RAG2 KO given IFNγ KO CD4+ T cells had comparable 
numbers of parasites / 1000 host cell nuclei in the spleen (1267 ± 342) to RAG2 KO infected mice 
(1996 ± 802), whereas this was reduced in mice receiving WT CD4+ T cell (257 ± 129, parasites/ 
1000 nuclei) (Figure 4.29a). Additionally, whereas WT CD4+ T cells transfer induced 
splenomegaly following infection, this did not occur following IFNγ KO CD4+ T cells transfer 
(Figure 4.29b), suggesting that CD4+ T cells IFNγ+ are required to drive inflammation in the 
spleen. 
Finally, it was found that both WT and IFNγ KO CD4+ T cells expanded to similar numbers in the 
BM of RAG2 KO recipient mice, which in both cases was due to high number of cell with an 
activated CD44hi phenotype (Figure 4.30a). The number of CD4+ T cells expressing either or both 
Ly6C or CD127 was comparable between WT CD4+ T cells and IFNγ KO CD4+ T cells (Figure 
4.30b). Nevertheless, significant changes were observed in the percentages of cells within the 
CD4+ T cell compartment; 82.85% ± 3.22 of WT CD4+ T cells were CD44high Ly6C -/low CD127-
/low compared to 66.62% ± 9.53 of IFNγ KO CD4+ T cells, whilst the frequency of CD44high Ly6C 
high CD127-/low was increased within of IFNγ KO CD4+ T cells (25.98% ± 10.62) compared to WT 
CD4+ T cells (5.68% ± 1.05) (Figure 4.30c). These findings show that IFNγ is dispensable for the 
expansion of CD4+ T cells (at least in a non-competitive environment). In contrast, CD4+ IFNγ+ T 
cells contributed to the immunophenotypic changes observed during the immune response to L. 
donovani infection. 
4.2.8 Loss of quiescent LT-HSCs was not mediated by intrinsic IFNγ receptor signalling 
in LT-HSCs  
HSCs express receptors for IFNγ, which have been directly associated with LSK expansion and 
impaired engraftment in X-irradiated hosts (K. Y. King et al., 2010, A. M. de Bruin et al., 2013, 
Y. Zhang et al., 2013). As such, we hypothesized that IFNγ signaling would be responsible for the 
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depletion of LT-HSCs in G0 during chronic infection with L. donovani (Figure 4.31). To test this 
hypothesis, we generated 50:50 mixed BM chimeras using cells derived from both WT and 
IFNγR2−/− mice. We assessed donor cells chimerism and alterations in progeny in response to 
subsequent infection with L. donovani (Figure 4.32).  
Twelve weeks after transplantation, in infected chimeric mice, the frequency of IFNγR2−/− cells 
was higher in the BM (60.18% ± 15.20) compared to naive mice (39.82% ± 15.20) but not 
statistically different, and in absolute cell number we found no significant differences. 
Furthermore, the frequency and number of WT or IFNγR2−/− donor cells did not change in BM 
following L. donovani infection (Figure 4.33a; Figure 4.33b).   
In the spleen, the percentage of cells derived from IFNγR2−/− donor cells was increased both in 
non-infected mice and infected mice (Figure 4.33c; Figure 4.33e), with similar data for absolute 
cell numbers (Figure 4.33d). This suggested that IFNγ signalling impacts on haematopoietic 
function both in steady-state and inflammatory conditions. The frequency of WT or IFNγR2−/− 
donor cells in the spleen was similar following L. donovani infection (Figure 4.33c). However, the 
absolute number of IFNγR2−/− donor cells was increased compared to WT (Figure 4.33d), 
suggesting that in the periphery IFNγR2−/− donor cells had a competitive advantage over WT cells 
in inflammatory conditions.  
In the BM of non-infected mice, the frequency and the number of LSK cells (enriched in 
multipotent progenitors) and Lin- Sca1- cKit+ cells (enriched in lineage-committed progenitors) 
was comparable between WT and IFNγR2−/− donor cells, suggesting that IFNγ signaling was not 
required for the maintenance of HSPCs under homeostatic conditions (Figure 4.34a; Figure 4.34b; 
Figure 4.349e).  
Following infection, the number of BM LSK cells derived from WT and IFNγR2−/− donor cells 
was increased compared to respective WT and IFNγR2−/− donor cell numbers found in non-
infected recipients (Figure 4.34b), and the same changes were observed in regard to their 
frequency within donor compartment cells (Figure 4.34a). However, the magnitude of the 
increase in number of LSK cells in infected mice was greater for WT donor cells (6 fold) 
compared to IFNγR2−/− derived LSK cells (2.6 fold) (Figure 4.34b). 
In the BM of infected mice, the increase in the frequency of WT LSK cells was concomitant with 
the contraction in the percentage Lin- Sca1- cKit+ cells (0.66% ± 0.32 vs 0.07 % ± 0.07, naive 
versus infected), while the increase in IFNγR2−/− LSK cells was not followed by alterations in Lin- 
Sca1- cKit+ cells frequency or absolute cell numbers (Figure 4.34a; Figure 4.34b; Figure 4.34e). 
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These alterations suggested that the up-regulation of Sca1 in HSPCs during L. donovani infection 
in WT B6 was directly mediated by IFNγ signaling.  
In the spleen of non-infected mice, we found comparable numbers and frequencies of LSK cells 
and Lin- Sca1- cKit+ cells derived from WT and IFNγR2−/− donor cells (Figure 4.34c; Figure 
4.34d). In infected mice the frequency and the cell numbers of WT LSK cells and IFNγR2−/− LSK 
cells were both increased in infected mice, compared to their respective cell numbers in non-
infected recipients (Figure 4.34d). In the spleen, we did not observe any differences in WT Lin- 
Sca1- cKit+ cells, but found the number of Lin- Sca1- cKit+ cells derived from IFNγR2−/− donor 
cells was increased following infection compared to WT cells (Figure 4.34c; Figure 4.34d). In 
summary, these finding suggested that IFNγ signaling acting directly upon HSPCs was not 
required to drive the increase in HSPCs in the spleen during chronic infection with L. donovani. 
We found no significant differences in the frequency of LSK CD150+ CD48- cells (enriched for 
LT-HSCs) and LSK CD150+ CD48+ cells (enriched for other multipotent progenitors) derived 
from WT donor cells and IFNγR2−/− donor cells, both in BM (Figure 4.35a) and in the spleen 
(Figure 4.35c). This was true in absolute cell number (Figure 4.35b; Figure 4.35d), suggesting 
that IFNγ signaling was dispensable in the steady-state to regulate the number of multipotent 
progenitors.  
In infected recipient mice, the frequency of WT LSK CD150+ CD48- cells and IFN-γR2−/− LSK 
CD150+ CD48- cells in the BM was unchanged (Figure 4.35a), and the same was observed in 
regard to their cell number (Figure 4.35b). Among IFNγR2−/− donor cells only in the spleen, there 
was a significant increase in the frequency and in the number of LSK CD150+ CD48- cells, while 
the frequency and the number of WT LSK CD150+ CD48- cells were not impacted by the 
infection (Figure 4.35c; Figure 4.35d). Finally, in infected mice, both in BM and in the spleen, an 
increase in LSK CD150+ CD48+ cells derived from WT donor cells and IFNγR2−/− donor cells 
was observed both in frequency and absolute cell number (Figure 4.35a-d). Overall, these results 
suggested that direct IFNγ signaling was not mediating the expansion of multipotent progenitors 
onward from LT-HSCs during infection with L. donovani. 
In the BM of naive chimeric mice, the study of lineage-committed progenitors showed that the 
frequencies and the absolute cell numbers of all the populations assessed were comparable 
between WT donor cells and IFN-γR2−/− donor cells (Figure 4.36a; Figure 4.36b). Following 
infection, the frequency of IFNγR2−/− GMPs was increased, while within WT donor cells the 
populations increased were the MEPs and CLPs, in comparison to respective populations in naive 
recipient mice (Figure 4.36a). However, we did not observe any significant changes in absolute 
cell number following in infection in all the other populations assessed. As such, it appears that 
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IFNγ signalling in lineage-committed progenitors was not required to sustain cell numbers under 
homeostatic conditions or in inflammatory conditions.   
In the spleen of non-infected recipient mice, there were no differences either in frequency or 
absolute number of all the lineage-committed progenitors evaluated (Figure 4.36c; Figure 4.36d). 
During infection, the alterations in WT and IFN-γR2−/− derived CLPs followed the same trends, 
i.e. in both compartments there was a significant decrease in their frequency compared to naive 
recipients, but in absolute cell numbers we did not observed any differences (Figure 4.36c; Figure 
4.36d). On the other hand, the frequencies and number of IFN-γR2−/− CMPs and GMPs were 
increased, whilst WT CMPs and WT GMPs were unchanged compared to respective naive 
populations (Figure 4.36c; Figure 4.36d). Finally, we observed that the number of MEPs derived 
either from donor WT or IFN-γR2−/− donor cells was increased following infection. These 
findings suggested that IFNγ signaling in lineage-committed progenitors was not necessary to 
sustain their number neither under homeostatic conditions nor for the expansion of CMPs, GMPs 
and MEPs in the spleen that followed infection.   
Under homeostatic conditions, the frequency and the number of BM LT-HSCs in G0 were 
comparable between WT and IFN-γR2−/− derived cells (Figure 4.37a; Figure 4.37b). Most 
importantly, there were no differences in the frequency of number of quiescent HSCs following 
infection between WT and IFN-γR2−/− derived cells, both decreasing compared to naive controls 
(Figure 4.37a-c). Overall, these findings led us to reject the hypothesis that cell intrinsic IFNγ 
signalling was responsible for the reductions in frequency and number of HSCs in G0 in VL.  
As previous experiments had shown IFNγ derived from CD4+ T cells was responsible for 
enhanced LT-HSCs proliferation (section 4.2.9), yet this was not due to IFNγ intrinsic signalling, 
these data suggested that IFNγ could indirectly regulate HSCs proliferation, during chronic 
infection with L. donovani.  
IFNγ is important in Th1 differentiation, but its role in T cells proliferation is unresolved due to 
opposing findings attributed to different models of infection (J. K. Whitmire et al., 2005, J. S. 
Haring and J. T. Harty, 2006, X. Li et al., 2007, O. Sercan et al., 2010). As such, we evaluated the 
alterations in T cell compartment in (B6.CD45.1 + B6.CD45.2.Ifnγr2-/-)èB6.CD45.1 chimeric 
mice following L. donovani infection. We also assessed whether IFNγ signalling was responsible 
for the alterations in other effector cells during infection and analyzed the B cell and myeloid 
compartments. In BM and spleen of non-infected recipient mice, the frequency and absolute 
number of T cells was comparable between WT and IFN-γR2 KO donor cells, (Figure 4.38a-d), 
indicating that IFNγ signalling in T cells was not required for their development or homeostatic 
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maintenance. In contrast, IFN-γR2 KO T cells in BM did not increase following infection, unlike 
their WT counterparts (Figure 4.38a; Figure 4.38b).  
In summary, in uninfected mice WT and IFN-γR2 KO donor cells made approximately equal 
contributions to the BM and splenic T cell populations, while during chronic infection IFNγ 
responsive (WT) T cells were significantly enriched at both sites, suggesting that IFNγ signalling 
in T cells conferred a competitive advantage under inflammatory conditions. As such, intrinsic 
IFNγ signalling confers a proliferative or survival advantage during L. donovani induced 
inflammation, but not in homeostatic conditions.  
In naive recipient mice, the analysis of the B cell compartment showed an increase in the 
frequency in BM B cells derived from IFNγR2 KO donor cells compared to BM WT B cells in 
non-infected mice (Figure 4.38a). Nevertheless, we did not detect differences in their absolute cell 
numbers (Figure 4.38b). Similarly, WT and IFNγR2 KO donor cells contributed at similar extent 
to the splenic B cell compartment in steady-state (Figure 4.38c; Figure 4.38d). Overall, these 
finding suggested that IFNγ signalling is not critical to sustain the number of B cell numbers 
under non-inflammatory conditions.  
In infected mice, there was a significant decrease in the frequency and number of WT BM B cells 
and IFNγR2 KO BM B cells, but no differences were observed in their absolute cell number, 
compared to uninfected mice (Figure 4.38a; Figure 4.38b). Following infection, in the spleen the 
percentages of WT B cells and IFNγR2 KO B cells were unchanged, nevertheless the absolute 
number of B cells derived from IFNγR2 KO donor cells was increased, in comparison to 
respective populations in naive recipients (Figure 4.38c; Figure 4.38d). As such, there was no 
indication that IFNγ signalling played a major role regulating the B cell compartment in BM and 
in the spleen. 
BM from non-infected mice displayed comparable frequencies and number of most myeloid 
populations derived from WT and IFNγR2 KO donor cells, except that CD11b+ F4/80- cells from 
IFNγR2 KO donor cells were reduced in frequency compared to WT, and the number CD11bhi 
F4/80hi cells and CD11b- F4/80hi cells from IFNγR2 KO donor were also decreased compared to 
WT (Figure 4.39a; Figure 4.39b). In the BM of infected mice the number of IFNγR2 KO CD11b+ 
F4/80hi cells was decreased (Figure 4.39b). In contrast, the number WT CD11b+ F4/80hi cells 
increased ~ 2 fold following infection (Figure 4.39b). The number of CD11chi MHC IIhi cells 
(DCs) and CD11b- F4/80hi cells derived from WT were increased compared IFNγR2 KO donor 
cells in BM following infection (Figure 4.39a; Figure 4.39b).  
 157 
In the spleens of non-infected mice, all populations of myeloid cells derived from IFN-γR2 KO 
donor cells were decreased compared to WT donor cells, both in frequency and cell number 
(Figure 4.39c; Figure 4.39d). Following infection, with the exception of IFN-γR2 KO CD11b+ 
F4/80- cells, all other myeloid populations derived from IFN-γR2 KO donor cells failed to expand 
(Figure 4.39c; Figure 4.39d). In contrast, the number of CD11chi MHCIIhi cells and CD11b+ 
F4/80- cells, derived from WT donor cells increased following infection (Figure 4.39d). To the 
quantitative differences in myeloid cells may have contributed cells derived from the recipient 
mice, since it was reported that macrophage resident cells are more resistant to x-irradiation (D. 
Hashimoto et al., 2013). 
In summary, with these findings we could exclude IFNγ signaling as a direct mediator of loss of 
LT-HSCs in G0 during experimental VL. Nevertheless, our results support a role for T cell 
intrinsic IFNγ signaling leading to expansion of T cell number in BM and the spleen during 
chronic VL.  
4.2.9 The number of LT-HSCs and onward progenitors expressing TNF receptors was 
increased following infection with L. donovani  
TNF has been proposed to play an important role in directly modulating HSCs function and may 
cooperate with other mechanisms in driving stress-induced haematopoiesis and mediating 
haematopoietic dysfunction (C. J. H. Pronk et al., 2011), and we have shown above that the 
number of T cells producing TNF was greatly enhanced in the BM during infection. We therefore 
tested an alternate hypothesis, namely that TNF may mediate changes in the BM HSPCs 
population. 
We first assessed the expression of the two functional receptors for TNF, TNFR1a (or TNFR-
p55), and TNFR1b (TNFR-p75), the latter normally restricted to haematopoietic cells and 
upregulated in inflammatory conditions (N. Askenasy, 2015).  
The majority of mature BM haematopoietic cells expressed TNFR1a in steady-state, and this 
increased following infections (60.98% ± 5.02 vs 75.70% ± 5.02, naive vs infected), whilst the 
absolute number of TNFR1a+ cells remained unchanged (Figure 4.40a; Figure 4.40b). We also 
found that the frequency and number of TNFR1a expressing Lineage- cKit+ cells (enriched for all 
HSPCs) were increased in chronically infected mice (Figure 4.40a; Figure 4.40b). 
Next we focused on the most primitive progenitors. Most LT-HSCs (enriched in LSK CD150+ 
CD34- CD48- cells) expressed TNFR1a under homeostatic conditions (Figure 4.41a), nevertheless 
their number increased following infection (Figure 4.41b), and TNFR1a was expressed at 
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increased levels following infection (Figure 4.41c; Figure 4.41d). These alterations were 
replicated in the onward multipotent progenitors (Figure 4.41a; Figure 4.41b; Figure 4.41c). 
The percentage of mature haematopoietic cells expressing TNFR1b increased significantly upon 
infection (27.74% ± 8.42 vs 59.98% ± 18.37, naive vs infected), but this did not result in 
significant alterations in absolute cell number in BM (Figure 4.42a; Figure 4.42b). The frequency 
of Lineage- cKit+ TNFR1b+ cells increased from 36.52% ± 12.67 in naive mice to 71.60% ± 15.64 
in infected mice, and this was reflected by an increase in absolute cell numbers (Figure 4.42a; 
Figure 4.42b). The frequency and number of LT-HSCs expressing TNFR1b increased in infected 
mice (Figure 4.43a; Figure 4.43b), and LT-HSCs in infected mice also expressed TNFR1b at 
elevated levels, as judged by MFI (Figure 4.43c; Figure 4.43d). Similar results were seen for 
onward multipotent progenitors (Figure 4.43a-c), suggesting a potential role for TNF signalling in 
the mediation of changes in HSPCs function. 
4.2.10 TNF intrinsic signalling does not regulate loss of LT-HSCs in G0  
To formally test whether direct cell intrinsic TNF signalling plays a role in driving LT-HSCs into 
active cell-cycle and subsequent depletion of the reservoir of quiescent LT-HSCs we generated 
further mixed chimeras (Figure 4.44). We transferred equal numbers of BM WT donor cells and 
BM donor cells devoid for both TNF receptors (TNFR-dKO) into lethally irradiated recipients 
(Figure 4.45). After thirteen weeks, it was expected that most of the haematopoietic cells found in 
the recipient would be derived from donor LT-HSCs, since most haematopoietic cells have a 
relatively short life (R. Duran-Struuck and R. C. Dyskoz, 2009).  
Under homeostatic conditions, WT donor cells constituted 28.88% ± 9.17 of total BM donor cells 
compared to 68.51% ± 7.58 TNFR-dKO cells (Figure 4.46a; Figure 4.46c). In absolute cells 
number TNFR-dKO donor cells were also dominant (Figure 4.46a). The competitive advantage of 
donor cell devoid in TNFR signaling over WT donor cells was also observed in the spleen of non-
infected recipient mice, in which the frequency and number of TNFR-dKO cells were also 
increased compared to WT donor cells (Figure 4.46a; Figure 4.46b), suggesting that TNF 
signalling may modulate on haematopoietic function in homeostasis.   
Following infection, the frequency of WT cells in BM was increased ~10% but their cell number 
remained comparable to those found non-infected recipients. In contrast, in infected mice the 
frequency of donor TNFR-dKO cells was not significantly changed (Figure 4.46a; Figure 4.46c), 
but their numbers decreased from 2.19 x 107 ± 4.22 x 106 cells in non-infected recipients to 1.17 x 
107 ± 3.17 x 106 cells in the BM of infected recipients (Figure 4.46b). The cell numbers of WT 
and TNFR-dKO donor cells in BM were comparable in mice chronically infected with L. 
 159 
donovani (Figure 4.46b). The frequency of WT donor cells expanded in the spleen of infected 
mice, but their absolute cell numbers seemed to follow this trend, although these changes were 
not statistically significant (Figure 4.46a; Figure 4.46b). In contrast, the percentage of engraftment 
of TNFR-dKO donor cells contracted following infection, whilst their absolute cell numbers were 
unchanged (Figure 4.46a; Figure 4.46b) 
In the BM of non-infected mice the frequency and the number of LSK cells (enriched in 
multipotent progenitors) and Lin- Sca1- cKit+ cells (enriched in lineage-committed progenitors) 
was comparable between TNFRdKO donor cells and WT donor cells, implying that TNF 
signaling was dispensable to sustain HSPCs number under homeostatic conditions (Figure 4.47a; 
Figure 4.47a).  The expansion of both WT LSK cells and TNFR-dKO LSK cells was made at the 
expense of the contraction in the Lin- Sca1- cKit+ cells compartment, suggesting that TNF 
signaling was not implicated in the up-regulation of Sca1 in most HSPCs during L. donovani 
infection (Figure 4.47c).  
In line with findings described above, in non-infected mice we could not find significant 
differences in the frequency of LSK CD150+ CD48- cells (enriched for LT-HSCs) and LSK 
CD150+ CD48+ cells (enriched for other multipotent progenitors) derived from WT donor cells 
and TNFR-dKO donor cells in the BM of non-infected recipients (Figure 4.48a) although in the 
latter, the absolute cell number of both cell populations was increased (Figure 4.48b). Following 
infection, the frequencies of WT LSK CD150+ CD48- cells and TNFR-dKO LSK CD150+ CD48- 
cells in the BM were unchanged (Figure 4.48a), but the number of TNFR-dKO LSK CD150+ 
CD48- cells was about two fold decreased in infected mice (Figure 4.48b), which can partially be 
explained by the contraction on BM cellularity (Figure 4.46b). In infected mice, we found that 
LSK CD150+ CD48+ cells were greatly increased both in percentage within WT donor cells and 
TNFRdKO donor cells (Figure 4.48a), and the same was observed in absolute terms (Figure 
4.48b). In summary, these findings argued against the possibility that TNF signaling was 
intrinsically mediating the expansion of multipotent progenitors onward from LT-HSCs during 
infection with L. donovani. 
In recipient mice under homeostatic conditions, the frequency of LT-HSCs in G0 was comparable 
between WT and TNFR-dKO donor derived cells (Figure 4.49a), but the number TNFR-dKO LT-
HSCs in G0 was 2.5 fold the number of WT HSCs in quiescence (Figure 4.49b). Of relevance, 
following infection, we observed no significant differences either in the percentage LT-HSCs in 
quiescence between donor cells or in their absolute cell number (Figure 4.49a; Figure 4.49b).  
Lastly, we determined that LT-HSCs lacking TNF functional signaling receptors were as with WT 
LT-HSCs, driven into active cell-cycle as a consequence of infection (Figure 4.49c; Figure 
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4.49d). Hence, TNF acting directly on LT-HSCs was not the underlying mechanisms responsible 
for the alteration in LT-HSCs proliferative status, and subsequent loss of the reservoir of LT-
HSCs in G0.  
TNF has been suggested to have direct effects on lineage-committed progenitors (C. J. H. Pronk 
et al., 2011). As such, we examined the frequency and number of mature haematopoietic cells in 
BM and spleen in the mixed chimeras described above. In BM, lineage-committed progenitors in 
non-infected mice were comparable between WT donor cells and TNFR-dKO donor cells (Figure 
4.50a). Most likely due to an overall competitive advantage of TNFR-dKO donor cells, the 
number of all considered cell populations of TNFR-dKO lineage-committed cells were increased 
compared to WT (Figure 4.50b). Following infection, the frequency of WT lineage-committed 
progenitors was unchanged or minimally reduced, and cell numbers were unchanged relative to 
TNFR-dKO donor derived cells (Figure 4.50a; Figure 4.50b). Reflecting an overall decrease in 
total BM cells derived from TNFR-dKO donor cells in infected recipient mice, the number of 
CMPs, GMPs and CLPs were decreased following infection (Figure 4.50b). These results 
suggested that TNF signaling neither was required nor deleterious to sustain the number of 
lineage-committed progenitors under homeostatic conditions, but may contribute to the decrease 
in myeloid-committed progenitors in BM that followed infection. 
In non-infected chimeras, we failed to find significant differences either in the frequencies or in 
the cell number of total T cells and CD4+ T cell derived from WT in comparison to TNFR-dKO 
donor cells (Figure 4.51a; Figure 4.51b).  In contrast following infection, differences in T cells 
derived from WT and TNFRdKO donor cells became evident in the BM (Figure 4.51a). The 
frequency of T cells within WT donor cells expanded from 9.43% ± 2.76 to 37.29% ± 11.32 
following infection, while the percentage of T cells derived from TNFRdKO donor cells was 
unchanged. These patterns of alterations were replicated in the alterations in absolute cell 
numbers (Figure 4.51b).  
Next focusing on WT BM CD4+ T cells, we observed an expansion in their frequency (2.17% ± 
0.82 vs. 27.70% ± 6.92, “WT naive” vs. “WT infected”) (Figure 4.51a) and number (~13 fold) in 
infected recipient mice (Figure 4.51b). In contrast, BM CD4+ T cells lacking TNF signaling failed 
to expand significantly following infection (0.5% ± 0.19 vs. 0.85% ± 0.28, “TNFR-dKO naive” 
vs. “TNFR-dKO infected”) (Figure 4.51a), and their cell number remain at basal levels (Figure 
4.51b). These findings did not suggest that intrinsic TNF signalling provided T cells with a 
competitive advantage to expand or seed in the BM under homeostatic conditions. Moreover, 
following infection, it appeared that TNF receptor signalling was critical to the expansion of the 
BM T cell compartment, and of CD4+ T cells in particular. 
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The frequency of BM TNFR-dKO B cells within donor was increased compared to WT donor 
cells in steady-state, but comparable following infection (Figure 4.51a). In the BM of infected 
recipient mice the percentage of WT B cells decreased about 2.4 fold compared to non-infected 
mice, while TNFR-dKO B had a less expressive 2 fold decrease following infection (Figure 
4.51a), and similar reductions were determined in B cell numbers (Figure 4.51b).  
In BM, the frequency of CD11b+ cells within WT and TNFR-dKO donor cells was comparable in 
steady-state (Figure 4.51a), however the number of CD11b+ cells TNFRdKO was found to be 
increased (Figure 4.51b). Following infection, the frequency of WT CD11b+ cells decreased while 
the frequency of TNFR-dKO CD11b+ cells was unchanged compared to non-infected mice 
(Figure 4.51a), but in absolute cell number there were no alteration in WT donor cells and TNFR-
dKO CD11b+ cells decreased (Figure 4.51b).  
According with these findings, intrinsic TNF signalling was dispensable to establishment of B cell 
and CD11b+ cell compartments in BM in steady-state. Following infection, in the absence of TNF 
signaling the alterations in these populations in BM resembled those observed in WT donor cells. 
In contrast, in BM the T cell compartment diverged considerably between WT and TNFR-dKO 
donor cells. The lack of intrinsic TNF signaling was not associated to an impairment of T cell 
reconstitution in BM, under homeostatic conditions, indicating that TNF signaling is not essential 
to the maintenance of BM T cells number in homeostasis. However, following infection, the lack 
of TNF signaling receptors completely abolished the expansion of T cells observed in WT T cells, 
which was mainly sustained by CD4+ T cells.  
In the spleen under homeostatic conditions, the percentage of total T cells and CD4+ T cells was 
decreased within TNFR-dKO donor cells compared to WT donor cells (Figure 4.52a). 
Nevertheless, in absolute cell number they were comparable (Figure 4.52b), suggesting that TNF 
signaling was not critical to T cell development nor conferred T cells with a competitive 
reconstitution advantage in steady-state. Following infection, WT T cells were increased in 
frequency and cell number (Figure 4.52a; Figure 4.52b). On the contrary, the percentage and the 
number of T cells within TNFRdKO donor cells were unchanged following infection (Figure 
4.52a; Figure 4.52b). The increase in total WT T cells observed during chronic in infection in the 
spleen, was mainly sustained by the increase in WT CD4+ T cells, which percentage varied from 
31.00% ± 3.56 in non-infected mice to 46.19% ± 4.03 in infected mice (Figure 4.52a) and their 
cell number increased ~ 3.55 fold (Figure 4.52b). In TNF-RdKO CD4+ T cells we failed to find 
any alteration both in percentage and cell number following infection (Figure 4.52a; Figure 
4.52b). Thus, TNF acting directly in CD4+ T cells mediated the expansion of CD4+ T cells 
compartment in the spleen following infection with L. donovani.  
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In the spleen, we also assessed the distribution of myeloid cells characterized according with the 
expression of CD11c, CD11b, MHC-II and F4/80 (Figure 4.53a). In steady-state, the percentages 
and the cell numbers of the myeloid populations assessed within donor cells were comparable 
between WT and TNF-RdKO cells, suggesting that TNF intrinsic signalling was unnecessary to 
the development and maintenance of homeostatic numbers of myeloid cells in the spleen.  
Following infection, the alterations in myeloid cells were characterized by an increase the 
frequencies of in CD11b+ F4/80- cells and CD11chi MHC-IIhi cells derived from TNF-RdKO 
donor cells, whilst in WT cells only the frequency of CD11b- F4/80hicells was increased, 
compared to naive recipients (Figure 4.53a). In absolute cell number, only TNF-RdKO CD11b- 
F4/80+ cells were increased in comparison to naive recpients (Figure 4.53b). Finally, the 
comparison between WT and TNF-RdKO donor cells showed that following infection all myeloid 
cells displayed similar cell number, except TNF-RdKO CD11b+ F4/80- cells, which were found 
increased in comparison to WT donor cells in infected recipients. These findings suggested that 
TNF signaling intrinsic signalling in these myeloid populations was dispensable for their 
expansion following infection with L. donovani. 
According with our findings TNF signaling was not a direct mediator of loss of LT-HSCs in G0 
during experimental VL. Of relevance, the results suggested that TNF acting directly on T cells 
underlined the huge enhancement in BM T cells that characterized infection with L. donovani, by 
means that remain to be established. TNF signaling may be required to recruitment, survival or 
proliferation of BM and splenic T cells during experimental VL.  
4.2.11 Loss of TNFR signaling prevents expansion of BM CD4+ T cells with the potential to 
express IFNγ  
In previous experiments, we established that CD4+ T cells could solely mediate the loss of LT-
HSC in G0 in BM and impairment of haematological function (anaemia and thrombocytopenia) in 
the periphery (section 4.2.8). The potential of CD4+ T cells to mediate these alterations during L. 
donovani infection critically relied on the expression of IFNγ (section 4.2.9).  The expansion of T 
cells following infection was prevented in cells lacking TNF signaling receptors, as such it was 
conceivable that this could also impact in their function. Therefore, we decided to assess if T cells 
devoid of TNF signaling were impaired in their efficiency to produce IFNγ. 
The requirement of TNF intrinsic signaling in T cells to express IFNγ during infection with L. 
donovani was evaluated in mixed BM chimeras WT:TNF-RdKO established as described in 
previous section. In our analysis we included B cells as a potential source of IFNγ that was not 
evaluated in previous analysis (Figure 4.54a; Figure 4.54b). The number of WT and TNF-RdKO 
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B cells expressing IFNγ in BM following infection was very low, excluding B cells as a relevant 
producer of IFNγ (Figure 4.54b). In total BM cells from infected mice upon in vitro stimulation, 
CD4+ T cells expressing IFNγ comprised 21.41% ± 4.83 within WT donor cells compartment, but 
less than 1% (0.6% ± 0.19) of TNF-RdKO donor cells (Figure 4.54a). This disparity in WT and 
TNF-RdKO donor CD4+T cells contribution to the overall expression IFNγ in BM, following 
infection was manifest in absolute cell number. The number of WT CD4+ T cells IFNγ+ increased 
about 100 fold upon infection, while the number of TNF-RdKO CD4+ T cells IFNγ+ was 
unchanged, following infection with L. donovani (Figure 4.54b). 
CD8+ T cells also contributed to the overexpression of IFNγ during chronic infection although to 
a limited extent in comparison to CD4+ T cells (Figure 4.54a; Figure 4.54b). The number of WT 
CD8+ T cells expressing IFNγ increased 2.5 fold in infected compared to non-infected recipient 
mice, while the number TNF-RdKO CD8+ T IFNγ+ remain at levels found under homeostatic 
conditions (Figure 4.54b). The frequency and the cell number of CD3+ CD4- CD8- T cells 
expressing IFNγ derived from both, WT and TNF-RdKO donor cells was very low under 
homeostatic conditions and remained unaltered following infection (Figure 4.54a; Figure 4.54b). 
These findings confirmed CD4+ T cells as the main source of IFNγ in BM of mice infected with 
L. donovani. Noteworthy, in the absence of TNF intrinsic signaling the number of CD4+ T cells 
expressing IFNγ was unchanged, suggesting that TNF may play a pivotal role in the expansion of 
CD4+ T cells mediating the loss of HSCs in G0 during experimental chronic VL. Arguing in favor 
of a central role for TNF in the mediation of IFNγ overexpression in BM of infected mice, was 
the observation that beside impairing the expansion of CD4+ T cell compartment in BM, TNF 
intrinsic signaling impacted on their efficiency to express IFNγ (Figure 4.54c; Figure 4.54d). In 
BM cells from infected recipient mice stimulated in vitro, 90.95% ± 3.43 of WT CD4+ T cell 
expressed IFNγ, but this dropped to 70.48% ± 6.66 in TNF-RdKO CD4+ T cells (Figure 4.54c; 
Figure 4.54d). Following infection, directly ex vivo we detected IFNγ in 12.05% ± 1.19 of WT 
CD4+ T cell, while within TNF-RdKO CD4+ T cells this frequency was limited to 4.47% ± 1.02 
(Figure 4.54c; Figure 4.54d). 
In summary, these findings suggested that TNF acting directly on CD4+ T cells was required to 
the accumulation of CD4+ T cells expressing IFNγ in BM of mice infected with L. donovani, at 
least in this competitive chimeric setting. In previous experiments, we determined that lack of 
IFNγ signaling in T cells also prevented their accumulation in BM during infection. Further 
experiments would be required to definitely determine the role of IFNγ and TNF intrinsic 
signaling in the alteration of BM CD4+ T cells in mice infected with L. donovani and, how these 
alterations relate to the loss of HSCs in G0. Nevertheless, in the light of the set of experiments its 
conceivable that following infection, (1) IFNγ and TNF signaling produced as part of immune 
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response co-operate to mediate the CD4+ T cells accumulation in BM; (2) in these cells, TNF 
signaling in association with other mediators drive the expression of IFNγ that by indirect 
mechanisms stimulate LT-HSCs to enter in active-cell cycle; (3) the “perpetuation” of LT-HSCs 
stimulation results in the depletion of HSCs in quiescence with consequent loss of function, and 
the accumulation of intermediary progenitors that are less efficient to produce effector mature 
progeny, resulting in the establishment of anaemia (Figure 4.55).  
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4.3 DISCUSSION 
The collection of findings presented in this chapter revealed that alongside the depletion of LT-
HSCs in G0 and subsequent loss of function associated to anaemia and thrombocytopenia 
(Chapter 3) induced by infection with L. donovani, there was the establishment of evident 
alterations in the composition of T cells residing in the BM. Following infection, there was a 
dramatic increase in the frequency and number of T cells, mainly sustained by the expansion of 
CD4+ T cells displaying an “effector” phenotype and releasing IFNγ at increased levels. The 
production of IFNγ by CD4+ T cells was sufficient to drive the depletion in LT-HSCs in G0 in 
addition to anaemia, defining this pro-inflammatory cytokine as a key modulator of 
haematopoiesis during infection with L. donovani. The absence of TNF signaling in CD4+ T cells 
prevented their expansion in the BM of infected mice, and limited their potential to produce IFNγ, 
suggesting that TNF plays a central role in regulating the alterations in the T-cell compartment of 
the BM, and therefore indirectly contributing to the impairment of haematopoietic function during 
chronic infection with L. donovani. 
To assess the direct impact of the parasite burden in haematopoiesis we established the condition 
for a “super-infection” in immunodeficient RAG2 KO mice, lacking functional T and B cells. In 
the current study, despite the increase of parasites/1000 nuclei in the spleen of immunodeficient 
mice compared to WT mice, RAG2 KO mice did not display any alterations in the number of 
HSPCs following infection. Additionally, the depletion of the reservoir of quiescent LT-HSCs in 
the BM was prevented in the absence of functional T and B cells in infected hosts. These findings 
suggested that in B6 mice, the alterations in haematopoiesis were not directly induced 
by pathogen-associated molecular patterns from L. donovani parasites, but dependent on 
mechanisms associated with the adaptive immune system.  
However, in previous studies carried out in BALB/c mice infected with L. donovani, in which 
CFU assays were used to quantify haematopoietic progenitors in the BM and spleen, it was shown 
that the magnitude of parasite burden was directly associated to the extent of increase in the 
number of haematopoietic progenitors found at both sites (S. E. J. Cotterell et al., 2000a). This 
trend was also observed in SCID (severe combined immunodeficiency) mice, suggesting that 
innate immune mechanisms contribute to the expansion of haematopoietic progenitors (S. E. J. 
Cotterell et al., 2000a).  
Different antigens from Leishmania species induce alterations in TLR signaling, and TLR4 
specifically seems to be required to control parasite burdens by acting as an inducer of nitric oxide 
synthase (iNOS), which is a crucial mechanism for parasites killing (R. K. Singh et al., 2012). 
LT-HSCs and other early haematopoietic progenitors express TLRs, and in vitro stimulation of 
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LSK cells with TLR ligands is sufficient to induce proliferation and myelopoiesis in vitro (Y. 
Nagai et al., 2006a). Similar results were described in mice challenged with TLR2, TLR4 and 
TLR9 agonists (J. Megias et al., 2012).  
Another example regarding the potential of TLRs to activate HSCs came from mice infected with 
Pseudomonas aeroginosa, model for sepsis, characterized by severe neutropenia due to block in 
myelopiesis and expansion of HSCs associated with functional impairment in long-term 
repopulating capacity. Interestingly, in mice deficient for TLR4 signalling, the neutropenia was 
prevented and the expansion of LSK cells limited, suggesting that TLR-signalling although 
advantageous to induce replenishment of post-mitotic short-lived myeloid cells during infection, 
may also be associated with the emergence of dysfunctional haematopoiesis (S. Rodriguez et al., 
2009). 
In contrast, it was reported that expansion of LSK cells during Staphylococcus aureus infection is 
independent of TLR signaling. The expansion of LSK cell following infection is not prevented in 
S. aureus-infected RAGKO mice (P. O. Scumpia et al., 2010), emphasizing the variability of 
mechanisms mediating alterations in haematopoiesis in response to different microbe insults. 
Another study showed that the loss of myeloid-committed progenitors in the BM during acute 
phase of infection in WT mice infected with the parasite Plasmodium chabaudi (malaria) is not 
prevented in mice deficient for MyD88 and TRIF, adaptor molecules that are required for TLR-
signalling (N. N. Belyaev et al., 2013). 
As previously described in BALB/c (S. E. J. Cotterell et al., 2000a), in the present study we also 
found the number of myeloid-committed progenitors increased in the spleen of mice chronically 
infected with L. donovani, in addition to increased frequency and number of non-committed 
progenitors. Signs of extramedullary myelopoiesis were also described in other models of 
parasitic infection such as malaria (N. N. Belyaev et al., 2013).   
In adult mammals, most of haematopoiesis takes place in the BM. The regulation of the dynamic 
process of retention and egress of haematopoietic progenitors is poorly understood, however, the 
current understanding is that various cell types composing the BM stroma such as, osteoblasts, 
CXC chemokine ligand 12 (CXCL12)-expressing reticular cells, and vascular endothelium cells 
contribute to these complex processes (C. H. Kim, 2010).  
However, during the response to an infection extramedullary haematopoiesis may be established 
in the spleen and liver as a consequence of increased haematopoietic activity in the BM, 
mobilization of haematopoietic progenitors and release of chemokines and growth factors, (J. L. 
Johns and M. M. Christopher, 2012). For example, the trafficking of LSK cells (with 
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reconstitution potential following transplant into x-irradiated recipients), between the BM and the 
periphery has been established in steady-state, however it was reported that pro-inflammatory 
conditions established by the administration of LPS, correlated to increased number of HSCs 
seeding into peripheral organs (S. Massberg et al., 2007).  
In humans and in animal models of disease, infection with L. donovani has been associated with 
the advents of BM alterations and cytopenias at various degrees of severity (N. Varma and S. 
Naseem, 2010, F. A. d. Pinho, 2015). The basis for these alterations are poorly defined, however 
splenic sequestration of blood cells and ineffective haematopoiesis have been appointed as the 
principal factors underlying the emergency of haematopoietic alterations both in the BM and in 
the periphery (N. Varma and S. Naseem, 2010). For instance, spleen removal has been for long 
defined as a therapeutic intervention when pharmacological approaches fail, which results in the 
recovery of blood cells in circulation to normal values (G. E. Cartwright et al., 1948). The clinical 
improvement upon splenectomy is not well defined, and some authors suggest that may be due to 
removal of a large amount of parasites (the spleen being a major reservoir), increased 
chemotherapeutic drugs available upon removal of hyperplasic spleen, and/or due to increased 
haemophagocytic activities of the enlarged spleen (G. E. Cartwright et al., 1948, R. A. Dutra et 
al., 2012).  
To assess the contribution of the spleen to the establishment of inflammation-induced 
haematopoiesis in the BM of mice infected for 28 days with L. donovani, the impact of spleen 
removal in BM cellularity was determined in the current study. During chronic infection with L. 
donovani, we failed to determine any differences either in frequencies of quiescent LT-HSCs, 
HSPCs (LSK CD150+ CD34- CD48- cells, LSK CD150+ CD34- CD48- cells, LSK CD150+ CD34- 
CD48- cells, CMPs, GMPs, MEPs and CLPs) or mature cells in the BM between splenectomized 
mice and “sham” infected mice, suggesting that for the alteration in BM cellularity do not 
contribute the alteration in the spleen, either by increased sequestering of haematopoietic effector 
cells or by it establishment as a site for extramedullary haematopoiesis. Nevertheless, it is 
conceivable that following spleen removal, extramedullary haematopoiesis could be established 
elsewhere, like the liver.  
Importantly, in previous work from P. T Bunn et al. it was reported that long-lasting immune 
response against L. donovani can be established in B6 mice lacking secondary lymphoid tissues 
and spleen, and that antigen-specific CD4+ T cells critical to control parasite growth can be 
generated in the liver (P. T. Bunn et al., 2014). 
We determined that alterations in haematopoiesis during infection with L. donovani were absent 
in mice lacking functional T and B cells, which suggested that adaptive immunity might play a 
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pivotal role in the regulation of haematopoietic function. In fact, the analysis of BM cellularity 
revealed profound alterations in the frequency and in the number of haematopoietic effector cells 
in BM. Amongst these alterations, the most compelling were the expansion of the T cell 
compartment followed by the contraction of the B cell compartment. However, the degree of the 
expansion of T cells, mainly sustained by CD4+ T cells, was far more extensive than the 
contraction of B cells. Furthermore, T cells in the BM are found in close proximity to IL-7 
producing stromal cells, which are required for maturation of B cells (F. E. Mercier et al., 2012). 
Most likely B cells are found in decreased numbers because they have to compete with T cells for 
the same niches in the BM, whose cell numbers are hugely increased during infection.  
In mice infected with L. donovani for 28 days we found the number of BM CD4+ T cells was 
increased ~20 fold compared to naive mice, and spleen removal did not limit the expansion of the 
CD4+ T cell compartment in BM. However, previous work carried out in mice infected with 
OVA-transgenic L. donovani parasites reported that 5 days following infection the number of 
proliferating Ag-specific CD4+ T cells in BM was unchanged compared to control (P. T. Bunn et 
al., 2014). In addition, treatment with FTY720 which causes S1P1R internalization preventing 
lymphocytes trafficking lead to a significant decrease in the number of Ag-specific CD4+ T cells 
in BM (P. T. Bunn et al., 2014). These finding suggested that is not BM a privileged site for T 
cell priming during L. donovani infection. As such in future experiment it would be pertinent to 
access using an OVA-Leish system the proportion of CD4+ T cells Ag-specific in BM, as well as, 
determined the contribution of ingress of Ag-specific T cells into BM, at various time points 
following infection.    
In steady-state mature CD4+ T cells and CD8+ T cells reside in BM in low numbers (K. Tokoyoda 
et al., 2009b, Y. Zhang et al., 2013), where priming of antigen-specific T cells can take place (M. 
Feuerer et al., 2003). The proof that BM T cells are fully functional came from the onset of graft 
versus host disease in allogeneic host receiving total BM cells transplants (F. Di Rosa and R. 
Pabst, 2005). Furthermore BM has been described as a privileged site for homing of memory T 
cells (C. Arieta Kuksin et al., 2015). 
It has been shown that CD4+ T cells play an important role in the regulation of normal 
haematopoiesis (J. P. Monteiro et al., 2005). Furthermore, changes in T cells in BM have been 
described in association with haematological alterations in experimental models of BMF 
syndromes and human monocytic ehrlichiosis (HME) (Y. Zhang et al., 2013, F.-c. Lin et al., 
2014, C. Arieta Kuksin et al., 2015). As such, there is an emerging demand to better understand 
the role of BM resident T cells in the immune response and in the regulation of haematopoiesis. 
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The association between alteration in T cells and haematopoietic activity has been formerly 
established in aplastic anaemia (AA) (C. Dufour et al., 2001, C. Dufour et al., 2003, N. S. Young 
et al., 2008). In humans, AA is characterized by the expansion of T cells displaying Th1 
phenotype that release IFNγ at increased levels. It was proposed that on the basis of AA 
pathophysiology is the increased cell death of HSPCs mediated by these expanded T cells, that 
ultimately results in BM failure (C. Dufour et al., 2001). Using experimental models for AA, it 
has been also suggested that T cells are key mediators of haematopoietic dysfunction and 
ultimately result in BM failure (F.-c. Lin et al., 2014, C. Arieta Kuksin et al., 2015). T cells 
migrate to the BM in response to chemokines, such as stromal-cell derived factor-1 (SDF-1, also 
known as CXCL12), the ligand for the chemokine receptor CXCR4 expressed in CD4+ T cells (C. 
Arieta Kuksin et al., 2015). Using an experimental model for lethal AA it was shown that the 
number of BM-infiltrating T cells was increased, in which the CXCR4 expression was aberrantly 
up-regulated, however, when the interaction of CXCR4-SDF1 was blocked this resulted in 
reduced accumulation of pathogenic T cells and sick mice were rescued from lethal BMF (N. S. 
Young et al., 2008, C. Arieta Kuksin et al., 2015). 
In other study, using mutant mice where IFNγ is constitutively expressed at low levels in T cells 
and Natural Killer cells (NK cells), it was reported that this is sufficient to promote AA phenotype 
(F.-c. Lin et al., 2014). Furthermore, in this experimental model of disease, as a result of the 
persistent exposure to low levels of IFNγ, the number of phenotypic HSCs (Lin– cKit+ Sca1hi 
CD34– Flt3– CD150+ cells) is increased and the differentiation of MPPs to myeloid progenitors, 
erythrocytes and B cells is defective, suggesting that the emergence of ineffective haematopoiesis 
contributes to AA (F.-c. Lin et al., 2014). 
Alterations in T cells in association with haematopoietic impairment are not restricted to BMF 
syndromes. For example, in experimental model of human monocytic ehrlichiosis (HME), 
infected mice, similarly to infected humans, display anaemia and thrombocytopenia (Y. Zhang et 
al., 2013). The establishment of infection correlated with the expansion of LSK cells in BM, 
which was dependent of IFNγR signalling in mice infected with Ehrlichia chaffeensis 
(experimental model of the disease), and then it was determined that during infection the main 
source of IFNγ were CD4+ T cells (Y. Zhang et al., 2013). 
A recent review compiled the most relevant studies performed on the characterization of T cells in 
BM using experimental models of disease. In an attempt to shed some light on the classification 
of activated T cells in the BM, it proposed the following: “effector” BM T cells are enriched in 
the CD44high CD127 (IL-7Rα)-/low Ly6C-/low population and “memory” BM T cells are enriched in 
CD44high CD127high Ly6Chigh population (K. Tokoyoda et al., 2010).  
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Based on the above studies reporting that T cells have the potential to impair haematopoietic 
function in periphery and induce the activation of HSCs into active cell-cycle in BM, we decided 
to characterize BM T cells in further detail. In the current study, the phenotypic and functional 
characterization of BM T cells revealed that following infection with L. donovani the vast 
majority (about 90%) of CD4+ T cells were CD44hi CD127-/low Ly6C-/low cells, a phenotype 
previously attributed to BM “effector-T cell” (K. Tokoyoda et al., 2010). Additionally, we found 
that both in steady-state percentage of BM CD4+ T cells CD44hi was higher in the spleen 
compared to BM, and this become further evident following infection. 
The observation of a higher proportion of T cells with an “activated” phenotype reside in BM in 
steady-state compared with the spleen has been made previously by others. These differences in 
the distribution of T cells population in BM are followed by other important phenotypic and 
functional differences in T cells between BM and the spleen (F. Di Rosa and R. Pabst, 2005).  
For example, it was reported that in mice, BM T cells express higher level of CD44 compared to 
other sites, as studies in LCMV models of infection demonstrated that CD8+ T cells CD44hi are 
more activated in BM compared to those found in the spleen. Antigen-specific CD8+ T cells 
persist for much longer periods of time in BM compared to other extra-lymphoid following 
infection resolution, while retaining their ability to perform an efficient secondary immune 
response when transferred to an immunodeficient infected host (F. Di Rosa and R. Pabst, 2005). 
In more recent study using LCMV model of infection these same features were also attributed to 
BM CD4+ T cells (K. Tokoyoda et al., 2009b). 
Activated T cells have been classically segregated in short-lived “effector” T cells and long-lived 
‘‘memory’’. “Memory” T cells are then classified into “central memory‘‘ that are in permanent 
circulation between the blood and secondary lymphoid organs and have a higher potential of 
expansion compared to the ‘‘effector memory” T cells, which survey extra-lymphoid organs 
providing a quick response to invading pathogens (F. Di Rosa and R. Pabst, 2005). The 
classification into the above mentioned categories has been a matter of debate for a long time due 
to differences in the expression of surface markers among T cells from different tissues, and due 
to the plasticity of ‘‘memory’’ and ‘‘effector’’ cells. In chronic infection where residual 
pathogens persist over time the distinction becomes even harder as effector T cells may be present 
for extended periods of time (F. Di Rosa and R. Pabst, 2005, K. Tokoyoda et al., 2010).  
The distinction between central memory and effector memory has been usually made on the 
assumption that “central memory” T cells express CCR7 and have a more proliferative compared 
to “effector memory” T cells that do not express CCR7 (F. Di Rosa and R. Pabst, 2005). To add 
more complexity to this subject it was reported that BM memory T cells may not express CCR7 
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or CD62L but the majority express Ly6C, rarely found expressed in memory T cells in other sites 
(K. Tokoyoda et al., 2009a, K. Tokoyoda et al., 2009b). Furthermore, memory T cells in BM 
rapidly expand extensively upon challenge, displaying simultaneously functional features 
classically associated to the so-called “central memory” (i.e. rapid extensive proliferation) and 
“effector memory” T cells (i.e. residing in BM) (F. Di Rosa and R. Pabst, 2005, K. Tokoyoda et 
al., 2009b). 
Further experiments would be required to functionally define the CD4+ T cells found in BM as 
“effector” or “memory” cells. A “memory” T cells is defined as a antigen-specific cells that 
persist after antigen removal and is capable to expand following a second encounter with cognate 
antigen (F. Di Rosa and R. Pabst, 2005). For example, experiments could be developed using 
transgenic mice bearing CD4+ T cells expressing a TCR specific for a defined antigen, in 
immunized mice following the removal of the cognate-antigen, the persistence and the phenotype 
of CD4+ T could be assessed, as well as their kinetics of expansion in a subsequent stimulation 
with target antigen, for example using an OVA-Leish OT II system. In addition, different 
populations Ag-specific BM CD4+ T cells (based on the differential expression of CD44, CD127 
and Ly6C) could be transferred to RAG2 KO recipients and their localization, phenotype and 
response to secondary L. donovani infection in comparison to naive BM CD4+ T cells isolated 
from naive mice.  
In the present study, we found that ~ 90% of BM CD4+ T cells, besides displaying an “effector” 
phenotype  (CD44hi CD127-/low Ly6C-/low cells), were primed to express IFNγ at increased levels. 
A substantial proportion of CD4+ T cells were actively expressing IFNγ and TNF in the BM of 
infected mice, suggesting though not proving a degree of antigen specificity to the response.  
In hamsters infected with L. donovani, characterized by severe anaemia and leucopenia, it was 
reported that mRNA levels of IFNγ and TNF-related apoptosis-inducing ligand (TRAIL) are 
significantly increase both in BM and the spleen, and this is coincident with an increase in 
apoptotic erythroblasts in BM, collectively suggesting that in the hamster, anaemia is mediated by 
cytokine-induced increased apoptosis of erythroid progenitors (W. P. Lafuse et al., 2013).    
Additionally, previous studies reported that both IFNγ and TNF are found expressed increased in 
the BM of patients suffering from BMF syndromes, suggesting that increased levels of expression 
of these cytokines may contribute to the decline of a haematopoietic function (C. Dufour et al., 
2001, C. Dufour et al., 2003).  
Initial studies in vitro suggested that IFNγ has an inhibitory impact in haematopoiesis, through the 
inhibition of proliferation and induction of apoptosis (A. M. de Bruin et al., 2014). However, in 
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vivo studies in different models of infections have been less consensual regarding the impact of 
IFNγ in the modulation of inflammation-induced haematopoiesis, and respective mechanisms of 
action (A. M. de Bruin et al., 2014). For example, in mice infected with Mycobacterium avium, it 
was proposed that IFNγ acting directly on LT-HSCs through the activation of the transcription 
factor STAT1 (Signal transducer and activator of transcription 1) induced proliferation with 
significant decrease of cells in quiescence, accumulation of early committed progenitors and loss 
of myeloid-committed progenitor in the BM (M. T. Baldridge et al., 2010). In this study from 
Baldridge et al, it was reported that in BMT competitive assays, BM cells derived from donors 
treated with IFNγ performed poorly in the reconstitution of haematopoietic system following 
transplantation in lethally x-irradiated recipients, compared to PBS treated controls. The cell 
numbers for LT-HSCs in the donors were very similar irrespective of IFNγ treatment, suggesting 
that the competitive disadvantage of  “IFNγ-activated” LT-HSCs results from their lower degree 
of quiescence, a property intrinsically related to engraftment potential (M. T. Baldridge et al., 
2010).  
The experimental model for HME provided another example supporting a role for IFNγ as a key 
mediator of haematopoietic dysfunction, established not only in the periphery but coincident with 
increased proliferation of HSCs and consequent loss of engraftment potential in long-term BMT 
assays (K. C. MacNamara et al., 2011a, K. C. MacNamara et al., 2011b). Mice infected with 
Ehrlichia muris are characterized by the emergence of anaemia, thrombocytopenia and BM cells 
show decreased colony forming activity in vitro, however all these features were prevented in 
infected mice deficient for IFNγ signalling. Importantly, infected mice lacking receptor for IFNγ 
only in the stromal compartment display similar alterations in haematopoiesis, including the 
expansion of LSK cells compartment in BM, compared to the IFNγR competent control (K. C. 
MacNamara et al., 2011b). Overall, these findings suggested that IFNγ signalling in 
haematopoietic cells is required to induce haematopoietic impairment during infection with E. 
muris (K. C. MacNamara et al., 2011b). In a following study, it was reported that infection with 
E. muris leads to the activation of HSCs (LSK CD150+ Flt3- cells) into active cell-cycle and this 
correlated with poor reconstitution upon transfer to non-infected recipient mice. In competitive 
BMT experiments, LSK cells derived from infected IFNγR deficient mice showed competitive 
advantage over LSK cells derived from infected WT mice. And so, it was proposed that IFNγ 
directly mediates HSCs loss of function through the induction of increased proliferation during 
infection with E. muris, however proliferative state of IFNγR KO HSCs in chimeric mice was not 
assessed (K. C. MacNamara et al., 2011a). 
On the contrary, in LCMV infected mice, a model for acute viral infection, it was proposed that 
IFNγ acting directly on LT-HSCs (LSK CD150+ CD48- cells) inhibits proliferation and reduces 
self-renewal divisions (A. M. de Bruin et al., 2013). Mice infected with Armstrong strain of 
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LCMV display BM hypocellularity, low number of LT-HSCs and leucopenia. In this study from 
de Bruin et al, it was reported that in vitro stimulation of LT-HSCs with IFNγ results in a lower 
division index. However, the infection of IFNγ-deficient mice or mixed BM-chimeric mice 
reconstituted with BM cells from IFNRγ-deficient mice and WT mice, resulted in both scenarios 
in a faster recovery of HSCs number from IFNγ-signalling deficient cells during the course of 
infection. In vitro stimulation of LT-HSCs with IFNγ impaired TPO-mediated phosphorylation of 
STAT5 by the induction of SOCS1 (inhibitor of STAT5 activation) and abrogated TPO-mediated 
proliferation of LT-HSCs, then it was determined that IFNγ limit the downregulation of the cell-
cycle inhibitor p57 induced by TPO in LT-HSCs. Finally, it was reported that WT HSCs from 
LCMV mice upregulate the expression of mRNA for p57 but this was prevented in HSCs 
deficient for IFNγR (A. M. de Bruin et al., 2013). As such, IFNγ in the context of LCMV 
infection seems to limit LT-HSCs function through the downregulation of the expression of genes 
involved in the regulation of cell-cycle progression (A. M. de Bruin et al., 2013).  
On the other hand, in a study designed to study the impact of CD8+ T cells in haematopoiesis in 
mice infected with WE strain LCMV, it was proposed that IFNγ mediates increased myelopoiesis 
not acting directly on HSPCs but instead mediating the release of IL-6 by BM stromal cells (C. 
M. Schuerch et al., 2014). In this study, to isolate the impact of CD8+ T cells, cells from TCR-
gp33 epitope of LCMV transgenenic mice (p14 CD8+ T cells) were transferred for mice 
expressing gp33 in all cells (H8 mice). In H8 mice, the transfer of p14 CD8+ T cells was related to 
the expansion of Lin- cKit+ cells, maintenance of LT-HSCs number followed by the expansion of 
all the other HSPCs, increase colony-forming activity biased toward myeloid differentiation in 
vitro and increased number of Ly6C+Ly6G SSClo inflammatory monocyte in circulation. These 
alterations were prevented in both H8 mice receiving IFNγ-deficient p14 CD8+ T cells and in 
IFNγR-deficient H8 mice receiving WT p14 CD8+ T cell. Subsequently, using mixed BM 
chimeras, it was demonstrated that in this system IFNγ released by CD8+ T cells acts directly on 
BM stromal cells to induce IL-6 release, which then mediates the downregulation of Runx-1 and 
Cebpa in Lin- cKit+ cells thus favoring myeloid differentiation (C. M. Schuerch et al., 2014). 
A different role for IFNγ in the modulation of alterations in the haematopoietic system was 
proposed following experiments in an experimental model for Malaria. Mice infected with 
Plasmodium chabaudi are characterized by the loss of myeloid-committed progenitors in BM, and 
it was proposed that this is mediated by IFNγ signalling acting directly on the stromal 
compartment, and increased systemic levels of CCL2, therefore promoting the conditions for 
increased mobilization of myeloid-committed progenitors to the periphery via CCR2 expressed on 
these progenitors (N. N. Belyaev et al., 2013). 
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These above given examples illustrate the requirement of studies on the impact of IFNγ in the 
infection-induced haematopoiesis in the pathogen-specific contexts, additionally emphasise the 
limitation associated to the so far proposed general mechanisms concerning the regulation of 
haematopoiesis in the face of stress or injury.   
In the present study, to dissect the role of CD4+ T cells in the changes in haematopoiesis in BM 
and haematopoietic dysfunction in periphery, purified CD4+ T cells from naive B6 mice were 
transplanted to RAG2 KO mice, subsequently infected with L. donovani. In line with previous 
experiments, in mice lacking functional T and B cells, the infection with L. donovani parasites did 
not result in significant changes in the number of HSPCs nor in the number of LT-HSCs in G0. 
On the contrary, RAG2 KO mice that received CD4+ T cells displayed profound alterations in the 
haematopoietic compartment, such as the expansion of early progenitors and the depletion in the 
reservoir of quiescent LT-HSCs, resembling the phenotype observed in WT infected mice.  
Furthermore, we determined that the establishment of anaemia and thrombocytopenia in WT mice 
chronically infected with L. donovani were absent in immunodeficient RAG2 KO mice, however 
those haematological anomalies in the periphery emerged in RAG2 KO mice transplanted with 
CD4+ T cells following infection. These findings demonstrated that CD4+ T cells could solely 
mediate the alteration in haematopoiesis in BM and in haematopoietic function in the periphery 
during infection with L. donovani. CD4+ T cells showed a much higher degree of alteration 
compared to CD8+ T in the BM of infected mice. Nevertheless, it is conceivable that CD8+ T cells 
could also play an important role in the haematological changes resulting from infection. 
The phenotypic alteration of transplanted CD4+ T cells replicated those from BM CD4+ T cells 
found in WT infected mice i.e. massive expansion and skewing towards “effector” BM T cells 
(CD44hi LyC6-/lo CD127-/lo T cells). Interestingly, in naive RAG2 KO mice, the vast majority of 
transplanted CD4+ T cells had a “memory” phenotype (CD44hi LyC6hi CD127hi T cells), which 
argues in favor of the phenotype proposed for memory T cells in the BM (K. Tokoyoda et al., 
2010).  
Given the central role of IFNγ in the mediation of haematological dysfunction in other models of 
infection (M. T. Baldridge et al., 2010, K. C. MacNamara et al., 2011a, K. C. MacNamara et al., 
2011b, A. M. de Bruin et al., 2013) in the present study, we assessed whether CD4+ T cells 
modulated stress-induced haematopoiesis during infection with L. donovani through the release of 
IFNγ, expressed at increased levels in the BM in chronically infected mice. This hypothesis was 
further supported by the report that expansion of LSK cells compartment of mice infected with E. 
muris depended of IFNγ derived from CD4+ T cells (Y. Zhang et al., 2013). 
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In clear opposition to the results obtained by the transfer of WT CD4+ T cells, the phenotype of 
infected RAG2 KO transferred with CD4+ T cells lacking IFNγ was identical to infected RAG2 
KO mice not subjected to any cell transfer, namely in the number of HSPCs in BM, number of 
quiescent LT-HSCs and maintenance of blood parameters (RBC and platelets) at basal levels. The 
number CD4+ T cells in IFNγ KO and WT mice were identical in the BM of infected RAG2 KO, 
suggesting that CD4+ T cells lacking IFNγ were competent to expand in response to infection in 
non-competitive experimental settings. As such, in our model of experimental VL, we defined 
CD4+ T cells expressing IFNγ as key modulators for the depletion of quiescent LT-HSCs driven 
by the massive expansion early progenitors and ineffective haematopoiesis reflected in the 
establishment of anaemia. Additionally, in the sequence of these set of experiments we also 
resolved that CD4+ T cells expressing IFNγ were required to the clearance of parasites and the 
onset of splenomegaly in immunodeficient mice, which is strongly suggestive of a central role of 
these cells underlying these same manifestations in WT infected mice.  
These findings conform to previous reports establishing IFNγ as a mediator of disease progression 
in VL (A. P. Taylor and H. W. Murray, 1997, R. Kumar et al., 2014). In culture of splenic 
aspirates from VL patients with clinical symptoms of Kala-azar, the addition of blocking 
antibodies against IFNγ correlated with increased parasite load, suggesting that IFNγ is important 
to control the parasite growth in humans (R. Kumar et al., 2014). Interestingly, in this same study 
CD4+ T cells were defined as the main source of IFNγ in PB blood of VL patients (R. Kumar et 
al., 2014). Furthermore, it was formerly reported in experimental VL using BALB/c mice infected 
with L. donovani that the absence of IFNγ signalling resulted in uncontrolled parasite burdens in 
the liver, which is controlled in IFNγ competent littermates (A. P. Taylor and H. W. Murray, 
1997).  
Increased proliferation of LT-HSCs into active cell-cycle and impaired repopulating activity, as a 
consequence of stress-induced haematopoiesis has been attributed to IFNγ signalling acting 
directly on these cells in other models of infection (M. T. Baldridge et al., 2010, K. C. 
MacNamara et al., 2011a, K. A. Matatall et al., 2014). To test the hypothesis that IFNγ signalling 
in LT-HSCs were driving increased proliferation during chronic infection with L. donovani, we 
established BM mixed chimeras with equal number of total BM cells derived from WT and 
IFNγR2KO (WT: IFN-γR2KOèWT). This approach allowed the experimental evaluation of the 
impact of IFNγR signalling in LT-HSCs, whilst excluded confounding findings resulting from a 
global loss of IFNγ signalling. In agreement with previous findings from Bruin and MacNamara, 
we determined that donor cells lacking IFNγ signalling displayed higher repopulating potential in 
lethally irradiated recipients, following the establishment of infection (K. C. MacNamara et al., 
2011a, A. M. de Bruin et al., 2013). Nonetheless, an increased repopulation activity of IFNγR2 
KO was already prevalent in uninfected recipient mice, and this was not significantly changed 
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following infection with L. donovani. These findings suggested that basal levels of IFNγ regulate 
haematopoietic activity, as formerly reported by others (A. M. de Bruin et al., 2013). Nevertheless 
in the current study, under conditions established by infection with L. donovani, the lack of IFNγ 
signalling did not constitute a further competitive advantage.  
In our study, the lack of intrinsic IFNγ signalling did not prevent the expansion of LSK cells 
compartment in BM of mice chronically infected with L. donovani. However, in the BM of 
chronically infected recipient mice, we found that within the WT compartment, the increase in the 
frequency of LSK cells was coincident with a dramatic contraction of Lin- cKit+ cells, whilst 
within IFNγR2 KO donor cells those remain unaltered. As such, to the increase in WT LSK cells 
may contribute to the upregulation of Sca1 in functional lineage-committed progenitors 
classically included Lin- cKit+ cells mediated by intrinsic IFNγ signalling. This phenomenon has 
been formerly reported in other models of infection (N. N. Belyaev et al., 2010, N. N. Belyaev et 
al., 2013) and following IFNγ stimulation haematopoietic cells in vivo and in vitro (T. R. Malek et 
al., 1989, A. Sinclair et al., 1996, A. M. de Bruin et al., 2013).  
In the absence of intrinsic IFNγ signalling, we found that early committed progenitors expanded 
extensively follow infection, and noticeably LT-HSCs were driven to an active proliferative status 
at a similar extent as WT LT-HSCs. Therefore, in mice infected with L. donovani we could 
exclude IFNγ as a direct mediator of LT-HSCs loss of quiescence, and subsequent functional 
impairment (Chapter 3). As a consequence of these findings, it would be important to establish 
BM chimeras in which the receptor for IFNγ is expressed in LT-HSCs but not in radio-resistant 
BM stromal cells, to determine whether the deleterious effect of IFNγ impact in haematopoietic 
function could be mediated by the IFNγ signalling acting directly on BM stromal cells. In fact, 
this mechanism has been proposed previously to explain increased myelopoiesis in mice infected 
with LCMV strain WE (C. M. Schuerch et al., 2014).   
Former studies proposed that IFNγR expressed in HSPCs was directly implicated in activation of 
“dormant’” LT-HSCs and/or haematopoietic dysfunctions, which was attributed to the lack of 
increased proliferation in LT-HSCs and/or alteration in other progenitors and mature effector cells 
in IFNγRKO mice, (M. T. Baldridge et al., 2010, K. C. MacNamara et al., 2011a, K. C. 
MacNamara et al., 2011b, Y. Zhang et al., 2013). Under those conditions, infections were 
established in an “all system” deficient for IFNγ signalling, which could explain the conflicting 
results obtained in our model of chronic infection. On the other hand, in mixed BM chimeric mice 
with WT and IFNγR2 KO donor cells, following LCMV strain Armstrong infection the 
proportion of LT-HSCs in active cell-cycle was comparable between WT and IFN-γR2KO donor 
cells at various time points, as such it was proposed that IFNγ-signalling in HSCs to be not 
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responsible the activation of quiescent LT-HSCs into an active proliferative status (A. M. de 
Bruin et al., 2013).  
In the current study, we established that in steady-state IFNγ was not required to T cell 
development; on the contrary, lack of intrinsic IFNγ signalling clearly limited the expansion of 
these cells following infection with L. donovani. This competitive advantage based on IFNγR-
signalling on T cells, was further evident in BM, suggesting that IFNγ contributes to the dramatic 
increase in the T cell compartment during experimental VL. On the other hand, in non-
competitive settings, as a consequence of transfer into RAG2 KO recipients, IFNγ KO T cells 
were able to expand in the BM at a similar rate to WT T cells. These findings are difficult to 
reconcile and pointed to various conceivable scenarios; it is plausible that in immunodeficient 
mice compensatory mechanisms are in place and IFNγ from other sources (i.e. NK cells) may be 
sufficient to drive the increase in T cells in the BM, yet below a threshold required to propel 
haematopoietic dysfunction.  
Another hypothesis would be that IFNγR-signalling equipped T cells with an increased capacity 
to expand and the endogenous expression of IFNγ intrinsically related to other functions, such as 
additional expression of growth factor or anti-apoptotic mediators, features not assessed in this 
experiment. For instance, it is well established that IFNγ is important for the differentiation of 
CD4+ T cells into Th1 cells in detriment of Th2 cells (V. Lazarevic et al., 2013). It was proposed 
that IFNγ receptor and TCR signalling induce the expression of T-bet, the master regulator of Th1 
cell differentiation, the expression of T-bet promotes the expression of IFNγ, which in an 
autocrine manner regulates further expression of T-bet and therefore the stabilization of Th1 
phenotype, and consequent acquisition of functional and migratory features (V. Lazarevic et al., 
2013). As such, it would be important to determine in further experiments if IFNγ signalling in 
CD4+ T cells is required to the upregulation of T-bet during chronic infection with L. donovani. 
In other models of infection there is evidence that direct IFNγ signalling modulates T cells either 
by enhancing or suppressing their responses to infection (J. K. Whitmire et al., 2005, J. S. Haring 
and J. T. Harty, 2006). For example, in mice immunized with LCMV, using competitive transfer 
assays it was shown that antigen-specific CD4+ T cells expand at a much higher rate compared to 
antigen-specific CD4+ T cells lacking IFNγ signalling. The expression of IFNγ receptor correlated 
with higher efficiency of IFNγ production, suggesting that direct IFNγ signalling enhance CD4+ T 
cells functions (J. K. Whitmire et al., 2005). On the contrary, in an experimental model for 
Listeria monocytogenes infection, it was observed that a higher percentage of antigen-specific 
CD4+ T cells expressed IFNγ and IL-12 in IFNγR KO mice compared to WT mice, their 
frequency in IFNγR KO mice remained increased at later time points while in WT mice it steadily 
decreased over a period from 7 to 150 days post-infection. As such, it was proposed that IFNγ 
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signalling is not required for the differentiation of effector Th1 cells but important for the 
contraction of CD4+ T cell compartment upon LCMV infection resolution (J. S. Haring and J. T. 
Harty, 2006). These two examples frame the relevance of determining the role of IFNγ signalling 
in the regulation of T cells functions in the context of specific microbe insults. 
In the current study, we demonstrated that CD4+ T cells competent to produce IFNγ mediate 
haematopoietic impairment during chronic infection with L. donovani. To definitely establish the 
role of IFNγR-signalling on these cells, it would be important to determine whether the transfer of 
CD4+ T cell devoid IFNγR to RAG2 KO mice prevents the onset of haematopoietic alterations, 
otherwise present following transfer of WT CD4+ T cells, and subsequently determine how the 
lack of IFNγR-signalling relates to the proficiency to express IFNγ in our model of chronic 
infection.  
In BM mixed chimeric mice WT: IFN-γR2KOèWT, we also determined noteworthy alterations 
in the myeloid cell compartment. Following infection with L. donovani, within the IFNγR KO 
donor progeny there was a contraction in the frequency of CD11b+ F4/80+ myeloid cells 
(phenotype associated to macrophages in most tissues (X. Zhang et al., 2008)) in the BM of 
infected recipient, in an opposite trend to the increase observed among WT derived CD11b+ 
F4/80+ myeloid cells. In steady-state, the frequency of CD11b+ F4/80+ myeloid cells lacking 
intrinsic IFNγ signalling was already decreased compared to those from derived WT donor cells, 
both in BM and in the spleen, suggesting that basal IFNγ levels contribute to their development 
and/or survival. The differences in the frequency of CD11b+ F4/80+ myeloid cells and other 
myeloid populations became further evident in chronically infected mice, both in the BM and 
spleen, suggesting that in the conditions established by the infection with L. donovani, intrinsic 
IFNγ signalling provides a competitive advantage to myeloid cells. These findings raised non-
exclusive hypothesis: that IFNγ-signalling may “equip” infected myeloid cells to kill the parasites 
more effectively and avoid cell-death (A. C. Stanley and C. R. Engwerda, 2007); IFNγ signalling 
could induce myeloid biased differentiation of haematopoietic progenitors, which was proposed in 
other models of infection (K. C. MacNamara et al., 2011b, A. M. de Bruin et al., 2012, K. A. 
Matatall et al., 2014). 
BM macrophages mediate the development of erythrocytes and the retention of HSCs in the BM, 
this was established in CD169-DTR mice expressing diphtheria toxin receptor (DTR) knocked in 
downstream of the endogenous CD169 promoter, which allowed to examine the specific role of 
BM macrophages in haematopoiesis, since CD169 in BM is specifically expressed in 
macrophages, but not in other myeloid cells. (A. Chow et al., 2011, A. Chow et al., 2013). In 
mice, the depletion of BM CD169+ macrophages leads to a substantial increase in the number of 
LSK Flt3-cells (enriched in HSCs) in circulation, and this enhanced mobilization of HSCs driven 
 179 
by the deletion of BM CD169+ macrophages correlated with the down-regulation in the gene 
expression of molecular mediators associated to HSCs retention within mesenchymal stromal 
cells (A. Chow et al., 2011). Moreover, the maturation of erythroid progenitors in BM takes place 
in special niches, the so-called erythroblastic islands, in which erythroblasts at various stages of 
development are found in close association with BM macrophages. In transgenic mice the 
deletion of BM CD169+ macrophages correlates with a dramatic reduction in the numbers of both 
F4/80+/Ter119+ islands, and erythroblasts in the BM, in addition to increased mobilization of 
erythroblasts to the circulation and the spleen (A. Chow et al., 2013). Given the important role of 
BM macrophages in haematopoiesis exemplified above, the alterations we observed in the 
myeloid compartment in the BM of chimeric mice WT:IFN-γRKO following L. donovani 
infection, it would be important to further assess the identity of BM myeloid cells (and expression 
of CD169), dissect their role in the establishment of haematopoietic dysfunction, and finally 
explore the significance of IFNγ signalling in these cells in the context of the alterations of 
haematopoiesis characterizing mice chronically infected with L. donovani. Moreover, it was 
recently reported in our laboratory that the frequency of myeloid cells CD169hi is decreased in the 
BM of B6 mice following L. donovani infection (O. Preham unpublished data). 
In the current study, we found that in mice chronically infected with L. donovani there was a 
significant increase in the level of TNF receptors (TNF-R1a or p55 and TNF-R1b or p75) 
expression in early haematopoietic progenitors including LT-HSCs, suggesting that these 
immature cells were responsive to the increase in pro-inflammatory cytokine availability in BM. 
These findings agree with previous studies reporting that TNF receptors expression is up-
regulated under conditions of stress-induced haematopoiesis, such as following transplantation 
(K. Mizrahi and N. Askenasy, 2014). 
In addition to IFNγ, changes in TNF levels of expression, both in BM and systemically have been 
reported in patients suffering from BMF syndromes (C. Dufour et al., 2001, C. Dufour et al., 
2003, W. Du et al., 2014). An important role for TNF mediating the establishment of 
haematopoietic dysfunction in patients suffering from Fanconi anaemia was proposed following 
the observation that the addition of anti-TNF fusion protein to cultures of BM cells from these 
patients was associated with an improvement in their potential to originate erythroid colonies in 
vitro (C. Dufour et al., 2003). Other in vitro studies, using human cells, defined TNF as a 
suppressor of haematopoiesis, for example the addition of TNF or IFNγ to total BM cultures 
results in a significant reduction of colony formation both from myeloid and erythroid lineages, 
however this inhibition was further increased by the combination of both cytokines, suggesting 
that TNF and IFNγ signalling may cooperate in the impairment of haematopoietic function (C. 
Selleri et al., 1995). Similar findings, reporting TNF as an inhibitor of haematopoiesis, were 
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produced in in vitro experiments conducted with murine cells (Y. Zhang et al., 1995, D. Bryder et 
al., 2001, C. J. H. Pronk et al., 2011). 
Nevertheless, other studies performed in vitro suggested that under specific contexts TNF might 
induce HSCs activation (H. W. Snoeck et al., 1996, M. T. Baldridge et al., 2011). For example, 
TNF in combination with IL-3 induced increased colony-formation activity of human BM CD34+ 
CD38- cells (enriched for HSCs), which was nearly absent in cultures supplemented with IL-3 
alone (H. W. Snoeck et al., 1996). In addition, it was reported that TNF acts synergistically with 
IL-3 and GM-CSF in the formation of colonies in vitro when added to the culture system in low 
concentration, but it had an antagonistic impact at high concentrations, suggesting that TNF 
impact in haematopoietic activity may be dosage-dependent (L. S. Rusten et al., 1994). 
Additionally, it was observed that the transfer of LSK cells pre-stimulated in vitro with TNF to 
lethally irradiated recipients correlated with impaired HSCs activity, since after a period of 14-18 
weeks, the level of reconstitution of these cells was very poor compared to control LSK cells 
culture in the same conditions without TNF, and the same was observed with donor cells deficient 
for Fas, suggesting that this cytokine has the potential to limit HSCs self-renewal activity 
independently of Fas pathway (D. Bryder et al., 2001). However, in another study carried out in a 
co-culture system, it was proposed that CD8+ cells through the release of TNF induce LSK 
expansion, and that these cells contribute to long-term engraftment (F. Rezzoug et al., 2008). 
Increased release of TNF was also described in mice infected with Ehrlichia muris (Y. Zhang et 
al., 2013) and in mice stimulated with Poly:IC (E. M. Pietras et al., 2014). Both of these 
inflammatory models display extensive expansion of LSK cells in BM. 
TNF plays a very important role in the establishment of an effective immune response to a wide 
variety of pathogens (J. J. Peschon et al., 1998, T. Ellerin et al., 2003), including L. donovani (C. 
R. Engwerda et al., 2004b). Despite the controversy regarding the role of TNF, either as inducer 
or inhibitor of haematopoietic activity, the present body of literature agrees that alterations of 
TNF expression impact haematopoietic function and in HSCs activity, and that the regulation of 
haematopoiesis by TNF should be a complex and context-dependent process (M. T. Baldridge et 
al., 2011, K. Mizrahi and N. Askenasy, 2014, N. Askenasy, 2015). 
In mice infected with L. donovani we found that the frequency of CD4+ T cells expressing TNF at 
increased levels was significantly expanded in the BM. Additionally, the expression of TNF can 
be also upregulated by myeloid population in pro-inflammatory condition (K. Matsui et al., 
2013). As such, we hypothesized that TNF could be acting directly on HSCs during experimental 
VL as a mediator of the activation of HSCs into active cell-cycle, and subsequent functional 
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impairment. Aiming to dissect the role of TNF receptor signalling during chronic VL, BM mixed 
chimeras were established with equal number of total BM cells derived from WT and TNF-RdKO 
(doubly deficient cells for TNF-R1a and TNF-R1b) into WT recipients (B6.CD45.1 : 
B6.CD45.2TNF-RdKO è B6.CD45.1), and therefore avoid confounding results due to the 
absence of TNF signalling in other cell populations.  
Similar to a previous study carried out by Pronk et al (C. J. H. Pronk et al., 2011), we 
demonstrated that lack of TNF receptor signalling constitutes a competitive advantage in the 
reconstitution of lethally irradiated recipients, which was reflected in a higher proportion of 
TNFR-dKO donor cells compared to WT donor cells, both in the BM and spleen of recipient 
mice. These analyses were performed after a period of 13 weeks, and at this time point it is 
expected that the vast majority of mature cells to be derived from donor HSCs.  
On the other hand, these findings contradict a study that proposed that intrinsic TNF signalling is 
required for long-term engraftment of BM donor cells into WT lethally irradiated recipients (M. 
Pearl-Yafe et al., 2010). In the study by Pearl-Yafe et al, the transplantation experiments were not 
performed in a competition with WT donor cells and it is therefore conceivable that TNF 
signalling in other cells beside HSCs is required to efficiently reconstitute the haematopoietic 
system (M. Pearl-Yafe et al., 2010).  
Importantly, we observed that following chronic infection with L. donovani the frequency of 
TNF-RdKO donor cells decreased in BM and in the spleen, in an opposite trend to the 
proportional increase observed the WT donor cells at both sites. This finding suggested that under 
the conditions established by infection with L. donovani, TNF signalling might contribute to the 
maintenance of the number of cells, both in the BM and spleen. 
In infected mice, we reported an expansion of the LSK cell compartment at the expense of a 
contraction Lin- cKit+ Sca- cells, both in WT and TNF-RdKO donor cells, suggesting that TNF 
receptor signalling is not required to the up-regulation of Sca1 in lineage-committed progenitors. 
Furthermore, the lack of TNF intrinsic signalling could not prevent the expansion of LSK CD150+ 
CD48+ cells (cell population onward LT-HSCs enriched in multipotent progenitors). Most 
importantly, there were no evidence that TNF acting directly of LT-HSCs was mediating the 
depletion of the reservoir of quiescent LT-HSCs, since a decline in the number of these cells were 
comparable between WT and TNF-RdKO donor cells in the BM of recipient mice during 
infection. 
As such, our findings excluded TNF as a direct mediator of loss of HSCs in G0. The higher 
proportion of donor cells deficient for TNF signalling, both in steady-state or following infection, 
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may be partially explained by the susceptibility of WT donor cells progeny to activation-induced 
cell death mediated by TNF signalling on competent donor cells (N. Askenasy, 2015), otherwise 
absent in TNF-RdKO donor cells. In agreement with this hypothesis, is the report that stimulation 
of LSK cells in culture with TNF leads to up-regulation of Fas in differentiated progeny, 
suggesting that differentiation leaves cells more vulnerable to apoptosis (D. Bryder et al., 2001). 
Our findings contrast with a study from Pronk et all, in which it was proposed that TNF signalling 
could directly mediate the loss of HSCs self-renewal in vivo under conditions of stress-induced 
haematopoiesis (C. J. H. Pronk et al., 2011). In this study, the potential of long-term 
reconstitution of HSCs lacking either one of the TNF receptors was enhanced compared to WT 
cells, and this was further enhanced when both TNF receptors were defective. Additionally, donor 
cells from mice subjected to myeloablation (induced by 5-Fluororacil administration) and then 
treated with TNF showed impaired ability to reconstitute the haematopoietic system following 
transfer to lethally irradiated recipients, in comparison to donor cells from myeloablated mice 
treated with PBS. These findings suggested that TNF acting upon both TNF receptors expressed 
on HSCs significantly impairs the maintenance of self-renewal potential (C. J. H. Pronk et al., 
2011).  
However, in a former study it was proposed that TNF-R1a is required to maintain HSCs self-
renewal potential following the observation that donor cells from older mice (>6 months) 
deficient for TNF-R1a display decreased reconstitution activity in comparison to those from age-
matched WT or TNF-R1b−/− donor mice (V. I. Rebel et al., 1999). The discrepancies between the 
above-cited works may be attributed to the age of the mice, suggesting that the impact of TNF 
signalling may suffer alterations across the lifetime of an individual. Nonetheless, despite the 
somewhat conflicting conclusion, these two studies performed in vivo agree that TNF is an 
important regulator of HSCs function in stress-induced conditions. 
In WT:TNF-RdKO mixed BM chimeric mice, we also evaluated the impact TNF signalling in the 
differentiation, of  lineage-committed progenitors and mature cells. In the steady-state, WT and 
TNF-RdKO mice progeny displayed comparable frequencies for all the lineage-committed 
progenitors assessed. Additionally, mice chronically infected displayed similar pattern of 
alterations between the two groups of donor cells. No major differences were found in the 
percentage of myeloid effector cells present in the spleen of recipient mice, segregated according 
with the expression of CD11c, CD11b and F4/80, both in steady-state or following infection. 
Moreover the lack of striking changes either in the percentages of myeloid progenitors or mature 
myeloid cells in mice infected with L. donovani suggested that in our model of infection, intrinsic 
TNF signalling is dispensable for the expansion of myeloid effector cells. 
 183 
Consistently with previous characterization of TNF-RdKO mice (J. J. Peschon et al., 1998), we 
found no indication that intrinsic TNF signalling was required for the development or sustenance 
of effector myeloid cells in basal conditions. Previous characterization of the mice lacking both 
receptors for TNF reported no signs that in steady-state TNF signalling was required to the 
development of T and B cells, which was assessed by flow cytometry in the thymus, spleen and 
mesenteric lymph node. Regarding others populations of leucocytes, the evaluation in histologic 
sections of spleen, mesenteric and inguinal lymph nodes did not reveal significant changes 
between WT and mutant mice (J. J. Peschon et al., 1998). Following infection with the bacteria 
Micropolyspora faeni, responsible for pulmonary infection characterized by high levels of TNF in 
the lungs, the frequency of lymphocytes and monocytes in the lung was comparable between WT 
mice, p55-/- mice, p75-/- and p55-/- p75-/- mice (J. J. Peschon et al., 1998).  
Nonetheless, in a model for acute infection using mice infected with pneumonia virus of mice 
(PVM), characterized by a specific increase in myeloid cells both in the BM and systemically, as 
well as an increase in myeloid progenitors in the BM, these features were prevented by the 
administration of anti-TNF mAbs, suggesting that in this model of infection TNF induces 
myelopoiesis under pro-inflammatory conditions (S. Maltby et al., 2014).  
In the current study the frequencies of overall T cells and CD4+ T cells deficient for TNF 
signalling were comparable in the BM, while in the spleen were decreased compared to those 
derived from WT donor cells, nonetheless their cell numbers were comparable at both sites in 
steady-state. These findings suggested that TNF receptor signalling did not provide a competitive 
advantage of WT T cells over TNF-RdKO T cells, arguing against impairment in the development 
or survival of T cells lacking TNF signalling. However, following infection with L. donovani, the 
deficiency in TNF signalling in T cells abolished their ability to expand in number in response to 
the presence of parasites, both in BM and in the spleen of recipient mice, otherwise greatly 
expanded within WT compartment. According to these findings, TNF acting directly on T cells 
and CD4+ T cells seems crucial to mediate their expansion and/or migration in mice infected with 
L. donovani.  
Rheumatoid arthritis (RA) is an autoimmune disease that ultimately results in the wastage of bone 
and cartilage. This affliction is driven by the production of autoantibodies in addition to the 
persistent inflammation of the synovial tissues. The chronic synovial inflammation is sustained by 
the presence of large infiltrates of leucocytes, amongst those CD4+ T cells were shown to be 
required to the establishment of disease (M. Mellado et al., 2015). TNF is crucial in RA, as 
proven by the effectiveness of TNF-signalling blocking agents in clinical contexts. It was reported 
that CD4+ T cells from RA patients; in transwell experiments migrate toward a TNF gradient, 
which was not observed in CD4+ T cells from controls. Subsequent experiments using blocking 
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antibodies demonstrated that the “migratory” potential of CD4+ T cells from RA patients depends 
on the expression of TNF-R1a, and this correlated to increased levels of intercellular adhesion 
molecule-1(ICAM-1) (M. Rossol et al., 2013). In mice, following LPS challenge in the absence of 
TNF-R1a mediated signalling there was a significant reduction in the number of lymphocytes 
found in the lungs airway (M. K. Oyoshi et al., 2007). These collection of findings suggested that 
TNF signalling is pivotal for the recruitment of T cells to sites of inflammation not only in 
autoimmune context but also under condition established by infection, and as such it is 
conceivable that in L. donovani chronic infection, TNF acting directly on T cells induces their 
recruitment to the BM, where through indirect mechanism they mediate alteration in 
haematopoiesis. Therefore, in future experiments it would be recommended to assess the 
expression of TNF receptors in T cells recovered from mice infected with L. donovani, and in vivo 
and in vitro to determine if they display aberrant migratory patterns.  
In addition to its role in the recruitment of cells to sites of inflammation, intrinsic TNF signalling 
has been implicated in the regulation of T cell development and survival during the course of the 
establishment of the immune response in experimental models of infection (A. Zganiacz et al., 
2004, E. Y. Kim et al., 2006). For example, in a study carried out to dissect the role of CD4+ and 
CD8+ T cell immune responses during Listeria monocytogenes infection, taking advantage of the 
availability well-characterized specific TCR transgenic systems for either MHC class I or MHC 
class II, it was reported that TNF receptor signalling plays a central role in T cell functions in 
mice infected with L. monocytogenes, a model widely used to study immune responses mediated 
by T cells following infection with intracellular bacteria (E. Y. Kim et al., 2006). The lack of 
TNF-R1b nearly abolish the expansion of CD4+ and CD8+ T cells in response to low 
concentrations of specific antigens, and even at high concentrations they expanded poorly 
compared to WT T cells, which was associated with a lower expression of anti-apoptotic 
mediators. Furthermore the absence of TNF-R1b signaling in CD4+ and CD8+ T cells extensively 
compromised the ability of T cells to express IFNγ following challenge with cognate antigen in 
vivo (E. Y. Kim et al., 2006). These findings suggested that TNF signalling under conditions 
established by infection with intracellular pathogens might be required to the development, 
expansion and survival of effector T cells. 
In contrast, other studies suggested that TNF was either not required or act as a suppressor in the 
expansion of T cells during the immune response to intracellular pathogens (M. I. Kafrouni et al., 
2003, A. Zganiacz et al., 2004). For example, the study of the role of TNF signalling in the 
development of T cell immune response during antiviral-immune responses in mice challenged 
with a replication-deficient β-galactosidase encoding recombinant adenovirus (AdCMV-lacZ), 
suggested that TNF signalling was dispensable to the expansion of CD8+ IFNγ+ T cells in mice 
deficient for the TNF receptors p55 or p75 (M. I. Kafrouni et al., 2003). This could be explained 
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by TNF receptor redundancy, since in TNF KO mice the expansion of these cells was limited 
compared to WT mice following infection (M. I. Kafrouni et al., 2003). Additionally, in TNF-
deficient mice infected with Mycobacterium bovis, it was reported that there is uncontrolled 
expansion of antigen-specific T cells expressing IFNγ, which depended on the expression of both 
TNF receptors to prevent the development of fatal immunopathology (A. Zganiacz et al., 2004). 
These above-mentioned examples embody the complexity of TNF signaling during immune 
response putting forward the requirement for studies in pathogen specific contexts and the risks 
associated anti-TNF therapies (T. Ellerin et al., 2003, X. Chen and J. J. Oppenheim, 2011). 
As such, we evaluated the impact of intrinsic TNF signaling in BM T cells potential to express 
IFNγ, during L. donovani infection. The lack of intrinsic TNF signalling limited over 30 times the 
expansion in BM CD4+ cells expressing IFNγ in chronically infected mice, and completely 
abrogated the expansion of BM CD8+ IFNγ+ T cells. The lack of CD4+ IFNγ+ T cells development 
from TNF-RdKO donor cells was evident not only in terms of the overall decrease in their cell 
numbers, but also their impaired efficiency to express IFNγ. Therefore, in our model of infection, 
TNF seems to be a crucial mediator in the development of functional T cells in the BM. However, 
to determine if TNF receptor signalling plays a pivotal role in the establishment of haematological 
dysfunction, it would be necessary to transfer CD4+ T cells TNF-RdKO to immunodeficient 
recipient mice and evaluate the alteration in haematopoietic progenitors within BM and 
haematological parameters in circulation, following the establishment of chronic infection with L. 
donovani. 
To our knowledge, this is the first study focusing on the factors modulating the alterations in BM 
haematopoiesis in experimental VL in B6 mice in vivo. In our model, we established that IFNγ 
produced by CD4+ T cells was sufficient to drive haematopoietic dysfunction, which was 
mirrored by the expansion of multipotent progenitors at the expense of quiescent LT-HSCs and 
the establishment of anaemia and thrombocytopenia. In addition, we determined that intrinsic 
IFNγ and TNF receptors signalling mediate the massive expansion of CD4+ T cells in BM of mice 
chronically infected with L. donovani. Furthermore, intrinsic TNF signalling in BM CD4+ T cells 
modulate their potential to produce IFNγ during chronic infection. As such, the collection of our 
findings suggested that TNF and IFNγ signalling pathway converge to induce the onset of 
impairment of haematopoietic function, during experimental VL.  
The pro-inflammatory mediators, IFNγ and TNF, are central players in the resolution of L. 
donovani infection, according to extensive studies carried in experimental models of disease (A. 
P. Taylor and H. W. Murray, 1997, P. M. Kaye et al., 2004). Therefore, directly targeting these 
molecules to prevent the establishment of dysfunctional haematopoiesis in the context of 
experimental VL would not be a viable option. However, we believe this study has paved new 
 186 
avenues for future studies aimed at isolating potential targets to prevent the onset of 
haematopoietic functional impairment, and consequent impact on morbidity, without 
compromising the parasite clearance following infection with L. donovani. 
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4.3 FIGURES 
 
Figure 4.1 - RAG2 KO mice do not lose quiescent HSCs following infection with L. 
donovani. (a) Number of LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs), LSK CD150+ 
CD34- CD48+ cells and LSK CD150+ CD34+ cells in bone marrow (BM). (b) Number of LSK 
CD150+ CD34- CD48- cells in G0 (Ki67-) in BM. (c) Spleen parasite burden presented as number 
of parasites per 1000 nuclei. (d) Spleen weight as percentage of body weight. Comparisons made 
between BM cells of wild-type (WT) B6 mice non-infected (n=12) and WT B6 mice infected 
(n=12) with L. donovani for 28 days or B6 RAG2 KO mice non-infected (n=9) and B6 RAG2 KO 
mice infected (n=13) with L. donovani for 28 days. Two femur and two tibias were used from 
each animal. Data from three independent experiments was presented as Mean ± SD; p values 
were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001. 
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Figure 4.2 - The number of HSPCs was increased in the spleen following infection with L. 
donovani. (a) Frequency of LSK, LSK CD150+ CD48- cells (enriched for LT-HSCs) and LSK 
CD150+ CD48+ cells in the spleen of naive mice (n=5) and infected mice (n=8), in two 
independent experiments. (b) Number of LSK, LSK CD150+ CD48- cells (enriched for LT-HSCs) 
and LSK CD150+ CD48+ cells in the spleen of naive mice (n=4) and infected mice (n=4), in one 
experiment. Comparisons were made between naive B6 mice and B6 mice infected with L. 
donovani for 28-35 days. Two femur and two tibias were used from each animal. Data was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05 and **p ≤0.01.  
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Figure 4.3 - The number of HSPCs was increased in spleen following infection with L. 
donovani. (a) Frequency of Lin- cKithi cells (enriched for haematopoietic progenitors), CMPs, 
GMPs, MEPs and CLPs cells in spleen of naive (n=5) and infected mice (n=8), determined in two 
independent experiments. (b) Number of Lin- cKithi cells, CMPs, GMPs, MEPs and CLPs cells in 
spleen of naive (n=4) and infected mice infected (n=4), determine in one experiment. 
Comparisons always made between naive mice and mice infected with L. donovani for 28-35 
days. Two femur and two tibias were used from each animal. Data was presented as Mean ± SD, p 
values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p 
≤0.001 and ****p ≤0.0001.  
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Figure 4.4 - Alterations in BM cellularity occurred independently from the processes taking 
place in the spleen. (a and b) Frequency and number LSK CD150+ CD48- CD34- cells (enriched 
for LT-HSCs) in G0 (Ki67-) in BM. (c and d) Frequency and number of non-committed 
progenitors (LSK CD150+ CD34- CD48- (enriched for LT-HSCs), LSK CD150+ CD34- CD48+ 
and LSK CD150+ CD34+ cells) in BM. (e and f) Frequency and number of lineage-committed 
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progenitor cells (CMPs, GMPs, MEPs and CLPs) in BM. (g and h) Frequency and number of 
mature haematopoietic cells B cells, CD4+ T cells, CD8+ T cells, CD4- CD8- CD3+ cells (DN T 
cells) and myeloid cells (CD11b+ cells) in BM. Comparisons were made between splenectomized 
(n=5) and “sham” (n=5) mice infected for 28 days with L. donovani. Data from one experiment 
was presented as Mean ± SD, p values were determined using Mann-Whitney: not significant 
(ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.5 - L. donovani infection lead to the expansion of T cell compartment in BM.  (a) 
Frequency of CD4+ T cells, CD8+ T cells and CD4- CD8- T (double negative (DN) T cells in bone 
marrow of naive mice and infected mice. (b) Number of CD4+ T cells, CD8+ T cells and DN T 
cells in bone marrow of non-infected mice and infected mice. (c) Representative dot plots of 
distribution of CD4+ T cells, CD8+ T cells and DN T cells within CD45+ CD3+ cells in bone 
marrow. Comparisons were made between naive mice (n=14) and mice infected (n=14) for 28 
days with L. donovani (Ld28). Two femur and two tibias were taken per animal. Data from four 
independent experiments was presented as Mean ± SD, p values were determined using unpaired t 
test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.6 - L. donovani infection was associated with the contraction of the B cell 
compartment in BM, during chronic phase of infection. (a) Frequency of B cells (CD45+ CD3- 
B220+ cells) in BM of non-infected mice and infected mice. (b) Number of B cells in BM of non-
infected mice and infected mice. Comparisons were made between naive mice (n=14) and mice 
infected (n=13) for 28 days with L. donovani (Ld28). Two femur and two tibias were taken per 
animal. Data from three independent experiments was presented as Mean ± SD, p values were 
determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001 
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Figure 4.7 - L. donovani infection was not associated with alterations in the number of total 
CD11b+ cells in BM. (a) Frequency of myeloid cells (CD45+ CD3- B220- CD11b+ cells) in BM of 
naive and infected mice. (b) Number of myeloid cells in BM of naive and infected mice. 
Comparisons were made between naive mice  (n=5) and mice infected (n=5) for 28 days with L. 
donovani (Ld28). Two femur and two tibias were used from each animal. Data from one 
experiment was presented as Mean ±SD, p values were determined using unpaired t test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001.  
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Figure 4.8 - L. donovani infection was associated with alterations in the number of MSCs in 
BM. (a) Diagram of gating strategy applied to select for stromal cells populations in BM. (b) 
Frequency of stromal cells (CD45- Ter119- cells), MSCs (CD45- Ter119- CD31- Sca1+ CD51+ 
cells), endothelial cells (CD45- Ter119- CD31+ cells) and osteoblastic lineage cells (CD45- 
Ter119- CD31- Sca1- CD51+ cells) in BM of naive and infected mice. (c) Number of stromal cells, 
MSCs, endothelial cells and osteoblastic lineage cells in BM of naive mice and infected mice. 
Comparisons were made between naive mice  (n=8) and mice infected (n=6) for 28 days with L. 
donovani (Ld28). Two femur and two tibias were taken per animal. Data from two independent 
experiments was presented as Mean ± SD, p values were determined using unpaired t test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. MSCs (mesenchymal 
stem cells), Endo (endothelial cells), Osteo (osteolineage cells), SSC (Side Scatter). 
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Figure 4.9 - L. donovani infection was not associated with alterations in the number of 
regulatory T cells in BM. (a) Frequency of CD4+ T cells and regulatory T cells (CD3+ CD4+ 
CD25hi FOXP3+ cells) in BM. (b) Number of CD4+ T cells and regulatory T cells in BM. (c) 
Frequency of CD4+ T cells and regulatory T cells in the spleen. (d) Number of CD4+ T cells and 
regulatory T cells in the spleen. Comparisons were made between naive mice (n=9) and mice 
infected (n=8) for 28 days with L. donovani (Ld28). Two femur and two tibias were used from 
each animal. Data from two independent experiments was presented as Mean ± SD, p values were 
determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001.  
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Figure 4.10 - The number of T cells CD62L-/low CD44high increased in the BM following L. 
donovani infection. (a) Frequency of total CD4+ T cells, and CD62Lhi CD44-/lo (naive), CD62L-/lo 
CD44-/lo (“effector”), CD62Lhi CD44hi (“central-memory”) and CD62L-/lo CD44hi (“effector-
memory”) CD4+ T cells in BM. (b) Number of total and CD4+ T cell subsets in BM. (c) 
Frequency of total CD8+ T cells, and CD62Lhi CD44-/lo (naive), CD62L-/lo CD44-/lo (“effector”), 
CD62Lhi CD44hi (“central-memory”) and CD62L-/lo CD44hi (“effector-memory”) CD8+ T cells in 
BM. (d) Number of total and CD8+ T cell subsets in BM. (e) Distribution of CD62Lhi CD44-/lo, 
CD62L-/lo CD44-/lo, CD62Lhi CD44hi and CD62L-/lo CD44hi cells within CD4+ T cells in the BM. 
(f) Distribution of CD62Lhi CD44-/lo, CD62L-/lo CD44-/lo, CD62Lhi CD44hi and CD62L-/lo CD44hi  
cells within CD8+ T cells in BM. (g) Representative dot plots of the expression of CD44 and 
CD62L in CD45+ CD3+ CD4+ cells in BM, from left to right: isotype control, naive mouse and 
infected mouse. Comparisons were made between naive mice (n=9) and mice infected (n=8) for 
28 days with L. donovani (Ld28). Two femur and two tibias were taken per animal. Data from 
two independent experiments was presented as Mean ± SD, p values were determined using 
unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. hi, 
high; lo, low. 
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Figure 4.11 - Following infection with L. donovani the number of CD4+ T cells CD62L-/lo 
CD44hi increased in the spleen. (a) Frequency of total CD4+ T cells, and CD62Lhi CD44-/lo 
(naive), CD62L-/lo CD44-/lo (“effector”), CD62Lhi CD44hi (“central-memory”) and CD62L-/lo 
CD44hi (“effector-memory”) CD4+ T cells in spleen. (b) Number of total and CD4+ T cell subsets 
in the spleen. (c) Frequency of total CD8+ T cells, and CD62Lhi CD44-/lo (naive), CD62L-/lo CD44-
/lo, CD62Lhi CD44hi (“central-memory”) and CD62L-/lo CD44hi (“effector-memory”) CD8+ T cells 
in spleen. (d) Number of total and CD8+ T cell subsets in spleen. (e) Distribution of CD62Lhi 
CD44-/lo, CD62L-/lo CD44-/lo, CD62Lhi CD44hi and CD62L-/lo CD44hi cells within CD4+ T cells in 
the spleen. (f) Distribution of CD62Lhi CD44-/lo, CD62L-/lo CD44-/lo, CD62Lhi CD44hi and CD62L-
/lo CD44hi cells within CD8+ T cells in spleen. (g) Representative dot plots of the expression of 
CD44 and CD62L in CD45+ CD3+ CD4+ cells in spleen, from left to right: isotype control, naive 
mouse and infected mouse. Comparisons were made between naive mice (n=9) and mice infected 
(n=8) for 28 days with L. donovani (Ld28). Data from two independent experiments was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. hi, high; lo, low.  
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Figure 4.12 - The number “Effector” CD4+ and CD8+ T cells increase in BM following L. 
donovani infection. (a) Number of total CD4+ CD44hi T cells, and CD44hi LyC6-/lo CD127-/lo 
(“effector”), CD44hi LyC6-/lo CD127hi, CD44hi LyC6hi CD127hi T cells (“memory”) and CD44hi 
LyC6hi CD127-/lo CD4+ T cell subsets in the BM. (b) Frequency within of total CD4+ T cells of 
CD44hi T cells, and CD44hi LyC6-/lo CD127-/lo (“effector”), CD44hi LyC6-/lo CD127hi, CD44hi 
LyC6hi CD127hi  (“memory”) and CD44hi LyC6hi CD127-/lo CD4+ T cell subsets in the BM. (c) 
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Number of CD8+ CD44hi T cells, CD44hi LyC6-/lo CD127-/lo (“effector”), CD44hi LyC6-/lo CD127hi, 
CD44hi LyC6hi CD127hi T cells (“memory”) and CD44hi LyC6hi CD127-/lo CD8+ T cell subsets in 
the BM. (d) Frequency within of total CD8+ T cells of CD44hi T cells, CD44hi LyC6-/lo CD127-/lo 
(“effector”), CD44hi LyC6-/lo CD127hi, CD44hi LyC6hi CD127hi T cells (“memory”) and CD44hi 
LyC6hi CD127-/lo CD8+ T cell subsets in the BM. (e) Representative dot plots of the expression of 
Ly6C and CD127 in CD45+ CD3+ CD4+ CD44+ cells and CD45+ CD3+ CD8+ CD44+ cells in BM: 
(middle left) isotype control, (top left) naive and (top right) infected gated in CD45+ CD3+ CD4+ 
CD44+ cells, (bottom left) naive mouse and (bottom right) infected mouse gated in CD45+ CD3+ 
CD8+ CD44+ cells. Comparisons were made between naive mice (n=9) and mice infected (n=8) 
for 28 days with L. donovani (Ld28). Data from two independent experiments was presented as 
Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p 
≤0.01, ***p ≤0.001 and ****p ≤0.0001. Two femur and two tibias were used from each animal. 
hi (high); lo (low). 
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Figure 4.13 - L. donovani infection was associated with an increase in the number of BM 
CD4+ T cells with potential for IFNγ expression. (a) Frequency of CD4+ T cells IFNγ+ and 
CD8+ T cells IFNγ+ in total BM upon in vitro stimulation. (b) Number of CD4+ T cells IFNγ+ and 
CD8+ T cells IFNγ+ upon in vitro stimulation. (c) Frequency of IFNγ+ cells within CD4+ T cells 
and CD8+ T cells following in vitro stimulation. (d) Mean of Fluorescence Intensity (MFI) of 
IFNγ in CD4+ T cells IFNγ+ and CD8+ T cells IFNγ+ following in vitro stimulation. (e) Frequency 
of IFNγ+ within CD4+ T cells and CD8+ T cells in ex vivo BM cells (not stimulated). (f) 
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Representative dot plots displaying frequencies of IFNγ expression within in CD45+ CD3+ CD4+ 
cells in BM: (top left) isotype control for IFNγ staining, (top center) naive mouse and (top right) 
infected upon in vitro stimulation with PMA/ionomycin, (bottom left) CD4+ T cells from (bottom 
right) naive and infected mice analyzed directly ex vivo. Comparisons were made between naive 
mice (n=9) and mice infected (n=9) for 28 days with L. donovani (Ld28). Two femur and two 
tibias were taken per animal. Data from three independent was presented as Mean ± SD, p values 
were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001. 
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Figure 4.14 - L. donovani infection was associated with increased number of BM CD4+ T 
cells with potential for TNF expression. (a) Frequency of CD4+ T cells TNF+ and CD8+ T cells 
TNF+ in total bone marrow following in vitro stimulation. (b) Number of CD4+ T TNF+ and CD8+ 
T TNF+ in total BM following in vitro stimulation. (c) Frequency of TNF+ cells within CD4+ T 
cells and CD8+ T cells following in vitro stimulation. (d) MFI of TNF in CD4+ T cells TNF+ and 
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CD8+ T cells TNF+ following in vitro stimulation. (e) Frequency of TNF+ cells within CD4+ T 
cells and CD8+ T cells determined in the absence of exogenous stimulation in BM. (f) 
Representative dot plots displaying frequencies TNF expression within in CD45+ CD3+ CD4+ 
cells in BM: (top left) isotype control for TNF staining, gated in CD4+ T cells from (top center) 
naive mouse and (top right) infected mouse upon in vitro stimulation, gated in CD4+ T cells from 
(bottom left) naive and infected analyzed in BM cells directly ex vivo Comparisons were made 
between naive mice (n=6) and mice infected (n=6) for 28 days with L. donovani (Ld28). Two 
femur and two tibias were taken per animal. Data from two independent was presented as Mean ± 
SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, 
***p ≤0.001 and ****p ≤0.0001.  
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Figure 4.15 - The number of BM CD4+ T cells with potential for IL-10 expression increased 
following L. donovani infection. (a) Frequency of CD4+ T cells IL-10+ and CD8+ T cells IL-10+ 
in total BM following in vitro stimulation. (b) Number of CD4+ T IL-10+ and CD8+ IL-10+ in BM 
following in vitro stimulation. (c) Frequency of IL-10+ cells within CD4+ T cells and CD8+ T cells 
following in vitro stimulation. (d) Mean of Fluorescence Intensity (MFI) of IL-10 in CD4+ T cells 
IL-10+ and CD8+ T cells IL-10+ following in vitro stimulation. (e) Frequency of IL-10+ cells 
within CD4+ T cells and CD8+ T cells in ex vivo bone marrow. (f) Representative dot plots 
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displaying frequencies of IL-10 expression within in CD45+ CD3+ CD4+ cells in BM: (top left) 
isotype control for IL-10 staining, gated in CD4+ T cells from (top center) naive mouse and (top 
center) infected mouse analyzed in BM cells upon in vitro stimulation, gated in CD4+ T cells from 
(bottom left) naive mouse and infected mouse analyzed in BM cells directly ex vivo. Comparisons 
were made between naive mice (n=9) and mice infected (n=9) for 28 days with L. donovani 
(Ld28). Two femur and two tibias were taken per animal. Data from three independent was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.16 - In BM the distribution of cells expressing TNF and/or IL-10 within CD4+ T 
cells IFNγ+ was unchanged following L. donovani infection. (a) Frequency of CD4+ T cells 
IFNγ+ expressing IL-10 and/or TNF following in vitro stimulation. (b) Frequency of CD8+ T cells 
IFNγ+ expressing IL-10 and/or TNF following in vitro stimulation. (f) Representative dot plots 
displaying frequencies of IL-10 and TNF expression within in CD45+ CD3+ CD4+ IFNγ+ cells in 
BM: (top left) Isotype control for TNF and IL-10 staining, gated in CD4+ T cells IFNγ+ from (top 
right) naive mouse and (bottom) infected mouse, analysis performed in BM upon in vitro 
stimulation. Comparisons were made between naive mice (n=6) and mice infected (n=6) for 28 
days with L. donovani (Ld28). Two femur and two tibias were taken per animal. Data from two 
independent was presented as Mean ± SD, p values were determined using unpaired t test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.17 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during the chronic infection with L. donovani (1). Following L. donovani 
infection, proliferating LT-HSCs and onward multipotent progenitors expand greatly at the 
expense of LT-HSCs in G0. The accumulation of intermediary multipotent progenitors was not 
associated with an increase in effective haematopoietic activity, since the numbers of effector 
haematopoietic cells were found either decreased or unchanged in PB. BM CD4+ T cells numbers 
greatly increase following infection and displayed immunophenotypic and functional alterations, 
suggesting that BM CD4+ T cell may act underlie haematological impairment. 
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Figure 4.18 - CD4+ T cells mediated expansion of intermediary non-committed progenitors 
onward LT-HSCs in BM following L. donovani infection. Frequency in Lineage negative cells of 
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(a) LSK cells, (b) LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs), (c) LSK CD150+ 
CD34- CD48+ cells and (d) LSK CD150+ CD34+ cells. Number of (e) LSK cells, (f) LSK CD150+ 
CD34- CD48- cells (enriched for LT-HSCs), (g) LSK CD150+ CD34- CD48+ cells and (h) LSK 
CD150+ CD34+ cells. Comparisons were made with BM cells recovered from B6 wild-type (WT) 
(n=12), B6 WT infected with LV9 for 28 days (Ld28) (n=12), B6 RAG2 knockout (KO)(lacking 
B and T cells) naive (n=12), RAG2KO B6 infected (n=17) and RAG2KO B6 infected inoculated 
with CD4+ T cells purified from spleen of naive WT mice (n=13). Two femur and two tibias were 
taken per animal. In each bar, data from at leat three independent experiments was presented as 
Mean ± SD, p values were determined using One-way Anova followed by Tukey’s multiple 
comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001.  
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Figure 4.19 - CD4+ T cells mediated the loss of HSCs in G0 in BM, following infection with 
L. donovani. (a) Frequency within Lineage negative cells of LSK CD150+ CD34- CD48- Ki67 cells 
(enriched for LT-HSCs in G0). (b) Number of LSK CD150+ CD34- CD48- Ki67- cells. (c) 
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Frequency of Ki67- cells within LSK CD150+ CD34- CD48- cells. (d) Representative dot plots of 
Ki67 expression within LSK CD150+ CD34- CD48- cells: (top left) isotype control for Ki67 
staining gated in LSK cells, (middle left) WT naive mouse, (middle right) WT infected mouse, 
(bottom left) RAG2 KO naive mouse, (bottom) centre RAG2 KO infected mouse and (bottom 
right) RAG2 KO mouse transplanted with CD4+ T cells prior to infected. Comparisons were made 
with BM cells recovered from B6 WT mice (n=12), B6 WT mice infected with L. donovani for 28 
days (Ld28) (n=12), B6 RAG2KO mice naive (lacking B and T cells) (n=9), RAG2KO B6 
infected mice (n=14) and RAG2KO B6 infected mice inoculated with CD4+ T cells purified from 
spleen of naive WT mice (n=13). Two femur and two tibias were taken per animal. In each bar, 
data from three independent experiments was presented as Mean ± SD, p values were determined 
using One-way Anova followed by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.20 - CD4+ T cells did mediate alteration in the number of myeloid-committed 
progenitors, following infection with L. donovani. (a) Frequency of Lineage negative cells 
(enriched for all HSPCs). (b) Frequency in Lineage negative cells. Frequency within Lineage negative 
cells of (c) CMPs, (d) GMPs, (e) MEPs and (f) CLPs. Number of (g) CMPs, (h) GMPs, (i) MEPs 
and (j) CLPs. Comparisons were made with BM cells recovered from B6 Wild Type (WT) (n=8), 
B6 WT mice infected with L. donovani for 28 days (Ld28) (n=8), B6 RAG2KO mice naive 
(lacking B and T cells) (n=7), RAG2KO B6 infected mice (n=12) and RAG2KO B6 infected mice 
inoculated with CD4+ T cells purified from spleen of naive WT mice (n=13). Two femur and two 
tibias were taken per animal. In each bar, data from at least two independent experiments was 
presented as Mean ± SD, p values were determined using One-way Anova followed by Tukey’s 
multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p 
≤0.0001. Common-myeloid progenitors (CMPs); Granulocyte-macrophage progenitors (GMPs); 
Megakaryocyte-erythrocyte progenitors (MEPs); Common lymphocyte progenitors (CLPs).  
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Figure 4.21 - The transfer of CD4+ T cells to naive RAG2 KO mice was not associated to 
alteration in the number of HSPCs in BM. (a) Number of LSK cell, LSK CD150+ CD34- 
CD48- cells (enriched for LT-HSCs), LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ 
cells. (b) Frequency within Lineageneg cells of LSK CD150+ CD34- CD48- Ki67- cells. (c) Number 
of CMPs, GMPs, MEPs and CLPs. Comparisons were made with BM cells recovered from naive 
B6 RAG2KO mice (n=5), and naive B6 RAG2KO mice infected inoculated with CD4+ T cells 
purified from spleen of naive WT mice (n=5). Two femur and two tibias were taken per animal. 
Data from one experiment was presented as Mean ± SD, p values were determined using unpaired 
t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001.  
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Figure 4.22 - CD4+ T cells mediate the establishment of mild anaemia and 
thrombocytopenia following infection with L. donovani. (a) Concentration of red blood cells 
(RBC) in peripheral blood (PB). (b) Concentration of platelets (PLT) in PB. (c) PB hematocrit 
(HCT). (d) Concentration of haemoglobin (Hb) in PB. Values were determined in whole blood 
collected in EDTA using an automated system for blood cell counting (Hemavet). Comparisons 
were made with PB recovered from B6 Wild Type (WT) (n=8), B6 WT infected with LV9 for 28 
days (Ld28) (n=8), B6 RAG2KO (n=6), RAG2KO B6 infected (n=9) and RAG2KO B6 infected 
inoculated with CD4+ T cells purified from spleen of naive WT mice (n=8). Two femur and two 
tibias were taken per animal. Data from two independent experiments was presented as Mean ± 
SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, 
***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.23 - CD4+ T cells do not induce anaemia and thrombocytopenia in naive RAG2 KO 
mice. (a) Concentration of red blood cells (RBC) in peripheral blood (PB). (b) Concentration of 
platelets (PLT) in PB. (c) Concentration of haemoglobin (Hb) in PB. (d) PB hematocrit (HCT). 
Values were determined in whole blood collected in EDTA, using an automated system for blood 
cell counting (Hemavet). Comparisons were made with PB recovered naive B6 RAG2KO mice 
(n=5) and naive B6 RAG2KO mice inoculated with CD4+ T cells purified from spleen of naive 
WT mice for 28 days (n=5). Data from one experiment was presented as Mean ± SD, p values 
were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001. 
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Figure 4.24 - CD4+ T cells mediated control of parasite burden during chronic infection with 
L. donovani in immunodeficient mice. (a) Parasites per 1000 nuclei in the spleen. (b) Spleen 
weight as percentage of body weight. Comparisons were made between B6 WT mice (n=8) and 
infected B6 RAG2KO mice (n=9), or between B6 RAG2KO infected mice and RAG2KO B6 
infected mice inoculated with CD4+ T cells purified from spleen of naive WT mice (n=9). All 
mice were infected with L. donovani for 28 days. Data from two independent experiments was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.25 - Adoptively transferred CD4+ T cells expand in infected RAG2 recipients and 
displayed a phenotype similar to BM CD4+ T cells of infected WT mice. (a) Number of CD4+ 
T cells, CD4+ T cells CD44hi and CD4+ T cells CD44lo cells. (b) Number of CD4+ CD44hi LyC6-/lo 
CD127-/lo T cells (“effector” T cells), CD4+ CD44hi LyC6-/lo CD127hi T cells, CD4+ CD44hi LyC6hi 
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CD127hi T cells (“memory” T cells) and CD4+ CD44hi LyC6hi CD127-/lo T cells in the bone 
marrow of naive and infected mice. (c) Frequency within of total CD4+ T cells of CD44hi, CD44hi 
LyC6-/lo CD127-/lo T cells (“effector” T cells), CD44hi LyC6-/lo CD127hi T cells, CD44hi LyC6hi 
CD127hi T cells (“memory” T cells) and CD44hi LyC6hi CD127-/lo CD4+ T cells. Comparisons 
were made between naive B6 WT mice (n=4) and infected B6 WT mice, or between naive 
RAG2KO inoculated with CD4+ T cells purified from spleen of naive WT mice (n=5) and 
infected RAG2KO inoculated with CD4+ T cells purified from spleen of naive WT mice (n=5). 
Mice were infected with L. donovani for 28 days (Ld28). Two femur and two tibias were taken 
per animal. Data from one experiments was presented as Mean ± SD, p values were determined 
using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
 
 
 
 223 
 
Figure 4.26 - CD4+ T cells through an IFNγ-dependent mechanism mediated the expansion 
of intermediary multipotent progenitors following infection with L. donovani. (a) Frequency 
in Lineage- cells of LSK cells, LSK CD150+ CD34- CD48- cells (enriched for LT-HSCs), LSK 
CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells. (b) Frequency within Lineage- cells of 
Lineage negative cKit+ cells, CMPs, GMPs, MEPs and CLPs. Comparisons were made between, B6 
RAG2KO infected mice (n=4), B6 RAG2KO infected mice inoculated with CD4+ T cells purified 
from spleen of naive WT mice (n=4), and B6 RAG2KO infected mice inoculated with CD4+ T 
cells purified from spleen of naive IFNγ KO mice (n=5), all mice were infected with L. donovani 
for 28 days (Ld28). Data from one experiment was presented as Mean ± SD, p values were 
determined using One-way Anova followed by Tukey’s multiple comparisons test: not significant 
(ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.27 - CD4+ T cells through an IFNγ-dependent mechanism mediated the loss of 
HSCs in G0 following infection with L. donovani. (a) Frequency within Lineage negative cells of 
LSK CD150+ CD34- CD48- Ki67 cells (enriched for LT-HSCs in G0). (b) Number of LSK 
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CD150+ CD34- CD48- Ki67- cells. (c) Frequency of Ki67- cells within LSK CD150+ CD34- CD48- 
cells. (d) Representative dot plots of Ki67 expression within LSK CD150+ CD34- CD48- cells: 
(top left) isotype control for Ki67 staining gated in Lineage negative cells, (bottom left) RAG2KO 
mouse infected, (bottom centre) RAG2KO mouse infected transplanted with WT CD4+ T cells, 
(bottom) right RAG2KO mouse infected transplanted with IFNγKO CD4+ T cells. Comparisons 
were made between, RAG2KO mice infected (n=3), RAG2KO mice infected inoculated with 
CD4+ T cells purified from spleen of naive WT mice (n=4), and RAG2KO mice infected 
inoculated with CD4+ T cells purified from spleen of naive IFNγKO mice (n=5), all mice were 
infected with L. donovani for 28 days (Ld28). Two femur and two tibias were taken per animal. 
Data from one experiment was presented as Mean ± SD, p values were determined using unpaired 
t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
 
 
 226 
 
Figure 4.28 - CD4+ T cells through an IFNγ-dependent mechanism mediated the 
establishment of anaemia and thrombocytopenia following infection with L. donovani. (a) 
Concentration of red blood cells (RBC) in peripheral blood (PB). (b) Concentration of 
haemoglobin (Hb) in PB. (c) Hematocrit (HCT) in PB. (d) Concentration of platelets (PLT) in PB. 
Values were determined in whole blood collected in EDTA, using an automated system for blood 
cell counting (Vet abc Plus+). Comparisons were made between, RAG2KO infected mice (n=3), 
RAG2KO infected mice inoculated with CD4+ T cells purified from the spleen of naive WT mice 
(n=4), and RAG2KO mice infected inoculated with CD4+ T cells purified from the spleen of naive 
IFNγKO mice (n=5), mice were infected with L. donovani for 28 days (Ld28). Data from one 
experiment presented as Mean ± SD, p values were determined using One-way Anova followed 
by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001 
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Figure 4.29 - CD4+ T cells through an IFNγ-dependent mechanism mediated decrease in 
parasites/1000 nuclei in the spleen following infection with L. donovani. (a) Parasites per 1000 
nuclei in the spleen. (b) Spleen weight as percentage of body weight. Comparisons were made 
between, RAG2KO mice infected (n=3), RAG2KO mice infected inoculated with CD4+ T cells 
purified from the spleen of naive WT mice (n=4), and RAG2KO mice infected inoculated with 
CD4+ T cells purified from the spleen of naive IFNγKO mice (n=5), mice were infected with L. 
donovani for 28 days (Ld28). Data from one experiment presented as Mean ± SD, p values were 
determined using One-way Anova followed by Tukey’s multiple comparisons test: not significant 
(ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.30 - Following transfer of CD4+ T cells to RAG2KO mice infected with L. donovani 
for 28 days, WT CD4+ T cells and IFNγ KO CD4+ T cells expanded at similar extent and 
displayed an “activated” phenotype. (a) Number of CD4+ T cells, CD4+ T cells CD44hi and 
CD4+ T cells CD44lo cells. (b) Number of CD4+ T CD44hi LyC6-/lo CD127-/lo (“effector” T cells), 
CD4+ T CD44hi LyC6-/lo CD127hi, CD4+ T CD44hi LyC6hi CD127hi (“memory” T cells) and CD4+ 
T CD44hi LyC6hi CD127-/lo in BM. (c) Frequency within of Total CD4+ T cells of CD44hi cells, 
0
2
4
6
8
10
20
40
60
80
100
Fr
eq
ue
nc
y 
w
ith
in
 C
D
4+
 T
 c
el
ls
 in
 b
on
e 
m
ar
ro
w
 
CD44 hi 
Ly6C -/lo 
CD127 -/lo
CD44 hi 
Ly6C hi 
CD127 -/lo
CD44 hi 
Ly6C -/lo 
CD127 hi
CD44 hi 
Ly6C hi 
CD127 hi
** * **ns
0
100000
200000
300000
400000
500000
1000000
2000000
3000000
4000000
N
um
be
r o
f c
el
ls
  i
n 
bo
ne
 m
ar
ro
w
 
CD4+ T cells CD44 -/lo CD44 hi 
CD4+ T cells
RAG2KO + CD4+ T cells WT Ld28
RAG2KO + CD4+ T cells  IFNγKO Ld28 
ns ns ns
0
20000
40000
60000
80000
100000
500000
1500000
2500000
3500000
4500000
N
um
be
r o
f c
el
ls
  i
n 
bo
ne
 m
ar
ro
w
 
CD44 hi 
Ly6C -/lo 
CD127 -/lo
CD44 hi 
Ly6C hi 
CD127 -/lo
CD44 hi 
Ly6C -/lo 
CD127 hi
CD44 hi 
Ly6C hi 
CD127 hi
CD4+ T cells
ns ns ns ns
a
b
c
 229 
CD44hi LyC6-/lo CD127-/lo, CD44hi LyC6-/lo CD127hi, CD44hi LyC6hi CD127hi and CD44hi LyC6hi 
CD127-/lo cells CD4+ T cells. Comparisons were made between, RAG2KO mice infected (n=3), 
RAG2KO mice infected inoculated with CD4+ T cells purified from the spleen of naive WT mice 
(n=4), and RAG2KO mice infected inoculated with CD4+ T cells purified from the spleen of naive 
IFNγKO mice (n=5), mice were infected with L. donovani for 28 days (Ld28). Two femur and 
two tibias were taken per animal. Data from one experiment presented as Mean ± SD, p values 
were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01 and ***p ≤0.001. 
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Figure 4.31 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during chronic infection with L. donovani (2). Following L. donovani infection 
LT-HSCs and onward multipotent progenitors expand greatly at the expense of LT-HSCs in G0. 
The accumulation of intermediary multipotent progenitors was not associated to an increase in 
effective haematopoietic activity, since the numbers of effector haematopoietic cells were found 
either decreased or unchanged in circulation. These alterations could be solely mediated by the 
transfer CD4+ T cells IFNγ+, but not by CD4+ T cells deficient for IFNγ expression, following 
transfer to L. donovani-infected immunodeficient mice, which are otherwise protected from 
impairment of haematological function. As such, IFNγ was defined as a critical modulator of 
haematopoiesis during chronic infection with L. donovani. As LT-HSCs express receptors for this 
pro-inflammatory cytokine, we hypothesized that IFNγ could act directly on the activation of LT-
HSCs into active cell-cycle, following infection.  
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Figure 4.32 - Experimental design for competitive mixed bone marrow chimeras using wild-
type (WT) and IFNγR2 knockout (IFNγR2 KO). Total unfractioned BM cells from WT 
(CD45.1) and IFNγR2 KO (CD45.2) mice were transferred in equal number into lethally 
irradiated recipients (CD45.1). Following eight weeks recipient mice were infected for 28 days 
with L. donovani, and haematopoietic reconstitution activity was assessed both in BM and in the 
spleen. 
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Figure 4.33 - The reconstitution potential of WT HSCs and IFNγR2−/− HSCs was similar in 
infected mixed BM chimeras. (a) Frequency of donor cells in BM. (b) Number of donor cells in 
BM. (c) Frequency of donor cells in spleen. (d) Number of donor cells in spleen. (e) 
Representative dot plots of frequency of donor cells in BM live cells; (left) isotype control, 
(centre) naive recipient and (right) infected recipient. Analyses were performed 12 weeks after 
transplant of total BM cells from CD45.2 IFNγR2−/− mice and CD45.1 WT mice (50:50) to 
lethally irradiated CD45.1 recipient mice. Comparisons were made within donor compartment 
between non-infected recipients (n=8) and recipient mice infected with L. donovani for 28 days 
(Ld28) (n=8). Two femur and two tibias were taken per animal. Data from two independent 
experiments was presented as scatter plot and mean bar. p values were determined using One-way 
Anova followed by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, 
***p ≤0.001 and ****p ≤0.0001.   
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Figure 4.34 - The frequency of Lin- cKit+ Sca1- cells was decreased in the WT but not 
IFNγR2−/− donor cells, following infection with L. donovani. (a) Frequency of LSK cells and 
Lin- cKit+ Sca1- cells within donor cells in BM. (b) Number of LSK cells and Lin- cKit+ Sca1- 
cells within donor cells in BM.(c) Frequency of LSK cells and Lin- cKit+ Sca1- cells within donor 
cells in the spleen. (d) LSK cells and Lin- cKit+ Sca1- cells within donor cells in the spleen. (e) 
Representative dot plots of the frequency of LSK cells and Lin- cKit+ Sca1- cells within donor Lin- 
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cells in BM; (top left) isotype control gated in Lin- cells, (top centre) naive recipient gated in WT 
donor Lin- cells, (top right) infected recipient gated in WT donor Lin- cells, (bottom left) naive 
recipient gated in IFNγR2−/− Lin- donor cells, (bottom right) infected recipient gated in IFNγR2−/− 
Lin- donor cells. Analysis performed 12 weeks after transplant of total BM cells from CD45.2 
IFNγR2−/− mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. 
Comparisons were made within donor compartment between non-infected recipients (n=8) and 
recipient mice infected with L. donovani for 28 days (Ld28) (n=8). Two femur and two tibias 
were taken per animal. Data from two independent experiments was presented as scatter plot and 
mean bar, p values were determined using One-way Anova followed by Tukey’s multiple 
comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.35 - L. donovani infection was associated with an increase in intermediary non-
committed progenitors within WT and IFNγR2−/− donor cells. (a) Frequency of LSK CD150+ 
CD48- cells (enriched for LT-HSCs) and LSK CD150+ CD48+ cells within donor cells in BM. (b) 
Number of LSK CD150+ CD48- cells and LSK CD150+ CD48+ cells in BM. (c) Frequency of 
LSK CD150+ CD48- cells (enriched for LT-HSCs) and LSK CD150+ CD48+ cells within donor 
cells in spleen. (d) Number of LSK CD150+ CD48- cells and LSK CD150+ CD48+ cells within 
donor cells in spleen. Analyses were performed 12 weeks after transplant of total BM cells from 
CD45.2 IFNγR2−/− mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient 
mice. Comparisons were made within donor compartment between non-infected recipients (n=8) 
and recipient mice infected with L. donovani for 28 days (Ld28) (n=8). Two femur and two tibias 
were taken per animal. Data from two independent experiments was presented as scatter plot and 
mean bar, p values were determined using One-way Anova followed by Tukey’s multiple 
comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.36 –The number of myeloid progenitors in BM was unchanged within WT and 
IFNγR2−/− donor cells, following L. donovani infection. (a) Frequency of lineage-committed 
progenitor cells (CMPs, GMPs, MEPs and CLPs) in BM. (b) Number of lineage-committed 
progenitor cells (CMPs, GMPs, MEPs and CLPs) in BM. (c) Frequency of lineage-committed 
progenitor cells (CMPs, GMPs, MEPs and CLPs) in the spleen. (d) Number of lineage-committed 
progenitor cells (CMPs, GMPs, MEPs and CLPs) in the spleen. Analyses were performed 12 
weeks after transplant of total BM cells from CD45.2 IFNγR2−/− mice and CD45.1 WT mice 
(50:50) to lethally irradiated CD45.1 recipient mice. Comparisons were made within donor 
compartment between non-infected recipients (n=4) and recipient mice infected with L. donovani 
for 28 days (Ld28) (n=4). Two femur and two tibias were taken per animal. Data from two 
independent experiments was presented as scatter plot and mean bar, p values were determined 
using One-way Anova followed by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.37 - The absence of direct IFNγ signaling in LT-HSCs did not prevent the depletion 
of the reservoir of quiescent HSCs, following L. donovani infection. (a) Frequency of LSK 
CD150+ CD48- cells (enriched for LT-HSCs) in G0 (Ki67-) within donor cells in BM. (b) Number 
of LSK CD150+ CD48- cells in G0 (Ki67-) in BM. (c) Representative dot plots of Ki67 
expression; (top left) isotype control gated in LSK cells, (top centre) naive recipient gated in WT 
donor LSK CD150+ CD48- cells, (top right) naive recipient gated in IFNγR2−/− donor LSK 
CD150+ CD48- cells, (bottom left) infected recipient gated in WT donor LSK CD150+ CD48- 
cells, (bottom right) infected recipient gated in IFNγR2−/− donor LSK CD150+ CD48- cells. 
Analyses were performed 12 weeks after transplant of total BM cells from CD45.2 IFNγR2−/− 
mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. Comparisons 
were made within donor compartment between non-infected recipients (n=6) and recipient mice 
infected with L. donovani for 28 days (Ld28) (n=6). Two femur and two tibias were taken per 
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animal. Data from two independent experiments was presented as scatter plot and mean bar, p 
values were determined using One-way Anova followed by Tukey’s multiple comparisons test: 
not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.38 - In the absence of intrinsic IFNγ signaling the expansion of T cells was limited 
in BM of mice infected with L. donovani.  (a) Frequency of T cells and B cells within donor 
cells in BM. (b) Number of donor T cells and B cells in BM. (c) Frequency of T cells and B cells 
within donor cells in the spleen. (d) Number of donor T cell and B cells in the spleen. Analyses 
were performed 12 weeks after transplant of total BM cells from CD45.2 IFNγR2−/− mice and 
CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. Comparisons were made 
between non-infected recipients (n=4) and recipient mice infected with L. donovani for 28 days 
(Ld28) (n=4). Two femur and two tibias were taken per animal. Data from one experiment was 
presented as scatter plot and mean bar, p values were determined using One-way Anova followed 
by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001. 
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Figure 4.39 - The absence of direct IFNγ signaling limited the expansion of macrophages in 
BM and spleen in mice infected with L. donovani.  (a) Frequency of CD11chi MHC-IIhi cells, 
CD11b- F4/80hi cells, CD11b+ F4/80hi cells and CD11b+ F4/80- cells within donor cells in BM. (b) 
Number of donor CD11chi MHC-IIhi cells, CD11b- F4/80hi cells, CD11b+ F4/80hi cells and 
CD11b+ F4/80- cells in BM. (c) Frequency of CD11chi MHC-IIhi cells, CD11b- F4/80hi cells, 
CD11b+ F4/80hi cells and CD11b+ F4/80- cells within donor cells in the spleen. (d) Number of 
donor CD11chi MHC-IIhi cells, CD11b- F4/80+ cells, CD11b+ F4/80+ cells and CD11b+ F4/80- 
cells in the spleen. Analyses were performed 12 weeks after transplant of total BM cells from 
CD45.2 IFNγR2−/− mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient 
mice. Comparisons were made within donor compartment between non-infected recipients (n=4) 
and recipient mice infected with L. donovani for 28 days (Ld28) (n=4). Two femur and two tibias 
were taken per animal. Data from one experiment was presented as scatter plot and mean bar, p 
values were determined using One-way Anova followed by Tukey’s multiple comparisons test: 
not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.40 - The number of HSPCs (enriched in Lineage- cKit+ cells) expressing TNF-R1a 
in BM increased L. donovani following infection. (a) Frequency of CD45+ Lineage+ cells 
(mature haematopoietic cells) TNF-R1a+ and Lineage- cKit+ cells (enriched for all HSPCs) TNF-
R1a+ in total BM cells. (b) Number of CD45+ Lineage+ TNF-R1a+ cells and Lineage- cKit+ TNF-
R1a+ cells. Comparisons were made between naive mice (n=5) and mice for 28 days with L. 
donovani (n=5). Two femur and two tibias were taken per animal. Data from one experiment was 
presented as Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 
0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.41 - The number of LT-HSCs and onward multipotent progenitors expressing 
TNF-R1a increased following L. donovani infection. (a) Frequency of LSK CD150+ CD34- 
CD48- cells (enriched for LT-HSCs), LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ 
cells expressing TNF-R1a in total BM cells. (b) Number of LSK CD150+ CD34- CD48- cells, 
LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells expressing TNF-R1a. (c) Mean 
intensity fluorescence (MFI) of TNF-R1a in LSK CD150+ CD34- CD48- cells (enriched for LT-
HSCs), LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells expressing TNF-R1. (c) 
Representative histogram of TNF-R1a expression on LSK CD150+ cells. Comparisons were made 
between naive mice (n=5) and mice for 28 days with L. donovani (n=5). Two femur and two 
tibias were taken per animal. Data from one experiment was presented as Mean ± SD, p values 
were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and 
****p ≤0.0001. 
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Figure 4.42 - The number of HSPCs (enriched in Lineage- cKit+ cells) expressing TNF-R1b 
increased following L. donovani infection. (a) Frequency of CD45+ Lineage+ cells TNF-R1b+ 
(mature haematopoietic cells) and Lineage- cKit+ cells (enriched for all HSPCs) TNF-R1b+ in total 
BM cells. (b) Number of CD45+ Lineage+ TNF-R1b+ cells and Lineage- cKit+ TNF-R1b+ cells. 
Comparisons were made between naive mice (n=5) and mice for 28 days with L. donovani (n=5). 
Two femur and two tibias were taken per animal. Data from one experiment was presented as 
Mean ± SD, p values were determined using unpaired t test: not significant (ns), *p ≤ 0.05, **p 
≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.43 - The number of LT-HSCs and onward multipotent progenitors expressing 
TNF-R1b increased following L. donovani infection. (a) Frequency of LSK CD150+ CD34- 
CD48- cells (enriched for LT-HSCs), LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ 
cells expressing TNF-R1b in total BM cells. (b) Number of LSK CD150+ CD34- CD48- cells 
(enriched for LT-HSCs), LSK CD150+ CD34- CD48+ cells and LSK CD150+ CD34+ cells 
expressing TNF-R1b. (c) Mean intensity fluorescence (MFI) of TNF-R1b expression on LSK 
CD150+ CD34- CD48- cells (enriched for LT-HSCs), LSK CD150+ CD34- CD48+ cells and LSK 
CD150+ CD34+ cells expressing TNF-R1b. (c) Representative histogram of TNF-R1b expression 
on LSK CD150+ cells. Comparisons were made between naive mice (n=5) and mice for 28 days 
with L. donovani (n=5). Two femur and two tibias were taken per animal. Data from one 
experiment was presented as Mean ± SD, p values were determined using unpaired t test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.44 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during the chronic infection with L. donovani (3). Following L. donovani 
infection proliferating LT-HSCs and onward multipotent progenitors expand greatly at the 
expense of LT-HSCs in G0. The accumulation of intermediary multipotent progenitors was not 
associated with an increase in effective haematopoietic activity, since the numbers of effector 
haematopoietic cells were found either decreased or unchanged in PB. CD4+ T cells could solely 
mediate these alterations through an IFNγ-dependent mechanism following transfer to L. 
donovani infected immunodeficient mice, otherwise protected from impairment of haematological 
function. The impact of IFNγ was not directly mediated through IFNγ receptor signalling in LT-
HSCs. In the BM of chronically infected mice, CD4+ T cells expressed increased levels of TNF, 
and LT-HSCs expressed increased levels of TNF receptors, being therefore conceivable that TNF 
could act directly modulating LT-HSCs proliferative status in mice chronically infected with L. 
donovani. 
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Figure 4.45 - Experimental design for competitive mixed BM chimeras using wild-type 
(WT) and TNF-R double knockout (TNF-RdKO HSCs) BM cells. Total unfractioned BM cells 
from WT (CD45.1) and TNF-RdKO (CD45.2) mice were transferred in equal number into lethally 
irradiated recipients (CD45.1). Following nine weeks recipient mice were infected for 28 days 
with L. donovani, and haematopoietic reconstitution activity was assessed both in BM and in the 
spleen. 
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Figure 4.46 - The reconstitution potential of WT HSCs and TNF-RdKO donor cells changed 
following infection with L. donovani. (a) Frequency of donor cells in BM and in the spleen. (b) 
Number of donor cells in BM and in the spleen. (c) Representative dot plots of frequency of donor 
cells in gated BM live cells; (left) isotype control, (centre) naive recipient and (right) infected 
recipient. Analysis performed 13 weeks after transplant of total BM cells from CD45.2 TNF-
RdKO mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. 
Comparisons were made within donor compartment between naive recipients (n=9) and recipient 
mice infected with L. donovani for 28 days (Ld28) (n=8). Two femur and two tibias were taken 
per animal. Data from two independent experiments was presented as Mean ± SD, p values were 
determined using One-way Anova followed by Tukey’s multiple comparisons test: not significant 
(ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.47 - Following infection with L. donovani the frequency of Lin- cKit+ Sca1- cells 
within WT and TNF-RdKO donor cells decreased in BM. (a) Frequency of LSK cells and Lin- 
cKit+ Sca1- cells within donor cells in BM. (b) Number of LSK cells and Lin- cKit+ Sca1- cells 
within donor cells in BM. (c) Representative dot plots of frequency of LSK cells and Lin- cKit+ 
Sca1- cells within donor Lin- cells in BM; (top left) naive recipient gated in WT donor Lin- cells, 
(top right) infected recipient gated in WT donor Lin- cells, (bottom left) naive recipient gated in 
TNF-RdKO donor Lin- donor cells, (bottom right) infected recipient gated in TNF-RdKO donor 
Lin- donor cells. Analysis performed 13 weeks after transplant of total BM cells from CD45.2 
TNF-RdKO donor mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient 
mice. Comparisons were made within donor compartment between non-infected recipients (n=9) 
and recipient mice infected with L. donovani for 28 days (Ld28) (n=8). Two femur and two tibias 
were taken per animal. Data from two independent experiments was presented as Mean ± SD, p 
values were determined using One-way Anova followed by Tukey’s multiple comparisons test: 
not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
0.0
0.1
0.2
0.3
0.5
1.0
1.5
2.0
Fr
eq
ue
nc
y 
w
ith
in
 d
on
or
 c
el
ls
 in
 b
on
e 
m
ar
ro
w
LSK Lin- Sca1- cKit+
**
*
ns ns
****
ns
********
0
10000
20000
30000
50000
150000
250000
350000
450000
N
um
be
r o
f d
on
or
 c
el
ls
 in
 b
on
e 
m
ar
ro
w
LSK Lin- Sca1- cKit+
*
*
ns ****
**
ns
*******
WT Naive
WT Infected
TNFRdKO Naive
TNFRdKO Infected
Naive
Gated in TNFRdKO Lineage negative cells
0 102 103 104 105
Sca1
0
102
103
104
105
cK
it
12.3
Naive
Gated in WT Lineage negative cells
0 102 103 104 105
Sca1
0
102
103
104
105
cK
it
8.13
Naive
Gated in TNFRdKO Lineage negative cells
0 102 103 104 105
Sca1
0
102
103
104
105
cK
it
74.1
Infected
Gated in WT Lineage negative cells
0 102 103 104 105
Sca1
0
102
103
104
105
cK
it
43.6
a b
c
 249 
 
Figure 4.48 - L. donovani infection was associated with an increase in intermediary non-
committed progenitors within WT and TNF-RdKO donor cells in BM. (a) Frequency of LSK 
CD150+ CD48- cells (enriched for HSCs) and LSK CD150+ CD48+ cells within donor cells in 
BM. (b) Number of LSK CD150+ CD48- cells (enriched for HSCs) and LSK CD150+ CD48+ 
cells. Analyses were performed 13 weeks after transplant of total BM cells from CD45.2 TNF-
RdKO mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. 
Comparisons were made within donor compartment between non-infected recipients (n=9) and 
recipient mice infected with L. donovani for 28 days (Ld28) (n=8). Two femur and two tibias 
were taken per animal. Data from two independent experiments was presented as Mean ± SD, p 
values were determined using One-way Anova followed by Tukey’s multiple comparisons test: 
not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.49 - The absence of intrinsic TNF-RdKO signaling did not prevent the depletion of 
the reservoir of quiescent HSCs, following L. donovani infection. (a) Frequency of LSK 
CD150+ CD48- cells (enriched for HSCs) in G0 (Ki67-) within donor cells in BM. (b) Number of 
LSK CD150+ CD48- cells (enriched for HSCs) in G0 (Ki67-). (c) Frequency of LSK CD150+ 
CD48- cells in G0. (d) Representative dot plots of Ki67 expression; (top left) Isotype control gated 
in Lineage negative, (middle left) naive recipient gated in WT donor LSK CD150+ CD48- cells, 
(middle right) naive recipient gated in TNF-RdKO donor LSK CD150+ CD48- cells, (bottom left) 
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infected recipient gated in WT donor LSK CD150+ CD48- cells, (bottom right) infected recipient 
gated in TNF-RdKO donor LSK CD150+ CD48- cells. Analyses were performed 13 weeks after 
transplant of total BM cells from CD45.2 TNF-RdKO mice and CD45.1 WT mice (50:50) to 
lethally irradiated CD45.1 recipient mice. Comparisons were made within donor compartment 
between non-infected recipients (n=9) and recipient mice infected with L. donovani for 28 days 
(Ld28) (n=8). Two femur and two tibias were taken per animal. Data from two independent 
experiments was presented as Mean ± SD, p values were determined using One-way Anova 
followed by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p 
≤0.001 and ****p ≤0.0001. 
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Figure 4.50 - Following infection with L. donovani, alterations in the frequency of myeloid 
progenitors were similar within WT and TNF-dKO donor cells. (a) Frequency of lineage-
committed progenitor cells (CMPs, GMPs, MEPs and CLPs) in BM. (b) Number of lineage-
committed progenitor cells (CMPs, GMPs, MEPs and CLPs) in BM. Analyses were performed 13 
weeks after transplant of total BM cells from CD45.2 TNF-RdKO mice and CD45.1 WT mice 
(50:50) to lethally irradiated CD45.1 recipient mice. Comparisons were made within donor 
compartment between non-infected recipients (n=9) and recipient mice infected with L. donovani 
for 28 days (Ld28) (n=8). Two femur and two tibias were taken per animal. Data from two 
independent experiments was presented as Mean ± SD, p values were determined using One-way 
Anova followed by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, 
***p ≤0.001 and ****p ≤0.0001.  
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Figure 4.51 - The absence of intrinsic TNF receptor signaling prevented the expansion of T 
cells in the BM of mice infected with L. donovani. (a) Frequency of T cell, B cells and CD11b+ 
cells within donor cells in BM. (b) Number of donor of T cell, B cells and CD11b+ cells in BM. 
Analyses were performed 13 weeks after transplant of total BM cells from CD45.2 TNF-RdKO 
mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient mice. Comparisons 
were made within donor compartment between non-infected recipients (n=9) and recipient mice 
infected with L. donovani for 28 days (Ld28) (n=8). Two femur and two tibias were taken per 
animal. Data from two independent experiments was presented as Mean ± SD, p values were 
determined using One-way Anova followed by Tukey’s multiple comparisons test: not significant 
(ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.52 - The absence of intrinsic TNF receptor signaling prevented the expansion of T 
cells in the spleen, following infection with L. donovani. (a) Frequency of T cell, CD4+ T cells 
and B cells within donor cells in the spleen. (b) Number of donor of T cell, CD4+ T cells and B 
cells in the spleen. Analyses were performed 13 weeks after transplant of total BM cells from 
CD45.2 TNF-RdKO mice and CD45.1 WT mice (50:50) to lethally irradiated CD45.1 recipient 
mice. Comparisons were made within donor compartment between non-infected recipients (n=9) 
and recipient mice infected with L. donovani for 28 days (Ld28) (n=8). Data from two 
independent experiments was presented as Mean ± SD, p values were determined using One-way 
Anova followed by Tukey’s multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, 
***p ≤0.001 and ****p ≤0.0001.  
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Figure 4.53 - The absence of TNF receptor signaling did not prevent the expansion of the 
myeloid cells in the spleen, following infection with L. donovani. (a) Frequency of CD11b+ 
F4/80- cells, CD11b+ F4/80hi cells, CD11b- F4/80hi cells and CD11chi MHC-IIhi cells within donor 
cells in the spleen. (b) Number of donor CD11b+ F4/80- cells, CD11b+ F4/80hi cells, CD11b- 
F4/80hi cells and CD11chi MHC-IIhi cells in the spleen. Analyses were performed 13 weeks after 
transplant of total BM cells from CD45.2 TNF-RdKO mice and CD45.1 WT mice (50:50) to 
lethally irradiated CD45.1 recipient mice. Comparisons were made within donor compartment 
between non-infected recipients (n=9) and recipient mice infected with L. donovani for 28 days 
(Ld28) (n=8). Data from two independent experiments was presented as Mean ± SD, p values 
were determined using One-way Anova followed by Tukey’s multiple comparisons test: not 
significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p ≤0.0001. 
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Figure 4.54 - Intrinsic TNF receptor signaling mediated expansion of CD4+ T cells 
expressing IFNγ in the BM following infection with L. donovani. (a) Frequency of B cells, 
CD4+ T cells, CD8+ T cells and CD3+ CD4- CD8- cells expressing IFNγ, following in vitro 
stimulation with PMA/ionomycin, within donor cells in BM. (b) Number of B cells, CD4+ T cells, 
CD8+ T cells and CD3+ CD4- CD8- cells expressing IFNγ following in vitro stimulation in BM. 
(c) Frequency of IFNγ+ cells within donor CD4+ T cells following in vitro stimulation and without 
exogenous stimulation. (d) Representative dot plots displaying frequencies of IFNγ expression 
gated in CD4+ T cells in BM;  (top left) isotype control, (top centre) naive recipient gated in WT 
donor CD4+ T cells, (top right) naive recipient gated in TNF-RdKO donor CD4+ T cells, (bottom 
left) infected recipient gated in WT donor CD4+ T cells cells, (bottom right) infected recipient 
gated in TNF-RdKO donor CD4+ T cells. Analyses were performed 13 weeks after transplant of 
total BM cells from CD45.2 TNF-RdKO mice and CD45.1 WT mice (50:50) to lethally irradiated 
CD45.1 recipient mice. Comparisons were made within donor compartment between non-infected 
recipients (n=4) and recipient mice infected with L. donovani for 28 days (Ld28) (n=4). Two 
femur and two tibias were taken per animal. Data from two independent experiments was 
presented as Mean ± SD, p values were determined using One-way Anova followed by Tukey’s 
multiple comparisons test: not significant (ns), *p ≤ 0.05, **p ≤0.01, ***p ≤0.001 and ****p 
≤0.0001. 
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Figure 4.55 - Proposed mechanism to explain depletion of LT-HSCs in G0 and inefficient 
haematopoiesis during the chronic infection with L. donovani (4). Following L. donovani 
infection proliferating LT-HSCs and onward multipotent progenitors expand greatly at the 
expense of LT-HSCs in G0. The accumulation of intermediary multipotent progenitors was not 
associated with an increase in effective haematopoietic activity, since the numbers of effector 
haematopoietic cells were found either decreased or unchanged in PB. CD4+ T cells could solely 
mediate these alterations, through an IFNγ-dependent mechanism following transfer to L. 
donovani infected immunodeficient mice, otherwise protected from impairment of haematological 
function. The expansion CD4+ T cells IFNγ+ was limited by the absence of intrinsic TNF receptor 
signaling, suggesting that TNF indirectly modulate LT-HSCs proliferative status through the 
induction of expansion of CD4+ T cell compartment, the main source of IFNγ in BM, during 
chronic infection in L. donovani. 
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CHAPTER 5. CONCLUDING DISCUSSION 
Although it is well established that impairment of haematological function occurs during human 
VL, the underlying mechanisms are poorly understood. In the current study, we sought to clarify 
these mechanisms by characterizing alterations in cellular components of BM and, through 
functional assays, to identify molecular mediators modulating haematopoietic activity.  
To our knowledge, this work represents the first detailed report characterizing the alterations in 
haematopoietic progenitors ex vivo during chronic experimental infection with L. donovani in 
mice. We identified accumulation of phenotypically defined non-committed early haematopoietic 
progenitors, without reciprocal increase in lineage-committed progenitors as a major change 
compared to steady state haematopoiesis, and this correlated with the establishment of anaemia 
and thrombocytopenia. The accumulation of early haematopoietic progenitors was driven by an 
increase in active proliferation at the expense of the reservoir of quiescent LT-HSCs, and resulted 
in loss of function, as determined by the impairment of long-term reconstitution potential in 
lethally irradiated syngeneic recipients. These findings are in agreement with studies reporting 
alterations in the proliferative status of LT-HSCs under pro-inflammatory conditions (M. T. 
Baldridge et al., 2010, K. C. MacNamara et al., 2011a, A. M. de Bruin et al., 2013, C. Frelin et 
al., 2013, K. A. Matatall et al., 2014, D. Walter et al., 2015). Recently, in vivo stress-induced 
haematopoiesis, including that promoted by chronic pro-inflammatory conditions, was shown to 
drive HSCs into active cell-cycle, and result in DNA damage (D. Walter et al., 2015), suggesting 
that single and double-strand breaks might also be found in LT-HSCs from L. donovani-infected 
mice.  
Alterations in haematopoiesis have been described in many models of infection. In some, it has 
been proposed that this promotes the differentiation of important effector cells (N. N. Belyaev et 
al., 2010, N. Mossadegh-Keller et al., 2013). In others, it has been suggested that inflammation-
induced haematopoiesis could result in impairment of haematopoietic function (K. C. MacNamara 
et al., 2009, S. Rodriguez et al., 2009), as suggested here. VL patients may die due to increased 
vulnerability to secondary infections or bleeding (F. Chappuis et al., 2007, V. E. Miranda de 
Araujo et al., 2012). The results reported here suggest that chronic infection with L. donovani 
may lead to deterioration of HSCs function and the ability of haematopoieis to respond to an 
increase demand of cells in a subsequent infection/injury. As such, further studies might 
profitably focus on examining how the haematopoietic system from mice chronically infected 
with L. donovani (or in resolution) copes with a secondary infection/injury.  
To begin to answer this important question we performed a pilot study in which mice infected 
with L. donovani for a period of seven weeks were treated with a single dose of 5-Fluoraracil (5-
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FU), a cytotoxic drug that eliminates haematopoietic progenitors in active proliferation and leads 
to the activation of quiescent HSCs into active proliferation (Figure 5.1). There was a significant 
decrease in the number of LT-HSCs in infected compared to naïve mice, and this difference 
became further evident after seven days. At both time points, the loss of HSCs in infected mice 
correlated with a decrease in the number of cells in circulation, that was far more deleterious in 
infected compared to naïve mice. This preliminary data suggested that following L. donovani 
infection, the haematopoietic system is functionally impaired to produce effector haematopoietic 
cells under severe stress conditions. 
In the current study the alteration in the proliferative status of LT-HSCs was associated with the 
upregulation of the expression of transcription factors GATA-3 and β-catenin. Alterations in the 
expression of these transcription factors have been previously associated with losses in the 
reconstitution potential of HSCs in BMT assays (T. C. Luis et al., 2011, T. Yoshida and K. 
Georgopoulos, 2013). These findings indicated that L. donovani infection has the potential to 
induce deleterious alterations in the mechanism regulating HSCs quiescence. In order to clarify 
the signaling networks inducing alterations in expression of GATA-3 and β-catenin, examination 
of the transcriptional profile of these cells, ideally using single cells analysis would be highly 
informative. 
The loss of quiescent LT-HSCs and expansion of early non-committed progenitors was not 
observed in chronically infected RAG2 KO mice, and these mice did not display alteration in PB. 
Together, these findings indicated that the presence of the parasite by itself was not responsible 
for the alterations in BM and PB cellularity, and pointed to a critical role for adaptive immunity in 
driving the haematopoietic dysfunction. We characterized for the first time a significant 
expansion of CD4+ T cells expressing IFNγ in the BM of chronically infected mice. Then, using 
adoptive transfer of WT and IFNγ KO CD4+ T, we established that CD4+ T cells mediate 
depletion of the reservoir of quiescent HSCs and the establishment of anaemia through an IFNγ-
dependent-mechanism. 
The vast majority of BM CD4+ T cells in infected mice were CD44+ Ly6C- CD127-, an 
immunophenotype associated with activated effector T cells in BM (K. Tokoyoda et al., 2010). 
These could be further characterized, for example, by determining the expression of T-bet (master 
regulator of Th1 differentiation), their persistence after spontaneous or drug induced disease 
resolution, and for their role in the control of parasite burden and the development of 
immunopathology. The application of MHC II tetramers would allow such analyses to be 
conducted on a defined antigen-specific population. 
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Finally, by using BM mixed chimeras we established that during L. donovani infection, intrinsic 
IFNγ and TNF receptor signaling did not directly mediate the loss of quiescent LT-HSCs. These 
results were unexpected since a wide body of literature suggested that IFNγ has the potential to 
directly mediate the activation of HSCs into active cell-cycle, and this was correlated with loss of 
reconstitution potential in BMT assays (M. T. Baldridge et al., 2010, K. C. MacNamara et al., 
2011a). More recently, TNF was also proposed as a direct mediator of impairment of HSCs 
function under myelosuppressive conditions (C. J. H. Pronk et al., 2011).  
Increased levels of IFNγ and TNF have been detected in the serum and in the BM in patients with 
BMF syndromes (C. Dufour et al., 2001, C. Dufour et al., 2003, C. Dufour et al., 2004), in 
experimental models of BMF and in an experimental model of infection (J. L. Johns et al., 2009, 
A. M. de Bruin et al., 2013, Y. Zhang et al., 2013). These clinical conditions share as a common 
denominator the emergence of alterations in haematopoietic function mirrored in alterations in 
haematopoiesis in BM or/and in effector cells in the periphery.  
Additionally, in several models of infection it was proposed that the alterations in the proliferative 
status of HSCs and subsequent functional impairment are directly mediated by IFNγ receptor 
signal in HSCs (M. T. Baldridge et al., 2010, K. C. MacNamara et al., 2011a, A. M. de Bruin et 
al., 2013). More recently, a similar role was suggested for TNF during stress-induced 
haematopoiesis (C. J. H. Pronk et al., 2011). However, our findings obtained in mixed BM 
chimeric mice disagreed with these previous reports and indicated that alternative mechanisms 
mediate the loss of quiescent HSCs during chronic VL. 
Our findings also strongly suggest that IFNγ and TNF receptor signaling converge to regulate the 
expansion of BM T cells following infection, since the absence of either IFNγR or TNFR 
expression on T cells prevented their accumulation. Additionally, CD4+ T cells from TNF-RdKO 
were impaired in their ability to express IFNγ compared to WT CD4+ T cells, arguing in favor for 
an important indirect role of TNF signaling in controlling T cell-dependent haematopoietic 
dysfunction. In this context, experiments involving transfer of IFNγR and TNFR deficient CD4+ T 
cells into RAG2 recipients would be highly informative.  
If proven true, the hypothesis that the signal from both IFNγR and TNFR in CD4+ T cells is 
required to mediate haematopoietic dysfunction during infection, efforts could then focus on 
determining which molecular mediators are activated non-redundantly by both signaling 
pathways. This could potentially lead to the isolation of a molecular target that could prevent 
CD4+ T cells from having a deleterious impact on haematopoiesis and simultaneously preserve 
their capacity to control parasite burden. A possible approach would be the transcriptional 
characterization of BM CD4+ T cells from WT, IFNγR KO and TNFR KO isolated from 
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chronically infected mice. From this initial screening, potential targets that are upregulated in WT 
BM CD4+ T cells but unchanged in both BM CD4+ T cells IFNγR KO and BM CD4+ T cells 
TNFR KO could be selected for further examination. 
In a preliminary transcriptomic analysis of BM CD4+ T cells from naïve and infected mice, we 
identified 861 differentially expressed (DE) transcripts  (Fold change > 4, p < 0.05). The top ten 
genes upregulated and downregulated in BM CD4+ T cells from infected mice are listed in Table 
5.1. 
As expected transcripts for Ifng and Tnf were upregulated in BM CD4+ T cells, ~11 fold and ~ 4 
fold, respectively in infected compared to naive mice. In infected mice the expression TNFR1b 
was upregulated (~3 fold), in contrast the expression IFNγR2 in BM CD4+ T cells was 
downregulated (~8 fold). These findings require confirmation by qPCR and flow cytometric 
analysis.  
The analysis the alterations in BM CD4+ T cells transcriptional profile in the context of 
predefined canonical pathways, using the analysis tool Ingenuity Pathways, showed the highest 
degree of association with the network associated to “T helper cell differentiation”, i.e. 29 genes 
out of a total of 71 genes were DE during L. donovani infection (Figure 5.2). Interestingly, the 
expression of T-bet (master regulator of Th1 cells) was found unchanged. In addition, BM CD4+ 
T cells upregulated the expression of IL-21, a cytokine mainly expressed by NKT cells, Th17 and 
T follicular helper cells, either suggesting that BM CD4+ T cells during chronic infection may 
display an intermediate immunophenotype (V. Lazarevic et al., 2013, R. Spolski and W. J. 
Leonard, 2014), or may reflect the heterogeneity of BM CD4+ T cell populations with potential to 
express IFNγ following infection, therefore requiring further extensive characterization.  
The anaemia and thrombocytopenia associated with human VL have been mainly attributed to the 
splenomegaly, due to the observation that splenectomy resolves these alteration in patients. Very 
recently in our laboratory, it was reported that in experimental VL splenectomy prevented the 
development of thrombocytopenia but not anaemia (O. Preham unpublished data), suggesting 
discordant regulation of these two processes. However, the onset of significant alterations in the 
morphology of BM cells, sometimes resembling myelodysplastic syndromes, have been more 
difficult to address and suggested that alteration in BM haematopoiesis could contribute to 
haematopoietic dysfunction, which is most likely multifactorial in VL patients (G. E. Cartwright 
et al., 1948, N. A. M. Aljurayyan et al., 1995, K. K. Dhingra et al., 2010, N. Varma and S. 
Naseem, 2010).  
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Many questions remain to be solved regarding the impact of VL on haematopoietic functions, 
some of which have been discussed above and elsewhere in this thesis. Nonetheless, the findings 
reported here have helped to shape a platform for future studies addressing the impact of VL in 
haematopoiesis, and have added to the extensive body of studies addressing the impact of chronic 
infection/inflammation in haematopoietic function. 
This thesis was developed in the context of a neglected tropical disease, and we hope that our 
findings contribute to future studies devoted to the improvement of therapeutics approach, namely 
the prevention/treatment of haematopoietic dysfunctions, which aggravate the life conditions of 
VL patients in areas commonly characterized by socioeconomic fragilities.  
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5.1 FIGURES 
 
Figure 5.1 - Changes in blood parameters after 5-FU treatment. (a) Number of LSK CD150+ 
CD34- CD48- cells (LT-HSCs) in BM following 5-Fluororacil (5-FU) administration.  (b-d) 
Concentration of white blood cells (WBC; b) red blood cells (RBC; c), and platelets (PLT; d) in 
PB following two days of 5-FU administration. (e-g) Concentration of WBC (e), RBC (f) and 
PLT (g) in PB following seven days of 5-FU administration. In each time point, one naive and 
one mouse infected with L. donovani for 38 days were injected intravenously with a single dose 
of 50 mg/kg of 5-FU, an unmanipulated naive mouse was used as control.  
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Table 5.1 - Top ten significantly up-/down-regulated genes in BM CD4+ T cells from mice 
infected with L. donovani for 28 days (compared to uninfected controls) 
 
Gene name Description Fold change infected vs. naive
log2 Fold change 
infected vs. naïve adjusted p value Regulation
Saa3 Mus musculus serum amyloid A 3 (Saa3), mRNA [NM_011315] 1802 11 0.0016 Up
Gm5486
Mus musculus 2 cells egg cDNA, RIKEN full-length enriched library, 
clone:B020041A18 product:hypothetical protein, full insert sequence. 
[AK139943]
200 8 0.0016 Up
Tff1 Mus musculus trefoil factor 1 (Tff1), mRNA [NM_009362] 181 7 0.0011 Up
Arnt2 Mus musculus aryl hydrocarbon receptor nuclear translocator 2 (Arnt2), mRNA [NM_007488] 178 7 0.0008 Up
Bace2 Mus musculus beta-site APP-cleaving enzyme 2 (Bace2), mRNA [NM_019517] 170 7 0.0049 Up
Rasd2 Mus musculus RASD family, member 2 (Rasd2), mRNA [NM_029182] 168 7 0.0005 Up
Tff1 Mus musculus trefoil factor 1 (Tff1), mRNA [NM_009362] 157 7 0.0014 Up
Il20ra Mus musculus interleukin 20 receptor, alpha (Il20ra), mRNA [NM_172786] 147 7 0.0001 Up
Synpo2 Mus musculus synaptopodin 2 (Synpo2), mRNA [NM_080451] 144 7 0.0003 Up
Serpina9
Mus musculus serine (or cysteine) peptidase inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), member 9 (Serpina9), mRNA 
[NM_027997]
137 7 0.0019 Up
Dapl1 Mus musculus death associated protein-like 1 (Dapl1), mRNA [NM_029723] 234 -8 0.0003 Down
Klra15 Mus musculus killer cell lectin-like receptor, subfamily A, member 15 (Klra15), mRNA [NM_013793] 230 -8 0.0013 Down
Gprc5b Mus musculus G protein-coupled receptor, family C, group 5, member B (Gprc5b), transcript variant 2, mRNA [NM_022420] 185 -8 0.0003 Down
Adh1 Mus musculus alcohol dehydrogenase 1 (class I) (Adh1), mRNA [NM_007409] 147 -7 0.0003 Down
A530021J07
Rik
PREDICTED: Mus musculus Riken cDNA A530021J07 gene 
(A530021J07Rik), miscRNA [XR_035179] 144 -7 0.0008 Down
Klra16 Mus musculus killer cell lectin-like receptor, subfamily A, member 16 (Klra16), mRNA [NM_013794] 135 -7 0.0003 Down
St8sia6 Mus musculus ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 (St8sia6), mRNA [NM_145838] 129 -7 0.0007 Down
Atp1b1 Mus musculus ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] 126 -7 0.0003 Down
Grm6 Mus musculus glutamate receptor, metabotropic 6 (Grm6), mRNA [NM_173372] 120 -7 0.0002 Down
2610019F03
Rik
Mus musculus RIKEN cDNA 2610019F03 gene (2610019F03Rik), 
mRNA [NM_173744] 108 -7 0.0012 Down
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Figure 5.2 - DE genes in BM CD4+ T cells of naïve vs. L. donovani infection mapped to IPA 
canonical pathway of Th cell differentiation. The Ingenuity Pathway Analysis tool analyzed 
nearly 1000 genes significantly regulated in BM CD4+ T cells following L. donovani infection 
(Fold change > 3, p < 0.05), with the canonical pathway “ T helper differentiation” identified as 
having significant enrichment (p= 5.25 x 10 -11). Red indicates upregulated and green down-
regulated genes. Grey indicates unchanged according with the defined cut-off. 
 267 
ABBREVIATIONS 
 
5-FU 5- Fluorouracil  
AA Aplastic anemia  
ACK2 Anti-Mouse CD117 (cKit) 
AdCMV-lacZ Replication-deficient β-galactosidase encoding recombinant adenovirus  
ALAS2 5'-Aminolevulinate Synthase 2 
Ang Angiopoietin 
AP-1 Activator protein 1 (TF) 
APC Antigen presenting cell 
APC Allophycocyanin  (Fluorochrome) 
APRIL 
A proliferation-inducing ligand, also known as tumor necrosis factor 
ligand superfamily member 13  
aPTT Activated Partial Thromboplastin Time  
ARRIVE Animal Research: Reporting of In Vivo Experiments (guidelines) 
ATF2 Activating Transcription Factor 2 
AXIN1 Axis inhibition protein 1  
B6 C57BL/6 mice, often referred to as black 6 mice 
BA Basophils 
BAFF 
B-cell activating factor, also known as tumor necrosis factor ligand 
superfamily member 13B 
BCL2 B-cell lymphoma 2 
BCLXL B-cell lymphoma-extra large  
BCP B-cell progenitor 
BFU-E Burst forming unit–erythrocyte  
BM Bone marrow 
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Bmi1 
Polycomb complex protein B lymphoma Mo-MLV insertion region 1 
homolog 
BMP-2  Bone morphogenetic protein 2  
BMP-6 Bone morphogenetic protein 6 
BMSCs  Bone marrow stromal cells  
BMT Bone marrow transfer assay 
BrdU Bromodeoxyuridine  
BSA Bovin serum albumin  
BSP Bone sialoprotein  
c-mpl 
Myeloproliferative leukemia protein, also known as thrombopoietin 
receptor 
C/EBPα CCAAT enhancer-binding protein α  
CAFC Cobblestone area-forming cells 
CAR CXCL12-abundant reticular (cells) 
CCL2 
Chemokine (C-C motif) ligand 2, also known as monocyte chemotactic 
protein 1  
CCL3  
Chemokine (C-C motif) ligand 3, also known as macrophage 
inflammatory protein 1-alpha 
CCL8 
Chemokine (C-C motif) ligand 8 (CCL8), also known as monocyte 
chemoattractant protein 2 
CCR2  C-C chemokine receptor type 2 
CCR7  C-C chemokine receptor type 7  
CD Cluster of differentiation 
Cdc42 Cell division cycle 42 (a Rho family GTPase) 
cdk Cyclin-dependent kinase  
CDKIs Cyclin dependent kinase inhibitors  
Cdkn Cyclin-dependent kinase inhibitor 
cDNA Complementary DNA  
CEMCs CXCL12-expressing mesenchymal cells  
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CFSE 5(6)-carboxyfluorescein diacetate N-succinimidyl ester  
CFU Colony forming units 
CFU-C Colony-Forming Unit Culture 
CFU-E  Colony forming unit-erythroid 
CFU-F  Colony forming units-fibroblast 
CFU-GEMM 
Colony-forming unit granulocyte–erythroid–macrophage–
megakaryocyte 
CFU-OB Colony-Forming Unit-osteoblast 
cKit 
Stem cell growth factor receptor, also called Proto-oncogene c-Kit or 
tyrosine-protein kinase Kit or CD117 
CLPs Common lymphoid progenitors  
CML Chronic myeloid leukaemia  
CMPs Common myeloid progenitors  
CMV Cytomegalovirus 
CRA 
Competitive repopulation assay, also referred as competitive bone 
marrow transfer assay 
Cre Cre recombinase 
Cre cAMP-responsive elements  
CRs Cytokine receptor 
CXCL10 
C-X-C motif chemokine 10, also known as Interferon gamma-induced 
protein 10 
CXCL12 
C-X-C motif chemokine ligand 12, also known as stromal cell-derived 
factor 1 
CXCR4 C-X-C chemokine receptor type 4 
CYLD Deubiquitinase cylindromatosis 
DAMPs Damage-associated molecular pattern molecules 
DAPI 4',6-Diamidino-2-Phenylindole, Dihydrochloride 
DCs Dendritic cells 
DICER1 Double-stranded RNA (dsRNA) endoribonuclease Type III 
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DKK1 Dickkopf-related protein 1 
DMEM Dulbecco's Modified Eagle medium  
DNA Deoxyribonucleic acid 
Dnmt3a DNA (cytosine-5)-methyltransferase 3A 
dsRNA Double-stranded RNA  
DTR Diphtheria toxin receptor 
E Embryonic day  
Ebf-1 Early B-Cell Factor 1 
Ebf1 Early B cell factor 1 
eGFP Enhanced green fluorescent protein 
EKLF Erythroid Krueppel-Like Transcription Factor  
EO Eosinophils  
EP Erythroid progenitor 
ERK Extracellular-signal-regulated kinases,  also known MAP kinases 
Ery Erythroid 
ES Embryonic stem (cells) 
EVl9 Ena/Vasodilator-Stimulated Phosphoprotein-Like 9 
FA Fanconi anemia  
FACS Fluorescence activated cell sorting (technology) 
Fas Fragment, apoptosis stimulating (cell receptor) 
FasL Fas ligand 
FcR Fragment crystallizable region receptor  
FCS  Fetal calf serum 
FLs Fetal livers  
Flt3 FMS-like tyrosine kinase 3 
 271 
FOG-1 Friend of GATA protein 1 
FOXO Forkhead box proteins O 
Foxp3 Forkhead box protein 3 
FZD Frizzled protein 
Fzd Frizzled (receptor) 
G-CSF 
Granulocyte colony stimulating factor, also known as colony-
stimulating factor 3  
GAS IFNγ-activated site promotor sequences 
GATA-1  Erythroid transcription factor, also known as GATA-binding factor 1  
GATA-2  GATA binding protein 2 
GATA-3 Trans-acting T-cell-specific transcription factor GATA-3  
Gfi-1b Growth Factor Independent 1B Transcription Repressor 
GFP Green fluorescent protein 
gIP-10 
Interferon gamma-induced protein 10, also known as C-X-C motif 
chemokine 10 
GM-CFCs Granulocyte-Macrophage colony forming cells  
GM-CSF Granulocyte/macrophage colony-stimulating factor 
GMPs Granulocyte/monocyte progenitors  
GSK3β Glycogen synthase kinase 3 beta  
H2B Histone Cluster 2 
Hb Hemoglobin 
HCT Hematocrit 
hi High 
HLA Human leukocyte antigen  
HME Human monocytic ehrlichiosis  
HOXB4 Homeobox protein Hox-B4 
HPC-1 Haematopoietic progenitor cells 1 
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HPC-2 Haematopoietic progenitor cells 2 
HSCs Haematopoietic ctem cells 
HSPCs Haematopoietic stem and progenitor cells 
ICAM1 Intercellular Adhesion Molecule 1 
IFNAR IFNα/β receptor  
IFNα/β  Interferon alpha/beta 
IFNγ Interferon-gamma 
IFNγR  Interferon gamma receptor 
Ig Immunoglobulin  
IKK Inhibitor of nuclear factor kappa-B kinase 
IL Interleukin 
IL-7Rα Interleukin-7 receptor-α, also referred as CD127  
INK4a  Inhibitor of kinase 4a. Also known asp16INK4a. 
iNOS Inducer of nitric oxide synthase 
IRF Interferon regulatory factors 
ISG Interferon Stimulated Genes 
ISRE Interferon-stimulated response elements 
IT-HSCs Intermediate-term Haematopoietic ctem cells 
IκBα 
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 
inhibitor alpha 
JAK Janus kinase (part of JAK-STAT pathway) 
JNK c-Jun N-terminal kinase (a MAPK) 
KCs Kupffer cells  
KO Knockout 
KSL cKit+ Sca1+ Lineage- cells (also referred as LSK) 
LCMV Lymphocytic choriomeningitis virus  
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Ld28 Infection with Leishmania donovani for a period of 28 days 
LDU Leishmania-Donovani units  
LEF Lymphoid enhancer binding factor  
lerp Leptin receptor 
LMPPs 
Immature lymphoid-biased progenitors/ lymphoid primed multipotent 
progenitors   
lo Low 
LPS Lipopolysaccharide 
LRP5/6 Single-membrane-spanning low-density receptor-related protein 5/6  
LSK Lineage- Sca1+ cKit+ cells (also referred as KSL) 
LT Lymphotoxin-α  
LT-HSCs Long-term Haematopoietic ctem cells 
LTC-IC Long-term culture-initiating cell  
LV9 Ethiopian strain of Leishmania donovani  
LY Lymphocytes  
M-CSF Macrophage colony stimulating factor  
mAb Monoclonal antibody 
MAPK Mitogen-activated protein kinases 
MCP-1 Monocyte chemotactic protein , also known as CCL2 
MD-2 
Origin of abbreviation unknown. Also referred to as lympocyte antigen 
LY96. 
MDS Myelodisplasic syndrome  
MegE Megakaryocytes / Erythrocytes cellular lineages 
MEKK1 Mitogen-activated protein kinase kinase kinase  
MEPs Megakaryocyte/erythrocyte progenitors  
mES Murine embryonic stem (cells) 
MFI Mean Intensity Fluorescence  
 274 
MHC I Major histocompatibility complex class I molecules 
MHC II Major histocompatibility complex class II molecules 
MIF 
Macrophage migration inhibitory factor, also known as glycosylation-
inhibiting factor  
MIP-1α Macrophage inflammatory protein 1-alpha 
miRNA Micro RNA 
MkP Megakaryocyte progenitor 
MO Monocytes 
MPPs Multipotent progenitor cells 
mRNA Messenger RNA 
MSCs Mesenchymal stem cells  
MX1 
Myxovirus (Influenza Virus) Resistance 1, Interferon-Inducible Protein 
P78 (Mouse) 
Myc Avian Myelocytomatosis Viral Oncogene Homolog 
MyD88 Myeloid differentiation primary response gene 88 protein 
MyRP Myeloid-restricted progenitor 
NE Neutrophil 
NES Nestin  
Nestin Neuroectodermal stem cell marker 
NFκB Nuclear factor kappa-light-chain-enhancer of activated B cells 
NK  Natural Killer (cells) 
NOS2 Nitric oxide synthase (enzyme) 
NOTCH 
Not an abbreviation but refers to a mutation resulting in a notch in 
Drosophila wings.  
ns Statistically not significant 
OB Osteoblast 
OCN Osteocalcin 
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ODN CpG oligodeoxynucleotides (TLR9 agonist) 
p38 P38 mitogen-activated protein kinases  
Pam3CSK4 
N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-
seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]-lysineSynthetic diacylated 
lipoprotein 
PAMPs Pathogen-associated molecular patterns 
PAX5 Paired box protein 5 
PB Peripheral blood 
PB  Peripheral blood 
PBMCs Peripheral blood mononuclear cells  
PBMNCs Peripheral blood mononuclear cells  
PBS Phosphate-Buffered Saline 
PDGFR Platelet-derived growth factor receptor 
PFA Paraformaldehyde 
PKDL Post-kala-azar dermal leishmaniasis 
PLT Platelets 
PMA Phorbol 12-myristate 13-acetate 
poly I:C  Polyinosinic:polycytidylic acid 
PRRs Pattern recognition receptors  
PT Prothrombin Time  
Pten Phosphatase and tensin homolog 
qPCR Quantitative real-time polymerase chain reaction  
RA Rheumatoid arthritis  
Rb retinoblastoma (protein) 
RBCs Red blood cells 
rDCs Regulatory dendritic cells 
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rIFNγ Purified mouse recombinant IFNγ 
RIP 
Receptor-Interacting Protein 1, also known as Receptor (TNFRSF)-
Interacting Serine-Threonine Kinase 
RNA Ribonucleic acid 
RNI Reactive nytrogen intermediates 
ROI Reactive oxygen intermediates 
ROS Reactive oxygen species  
RPMI Roswell Park Memorial Institute medium 
RT Room temperature 
RT (reaction) Reverse transcription reaction  
Runx-1  
Runt-related transcription factor 1, also known as acute myeloid 
leukemia 1 protein  
Runx2 Runt-related transcription factor 2 
Sca1 Stem cell antigen 1  
SCF Stem cell factor,  KIT-ligand or steel factor  
SCID Severe combined immunodeficiency 
SCL/TAL1 Stem cell leukemia/T-cell acute lymphocytic leukemia protein 1  
SD Standard Deviation  
SDF-1 Stromal cell-derived factor 1 
SDF-1α  Stromal-cell derived factor-1α, also known as CXCL12 
SDF1 
Stromal cell-derived factor 1, also referred as C-X-C motif chemokine 
12 (CXCL12)  
SEM Standard Error Mean  
siRNA Small interfering RNA  
SLAM Signaling lymphocyte activation molecule  
SOCS1 Suppressor of cytokine signaling 1  
SP Side population  
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ST-HSCs Short-term Haematopoietic ctem cells 
STAT Signal transducer and activator of transcription (STAT) protein family 
T-bet  T-cell-specific T-box transcription factor T-bet 
TCF-1 T-cell factor transcription factor 
TCR T cell receptor 
TFs Transcription Factors 
TGF-β Transforming growth factor beta  
Th T-helper 
Th1 T-helper type 1 lymphocytes 
Th2 T helper type 2 lymphocytes 
TIR Toll/interleukin-1 receptor 
TLRs Toll-like receptors 
TNF Tumor necrosis factor 
TNFR Tumor necrosis factor receptor 
TNFR-dKO Tumor necrosis factor receptor double KO, also referred as Tnfrsf1-dKO  
TNFRα Tumor necrosis factor receptor 1a or Tnfr-p55 
TNFRβ Tumor necrosis factor receptor 1b or Tnfr-p75  
TNK T-cell natural killer cell progenitor  
TPA 
12-O-Tetradecanoylphorbol-13-acetate, also known phorbol 12-
myristate 13-acetate 
TPO Thrombopoietin  
TRADD 
Tumor necrosis factor receptor type 1-associated DEATH domain 
protein 
TRAF2 Tumor necrosis factor receptor-associated factor 2  
TRE TPA DNA-response elements  
Treg Regulatory T cells 
TRIF TIR-domain-containing adapter-inducing interferon-β  
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TYK2 Tyrosine-protein kinase 2 
VCAM1 Vascular cell adhesion molecule 1 
VL Visceral leishmaniasis 
vWF Willebrand factor  
WBC White blood cells 
WNT 
Wingless-Int, also known as Wingless-type MMTV integration site 
family member 
WT Wild-type 
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